,CUI1,CUI2
0,ADB,Whole Blood ADB Test
1,Bacteria,Culture of Body Fluid (Aerobic/Anaerobic)
2,Bacteria,Culture of Body Fluid
3,Bacteria,Culture of Exudate/Pus (Aerobic/Anaerobic)
4,Bacteria,Culture of Surgical Specimen (Aerobic/Anaerobic)
5,Bacteria,Culture of Unidentified Specimen Site
6,Bacteria,Cyst Culture
7,Bacteria,Decubitus for Culture
8,Bacteria,Dialysis Machine Fluid Culture
9,Bacteria,Drug Sample Culture
10,Bacteria,Ear Culture
11,Bacteria,Endocervical Culture
12,Bacteria,Environmental culture
13,Bacteria,Amniotic Fluid Culture
14,Bacteria,Exudate/Pus Culture
15,Bacteria,Eye Culture
16,Bacteria,Female Genital Culture
17,Bacteria,Female Urethra Culture
18,Bacteria,Fiberoptic Bronchoscopy Culture (Aerobic/Anaerobic)
19,Bacteria,Fomite Culture
20,Bacteria,Food culture
21,Bacteria,IV Catheter Culture
22,Bacteria,IV Solution Culture
23,Bacteria,Instruments Culture
24,Bacteria,Joint Fluid Culture (Aerobic/Anaerobic)
25,Bacteria,Labia Culture
26,Bacteria,Lesion Culture
27,Bacteria,Lochia Culture
28,Bacteria,Lung Biopsy Culture
29,Bacteria,Lymph Node Culture
30,Bacteria,Male Genital Culture
31,Bacteria,Male Urethra Culture
32,Bacteria,Milk Culture
33,Bacteria,Mouth Culture
34,Bacteria,Nasopharynx Culture
35,Bacteria,Nonspecific Bacterial Culture
36,Bacteria,Nose Culture
37,Bacteria,Outside Specimen for Culture
38,Bacteria,Patient Specimen Culture
39,Bacteria,Pelvic Examination Culture (Aerobic/Anaerobic)
40,Bacteria,Pericardial Fluid Culture (Aerobic/Anaerobic)
41,Bacteria,Perineum Culture
42,Bacteria,Peritoneal Dialysis Fluid Culture
43,Bacteria,Peritoneal Fluid Culture (Aerobic/Anaerobic)
44,Bacteria,Peritoneal Fluid Culture
45,Bacteria,Placenta Culture
46,Bacteria,Pleural Fluid Culture (Aerobic/Anaerobic)
47,Bacteria,Pool Water Culture
48,Bacteria,Prenatal Screening Culture
49,Bacteria,Prostatic Fluid Culture
50,Bacteria,Rectal Culture
51,Bacteria,Referred Organism for Identification and Sensitivity
52,Bacteria,Seminal Fluid Culture
53,Bacteria,Specimen for Aerobe/Anaerobe Culture
54,Bacteria,Microbial culture of sputum
55,Bacteria,Stool culture
56,Bacteria,Stool for Colonization Culture
57,Bacteria,Surface Sample Culture
58,Bacteria,Surgical Specimen Culture
59,Bacteria,Throat Colonization Culture
60,Bacteria,Throat culture
61,Bacteria,Tissue Culture Fluid Culture
62,Bacteria,"Tissue, Post Mortem Culture"
63,Bacteria,Tracheal Suction Culture
64,Bacteria,Transfusion Blood Culture
65,Bacteria,Transtracheal Aspirate Culture
66,Bacteria,Ulcer Culture 2
67,Bacteria,Ulcer Culture
68,Bacteria,Umbilical Culture
69,Bacteria,Umbilical Screen
70,Bacteria,Unusual Specimen/Site Culture
71,Bacteria,Ureteral Urine Culture
72,Bacteria,Urinalysis Bacteria Counts
73,Bacteria,Urine Bacteria Test
74,Bacteria,Urine Stamey Test VB-1
75,Bacteria,Urine Stamey Test VB-2
76,Bacteria,Urine Stamey Test VB-3
77,Bacteria,Vaginal Culture
78,Bacteria,Voided Urine Culture
79,Bacteria,Vulva Culture
80,Bacteria,Water/Ice Sample Culture
81,Bacteria,Wound Culture (Aerobic/Anaerobic)
82,Bacteria,Wound Culture
83,Bacteria,"Wound, Quantitative Culture"
84,Bacteria,ATTEST Culture
85,Bacteria,Abscess Culture (Aerobic/Anaerobic)
86,Bacteria,Abscess Culture
87,Bacteria,"Urinalysis, bacteriuria screen"
88,Bacteria,Bile Culture (Aerobic/Anaerobic)
89,Bacteria,Bile Culture
90,Bacteria,Biopsy Culture (Aerobic/Anaerobic)
91,Bacteria,Bladder Aspiration Urine Culture
92,Bacteria,blood culture bacteria (lab test)
93,Bacteria,Blood Culture (Resin Bottle)
94,Bacteria,Blood culture
95,Bacteria,Blood Post Mortem Culture
96,Bacteria,Bone marrow culture
97,Bacteria,Bowel Contents/Intestinal Fluid Culture
98,Bacteria,Bronchial Brush Culture
99,Bacteria,Bronchial Washing Culture
100,Bacteria,Bronchoscopy for Culture
101,Bacteria,Air Sample Culture
102,Bacteria,Burn Site Culture
103,Bacteria,Burn Site Quantitative Culture
104,Bacteria,Cerebrospinal fluid culture (procedure)
105,Bacteria,Catheterized Urine Culture
106,Bacteria,Central Venous Line Site Culture
107,Bacteria,Combined Aerobic and Anaerobic Bacterial Culture
108,Bacteria,Cord Blood Culture
109,Chloride Ion,24 Hour Urine Chloride Test
110,Chloride Ion,Intravascular Chloride Test
111,Chloride Ion,Operating Room Misc Labs: Cl
112,Chloride Ion,Random Urine Chloride Test
113,Chloride Ion,SERUM CHLORIDE ION TESTS
114,Chloride Ion,Whole Blood Chloride Test
115,Chloride Ion,Body fluid chloride measurement
116,Chloride Ion,CHEM-7 Chloride Ion Measurement
117,Chloride Ion,CSF chloride measurement
118,Chloride Ion,Cystic fibrosis sweat test
119,Lipids,Intravascular Lipemia Test
120,Lipids,Serum Lipid Test
121,Porphyrins,Intravascular Total Porphyrins Test
122,Porphyrins,24 Hours Non-Specific Urine Porphyrins Test
123,Protoporphyrins,Intravascular Protoporphyrin Test
124,macrophage,Body Fluid Macrophage Test
125,Proerythroblasts,Bm Pronormoblast Test
126,Cells,Sudan Black Stain Test
127,phosphate ion,Intravascular Phosphate Test
128,phosphate ion,24 Hour Urine Phosphate Test
129,phosphate ion,Plasma Phosphate Test
130,phosphate ion,Random Urine Phosphorus Test
131,phosphate ion,Serum Phosphate Test
132,phosphate ion,Timed Urine Phosphorus Test
133,phosphate ion,Urine Amorphous Phosphate Observation Test
134,phosphate ion,Urine Phosphate Test
135,phosphate ion,Urine Phosphorus Excretion Test
136,phosphate ion,urine phosphorus measurement
137,phosphate ion,Urine Triple Phosphate Observation Test
138,Amikacin,Intravascular Amikacin Test
139,Amikacin,Intravascular Peak Amikacin Test
140,Amikacin,Intravascular Random Amikacin Test
141,Amikacin,Intravascular Trough Amikacin Test
142,Amikacin,Plasma amikacin measurement
143,Amikacin,Serum amikacin measurement
144,Amitriptyline,Serum Amitriptyline Test
145,Caffeine,Intravascular Caffeine Test
146,Caffeine,NYH Lab Procedure: Caffeine
147,Caffeine,Serum caffeine measurement
148,Citrate,Timed Urine Citrate Test
149,Citrate,Urine Citrate Test
150,Clonazepam,Intravascular Clonazepamn Drug Test
151,Clonazepam,NYH Lab Procedure: Clonazepam
152,Desipramine,Intravascular Desipramine Metabolite Test
153,Desipramine,Serum Desipramine Test
154,Diazepam,Intravascular Total Diazepam+Nordiazepam Test
155,Diazepam,Serum Diazepam Test
156,Diazepam,Urine Diazepam Test
157,Doxepin,Intravascular Doxepin Test
158,Doxepin,Intravascular Total Dox+Nordoxepin Test
159,Ethosuximide,Intravascular Ethosuximide Drug Test
160,Histamine,Intravascular Histamine Test
161,Histamine,24 Hours Urine Histamine Test
162,Imipramine,Intravascular Total Imi+Desipramine Test
163,Imipramine,Serum Imipramine Test
164,Lidocaine,Serum Lidocaine Test
165,Methadone,Urine Methadone Test
166,Phenytoin,Intravascular Free Phenytoin Drug Test
167,Phenytoin,Intravascular Phenytoin Drug Test
168,Phenytoin,Intravascular Total Phenytoin Drug Test
169,Phenytoin,Serum phenytoin measurement
170,Primidone,Intravascular Primidone Drug Test
171,Procainamide,Serum Procainamide Test
172,Gentamicin,Serum gentamicin measurement
173,Tobramycin,Serum tobramycin measurement
174,17-Ketosteroids,Urine 17-Ketosteroids Test
175,17-Ketosteroids,24 Hour Urine 17-Ketosteroids Test
176,5'-NUCLEOTIDASE,Intravascular 5' Nucleotidase Test
177,Acetaldehyde,Intravascular Acetaldehyde Test
178,Acetaminophen,Serum Acetaminophen Test
179,Acetone,Serum Acetone Test
180,Acetone,Urine Acetone Test
181,Acecainide,Serum N-Acetylprocainamide Test
182,Acid Phosphatase,Intravascular Acid Phosphatase Test
183,Acid Phosphatase,Intravascular Prostatic Acid Phosphatase Test
184,Acid Phosphatase,Serum acid phosphatase measurement
185,Acid Phosphatase,Serum acid phosphatase measurement
186,Corticotropin,Adrenocorticotropic hormone measurement
187,Alanine,Intravascular Alanine Test
188,Alanine,Plasma alanine measurement
189,Alanine,Urine alanine measurement
190,Alanine,Alanine measurement
191,Alanine Transaminase,Intravascular Alanine Aminotransferase Test
192,Alanine Transaminase,Plasma Alanine Aminotransferase Test
193,Alanine Transaminase,Serum Alanine Transaminase tests
194,Ethanol,Ethanol measurement
195,Ethanol,Intravascular Ethyl Alcohol Test
196,Ethanol,"Plasma Ethyl Alcohol, Test"
197,Ethanol,Urine Ethyl Alcohol Test
198,Fructosediphosphate Aldolase,Intravascular Aldolase Test
199,Alkaline Phosphatase,Intravascular Alkaline Phosphatase Test
200,Alkaline Phosphatase,Intravascular Total Alkaline Phosphatase Test
201,Alkaline Phosphatase,Plasma Alkaline Phosphatase Test
202,Alkaline Phosphatase,Plasma Total Alkaline Phosphatase Test
203,Alkaline Phosphatase,Serum alkaline phosphatase measurement
204,Alkaline Phosphatase,Serum Total Alkaline Phosphatase Test
205,Aluminum,Intravascular Aluminum Test
206,Amino Acids,1-Methyl-Histidine Test
207,Amino Acids,Cystine measurement
208,Amino Acids,Amino acids measurement
209,Amino Acids,Gamma-Amino-Butyric Acid Test
210,Amino Acids,General Urine Amino Acids Test
211,Amino Acids,Anserine measurement
212,Amino Acids,Histidine measurement
213,Amino Acids,Hydroxylysine measurement
214,Amino Acids,Intracellular Cystine Test
215,Amino Acids,Intravascular 1-Methyl-Histidine Test
216,Amino Acids,Intravascular Amino Acid Fractionation Test
217,Amino Acids,Intravascular Amino Acids Screen Test
218,Amino Acids,Intravascular Amino Acids Test
219,Amino Acids,Intravascular Anserine Test
220,Amino Acids,Intravascular Carnosine Test
221,Amino Acids,Intravascular Cystine Test
222,Amino Acids,Intravascular Gamma-Amino-Butyric Acid Test
223,Amino Acids,Intravascular Histidine Test
224,Amino Acids,Intravascular Hydroxylysine Test
225,Amino Acids,Intravascular Lysine Test
226,Amino Acids,Intravascular Methylmalonic Acid Test
227,Amino Acids,Intravascular Tryptophan Test
228,Amino Acids,Arginine measurement
229,Amino Acids,Lysine measurement
230,Amino Acids,Methylmalonic Acid Test
231,Amino Acids,Plasma amino acid measurement
232,Amino Acids,Measurement of serum amino acid level
233,Amino Acids,Tryptophan measurement
234,Amino Acids,Urine 1-Methyl-Histidine Test
235,Amino Acids,Urine Amino Acid Test (Dinitrophenylhydrazine Method)
236,Amino Acids,Urine Amino Acid Test (Ferric Chloride Method)
237,Amino Acids,Urine Amino Acids Test
238,Amino Acids,Urine Arginine Test
239,Amino Acids,Urine Carnosine Test
240,Amino Acids,Urine Gamma-Amino-Butyric Acid Test
241,Amino Acids,Urine Histidine Test
242,Amino Acids,Urine Hydroxylysine Test
243,Amino Acids,Urine Lysine Test
244,Amino Acids,Urine Methylmalonic Acid Test
245,Amino Acids,Urine Tryptophan Test
246,Amino Acids,3-Methyl-Histidine Test
247,Amino Acids,CSF Amino Acids Test
248,Amino Acids,Carnosine measurement
249,Aminolevulinic Acid,24 Hours Urine Aminolevulinic Acid Test
250,Ammonia,Intravascular Ammonia Test
251,Ammonia,Plasma ammonia measurement
252,Amphetamine,Urine amphetamine measurement
253,Amylases,General Body Fluid Amylase Test
254,Amylases,Paracentesis Fluid Amylase Test
255,Amylases,"Amylase measurement, pleural fluid"
256,Amylases,Salivary Isoenzymes Test
257,Amylases,"Amylase measurement, serum (procedure)"
258,Amylases,Serum Total Amylase Test
259,Amylases,"Amylase measurement, urine"
260,Amylases,24 Hour Urine Amylase Test
261,Amylases,Fluid sample amylase measurement
262,Androstenedione,Serum Androstenedione Test
263,Peptidyl-Dipeptidase A,Intravascular Angiotensin Converting Enzyme Test
264,Peptidyl-Dipeptidase A,Intravascular Renin Test
265,"Antibodies, Anti-DNA",ANTI-DNA ANTIBODIES MEASUREMENT
266,"Antibodies, Antinuclear",Ana Pattern Test
267,"Antibodies, Antinuclear",Ana Presence Test
268,"Antibodies, Antinuclear",Ana Titer Test
269,"Antibodies, Antinuclear","Serum Antibodies, Antinuclear Test"
270,"Antibodies, Antinuclear",Whole Blood Antinuclear Antibodies Test
271,Heterophile Antibodies,Blood heterophile antibodies tests
272,Antigens,Single-Result Antigen Test
273,Antigens,Blood Bank Antigen Test
274,Antigens,Blood Bank C-3 Test
275,Antigens,Blood Bank Eluate Test
276,Antigens,Blood Bank IgG Test
277,Antigens,CSF Counter Immunoelectrophoresis Test
278,Antigens,Cord Blood A1 Antigen Test
279,Antigens,Cord Blood Antigen Test
280,Antigens,Cord Blood B Antigen Test
281,"Antigens, Bacterial",Haemophilus Influenza Type B Antigen Test
282,"Antigens, Bacterial",Bacterial Antigen Screen Test
283,"Antigens, Bacterial",Detection of bacterial antigen procedure
284,"Antigens, Viral",Direct IF for Viral Antigens Test
285,"Antigens, Viral",Hepatitis C antigen measurement
286,"Antigens, Viral",Hepatitis C RNA Quantification Test
287,"Antigens, Viral",Intravascular HCV COPIES Test
288,"Antigens, Viral","Intravascular HCV RNA,QUAL ASSAY(PCR) Test"
289,"Antigens, Viral",Intravascular HIV P24 Antigen Test
290,"Antigens, Viral",Viral antigen assay
291,Antistreptolysin O,Intravascular Antistreptolysin O Test
292,Antistreptolysin O,Serum Antistreptolysin O Test
293,Antistreptolysin O,Whole Blood Antistreptolysin O Test
294,Antithrombin III,Intravascular Anti-Thrombin III Test
295,Anxiety,Assessment of Patient Status Related to Anxiety
296,Arginine,Intravascular Arginine Test
297,Arsenic,"Arsenic measurement, hair"
298,Arsenic,Intravascular Arsenic Test
299,Arsenic,Arsenic Test (Combined)
300,Arsenic,"Arsenic measurement, urine"
301,Asparagine,Intravascular Asparagine Test
302,Asparagine,Asparagine measurement
303,Asparagine,Plasma Asparagine Test
304,Asparagine,Urine Asparagine Test
305,Aspartate Transaminase,Intravascular Aspartate Aminotransferase Test
306,Aspartate Transaminase,Plasma Aspartate Aminotransferase Test
307,Aspartate Transaminase,Aspartate aminotransferase measurement
308,Aspartic Acid,Intravascular Aspartic Acid Test
309,Aspartic Acid,Aspartic Acid Test
310,Aspartic Acid,Plasma Aspartic Acid Test
311,Aspartic Acid,Urine Aspartic Acid Test
312,Autoantibodies,Direct Coombs test
313,Autoantibodies,Intravascular Acetylcholine Receptor Binding Antibody Test
314,Autoantibodies,Intravascular Acetylcholine Receptor Blocking Antibody Test
315,Autoantibodies,Intravascular Acetylcholine Receptor Modulating Antibody Test
316,Autoantibodies,Intravascular Acetylcholine Receptor Test
317,Autoantibodies,Intravascular Anti-Mitochondrial Antibody Test
318,Autoantibodies,Intravascular Autoantibody Test
319,Autoantibodies,Intravascular Cancer Associated Retinopathy Test
320,Autoantibodies,Intravascular Glomerular Basement Membrane Antibody Test
321,Autoantibodies,Antibody screen
322,Autoantibodies,Intravascular Mata Autoantibodies
323,Autoantibodies,Intravascular SGPG IGM AB Test
324,Autoantibodies,Intravascular Skeletal Muscle Antibody Test
325,Autoantibodies,Intravascular Soluble Liver Antigen IgG Ab Test
326,Autoantibodies,Intravascular TSH Receptor Antibodies Test
327,Autoantibodies,Liver/kidney Microsomal Ab Test
328,Autoantibodies,Serum Anti Growth Hormone (Somatotropin) Antibodies Test
329,Autoantibodies,Serum Autoantibody Test
330,Autoantibodies,Serum Gad65 Auto Antibodies Test
331,Autoantibodies,Whole Blood Autoantibodies Test
332,Autoantibodies,Autoantibody measurement
333,Autoantibodies,CSF Mata Autoantibodies
334,Barbiturates,"NYH Lab Procedure: Barbiturates, Serum (drug S)"
335,Barbiturates,Serum Barbiturate Screen Test
336,Barbiturates,Urine barbiturate measurement
337,Basophils,Whole Blood Absolute Basophil Counts
338,Basophils,Whole Blood Basophil Counts
339,Basophils,Whole Blood Percentage Basophil Counts
340,Basophils,Bm Basophile Test
341,Basophils,Body Fluid Absolute Basophil Counts
342,Basophils,Body Fluid Basophil Test
343,Basophils,Body Fluid Percentage Basophil Counts
344,Benzodiazepines,Urine benzodiazepine measurement
345,Bilirubin,"Bilirubin measurement, amniotic fluid"
346,Bilirubin,General Body Fluid Bilirubin Test
347,Bilirubin,Intravascular Bilirubin Test
348,Bilirubin,Intravascular Total Bilirubin Test
349,Bilirubin,Plasma Bilirubin Test
350,Bilirubin,Plasma total bilirubin measurement
351,Bilirubin,Serum Bilirubin Test
352,Bilirubin,Serum Total Bilirubin Test
353,Bilirubin,Urine bilirubin tests
354,Bilirubin,Backoffice Urine Bilirubin Test
355,Bilirubin,Body Fluid Bilirubin Body Test
356,Blood coagulation,Blood coagulation tests
357,Blood coagulation,Sonoclot Coagulation Rate Test
358,Blood coagulation,Sonoclot Peak Time Test
359,Blood coagulation,Whole Blood Clot Onset Time Test
360,Blood coagulation,Blood coagulation tests
361,Blood Platelets,Operating Room Misc Labs: Platelets
362,Blood Platelets,Platelet estimate
363,Blood Platelets,Platelet Count measurement
364,Body Temperature,Respiratory Blood Temperature Test
365,Bromides,Serum Bromides Test
366,C-Peptide,Intravascular C-Peptide Test
367,C-reactive protein,Serum C-Reactive Protein Test
368,Cadmium,Intravascular Cadmium Test
369,Cadmium,"Cadmium measurement, urine"
370,Cadmium,Cadmium measurement
371,Calcitonin,Intravascular Calcitonin Test
372,Calcium,Intravascular Calcium Test
373,Calcium,Intravascular Total Calcium Test
374,Calcium,Plasma Calcium Test
375,Calcium,Plasma Total Calcium Test
376,Calcium,Random Urine Calcium Test
377,Calcium,Serum calcium measurement
378,Calcium,Serum Total Calcium Test
379,Calcium,"Calcium measurement, urine"
380,Calcium,Whole Blood Calcium Test
381,Calcium,Whole Blood Total Calcium Test
382,Calcium,24 Hour Urine Calcium Test
383,Calcium Oxalate,Urine Calcium Oxalate Crystal Observation Test
384,Carbamazepine,Intravascular Bound Carbamazepine Test
385,Carbamazepine,Intravascular Carbamazepine Drug Test
386,Carbamazepine,Intravascular Free Carbamazepine Test
387,Carbon Dioxide,Arterial Blood CO2 Partial Pressure Test
388,Carbon Dioxide,Mixed Venous CO2 Partial Pressure Test
389,Carbon Dioxide,Arterial Cord Blood CO2 Partial Pressure Test
390,Carbon Dioxide,Arterial Whole Blood Total CO2 Test
391,Carbon Dioxide,Operating Room Misc Labs: PCO2
392,Carbon Dioxide,Venous Blood CO2 Partial Pressure Test
393,Carbon Dioxide,Venous Cord Blood CO2 Parial Pressure Test
394,Carbon Dioxide,Venous Whole Blood Total CO2 Test
395,Carbon Dioxide,Whole Blood CO2 Partial Pressure Test
396,Carbon Dioxide,Whole Blood Total CO2 Test
397,Carbon Dioxide,Body Fluid PCO2 Test
398,Carbon Dioxide,Capillary Blood PCO2 Test
399,Carbon Dioxide,Capillary Whole Blood Total CO2 Test
400,Carbon Dioxide,Cardiopulmonary Bypass Whole Blood CO2 Partial Pressure Test
401,Carbon Dioxide,Cardiopulmonary Bypass Whole Blood Total CO2 Test
402,Carbon Dioxide,Cord Blood CO2 Partial Pressure Test
403,Carbon Monoxide,Whole Blood Carbon Monoxide Test
404,Carboxyhemoglobin,Intravascular Carboxyhemoglobin Test
405,Carboxyhemoglobin,Whole Blood Carboxyhemoglobin Test
406,Carboxylic Acids,Urine Carboxylic Acids Test
407,Carboxylic Acids,Urine Organic Acids Test
408,Carcinoembryonic Antigen,Intravascular Carcinoembrionic Antigen Test
409,Carcinoembryonic Antigen,Serum CEA (Carcinoembryonic Antigen) Test
410,Carcinoembryonic Antigen,Body Fluid Carcinoembryonic Antigen (CEA) Test
411,Carotene,Serum Carotene Test
412,Catecholamines,Intravascular Catecholamines Test
413,Catecholamines,Urine catecholamine measurement
414,Ceruloplasmin,Serum ceruloplasmin measurement
415,Cholesterol,Intravascular Cholesterol Test
416,Cholesterol,Plasma Cholesterol Test
417,Cholesterol,Serum cholesterol measurement
418,Cholesterol,Body Fluid Cholesterol Test
419,Chromium,Intravascular Chromium Test
420,Chylomicrons,Intravascular Chylomicron Measurement
421,Chylomicrons,Serum Chylomicrons Test
422,Citrulline,Intravascular Citrulline Test
423,Citrulline,Plasma Citrulline Test
424,Citrulline,Urine Citrulline Test
425,Citrulline,Citrulline measurement
426,Clomipramine,Intravascular Clomipramine Test
427,Cocaine,Urine cocaine metabolite screening
428,Cocaine,Urine Cocaine / Metabolites / Cocaine&Metab. Test
429,Cocaine,Urine cocaine metabolite screening
430,Cocaine,Urine cocaine measurement
431,Codeine,Urine Codeine Test
432,Color,Urine Icto Test
433,Color,Backoffice Urine Color Test
434,Color,Body Fluid Color Test
435,Color,Color Test
436,Complement System Proteins,Serum Total Complement Test
437,Complement C1q,Intravascular Complement C1q Binding Test
438,Complement C1q,Intravascular Complement C1q Test
439,Complement C1q,Serum Complement 1q Test
440,Complement component C1s,Intravascular C1 Esterase Inhibitor Test
441,Complement 2,Serum Complement 2 Test
442,Complement 3,Serum Complement 3 Test
443,Complement component C4,Serum Complement 4 Test
444,Complement component C5,Serum Complement 5 Test
445,Complement component C6,Serum Complement C6 Test
446,Complement component C7,Serum Complement C7 Test
447,Complement component C8,Serum Complement C8 Test
448,Complement component 9,Serum Complement C9 Level Test
449,Copper,Intravascular Copper Test
450,Copper,Urine copper measurement
451,Copper,Copper measurement
452,Creatine Kinase,Intravascular Creatine Kinase Test
453,Creatine Kinase,Intravascular Total Creatine Kinase Test
454,Creatine Kinase,Plasma Total Creatine Kinase Test
455,Creatine Kinase,Creatine kinase measurement
456,"Creatine Kinase, BB Form",Intravascular CK-BB Fraction Test
457,"Creatine Kinase, BB Form",Intravascular CK-BB Isoenzyme Test
458,"Creatine Kinase, BB Form",Intravascular Quantitative CK-BB Test
459,"Creatine Kinase, BB Form",Serum Creatine Kinase BB Test
460,Creatine Kinase MB Isoenzyme,Intravascular CK-MB Fraction Test
461,Creatine Kinase MB Isoenzyme,Intravascular CK-MB Isoenzyme Test
462,Creatine Kinase MB Isoenzyme,Intravascular Quantitative CK-MB Test
463,Creatine Kinase MB Isoenzyme,Serum Creatine Kinase MB Test
464,"Creatine Kinase, MM Form",Intravascular CK-MM Fraction Test
465,"Creatine Kinase, MM Form",Intravascular CK-MM Isoenzyme Test
466,"Creatine Kinase, MM Form",Intravascular Quantitative CK-MM Test
467,"Creatine Kinase, MM Form",Serum Creatine Kinase MM Test
468,Creatinine,Amniotic Fluid Creatinine Test
469,Creatinine,General Body Fluid Creatinine Test
470,Creatinine,"Creatinine measurement, 24 hour urine"
471,Creatinine,Intravascular Creatinine Test
472,Creatinine,Random Urine Creatinine Test
473,Creatinine,"Creatinine measurement, serum (procedure)"
474,Creatinine,Urine Creatinine Test
475,Creatinine,Whole Blood Creatinine Test
476,Creatinine,Fluid sample creatinine measurement
477,Creatinine,CHEM-7 Creatinine Measurement
478,Cyclosporins,Intravascular Cyclosporin Test
479,Cyclosporins,Serum cyclosporin measurement
480,Cyclosporins,Whole Blood Cyclosporin Test
481,Cystathionine,Cystathionine measurement
482,Cystathionine,Intravascular Cystathionine Test
483,Cystathionine,Plasma Cystathionine Test
484,Cystathionine,Urine Cystathionine Test
485,Cystine,"Cystine measurement, 24H urine"
486,Cystine,Urine cystine measurement
487,Denial (Psychology),Assessment of Patient Status Related to Denial
488,Diacetyl,Urine Diacetyl Test
489,Diarrhea,Assessment of Patient Status Related to Diarrhea
490,Digitoxin,Intravascular Digitoxin Test
491,Digitoxin,Serum Digitoxin Level Test
492,Digoxin,Serum digoxin measurement
493,Hydromorphone,Urine Hydromorphone Test
494,Dihydrotestosterone,Intravascular Dihydrotestosterone Test
495,Disopyramide,Serum Disopyramide Test
496,DNA,DNA probe analysis
497,DNA,Legionella DNA Probe Test
498,DNA,M.gordonii DNA Probe Test
499,DNA,M.kansasii DNA Probe Test
500,DNA,Mai DNA Probe Test
501,DNA,Mtb DNA Probe Test
502,Dopamine,Intravascular Dopamine Test
503,Dopamine,"Dopamine measurement, urine"
504,eosinophil,Whole Blood Absolute Eosinophil Countsrsv
505,eosinophil,Whole Blood Eosinophil Counts
506,eosinophil,Whole Blood Percentage Eosinophil Counts
507,eosinophil,Bm Eosinophile Test
508,eosinophil,Body Fluid Absolute Eosinophil Counts
509,eosinophil,Body Fluid Eosinophil Test
510,eosinophil,Body Fluid Percentage Eosinophil Counts
511,Epinephrine,Intravascular Epinephrine Test
512,Epinephrine,Urine Epinephrine Test
513,Blood Sedimentation,Erythrocyte sedimentation rate measurement
514,Erythrocyte volume,Erythrocyte Size Determination
515,Estradiol,Serum estradiol measurement
516,Estrone,Serum Estrone Test
517,factor IX,Plasma Factor IX Test
518,Factor V,Plasma Factor V Test
519,factor VII,Plasma Factor VII Test
520,Factor VIII,Plasma Factor VIII Test
521,factor X,Plasma Factor X Test
522,Factor XI,Plasma Factor XI Test
523,Factor XII,Plasma Factor XII Test
524,factor XIII,Plasma Factor XIII Test
525,Fatigue,Assessment of Patient Status Related to Fatigue
526,Fatty acid glycerol esters,Stool Fat Test
527,Fear (Mental Process),Assessment of Patient Status Related to Fear
528,Ferritin,Serum Chemistry Ferritin Test
529,Fibrinogen,Plasma Fibrinogen Test
530,Fibronectins,Fetal fibronectin measurement
531,Flecainide,Serum Flecainide Test
532,Flucytosine,Serum Flucytosine Test
533,Fluoxetine,Intravascular Fluoxetine Test
534,Folic Acid,Intravascular Folate Measurement
535,Folic Acid,Red Cell Folic Acid Test
536,Folic Acid,"Folic acid measurement, serum"
537,Folic Acid,CSF Folate Test
538,Follicle Stimulating Hormone,Intravascular FSH Stimulation Test
539,Follicle Stimulating Hormone,Intravascular FSH Test
540,Follicle Stimulating Hormone,Non-Specific Intravascular FSH Test
541,Follicle Stimulating Hormone,Serum FSH Test
542,Nonesterified Fatty Acids,Intravascular Free Fatty Acids Test
543,Nonesterified Fatty Acids,Whole Blood Free Fatty Acids Test
544,Galactose,Plasma Galactose Test
545,Gastrin,Intravascular Gastrin Test
546,Glucagon,Intravascular Glucagon Test
547,Glucose,General Body Fluid Glucose Test
548,Glucose,Ideatel Fingerstick Glucose Test
549,Glucose,24 Hour Urine Glucose Test
550,Glucose,Intravascular Fingerstick Glucose Test
551,Glucose,"Intravascular Glucose Test, Not Timed"
552,Glucose,Intravascular Glucose Test
553,Glucose,Operating Room Misc Labs: Glucose
554,Glucose,Plasma Glucose Measurement
555,Glucose,"Glucose measurement, serum"
556,Glucose,"Glucose measurement, urine"
557,Glucose,Whole Blood Glucose Test
558,Glucose,Backoffice Urine Glucose Test
559,Glucose,Fluid sample glucose measurement
560,Glucose,CHEM-7 Glucose Measurement
561,Glucose,"Glucose measurement, CSF"
562,Glutamine,Glutamine measurement
563,Glutamine,Intravascular Glutamine Test
564,Glutamine,Plasma glutamine measurement
565,Glutamine,Urine Glutamine Test
566,"Hemoglobin, Glycosylated",Glucohemoglobin measurement
567,"Hemoglobin, Glycosylated",Total Glycosylated Hemoglobins Test
568,Glycine,Glycine measurement
569,Glycine,Intravascular Glycine Test
570,Glycine,Plasma glycine measurement
571,Glycine,Urine Glycine Test
572,Glycosaminoglycans,Urine Glycosaminoglycans Test
573,Human Chorionic Gonadotropin,Intravascular Beta-HCG Test
574,Human Chorionic Gonadotropin,Qualitative Urine HCG Test
575,Human Chorionic Gonadotropin,Quantitative Urine HCG Test
576,Human Chorionic Gonadotropin,Serum Beta-HCG Test
577,Human Chorionic Gonadotropin,Serum Human Chorionic Gonadotropin Test
578,Human Chorionic Gonadotropin,Urine HCG Test
579,Human Chorionic Gonadotropin,Backoffice Qualitative Urine HCG Test
580,Human Chorionic Gonadotropin,CSF Human Chorionic Gonadotropin (HCG) Test
581,Haloperidol,Intravascular Haloperidol Test
582,High Density Lipoprotein Cholesterol,Intravascular HDL Test
583,High Density Lipoprotein Cholesterol,Serum HDL cholesterol measurement
584,hematocrit attribute,Operating Room Misc Labs: Hct
585,hematocrit attribute,Hematocrit procedure
586,Fetal Hemoglobin,Hemoglobin F Test
587,Fetal Hemoglobin,Body Fluid Hemoglobin F Test
588,Hemoglobin,Hemoglobin electrophoresis
589,Hemoglobin,Intravascular Total Hemoglobin Test
590,Hemoglobin,Misc. Plasma Hemoglobins Test
591,Hemoglobin,Operating Room Misc Labs: Hgb
592,Hemoglobin,Assay of plasma hemoglobin
593,Hemoglobin,Stool Occult Blood Test #1
594,Hemoglobin,Stool Occult Blood Test #2
595,Hemoglobin,Stool Occult Blood Test #3
596,Hemoglobin,Stool Occult Blood Test #4
597,Hemoglobin,Stool Occult Blood Test #5
598,Hemoglobin,Stool Occult Blood Test #6
599,Hemoglobin,Fecal occult blood test
600,Hemoglobin,Urine Hemoglobin Test
601,Hemoglobin,Whole Blood Hemoglobin Concentration Test
602,Hemoglobin,Backoffice Urine Blood Test
603,Hemolysis (biological function),Sucrose hemolysis test
604,Hemolysis (biological function),Autohemolysis Test
605,Hemosiderin,Urinary hemosiderin detection
606,heparin,Intravascular Heparin Assay Test
607,Hepatitis B Surface Antigens,Intravascular Hepatitis B Surface Antigen Test
608,Hepatitis B Surface Antigens,Serum Hepatitis B Surface Antigen Test
609,BETA-N-ACETYLHEXOSAMINIDASE,Intravascular Total Hexosaminidase Test
610,Hexosaminidase A,Intravascular Combined Hexosaminidase A Test
611,Hexosaminidase A,Intravascular Hexosaminidase A Test
612,Hexosaminidase A,Intravascular PERCENT A Test
613,Hexosaminidase A,Leukocyte Hexosaminidase A Test
614,Hexosaminidase A,Leukocyte Percent A Test
615,Hexosaminidase A,Platelet Hexosaminidase A Test
616,homocysteine,Homocysteine measurement
617,homocysteine,Intravascular Homocysteine Test
618,homocysteine,Plasma homocysteine measurement
619,homocysteine,Serum homocysteine measurement
620,homocysteine,Urine Homocysteine Test
621,Homovanillic Acid,Urine Homovanillic Acid Test
622,Hydrocodone,Urine Hydrocodone Test
623,Hydrocortisone,24 Hour Urine Cortisol Test
624,Hydrocortisone,Urine free cortisol 24 hour assay
625,Hydrocortisone,Serum Hydrocortisone Test
626,Hydrocortisone,Urine Cortisol Test
627,Hydrocortisone,Cortisol Stimulation Test
628,Hydroxyproline,Hydroxyproline measurement
629,Hydroxyproline,Hydroxyproline urine measurement
630,Hydroxyproline,"Hydroxyproline, Total Test"
631,Hydroxyproline,Intravascular Hydroxyproline Test
632,Hydroxyproline,Intravascular Total Hydroxyproline Test
633,Hydroxyproline,Plasma Hydroxyproline Test
634,Hydroxyproline,"Hydroxyproline measurement, free, urine"
635,Hydroxyproline,"Hydroxyproline measurement, urine, total"
636,Fever,Assessment of Patient Status Related to Hyperthermia
637,"Hypothermia, natural",Assessment of Patient Status Related to Hypothermia
638,Secretory Immunoglobulin A,Hematopathology IgA Test
639,Secretory Immunoglobulin A,Serum IgA Test
640,Immunoglobulin D,Hematopathology IgD Test
641,Immunoglobulin D,Intravascular IgD Test
642,Immunoglobulin E,Serum IgE Test
643,Immunoglobulin G,Hematopathology IgG Test
644,Immunoglobulin G,Serum IgG Test
645,Immunoglobulin G,Total Serum IgG Test
646,Immunoglobulin G,CSF CSF IGG INDEX Test
647,Immunoglobulin G,CSF IgG Test
648,Immunoglobulin G,CSF IgG Concentration Measurement Test
649,Immunoglobulin G,CSF IgG Synthesis Rate Test
650,Immunoglobulin G,CSF IgG Test
651,Immunoglobulin IgG1,Serum IgG1 Test
652,Immunoglobulin IgG2,Serum IgG2 Test
653,Immunoglobulin IgG3,Serum IgG3 Test
654,Immunoglobulin IgG4,Serum IgG4 Test
655,Immunoglobulin M,Hematopathology IgM Test
656,Immunoglobulin M,Serum IgM Test
657,Insulin,Intravascular Insulin Test
658,Insulin Antibodies,General Serum Insulin Antibodies Test
659,Insulin Antibodies,Serum Anti-Insulin Antibody Test
660,Iron,Serum iron tests
661,Iron,Bm Iron Stain Test
662,Isoleucine,Intravascular Isoleucine Test
663,Isoleucine,Isoleucine measurement
664,Isoleucine,Plasma isoleucine measurement
665,Isoleucine,Urine Isoleucine Test
666,Ketones,Serum Ketones Test
667,Ketones,Urine ketone test
668,Ketones,Backoffice Urine Ketone Test
669,Lactate Dehydrogenase,General Body Fluid Lactate Dehydrogenase Test
670,Lactate Dehydrogenase,Intravascular Lactate Dehydrogenase Test
671,Lactate Dehydrogenase,Paracentesis Fluid Lactate Dehydrogenase Test
672,Lactate Dehydrogenase,Plasma lactate dehydrogenase measurement
673,Lactate Dehydrogenase,Pleural Fluid Lactate Dehydrogenase Test
674,Lactate Dehydrogenase,Serum lactate dehydrogenase measurement
675,Lactate Dehydrogenase,"Lactate dehydrogenase measurement, body fluid"
676,Lactate Dehydrogenase,CSF Lactate Dehydrogenase Test
677,Lactic dehydrogenase isoenzyme,Serum Lactate Dehydrogenase Isoenzymes Test
678,Leucine,Intravascular Leucine Test
679,Leucine,Leucine measurement
680,Leucine,Plasma leucine measurement
681,Leucine,Urine Leucine Test
682,Leukocytes,Spinal Fluid Leukocyte Test
683,Leukocytes,Urine Leukocyte Counts
684,Leukocytes,Urine Leukocyte Test
685,Leukocytes,White blood cell morphology measurement
686,Leukocytes,Whole Blood Hypersegmented Neutrophil Test
687,Leukocytes,White Blood Cell Count procedure
688,Leukocytes,Whole Blood Myeloid Precursor Counts
689,Leukocytes,Whole Blood Prolymphocyte Counts
690,Leukocytes,Whole Blood Promonocyte Counts
691,Leukocytes,Whole Blood Total Leukocyte Count
692,Leukocytes,Body Fluid Leukocyte Test
693,Leukocytes,Body Fluids Wbc Test
694,Leukocytes,Cd10 (Calla) Test
695,Leukocytes,Cd13 (My7) Myeloid Cell Test
696,Leukocytes,Cd33 (My9) Myeloid Cell Test
697,Lipase,Serum Lipase Test
698,LDL Cholesterol Lipoproteins,Intravascular LDL Test
699,LDL Cholesterol Lipoproteins,Serum LDL cholesterol measurement
700,Lithium,Serum lithium measurement
701,Lupus Coagulation Inhibitor,Lupus anticoagulant measurement
702,Luteinizing Hormone,Intravascular LH Stimulation Test
703,Luteinizing Hormone,Intravascular LH Test
704,Luteinizing Hormone,Non-Specific Intravascular LH Test
705,Luteinizing Hormone,Serum LH measurement
706,Lymphocyte,Lymphocyte percent differential count
707,Lymphocyte,Unspecified Body Fluid Lymphocyte Test
708,Lymphocyte,Whole Blood Absolute Lymphocyte Counts
709,Lymphocyte,Whole Blood Cd25 Lymphocyte Counts
710,Lymphocyte,Whole Blood Lymphocyte Counts
711,Lymphocyte,Whole Blood Percent Cd25 Lymphocyte Counts
712,Lymphocyte,Bm Lymphocyte Test
713,Lymphocyte,Body Fluid Lymphocytes Test
714,Magnesium,General Body Fluid Magnesium Test
715,Magnesium,Intravascular Magnesium Test
716,Magnesium,24 Hour Urine Magnesium Test
717,Magnesium,Random Urine Magnesium Test
718,Magnesium,Serum magnesium measurement
719,Magnesium,"Magnesium measurement, urine"
720,Magnesium,Body Fluid Magnesium Test
721,Mercury,Intravascular Mercury Test
722,Mercury,Mercury Test (Combined)
723,Mercury,Urine mercury measurement
724,Metanephrine,Urine Metanephrine Test
725,Metanephrine,Urine Total Metanephrine Test
726,Methamphetamine,Urine methamphetamine measurement
727,Methanol,Intravascular Methanol Test
728,Methemoglobin,Whole Blood Methemoglobin Measurement
729,Methionine,Intravascular Methionine Test
730,Methionine,Methionine measurement
731,Methionine,Plasma methionine measurement
732,Methionine,Urine Methionine Test
733,Methotrexate,Intravascular Methotrexate Test
734,Methotrexate,Serum methotrexate measurement
735,Methotrexate,CSF Methotrexate Test
736,Mexiletine,Serum Mexiletine Test
737,Monocytes,Whole Blood Absolute Monocyte Test
738,Monocytes,Whole Blood Monocyte Counts
739,Monocytes,Whole Blood Percentage Monocyte Test
740,Monocytes,Bm Monocyte Test
741,Monocytes,Body Fluid Absolute Monocyte Test
742,Monocytes,Body Fluid Monocyte Test
743,Monocytes,Body Fluid Percentage Monocyte Test
744,Monocytes,Cd14 (Leu M3) Monocyte Test
745,Morphine,Urine Morphine Test
746,Mucous body substance,Urine Mucous Thread Observation Test
747,Peroxidase,Myeloperoxidase Test
748,Myoglobin,Intravascular Myoglobin Test
749,Myoglobin,Myoglobin urine measurement
750,neutrophil,Unspecified Body Fluid Neutrophils Test
751,neutrophil,Whole Blood Absolute Neutrophil Counts
752,neutrophil,Whole Blood Neutrophil Counts
753,neutrophil,Whole Blood Percentage Neutrophil Counts
754,neutrophil,Bm Neutrophile Test
755,neutrophil,Body Fluid Neutrophils Test
756,Nitrites,"Urinalysis, bacteriuria screen"
757,Nitrites,Backoffice Urine Nitrites Test
758,Nordazepam,Serum Nordiazepam Test
759,Norepinephrine,Intravascular Norepinephrine Test
760,Norepinephrine,Urine Norepinephrine Test
761,Normetanephrine,Urine Normetanephrine Test
762,Nortriptyline,Intravascular Nortriptyline Metabolite Test
763,Nortriptyline,Serum Nortriptyline Test
764,Opiates,Urine opiate measurement
765,Opiates,Urine Total Opiate Test
766,Osmolality,General Body Fluid Osmolality Test
767,Osmolality,Intravascular Osmolality Test
768,Osmolality,Osmolality Test
769,Osmolality,Serum osmolality measurement
770,Osmolality,Urine osmolality measurement
771,Osmolality,Body Fluid Osmolality Test
772,Osteocalcin,Intravascular Osteocalcin Test
773,Oxalates,Quantitative Urine Oxalate Test
774,Oxalates,Urine oxalate measurement
775,Oxygen,Arterial Blood O2 Partial Pressure Test
776,Oxygen,Mixed Venous O2 Partial Pressure Test
777,Oxygen,Arterial Cord Blood O2 Partial Pressure Test
778,Oxygen,Operating Room Misc Labs: PO2
779,Oxygen,Respiratory Blood FIO2 Test
780,Oxygen,Venous Blood O2 Partial Pressure Test
781,Oxygen,Venous Cord Blood O2 Partial Pressure Test
782,Oxygen,Whole Blood O2 Partial Pressure Test
783,Oxygen,Body Fluid PO2 Test
784,Oxygen,Capillary Blood PO2 Test
785,Oxygen,Cardiopulmonary Bypass Whole Blood O2 Partial Pressure Test
786,Oxygen,Cord Blood O2 Partial Pressure Test
787,Oxyhemoglobin,Mixed Venous Saturation Oxyhemoglobin Test
788,Oxyhemoglobin,Arterial Blood Saturation Oxyhemoglobin Test
789,Oxyhemoglobin,Arterial Cord Blood Saturation Oxyhemoglobin Test
790,Oxyhemoglobin,Unspecified Oxyhemoglobin Test
791,Oxyhemoglobin,Venous Blood Saturation Oxyhemoglobin Test
792,Oxyhemoglobin,Venous Cord Blood Saturation Oxyhemoglobin Test
793,Oxyhemoglobin,Whole Blood Saturation Oxyhemoglobin Test
794,Oxyhemoglobin,Capillary Blood Saturated Oxyhemoglobin Test
795,Oxyhemoglobin,Cardiopulmonary Bypass Whole Blood Saturation Oxyhemoglobin Test
796,Oxyhemoglobin,Cord Blood Saturation Oxyhemoglobin Test
797,Paraldehyde,Intravascular Paraldehyde Test
798,Parathyroid Hormone,Intravascular Parathyroid Hormone Test
799,Parathyroid Hormone,Parathyroid hormone measurement
800,Parathyroid Hormone,Serum Intact Parathyroid Hormone Test
801,Parathyroid Hormone,Serum Parathyroid Hormone Test
802,Phencyclidine,Urine Phencyclidine Test
803,Phenobarbital,Intravascular Phenobarbital Drug Test
804,Phenylalanine,Intravascular Phenylalanine Test
805,Phenylalanine,blood phenylalanine measurement by Guthrie microbiologic assay
806,Phenylalanine,Plasma phenylalanine measurement
807,Phenylalanine,Urine Phenylalanine Test
808,Plasma Cells,Whole Blood Plasma Cell Counts
809,Plasma Cells,Bm Plasmacyte Test
810,Plasma Cells,Body Fluid Plasma Cell Test
811,Plasminogen,Plasminogen Activity Test
812,Porphobilinogen,24 Hors Urine Porphobilinogen Test
813,Potassium,Intravascular Potassium Test
814,Potassium,Operating Room Misc Labs: K
815,Potassium,Plasma Potassium Test
816,Potassium,24 Hour Urine Potassium Test
817,Potassium,Random Urine Potassium Test
818,Potassium,Serum Potassium Ion Test
819,Potassium,Whole Blood Potassium Test
820,Potassium,Body Fluid Potassium Test
821,Potassium,CHEM-7 Potassium Ion Measurement
822,Prealbumin,Intravascular Non-Specific Prealbumin Test
823,Prealbumin,CSF Percentage Prealbumin Test
824,Prealbumin,CSF Prealbumin Test
825,Pregnanetriol,Urine pregnanetriol 24 hour assay
826,Pregnanetriol,Urine Pregnanetriol Test
827,Progesterone,Serum progesterone measurement
828,Prolactin,Intravascular Prolactin Test
829,Prolactin,Serum Prolactin Test
830,Proline,Intravascular Proline Test
831,Proline,Plasma proline measurement
832,Proline,Proline measurement
833,Proline,Urine Proline Test
834,Promyelocytes,Whole Blood Promyelocyte Counts
835,Promyelocytes,Bm Promyelocyte Test
836,Protein C,Protein C Activity Test
837,Proteins,General Body Fluid Protein Test
838,Proteins,Intravascular Protein Test
839,Proteins,Intravascular Total Proteins Test
840,Proteins,24 Hour Urine Microalbumin Test
841,Proteins,Operating Room Misc Labs: Tp
842,Proteins,Plasma total protein measurement
843,Proteins,Qualitative Urine Protein Test
844,Proteins,Quantitative Urine Protein Measurement
845,Proteins,"Quantitative Urine Protein Test, Random"
846,Proteins,24 Hour Urine Protein Test
847,Proteins,Serum protein electrophoresis
848,Proteins,Serum total protein measurement
849,Proteins,Urine protein electrophoresis
850,Proteins,Urine protein test
851,Proteins,Backoffice Urine Protein Test
852,Proteins,Body Fluid Protein Test
853,Proteins,Body Fluid Total Protein Test
854,Proteins,CSF Protein Test
855,Prothrombin,Factor II (Prothrombin) Test
856,Protriptyline,Intravascular Protriptyline Test
857,Pyruvate Kinase,Pyruvate kinase measurement
858,Quinidine,Serum Quinidine Test
859,Reticulocytes,Whole Blood Reticulocyte Counts
860,Rheumatoid Factor,Qualitative Rheumatoid Factor Test
861,Rheumatoid Factor,Quant Rheumatoid Factor Test
862,Rheumatoid Factor,Rf Titer Test
863,Rheumatoid Factor,Rheumatoid Factor Measurement
864,Sarcosine,Intravascular Sarcosine Test
865,Sarcosine,Plasma Sarcosine Test
866,Sarcosine,Sarcosine measurement
867,Sarcosine,Urine Sarcosine Test
868,Schiff Bases,Arterial Blood Base Excess Test
869,Schiff Bases,Mixed Venous Base Excess Test
870,Schiff Bases,Operating Room Misc Labs: Be
871,Schiff Bases,Venous Blood Base Excess Test
872,Schiff Bases,Whole Blood Base Excess Test
873,Schiff Bases,Capillary Whole Blood Base Excess Test
874,Schiff Bases,Cardiopulmonary Bypass Whole Blood Base Excess Test
875,Selenium,Intravascular Selenium Test
876,Selenium,"Selenium measurement, urine"
877,Serine,Intravascular Serine Test
878,Serine,Plasma serine measurement
879,Serine,Serine measurement
880,Serine,Urine Serine Test
881,Serotonin,Intravascular Serotonin Test
882,Serum Albumin,Intravascular Albumin Test
883,Serum Albumin,Ascitic Fluid Albumin Test
884,Serum Albumin,Plasma Albumin Test
885,Serum Albumin,Qualitative (Dipstick) Urine Albumin Measurement
886,Serum Albumin,Serum albumin measurement
887,Serum Albumin,Urine albumin tests
888,Serum Albumin,Microalbuminuria measurement
889,Serum Albumin,Body Fluid Albumin Test
890,Social isolation,Assessment of Patient Status Related to Social Isolation
891,Sodium,Intravascular Sodium Test
892,Sodium,Operating Room Misc Labs: Na
893,Sodium,Plasma Sodium Test
894,Sodium,Random Urine Sodium Test
895,Sodium,24 Hour Urine Sodium Test
896,Sodium,Serum sodium measurement
897,Sodium,Sodium Sweat Test
898,Sodium,Whole Blood Sodium Test
899,Sodium,Body Fluid Sodium Test
900,Sodium,CHEM-7 Sodium Ion Measurement
901,Insulin-Like Growth Factor I,Serum Somatomedin C Test
902,Growth Hormone,Growth hormone stimulation test
903,Growth Hormone,Serum Growth Hormone Test
904,Specific Gravity,"Specific gravity measurement, urine"
905,Specific Gravity,Backoffice Urine Specific Gravity Test
906,Spherocytes,Whole Blood Spherocytes Counts
907,Starch,Fecal starch test
908,Substance P,"Substance P, Amniotic Fluid Test"
909,SUCRASE,Sucrase measurement
910,Taurine,Intravascular Taurine Test
911,Taurine,Plasma taurine measurement
912,Taurine,Taurine measurement
913,Taurine,Urine Taurine Test
914,DNA Nucleotidylexotransferase,Terminal Transferase (Tdt) Test
915,Testosterone,Intravascular Free Testosterone Test
916,Testosterone,Intravascular Testosterone Test
917,Testosterone,Intravascular Total Testosterone Test
918,Testosterone,Serum Free Testosterone Test
919,Testosterone,Serum testosterone measurement
920,Testosterone,Serum Total Testosterone Test
921,dronabinol,Urine Cannabinoid Metabolite Test
922,dronabinol,Urine Tetrahydrocannabinol / Metabolite Test
923,dronabinol,Urine Tetrahydrocannabinol Test
924,Theophylline,Intravascular Theophylline Level
925,Theophylline,Serum Theophylline Test
926,Thiamine,Intravascular Vitamin B1 Test
927,Threonine,Intravascular Threonine Test
928,Threonine,Plasma threonine measurement
929,Threonine,Threonine measurement
930,Threonine,Urine Threonine Test
931,Thrombin,Plasma Control Reptilase Time Test
932,Thrombin,Plasma Control Thrombin Test
933,Thrombin,Plasma Patient Reptilase Time Test
934,Thrombin,Plasma Patient Thrombin Test
935,Thrombin,Plasma Reptilase Test
936,Thrombin,Plasma Thrombin & Reptilase Test
937,Thrombin,Thrombin Time Assay
938,Thromboplastin,Plasma Control Thromboplastin Test
939,Thromboplastin,Plasma Patient Thromboplastin Test
940,Thromboplastin,Activated Partial Thromboplastin Time measurement
941,Thyroglobulin,Intravascular Thyroglobulin Test
942,Thyroglobulin,Serum Thyroglobulin Test
943,Thyrotropin,Intravascular TSH Stimulation Test
944,Thyrotropin,Intravascular Thyrotropin Test
945,Thyrotropin,Non-Specific Intravascular Thyrotropin Test
946,Thyrotropin,Serum Thyrotropin Test
947,levothyroxine,Intravascular Free T4 Test
948,levothyroxine,Intravascular Thyroxine Test
949,levothyroxine,Serum Thyroxine Test
950,Thyroxine-Binding Globulin,Intravascular Thyroxine Binding Globulin Test
951,Thyroxine-Binding Globulin,Thyroxine Binding Globulin Serum Test
952,Time,Intravascular Time Measurements
953,Time,Time Measurements
954,Time,Urine Time Measurements
955,Time,Xylose Time Measurements
956,TRANSKETOLASE,Intravascular Transketolase Test
957,Trichomonas (invertebrate),Urine Trichomonas Observation Test
958,Triglycerides,General Body Fluid Triglyceride Test
959,Triglycerides,Intravascular Triglyceride Test
960,Triglycerides,Paracentesis Fluid Triglyceride Test
961,Triglycerides,Plasma triglyceride measurement
962,Triglycerides,Pleaural Fluid Triglyceride Test
963,Triglycerides,Serum Triglyceride Measurement
964,Triglycerides,Body Fluid Triglyceride Test
965,liothyronine,Intravascular Free T3 Test
966,liothyronine,Intravascular Reverse T3 Test
967,liothyronine,Intravascular Total T3 Test
968,liothyronine,Serum Triiodothyronine Test
969,liothyronine,T3 by RIA Test
970,Tyrosine,Intravascular Tyrosine Test
971,Tyrosine,Plasma tyrosine measurement
972,Tyrosine,Tyrosine measurement
973,Tyrosine,Urine Tyrosine Test
974,Uric Acid,Intravascular Uric Acid Test
975,Uric Acid,Plasma Uric Acid Test
976,Uric Acid,Quantitative Urine Uric Acid Test
977,Uric Acid,Random Urine Uric Acid Test
978,Uric Acid,Serum urate measurement
979,Uric Acid,Urine Amorphous Urate Observation Test
980,Uric Acid,24 Hour Urine Uric Acid Test
981,Uric Acid,Urine Uric Acid Crystal Observation Test
982,Uric Acid,Urine urate measurement
983,Uric Acid,Body Fluid Uric Acid Test
984,Urinary Retention,Assessment of Patient Status Related to Urinary Retention
985,Urobilinogen,Urine urobilinogen test
986,Urobilinogen,Backoffice Urine Urobilinogen Test
987,Valine,Intravascular Valine Test
988,Valine,Plasma valine measurement
989,Valine,Urine Valine Test
990,Valine,Valine measurement
991,Valproic Acid,Intravascular Valproic Acid Drug Test
992,Valproic Acid,"Intravascular Valproic Acid, Free Test"
993,Vancomycin,Intravascular Peak Vancomycin Test
994,Vancomycin,Intravascular Random Vancomycin Test
995,Vancomycin,Intravascular Trough Vancomycin Test
996,Vancomycin,Intravascular Vancomycin Test
997,vanilmandelic acid,Urine Vanilmandelic Acid Test
998,Verapamil,Intravascular Verapamil Test
999,Viscosity,Serum Viscosity Measurment
1000,Vitamin A,Serum Vitamin A Test
1001,Vitamin B 12,Serum Vitamin B 12 Test
1002,D Vitamin,"1,25-Oh D Vitamin Test"
1003,Ergocalciferol,25-Oh D Vitamin Test
1004,Vitamin E,Intravascular Vitamin E Test
1005,Xylose,Intravascular Xylose Absorbtion Test
1006,Xylose,Intravascular Xylose Test
1007,Xylose,Serum Xylose Absorbtion Test
1008,Xylose,Urine xylose measurement
1009,Xylose,Whole Blood Xylose Absorbtion Test
1010,Xylose,Xylose Percent Excretion Calculation
1011,Xylose,5 Hour Urine Xylose Absorption Test
1012,Yeasts,Urine Yeast Observation Test
1013,Zinc,Plasma Zinc
1014,Epithelial Cells,Urine Epithelial Cell Observation Test
1015,bicarbonate ion,Intravascular Bicarbonate Test
1016,bicarbonate ion,Intravascular Measured (Non-Blood Gas) Bicarbonate Test
1017,bicarbonate ion,Arterial Blood Bicarbonate Ion Test
1018,bicarbonate ion,Mixed Venous Calculated Bicarbonate Ion Test
1019,bicarbonate ion,Arterial Cord Blood Bicarbonate Ion Test
1020,bicarbonate ion,Operating Room Misc Labs: Hco3
1021,bicarbonate ion,Plasma bicarbonate measurement
1022,bicarbonate ion,Serum Bicarbonate Ion Test
1023,bicarbonate ion,Venous Blood Bicarbonate Ion Test
1024,bicarbonate ion,Venous Cord Blood Bicarbonate Ion Test
1025,bicarbonate ion,Whole Blood (Blood Gas) Calculated Bicarbonate Ion Test
1026,bicarbonate ion,Whole Blood Measured (Non-Blood Gas) Bicarbonate Test
1027,bicarbonate ion,CHEM-7 Bicarbonate Ion Measurement
1028,bicarbonate ion,"Calculated Bicarbonate Ion Test, Nos"
1029,bicarbonate ion,Capillary Blood Bicarbonate Ion Test
1030,bicarbonate ion,Cardiopulmonary Bypass Whole Blood Calculated Bicarbonate Ion Test
1031,bicarbonate ion,Cord Blood Bicarbonate Ion Test
1032,Lactate,Intravascular Lactate Nos
1033,Lactate,Intravascular Lactate Test
1034,Lactate,Plasma Lactate Test
1035,Lactate,Serum lactate measurement
1036,Lactate,Whole Blood Arterial Lactate Test
1037,Lactate,Whole Blood Venous Lactate Test
1038,Lactate,CSF Lactate Test
1039,Prostate-Specific Antigen,Intravascular Free Psa Concentration Test
1040,Prostate-Specific Antigen,Intravascular Free Psa Fraction Test
1041,Prostate-Specific Antigen,Intravascular Free Psa Test
1042,Prostate-Specific Antigen,Intravascular Prostatic Specific Antigen Test
1043,Prostate-Specific Antigen,Non-Specific Intravascular Prostatic Specific Antigen Test
1044,Prostate-Specific Antigen,Serum Prostate Specific Antigen Test
1045,Pyruvate,Intravascular Pyruvate Test
1046,Pyruvate,Whole Blood Pyruvate Test
1047,Pyruvate,CSF Pyruvate Test
1048,thiocyanate,Serum Thiocyanate Test
1049,Activity intolerance,Assessment of Patient Status Related to Activity Intolerance
1050,Distorted body image,Assessment of Patient Status Related to Body Image Disturbance
1051,Decisional conflict,Assessment of Patient Status Related to Decisional Conflict
1052,Dysfunctional coping using self defense mechanisms,Assessment of Patient Status Related to Defensive Coping
1053,Diversional activity deficit,Assessment of Patient Status Related to Diversional Activity Deficit
1054,Autonomic Dysreflexia,Assessment of Patient Status Related to Dysreflexia
1055,Hypovolemia,Assessment of Patient Status Related to Fluid Volume Deficit
1056,Fluid overload,Assessment of Patient Status Related to Fluid Volume Excess
1057,Feeling hopeless,Assessment of Patient Status Related to Hopelessness
1058,Deficient knowledge,Assessment of Patient Status Related to Knowledge Deficit
1059,Patient Non-Compliance,Assessment of Patient Status Related to Noncompliance
1060,Parental role conflict,Assessment of Patient Status Related to Parental Role Conflict
1061,Feeling powerless,Assessment of Patient Status Related to Powerlessness
1062,Sexual Dysfunction,Assessment of Patient Status Related to Sexual Dysfunction
1063,Sleep pattern disturbance,Assessment of Patient Status Related to Sleep Pattern Disturbance
1064,Hemi-neglect,Assessment of Patient Status Related to Unilateral Neglect
1065,Immune complex,Intravascular Peg Immune Complex Test
1066,Immune complex,Intravascular Raji Immune Complex Test
1067,Activity alteration,Assessment of Patient Status Related to Activity Alteration
1068,At risk for activity intolerance,Assessment of Patient Status Related to Activity Intolerance Risk
1069,Impaired mobility,Assessment of Patient Status Related to Physical Mobility Impairment
1070,Musculoskeletal alteration,Assessment of Patient Status Related to Musculoskeletal Alteration
1071,Impaired Defecation,Assessment of Patient Status Related to Bowel Elimination Alteration
1072,Fecal Incontinence,Assessment of Patient Status Related to Bowel Incontinence
1073,Slow transit constipation,Assessment of Patient Status Related to Colonic Constipation
1074,Perceived constipation (disorder),Assessment of Patient Status Related to Perceived Constipation
1075,Constipation,Assessment of Patient Status Related to Unspecified Constipation
1076,Abnormal digestive tract function,Assessment of Patient Status Related to Gastrointestinal Alteration
1077,Actual Negative Cardiac Output,Assessment of Patient Status Related to Cardiac Output Alteration
1078,Cardiovascular system alteration,Assessment of Patient Status Related to Cardiovascular Alteration
1079,Blood pressure alteration (finding),Assessment of Patient Status Related to Blood Pressure Alteration
1080,Cerebral alteration,Assessment of Patient Status Related to Cerebral Alteration
1081,Knowledge Deficit of Diagnostic Test,Assessment of Patient Status Related to Knowledge Deficit of Diagnostic Test
1082,Knowledge Deficit of Dietary Regimen,Assessment of Patient Status Related to Knowledge Deficit of Dietary Regimen
1083,Knowledge Deficit of Disease Process,Assessment of Patient Status Related to Knowledge Deficit of Disease Process
1084,Knowledge Deficit of Fluid Volume,Assessment of Patient Status Related to Fluid Volume Deficit
1085,Knowledge Deficit of Medication Regimen,Assessment of Patient Status Related to Knowledge Deficit of Medication Regimen
1086,Knowledge Deficit of Safety Precautions,Assessment of Patient Status Related to Knowledge Deficit of Safety Precautions
1087,Knowledge Deficit of Therapeutic Regimen,Assessment of Patient Status Related to Knowledge Deficit of Therapeutic Regimen
1088,Dying Process,Assessment of Patient Status Related to Dying Process
1089,Ineffective family coping,Assessment of Patient Status Related to Family Coping Impairment
1090,Ineffective family coping: compromised,Assessment of Patient Status Related to Compromised Family Coping
1091,Ineffective family coping: disabling,Assessment of Patient Status Related to Disabled Family Coping
1092,Actual Negative Coping,Assessment of Patient Status Related to Individual Coping Impairment
1093,Adjustment Impairment,Assessment of Patient Status Related to Adjustment Impairment
1094,Spiritual state alteration,Assessment of Patient Status Related to Spiritual State Alteration
1095,Fluid imbalance,Assessment of Patient Status Related to Fluid Volume Alteration
1096,At risk for deficient fluid volume,Assessment of Patient Status Related to Fluid Volume Deficit Risk
1097,Potential for Excess Fluid Volume,Assessment of Patient Status Related to Fluid Volume Excess Risk
1098,Health maintenance alteration,Assessment of Patient Status Related to Health Maintenance Alteration
1099,Impaired home maintenance management,Assessment of Patient Status Related to Home Maintenance Alteration
1100,Medication Risk,Assessment of Patient Status Related to Medication Risk
1101,Polypharmacy,Assessment of Patient Status Related Polypharmacy
1102,Endocrine system alteration,Assessment of Patient Status Related to Endocrine Alteration
1103,Altered immunity,Assessment of Patient Status Related to Immunologic Alteration
1104,Ineffective protection,Assessment of Patient Status Related to Protection Alteration
1105,Alteration in nutrition,Assessment of Patient Status Related to Nutrition Alteration
1106,Deficient Food Intake,Assessment of Patient Status Related to Body Nutrition Deficit
1107,"At risk for imbalanced nutrition, less than body requirements",Assessment of Patient Status Related to Body Nutrition Deficit Risk
1108,Alteration in nutrition: more than body requirements,Assessment of Patient Status Related to Body Nutrition Excess
1109,Potential For Excess Food Intake,Assessment of Patient Status Related to Body Nutrition Excess Risk
1110,Physical Regulation Alteration,Assessment of Patient Status Related to Physical Regulation Alteration
1111,Impaired Thermoregulation,Assessment of Pateint Status Related to Thermoregualtion Impairment
1112,At risk of infection,Assessment of Patient Status Related to Infection Risk
1113,Communicable Diseases,Assessment of Patient Status Related to Infection Unspecified
1114,Respiration Alteration,Assessment of Patient Status Related to Respiration Alteration
1115,Ineffective airway clearance,Assessment of Patient Status Related to Airway Clearance Impairment
1116,Ineffective breathing pattern,Assessment of Patient Status Related to Breathing Pattern Impairment
1117,Impaired gas exchange,Assessment of Patient Status Related to Gas Exchange Impairment
1118,Disturbance in role performance,Assessment of Patient Status Related to Role Performance Alteration
1119,Alteration in parenting,Assessment of Patient Status Related to Parenting Alteration
1120,Communication impairment,Assessment of Patient Status Related to Communication Impairment
1121,Verbal impairment,Assessment of Patient Status Related to Verbal Impairment
1122,Grief reaction,Assessment of Patient Status Related to Grieving
1123,Anticipatory grief,Assessment of Patient Status Related to Anticipatory Grieving
1124,Dysfunctional grieving,Assessment of Patient Status Related to Dysfunctional Grieving
1125,Altered sexuality patterns,Assessment of Patient Status Related to Sexuality Patterns Alteration
1126,Socialization alteration,Assessment of Patient Status Related to Socialization Alteration
1127,Actual Impaired Interactive Behavior,Assessment of Patient Status Related to Social Interaction Alteration
1128,At risk of injury,Assessment of Patient Status Related to Injury Risk
1129,At risk for aspiration,Assessment of Patient Status Related to Aspiration Risk
1130,Disuse syndrome,Assessment of Patient Status Related to Disuse Syndrome
1131,At risk for poisoning injury,Assessment of Patient Status Related to Poisoning Risk
1132,At risk for suffocation,Assessment of Patient Status Related to Suffocation Risk
1133,At risk of injury,Assessment of Patient Status Related to Trauma Risk
1134,At risk for violence,Assessment of Patient Status Related to Violence Risk
1135,Self-feeding deficit,Assessment of Patient Status Related to Feeding Deficit
1136,Abnormal breast feeding,Assessment of Patient Status Related to Breastfeeding Impairment
1137,Swallowing problem,Assessment of Patient Status Related to Swallowing Impairment
1138,Self-toileting deficit,Assessment of Patient Status Related to Toileting Deficit
1139,Meaningfulness alteration,Assessment of Patient Status Related to Meaningfulness Alteration
1140,Personal identity confusion,Assessment of Patient Status Related to Personal Identity Disturbance
1141,Disturbed sensory perception,Assessment of Patient Status Related to Sensory Perceptual Alteration
1142,Hearing problem,Assessment of Patient Status Related to Auditory Alteration
1143,Dysgeusia,Assessment of Patient Status Related to Gustatory Alteration
1144,Kinesthetic alteration,Assessment of Patient Status Related to Kinesthetic Alteration
1145,Sense of smell altered,Assessment of Patient Status Related to Olfactory Alteration
1146,Tactile alteration,Assessment of Patient Status Related to Tactile Alteration
1147,Visual disturbance,Assessment of Patient Status Related to Visual Alteration
1148,Comfort alteration,Assessment of Patient Status Related to Comfort Alteration
1149,Acute onset pain,Assessment of Patient Status Related to Acute Pain
1150,Chronic pain,Assessment of Patient Status Related to Chronic Pain
1151,Pain,Assessment of Patient Status Related to Unspecified Pain
1152,Alteration in oral mucous membrane,Assessment of Patient Status Related to Oral Mucous Membranes Impairment
1153,Impaired skin integrity,Assessment of Patient Status Related to Skin Integrity Impairment
1154,At risk for impaired skin integrity,Assessment of Patient Status Related to Skin Integrity Impairment Risk
1155,Skin Incision (finding),Assessment of Patient Status Related to Skin Incision
1156,Peripheral vascular alteration,Assessment of Patient Status Related to Peripheral Alteration
1157,Ineffective tissue perfusion,Assessment of Patient Status Related to Tissue Perfusion Alteration
1158,Alteration in patterns of urinary elimination,Assessment of Patient Status Related to Urinary Elimination Alteration
1159,Functional urinary incontinence,Assessment of Patient Status Related to Functional Urinary Incontinence
1160,Reflex incontinence of urine,Assessment of Patient Status Related to Reflex Urinary Incontinence
1161,Urinary Stress Incontinence,Assessment of Patient Status Related to Stress Urinary Incontinence
1162,Total urinary incontinence,Assessment of Patient Status Related to Total Urinary Incontinence
1163,Urge Incontinence,Assessment of Patient Status Related to Urge Urinary Incontinence
1164,Renal alteration,Assessment of Patient Status Related to Renal Alteration
1165,vasoactive intestinal peptide,Intravascular Vasoactive Intestinal Polypetide Test
1166,17-alpha-Hydroxyprogesterone,"17 Hydroxyprogesterone measurement, serum"
1167,Fecal Impaction,Assessment of Patient Status Related to Fecal Impaction
1168,Glutamic Acid,Glutamic Acid Test
1169,Glutamic Acid,Intravascular Glutamic Acid Test
1170,Glutamic Acid,Plasma Glutamic Acid Test
1171,Glutamic Acid,Urine Glutamic Acid Test
1172,Protons,Mixed Venous pH Measurement
1173,Protons,Arterial blood pH measurement
1174,Protons,Arterial Cord Blood pH Test
1175,Protons,Operating Room Blood pH Measurement
1176,Protons,Operating Room Misc Labs: pH
1177,Protons,Scalp Blood pH Measurement
1178,Protons,Urine pH measurement
1179,Protons,Blood venous pH measurement
1180,Protons,Venous Cord Blood pH Test
1181,Protons,Whole Blood pH Measurement
1182,Protons,Backoffice Urine pH Test
1183,Protons,Body Fluid Hydrogen Ion Test
1184,Protons,Capillary Blood pH Test
1185,Protons,Cardiopulmonary Bypass Whole Blood pH Test
1186,Protons,Cord Blood pH Test
1187,Lactase,Lactase Test
1188,Alpha-glucosidase,Maltase Test
1189,Metamyelocytes,Whole Blood Metamyelocyte Counts
1190,Metamyelocytes,Bm Metamyelocyte Test
1191,methsuximide,Intravascular Methsuximide Drug Test
1192,myeloblast,Bm Myeloblast Test
1193,Elliptocyte (cell),Whole Blood Ovalocyte Counts
1194,phosphoethanolamine,Intravascular Phosphoethanoloamine Test
1195,phosphoethanolamine,Phosphoethanolamine measurement
1196,phosphoethanolamine,Plasma Phosphoethanoloamine Test
1197,phosphoethanolamine,Urine Phosphoethanoloamine Test
1198,Rape trauma syndrome,Assessment of Patient Status Related to Rape Trauma Syndrome
1199,salicylate,Serum salicylate measurement
1200,Thyroid stimulating immunoglobulins,Serum Thyroid Stimulating Immunnoglobulin Test
1201,Insulin-Like Growth Factor Binding Protein 3,Intravascular Insulin-Like Growth Factor Binding Protein 3 Test
1202,Methylphenidate Hydrochloride,Plasma Ritalin Test
1203,Sulfatases,Intravascular Leukocyte Arylsulfatase A Test
1204,Cyanides,Intravascular Cyanide Test
1205,Dehydroepiandrosterone Sulfate,Serum Dehydroepiandrosterone Sulfate Test
1206,ethanolamine,Intravascular Ethanolamine Test
1207,ethanolamine,Urine Ethanolamine Test
1208,Glycosylated hemoglobin A,Hemoglobin A1c measurement
1209,Glycosylated hemoglobin A,NYH Lab Procedure: Glycohgb A1c-Rogosin
1210,Poikilocyte (cell),Whole Blood Poikilocyte Counts
1211,Reducing Agents,Fecal reducing substance screening
1212,Reducing Agents,Urine reducing substance measurement
1213,deoxypyridinoline,Urine Deoxypyridinoline Test
1214,desethylamiodarone,Desethylamiodarone measurement
1215,desmethylclomipramine,Intravascular Desmethylclomipramine Test
1216,ethylene glycol,Intravascular Ethylene Glycol Test
1217,felbamate,Intravascular Felbamate Test
1218,Heptacarboxylporphyrin,24 Hours Urine Heptacarboxylporphyrin Test
1219,Fat-laden macrophage,Body Fluid Lipophage Test
1220,macroamylase,Serum Macroamylase Test
1221,Myelocytes,Myelocyte percent differential count
1222,Myelocytes,Whole Blood Myelocyte Counts
1223,Myelocytes,Bm Myelocyte Test
1224,desmethyldoxepin,Intravascular Nordoxepin Test
1225,desmethyldoxepin,Intravascular Total Dox+Nordoxepin Test
1226,norfluoxetine,Intravascular Norfluoxetine Test
1227,norverapamil,Serum Norverapamil Test
1228,pyridinoline,Random Urine Pyridinoline Test
1229,pyridinoline,Urine Pyridinoline Test
1230,pyridinoline,24 Hours Urine Pyridinium Crosslinks Test
1231,Volume,Five (5) Hour Urine Volume Measurements
1232,Volume,Timed Urine Volume Measurements
1233,Volume,Twelve (12) Hour Urine Volume Measurements
1234,Volume,Twenty Four (24) Hour Urine Volume Measurements
1235,Volume,Urine Volume Measurements
1236,3-Hydroxybutyric Acid,Plasma Beta Hydroxybutyrate Test
1237,Erythroblasts,Whole Blood Nucleated Erythrocyte Counts
1238,Cortodoxone,Serum 11 Deoxycortisol (Compound s) Test
1239,hepatitis A virus antibodies,Intravascular Anti-Hav IgG Test
1240,hepatitis A virus antibodies,Intravascular Anti-Hav IgM Test
1241,hepatitis A virus antibodies,Intravascular Hepatitis A Antibody Test
1242,hepatitis A virus antibodies,Intravascular Total Anti-Hav Antibodies Test
1243,hepatitis A virus antibodies,Whole Blood Hepatitis A Virus Antibodies Test
1244,Iron-Binding Proteins,Serum Iron-Binding Proteins Test
1245,alpha 1-Antitrypsin,Intravascular Alpha-1-Antitrypsin Phenotype Test
1246,alpha 1-Antitrypsin,Intravascular Alpha-1-Antitrypsin Test
1247,alpha-amylase,Serum Alpha-Amylase Test
1248,alpha-amylase,Serum amylase (pancreatic) measurement
1249,alpha-amylase,Serum Salivary Amylase Test
1250,Cryptococcus Antibody,CSF Cryptococcus Antibody Test
1251,Cryptococcus Antibody,Cryptococcus antibody assay
1252,Cysticercus antibody,Cysticercosis Antibody Test
1253,Cytomegalovirus antibody,Intravascular Cytomegalovirus Antibody Test
1254,Cytomegalovirus antibody,Blood Cytomegalovirus Antibody Test
1255,Cytomegalovirus IgM Antibody,Intravascular Cytomegalovirus IgM Antibody Test
1256,Cytomegalovirus IgM Antibody,Blood Cytomegalovirus IgM Antibody Test
1257,Dentition:behavior,Assessment of Family Behavior Related to Dentition
1258,Dentition:behavior,Assessment of Patient Behavior Related to Dentition
1259,Dentition:knowledge,Assessment of Family Knowledge Related to Dentition
1260,Dentition:knowledge,Assessment of Patient Knowledge Related to Dentition
1261,Dentition:status,Assessment of Family Status Related to Dentition
1262,Dentition:status,Assessment of Patient Status Related to Dentition
1263,Digestion-hydration:behavior,Assessment of Family Behavior Related to Digestion-hydration
1264,Digestion-hydration:behavior,Assessment of Patient Behavior Related to Digestion-hydration
1265,Digestion-hydration:knowledge,Assessment of Family Knowledge Related to Digestion-hydration
1266,Digestion-hydration:knowledge,Assessment of Patient Knowledge Related to Digestion-hydration
1267,Digestion-hydration:status,Assessment of Family Status Related to Digestion-hydration
1268,Digestion-hydration:status,Assessment of Patient Status Related to Digestion-hydration
1269,Direct reacting bilirubin,Intravascular Direct (Conjugated) Bilirubin Test
1270,Direct reacting bilirubin,Plasma Direct (Conjugated) Bilirubin Test
1271,Direct reacting bilirubin,Serum conjugated bilirubin measurement
1272,deoxyribonuclease B,Dnase B Test
1273,Dressing-grooming self-care deficit,Assessment of Patient Status Related to Dressing/grooming Deficit
1274,Echinococcus species antibody,Intravascular Echinococcus Antibody Test
1275,Emotional Stability:behavior,Assessment of Family Behavior Related to Emotional Stability
1276,Emotional Stability:behavior,Assessment of Patient Behavior Related to Emotional Stability
1277,Emotional Stability:knowledge,Assessment of Family Knowledge Related to Emotional Stability
1278,Emotional Stability:knowledge,Assessment of Patient Knowledge Related to Emotional Stability
1279,Emotional Stability:status,Assessment of Family Status Related to Emotional Stability
1280,Emotional Stability:status,Assessment of Patient Status Related to Emotional Stability
1281,Endomysial IgA Antibody,Endomysial IgA Antibody Test
1282,Enterovirus antibody,Measurement of enterovirus antibody
1283,Epinephrine induced platelet aggregation,Platelet Epinhephrine Aggregation Test
1284,Epstein-Barr Virus Nuclear Antigens,Epstein Barr Nuclear Antigen Test
1285,Epstein-Barr virus antibody,Epstein Barr Virus (EBV) Antibody Titer Test
1286,Epstein-Barr virus antibody,Intravascular Epstein Barr Virus (EBV) Ab Test
1287,Epstein-Barr virus antibody,Blood Epstein Barr Virus Antibody Test
1288,Epstein Barr Virus IgA Antibody,Serum Epstein Barr Virus IgA Antibody Test
1289,Epstein Barr Virus IgG Antibody,Serum Epstein Barr Virus IgG Antibody Test
1290,Epstein Barr Virus IgM Antibody,Serum Epstein Barr Virus IgM Antibody Test
1291,Mean corpuscular hemoglobin concentration determination,Whole Blood Mean Red Cell Hemoglobin Concentration Test
1292,Finding of Mean Corpuscular Hemoglobin,Whole Blood Mean Red Cell Hemoglobin Test
1293,Erythrocyte Size Distribution,Rdw Test
1294,Erythrocytes,Heinz body screen
1295,Erythrocytes,Howell Jolly Bodies Test
1296,Erythrocytes,Red Blood Cell Count measurement
1297,Erythropoietin,Intravascular Erythropoietin Test
1298,Explicit Microorganism Result,Direct Exam Test
1299,Explicit Microorganism Result,Ehrlichia HGE DNA Test
1300,Explicit Microorganism Result,Enterovirus DNA assay (procedure)
1301,Explicit Microorganism Result,Hepatitis C virus genotype determination
1302,Explicit Microorganism Result,"Hbv DNA Test, Quant"
1303,Explicit Microorganism Result,Hbv DNA Test
1304,Explicit Microorganism Result,Hhv6 DNA Test
1305,Explicit Microorganism Result,"Hsv DNA Test, CSF"
1306,Explicit Microorganism Result,Hsv DNA Test
1307,Explicit Microorganism Result,Hsv Shell Vial Test
1308,Explicit Microorganism Result,Hsv1 DNA Test
1309,Explicit Microorganism Result,Hsv2 DNA Test
1310,Explicit Microorganism Result,Influenza A Dfa Test
1311,Explicit Microorganism Result,Influenza B Dfa Test
1312,Explicit Microorganism Result,"Intravascular Cmv Test, Quantitative"
1313,Explicit Microorganism Result,Intravascular Cmv Viral Load Test
1314,Explicit Microorganism Result,"Intravascular EBV,PCR Test"
1315,Explicit Microorganism Result,Intravascular HIV 1 Viral Load Test: Copies
1316,Explicit Microorganism Result,Intravascular Hiv1 Viral Load: Log Copies
1317,Explicit Microorganism Result,Jc Virus DNA Test
1318,Explicit Microorganism Result,Lyme DNA Test Blood
1319,Explicit Microorganism Result,Lyme DNA Test CSF
1320,Explicit Microorganism Result,Misc Direct Exam Test
1321,Explicit Microorganism Result,"Mycoplasma, Ureaplasma and Legionella Cultures"
1322,Explicit Microorganism Result,Parainfluenza 1 Dfa Test
1323,Explicit Microorganism Result,Parainfluenza 2 Dfa Test
1324,Explicit Microorganism Result,Parainfluenza 3 Dfa Test
1325,Explicit Microorganism Result,Detection of parasite
1326,Explicit Microorganism Result,Parvo B19 Pcr Test
1327,Explicit Microorganism Result,Rsv Dfa Test
1328,Explicit Microorganism Result,Sexually Transmitted Diseases Screen Test
1329,Explicit Microorganism Result,Single Result Viral Test
1330,Explicit Microorganism Result,Single-Result Organism Test
1331,Explicit Microorganism Result,Specimen for Colony Count Test
1332,Explicit Microorganism Result,Specimen for Culture Test
1333,Explicit Microorganism Result,Specimen for Organism Test
1334,Explicit Microorganism Result,Stains & Preparations Direct Exam Test
1335,Explicit Microorganism Result,Tropheryma Whippelii DNA Test
1336,Explicit Microorganism Result,Urine Bk Virus DNA Test
1337,Explicit Microorganism Result,Urine Jc Virus DNA Test
1338,Explicit Microorganism Result,Urinehistoplasma Antigen Test
1339,Explicit Microorganism Result,Viral Direct Exam Test
1340,Explicit Microorganism Result,Viral Hemadsorption Test
1341,Explicit Microorganism Result,"Vzv DNA Test, CSF"
1342,Explicit Microorganism Result,Vzv Shell Vial Test
1343,Explicit Microorganism Result,Babesia DNA Test
1344,Explicit Microorganism Result,Bartonella DNA Test
1345,Explicit Microorganism Result,Adenovirus Dfa Test
1346,Explicit Microorganism Result,"CSF Evb,pcr,csf Test"
1347,Explicit Microorganism Result,Chlamydia culture
1348,Explicit Microorganism Result,Chlamydia Immunofluorescence Test
1349,Explicit Microorganism Result,Cmv Shell Vial Test
1350,Family Planning:behavior,Assessment of Family Behavior Related to Family Planning
1351,Family Planning:behavior,Assessment of Patient Behavior Related to Family Planning
1352,Family Planning:status,Assessment of Family Status Related to Family Planning
1353,Family Planning:status,Assessment of Patient Status Related to Family Planning
1354,Alteration in family processes (finding),Assessment of Patient Status Related to Family Process Alteration
1355,Febrile Agglutinin,Febrile Agglutinins Test
1356,Fibrin fragment D,Ddimer Test
1357,Fibrin split products,Fibrinogen degradation product screening
1358,Fibrin split products,Operating Room Misc Labs: Fib/Fsp
1359,Calcium ion,Intravascular Ionized Calcium Test
1360,Calcium ion,Operating Room Misc Labs: Ica
1361,Calcium ion,Plasma Ionized Calcium Test
1362,Calcium ion,Whole Blood Ionized Calcium Test
1363,Free thyroxin,Intravascular Free Thyroxine Index Test
1364,galactose-1-phosphate,Plasma Galactose-1-Phosphate Test
1365,Gamma-glutamyl transferase,Serum Gamma-Glutamyltransferase Test
1366,Gamma-glutamyl transferase,Plasma Gamma-Glutamyltransferase Test
1367,Gamma-glutamyl transferase,Serum Gamma-Glutamyltransferase Test
1368,Gd1a Antibody,Anti-Gd1a Test
1369,Gd1b Antibody,Anti-Gd1b Test
1370,Genito-urinary Function:knowledge,Assessment of Family Knowledge Related to Genito-urinary Function
1371,Genito-urinary Function:knowledge,Assessment of Patient Knowledge Related to Genito-urinary Function
1372,Genito-urinary Function:status,Assessment of Family Status Related to Genito-urinary Function
1373,Genito-urinary Function:status,Assessment of Patient Status Related to Genito-urinary Function
1374,Giardia lamblia antibody,Giardia lamblia antibody test
1375,Giardia lamblia antigen,Giardia lamblia antigen assay
1376,Gm1 Antibody,Anti-Gm1 Test
1377,Gonococcal DNA,Gonococcal DNA Probe Test
1378,Gq1b Antibody,Anti-Gq1b Test
1379,Granular Casts in Urine,Urine Granular Cast Test
1380,Grief:behavior,Assessment of Family Behavior Related to Grief
1381,Grief:behavior,Assessment of Patient Behavior Related to Grief
1382,Grief:knowledge,Assessment of Family Knowledge Related to Grief
1383,Grief:knowledge,Assessment of Patient Knowledge Related to Grief
1384,Grief:status,Assessment of Family Status Related to Grief
1385,Grief:status,Assessment of Patient Status Related to Grieving
1386,Childhood growth AND/OR development alteration,Assessment of Patient Status Related to Growth & Development Alteration
1387,Growth and Development:behavior,Assessment of Family Behavior Related to Growth and Development
1388,Growth and Development:behavior,Assessment of Patient Behavior Related to Growth and Development
1389,Growth and Development:knowledge,Assessment of Family Knowledge Related to Growth and Development
1390,Growth and Development:knowledge,Assessment of Patient Knowledge Related to Growth and Development
1391,Growth and Development:status,Assessment of Family Status Related to Growth and Development
1392,Growth and Development:status,Assessment of Patient Status Related to Growth and Development
1393,Blood group antigen H,Salmonella H Antigen Test
1394,Hatts Antibody,Hatts-Abs Test
1395,Health Care Supervision:behavior,Assessment of Family Behavior Related to Health Care Supervision
1396,Health Care Supervision:behavior,Assessment of Patient Behavior Related to Health Care Supervision
1397,Health Care Supervision:knowledge,Assessment of Family Knowledge Related to Health Care Supervision
1398,Health Care Supervision:knowledge,Assessment of Patient Knowledge Related to Health Care Supervision
1399,Health Care Supervision:status,Assessment of Family Status Related to Health Care Supervision
1400,Health Care Supervision:status,Assessment of Patient Status Related to Health Care Supervision
1401,Health seeking behavior alteration,Assessment of Patient Status Related to Health-seeking Behavior Alteration
1402,Hearing:behavior,Assessment of Family Behavior Related to Hearing
1403,Hearing:behavior,Assessment of Patient Behavior Related to Hearing
1404,Hearing:knowledge,Assessment of Family Knowledge Related to Hearing
1405,Hearing:knowledge,Assessment of Patient Knowledge Related to Hearing
1406,Hearing:status,Assessment of Family Status Related to Hearing
1407,Hearing:status,Assessment of Patient Status Related to Hearing
1408,Helicobacter pylori antibody,Helicobacter pylori antibody Test
1409,Anisocyte (cell),Whole Blood Anisocyte Counts
1410,Hepatitis B Antibodies,Intravascular Hepatitis B Antibody Test
1411,Hepatitis B Antibodies,Blood Hepatitis B Antibody Test
1412,Hepatitis B Antigens,Hepatitis B Viral Antigen Test
1413,Hepatitis B e Antigens,Hepatitis Be antigen measurement
1414,Hepatitis C Antibodies,Intravascular Hepatitis C Antibody Test
1415,Hepatitis Delta (D) Virus Antibodies,Hepatitis Delta Antibody Test
1416,Antepartum/postpartum:behavior,Assessment of Family Behavior Related to Antepartum/postpartum
1417,Antepartum/postpartum:behavior,Assessment of Patient Behavior Related to Antepartum/postpartum
1418,Hepatitis E Virus IgG Antibodies (2),Intravascular Hepatitis E IgG Test
1419,Hepatitis E virus IgM,Intravascular Hepatitis E IgM Test
1420,Hepatitis Antibodies,Intravascular Hepatitis Antibody Test
1421,Hepatitis Antibodies,Intravascular Hepatitis E Antibody Test
1422,Hepatitis Antibodies,Blood Viral Hepatitis Antibody Test
1423,Human herpes simplex virus antibody,Herpes EIA Test
1424,Human herpes simplex virus antibody,Herpes Simplex Virus Type I Test
1425,Human herpes simplex virus antibody,Herpes Simplex Virus Type II Test
1426,Human herpes simplex virus antibody,Herpes Simplex Viruses IgG Test
1427,Human herpes simplex virus antibody,Herpes Simplex Viruses IgM Test
1428,Human herpes simplex virus antibody,Intravascular Herpes Simplex Viruses Test
1429,Antepartum/postpartum:knowledge,Assessment of Family Status Related to Antepartum/postpartum
1430,Antepartum/postpartum:knowledge,Assessment of Patient Status Related to Antepartum/postpartum
1431,Hexacarboxylporphyrin,24 Hours Urine Hexacarboxylporphyrin Test
1432,Histoplasmosis Antibody,Intravascular Histoplasmosis Antibody Test
1433,HLA-B27 Antigen,Intravascular Hla-B27 Test
1434,Antepartum/postpartum:status,Assessment of Family Knowledge Related to Antepartum/postpartum
1435,Antepartum/postpartum:status,Assessment of Patient Knowledge Related to Antepartum/postpartum
1436,HLA-DR Antigens,Ia (Hla-Dr) Test
1437,Neuronal nuclear type 1 antibody,Serum Hu Antibody Test
1438,Neuronal nuclear type 1 antibody,CSF Anti-Hu Test
1439,Human Immunodeficiency Virus 1 (HIV-1) Antibodies,Intravascular Confirmatory HIV-1 Test
1440,Human Immunodeficiency Virus 1 (HIV-1) Antibodies,Intravascular HIV 1 Antibody Test
1441,Human Immunodeficiency Virus 1 (HIV-1) Antibodies,Intravascular HIV-1 & HIV-2 Antibody Combo Test
1442,Human Immunodeficiency Virus 1 (HIV-1) Antibodies,Intravascular HIV-1-Only Antibody Test
1443,Human Immunodeficiency Virus 1 (HIV-1) Antibodies,Serum Human Immunodeficiency Virus 1 (HIV-1) Only Antibody Test
1444,Human Immunodeficiency Virus 2 (HIV-2 ) Antibodies,Intravascular HIV 2 Antibody Test
1445,Human Immunodeficiency Virus 2 (HIV-2 ) Antibodies,Intravascular HIV-1 & HIV-2 Antibody Combo Test
1446,Human Sexuality:behavior,Assessment of Family Behavior Related to Human Sexuality
1447,Human Sexuality:behavior,Assessment of Patient Behavior Related to Human Sexuality
1448,Human Sexuality:knowledge,Assessment of Family Knowledge Related to Human Sexuality
1449,Human Sexuality:knowledge,Assessment of Patient Knowledge Related to Human Sexuality
1450,Ribosomal ribonucleoprotein antibody,Serum Anti Rnp Test
1451,Human Sexuality:status,Assessment of Family Status Related to Human Sexuality
1452,Human Sexuality:status,Assessment of Patient Status Related to Human Sexuality
1453,HTLV-I Antibodies,Measurement of Human T-lymphotropic virus 1 antibody
1454,Urine microscopy: hyaline casts (finding),Urine Hyaline Cast Test
1455,"Antibodies, Anticardiolipin",Serum Anticardiolipin Antibody Test
1456,"Antibodies, Anticardiolipin",Serum Anticardiolipin IgG Antibody Test
1457,"Antibodies, Anticardiolipin",Serum Anticardiolipin IgM Antibody Test
1458,Hypochromic erythrocyte,Whole Blood Hypochromic Erythrocyte Counts
1459,Centromere antibody,Serum Anti-Centromere Antibody Test
1460,IgG/Total Protein Ratio,IgG/Total Protein Ratio Calculations
1461,Income:behavior,Assessment of Family Behavior Related to Income
1462,Income:behavior,Assessment of Patient Behavior Related to Income
1463,Income:knowledge,Assessment of Family Knowledge Related to Income
1464,Income:knowledge,Assessment of Patient Knowledge Related to Income
1465,Income:status,Assessment of Family Status Related to Income
1466,Income:status,Assessment of Patient Status Related to Income
1467,Indirect reacting bilirubin,Intravascular Indirect (Unconjugated) Bilirubin Test
1468,Indirect reacting bilirubin,Serum Indirect (Unconjugated) Bilirubin Test
1469,Influenza A virus antibody,Intravascular Influenza A Antibody Test
1470,Influenza antibody,Intravascular Influenza Antibody Test
1471,Influenza antibody,Blood Influenza Antibody Measurement
1472,Influenza B virus antibody,Intravascular Influenza B Antibody Test
1473,Instrumental activity of daily living (IADLs) alteration,Assessment of Patient Status Related to Instrumental Activity of Daily Living Iadls) Alteration
1474,Bovine insulin antibody,Serum Beef Insulin Antibody Test
1475,Human insulin antibody,Serum Human Insulin Antibody Test
1476,Insulin Pork Antibodies,Serum Pork Insulin Antibody Test
1477,anti-extractable nuclear antigen antibodies,Serum Anti-Ena Antibody Test
1478,Integument:behavior,Assessment of Family Behavior Related to Integument
1479,Integument:behavior,Assessment of Patient Behavior Related to Integument
1480,Integument:knowledge,Assessment of Family Knowledge Related to Integument
1481,Integument:knowledge,Assessment of Patient Knowledge Related to Integument
1482,Integument:status,Assessment of Family Status Related to Integument
1483,Integument:status,Assessment of Patient Status Related to Integument
1484,Interpersonal Relationship:behavior,Assessment of Family Behavior Related to Interpersonal Relationship
1485,Interpersonal Relationship:behavior,Assessment of Patient Behavior Related to Interpersonal Relationship
1486,Interpersonal Relationship:knowledge,Assessment of Family Knowledge Related to Interpersonal Relationship
1487,Interpersonal Relationship:knowledge,Assessment of Patient Knowledge Related to Interpersonal Relationship
1488,Interpersonal Relationship:status,Assessment of Family Status Related to Interpersonal Relationship
1489,Interpersonal Relationship:status,Assessment of Patient Status Related to Interpersonal Relationship
1490,Intestine Alkaline Phosphatase,Serum Intestine Alkaline Phosphatase Test
1491,Gliadin antibody,Intravascular Gliadin IgA Antibody Test
1492,Gliadin antibody,Intravascular Gliadin IgG Antibody Test
1493,Histone antibody,Serum Anti-Histone Antibody Test
1494,Jo-1 antibody,Anti Jo-1 Test
1495,Jo-1 antibody,Anti-Jo-1 Spinal Fluid Test
1496,Jo-1 antibody,Serum Anti Jo-1 Test
1497,Anti-Microsomal Antibody,Serum Anti-Microsomal Antibody Test
1498,Parietal cell antibody,Anti-Parietal Cell Antibodies Test
1499,Anti-Scl70 Antibody,Anti-Scl70 Antibody Test
1500,Antibody to Smith Antigen,Serum Anti Sm Test
1501,Anti-Yo Antibody,Serum Anti-Yo Antibody Test
1502,Thyroid microsomal antibodies,Intravascular Anti-thyroid Peroxidase Antibodies Test
1503,Thyroid microsomal antibodies,Serum Anti-Thyroid Peroxidase Antibodies Test
1504,Antibody to hepatitis Be antigen,Intravascular Hepatitis B E-Antibody Test
1505,Antibody to hepatitis B core antigen,Intravascular Hepatitis B Core Antibody Test
1506,"Antibody to Hepatitis Surface Antigen, Hbsag1",Intravascular Hepatitis B Surface Antibody Test
1507,Antineutrophil Cytoplasmic Antibodies,Anti-Cytoplasmic Neutrophil Antibodies Test
1508,Antineutrophil Cytoplasmic Antibodies,P-Anca Titer Test
1509,Antineutrophil Cytoplasmic Antibodies,Serum Anti-Neutrophil Cytoplasmic Antibody Test
1510,Antineutrophil Cytoplasmic Antibodies,C-Anca Titer Test
1511,Vasopressin (USP),Intravascular Anti-Diuretic Hormone Test
1512,Antierythrocyte Antibody,Blood Antierythrocyte Antibody Test
1513,Antiproteus Antibodies,Blood Antiproteus Antibody Measurement
1514,Antiproteus OX-19 Antibodies,Blood Antiproteus OX-19 Test
1515,Intrinsic factor antibody,Intrinsic factor antibody measurement
1516,Antiproteus OX-2 Antibodies,Blood Antiproteus OX-2 Test
1517,Immunoglobulin kappa-Chains,Kappa Chain Test
1518,Ketogenic Steroids,24 Hour Urine Ketogenic Steroid Test
1519,Ketogenic Steroids,Urine Ketogenic Steroids Test
1520,Antiproteus OX-K Antibodies,Blood Antiproteus OX-K Test
1521,Lactic acid dehydrogenase isoenzyme 2,Serum Lactate Dehydrogenase Isoenzyme 2 Test
1522,Lactic acid dehydrogenase isoenzyme 3,Serum Lactate Dehydrogenase Isoenzyme 3 Test
1523,Lactic acid dehydrogenase isoenzyme 4,Serum Lactate Dehydrogenase Isoenzyme 4 Test
1524,Lactic acid dehydrogenase isoenzyme 5,Serum Lactate Dehydrogenase Isoenzyme 5 Test
1525,Immunoglobulin lambda-Chains,Lambda Chain Test
1526,Legionella antibody,Intravascular Legionella Antibody Test
1527,Thyroglobulin antibody,Intravascular Antithyroglobulin Antibody Test
1528,Thyroglobulin antibody,Serum Antithyroglobulin Test
1529,Leptospira species antibody,Leptospira antibody assay
1530,Leptospira species antibody,Serum Leptospira Antibody Test
1531,Leptospira species antibody,Blood Leptospira Agglutination Measurement
1532,Leukocyte alkaline phosphatase,Leuk.Alk.P'Tase Test
1533,Leukocyte alkaline phosphatase,Leukocyte Alkaline Phosphatase with Count
1534,Antitreponemal Antibodies,Serum Anti Treponemal Antibody Test
1535,Leucocyte esterase,Qualitative Urine Leukocyte Esterase Test
1536,Leucocyte esterase,Backoffice Urine Leukocyte Esterase Test
1537,Lupus erythematosus cell,Whole Blood LE Cell Test
1538,Borrelia burgdorferi antibody,Lyme Ab Patient OD Test
1539,Borrelia burgdorferi antibody,Lyme Ab Rea.Cut-Off: Test
1540,Borrelia burgdorferi antibody,Lyme Antibody Test
1541,Borrelia burgdorferi antibody,Lyme IgG Test
1542,Borrelia burgdorferi antibody,Lyme IgM Test
1543,Borrelia burgdorferi antibody,Lyme Wb IgG Band Test
1544,Borrelia burgdorferi antibody,Lyme Wb IgG Result Test
1545,Borrelia burgdorferi antibody,Lyme Wb IgM Band Test
1546,Borrelia burgdorferi antibody,Lyme Wb IgM Result Test
1547,Borrelia burgdorferi antibody,Lyme Western Blot Components Test
1548,Borrelia burgdorferi antibody,Lyme Western Blot IG Bands Test
1549,Borrelia burgdorferi antibody,Lyme Western Blot IG Results Test
1550,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi 1gg 18kd
1551,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgG 23kd
1552,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgG 28kd
1553,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgG 30kd
1554,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgG 39kd
1555,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgG 41kd
1556,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgG 45kd
1557,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgG 58kd
1558,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgG 66kd
1559,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgG 93kd
1560,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgG Interp
1561,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgM 23kd
1562,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgM 39kd
1563,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgM 41kd
1564,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgM Interp
1565,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi Interp
1566,Borrelia burgdorferi antibody,Blood Lyme Antibody Test
1567,Borrelia burgdorferi antibody,Total Lyme Antibody Test
1568,Borrelia burgdorferi antibody,Western Blot Lyme Antibody Test
1569,Borrelia burgdorferi antibody,B.burgd 18kd(igg) Test
1570,Borrelia burgdorferi antibody,B.burgd 23kd(igg) Test
1571,Borrelia burgdorferi antibody,B.burgd 23kd(igm) Test
1572,Borrelia burgdorferi antibody,B.burgd 28kd(igg) Test
1573,Borrelia burgdorferi antibody,B.burgd 30kd(igg) Test
1574,Borrelia burgdorferi antibody,B.burgd 39kd(igg) Test
1575,Borrelia burgdorferi antibody,B.burgd 39kd(igm) Test
1576,Borrelia burgdorferi antibody,B.burgd 41kd(igg) Test
1577,Borrelia burgdorferi antibody,B.burgd 41kd(igm) Test
1578,Borrelia burgdorferi antibody,B.burgd 45kd(igg) Test
1579,Borrelia burgdorferi antibody,B.burgd 58kd(igg) Test
1580,Borrelia burgdorferi antibody,B.burgd 66kd(igg) Test
1581,Borrelia burgdorferi antibody,B.burgd 93kd(igg) Test
1582,Borrelia burgdorferi antibody,B.burgd Ab(igg) Test
1583,Borrelia burgdorferi antibody,B.burgd Ab(igm) Test
1584,Borrelia burgdorferi antibody,B.burgd Interp(igg) Test
1585,Borrelia burgdorferi antibody,B.burgd Interp(igm) Test
1586,Borrelia burgdorferi antibody,B.burgd Interpretation Test
1587,Borrelia burgdorferi antibody,Blood Lyme Antibody Test
1588,Borrelia burgdorferi antibody,CSF Lyme Antibody Test
1589,Lyme IgG Antibody,Borrelia burgdorferi IgG antibody test
1590,Lyme IgM Antibody,Serum IgM Lyme Antibody Test
1591,Lyme IgM Antibody,Blood Lyme IgM Antibody Test
1592,Lymphocytic choriomeningitis virus antibody,lymphocytic choriomeningitis antibody assay (lab test)
1593,Lymphogranuloma Venereum Antibodies,Lymphogranuloma venereum antibody assay
1594,Myelin-Associated Glycoprotein Antibody,Anti-Mag Test
1595,Malaria antibody,Malaria Antibodies Test
1596,Mature Erythrocytes,Unspecified Fluid Erythrocyte Test
1597,Mature Erythrocytes,Urine Erythrocyte Count
1598,Mature Erythrocytes,Whole Blood Mature Erythrocyte Counts
1599,Mesothelial cell,Body Fluid Mesothelial Cell Test
1600,methionine sulfoxide,Intravascular Methionine Sulfoxide Test
1601,methionine sulfoxide,Methionine Sulfoxide Test
1602,methionine sulfoxide,Plasma Methionine Sulfoxide Test
1603,methionine sulfoxide,Urine Methionine Sulfoxide Test
1604,Nongranular leukocyte,Intravascular CD45+(LYMPHOCYTES) Test
1605,Nongranular leukocyte,Mononucleated Cell Body Fluid Test
1606,Nongranular leukocyte,Unspecified Fluid Mononuclear Test
1607,Nongranular leukocyte,Whole Blood Mononucleated Cell Count
1608,Nongranular leukocyte,Whole Blood Percent Cd45+14+ Mononucleated Cell Counts
1609,Nongranular leukocyte,Body Fluid Lg Imm Mononuclear Test
1610,Nongranular leukocyte,Body Fluid Lg Mononuclear Test
1611,Nongranular leukocyte,Body Fluids Mononuclear Test
1612,Mumps virus antibody,Mumps Antibody Test
1613,Muramidase,NYH Lab Procedure: Lysozyme
1614,Muramidase,Urine Muramidase (Lysozyme) Test
1615,Mycoplasma Ag,Mycoplasma CF Test
1616,Mycoplasma pneumoniae antibody,Mycoplasma Pneumoniae IgM Antibody Test
1617,Mycoplasma pneumoniae DNA,Mycoplasma Pneumoniae DNA Probe Test
1618,Myelin Basic Proteins,"Myelin basic protein measurement, spinal fluid"
1619,N-telopeptide,Random Urine N-Telopeptide Test
1620,N-telopeptide,Timed Urine N-Telopeptide Testa
1621,N-telopeptide,Urine N-Telopeptide Test
1622,Neglected Child/adult:behavior,Assessment of Family Behavior Related to Neglected Child/adult
1623,Neglected Child/adult:behavior,Assessment of Patient Behavior Related to Neglected Child/adult
1624,Neglected Child/adult:knowledge,Assessment of Family Knowledge Related to Neglected Child/adult
1625,Neglected Child/adult:knowledge,Assessment of Patient Knowledge Related to Neglected Child/adult
1626,Neglected Child/adult:status,Assessment of Family Status Related to Neglected Child/adult
1627,Neglected Child/adult:status,Assessment of Patient Status Related to Neglected Child/adult
1628,Neighborhood/workplace Safety:behavior,Assessment of Family Behavior Related to Neighborhood/workplace Safety
1629,Neighborhood/workplace Safety:behavior,Assessment of Patient Behavior Related to Neighborhood/workplace Safety
1630,Neighborhood/workplace Safety:knowledge,Assessment of Family Knowledge Related to Neighborhood/workplace Safety
1631,Neighborhood/workplace Safety:knowledge,Assessment of Patient Knowledge Related to Neighborhood/workplace Safety
1632,Neighborhood/workplace Safety:status,Assessment of Family Status Related to Neighborhood/workplace Safety
1633,Neighborhood/workplace Safety:status,Assessment of Patient Status Related to Neighborhood/workplace Safety
1634,Neuro-musculo-skeletal Function:behavior,Assessment of Family Behavior Related to Neuro-musculo-skeletal Function
1635,Neuro-musculo-skeletal Function:behavior,Assessment of Patient Behavior Related to Neuro-musculo-skeletal Function
1636,Neuro-musculo-skeletal Function:knowledge,Assessment of Family Knowledge Related to Neuro-musculo-skeletal Function
1637,Neuro-musculo-skeletal Function:knowledge,Assessment of Patient Knowledge Related to Neuro-musculo-skeletal Function
1638,Neuro-musculo-skeletal Function:status,Assessment of Family Status Related to Neuro-musculo-skeletal Function
1639,Neuro-musculo-skeletal Function:status,Assessment of Patient Status Related to Neuro-musculo-skeletal Function
1640,Nk Lymphocyte,Whole Blood Absolute Nk Lymphocyte Counts
1641,Nk Lymphocyte,Whole Blood Nk Lymphocyte Counts
1642,Nk Lymphocyte,Whole Blood Percent Nk Lymphocyte Counts
1643,Noncompliance with diagnostic testing,Assessment of Patient Status Related to Noncompliance with Diagnostic Test
1644,Noncompliance with dietary regimen,Assessment of Patient Status Related to Noncompliance with Dietary Regimen
1645,Noncompliance with Fluid Volume,Assessment of Patient Status Related to Noncompliance with Fluid Volume
1646,Medication Nonadherence,Assessment of Patient Status Related to Noncompliance with Medication Regimen
1647,Actual Non Adherence To Safety Precautions,Assessment of Patient Status Related to Noncompliance with Safety Precautions
1648,Noncompliance with therapeutic regimen,Assessment of Patient Status Related to Noncompliance with Therapeutic Regimen
1649,Nutrition:behavior,Assessment of Family Behavior Related to Nutrition
1650,Nutrition:behavior,Assessment of Patient Behavior Related to Nutrition
1651,Nutrition:knowledge,Assessment of Family Knowledge Related to Nutrition
1652,Nutrition:knowledge,Assessment of Patient Knowledge Related to Nutrition
1653,Nutritional status,Assessment of Family Status Relaed to Nutrition
1654,Nutritional status,Assessment of Patient Status Relaed to Nutrition
1655,Octacarboxylorphyrin,Random Urine Octacarboxyporphyrin Test
1656,Octacarboxylorphyrin,24 Hours Urine Octacarboxyporphyrin Test
1657,Okt3 Lymphocyte,Whole Blood Absolute Okt3 Lymphocyte Counts
1658,Okt3 Lymphocyte,Whole Blood Okt3 Lymphocyte Counts
1659,Okt3 Lymphocyte,Whole Blood Percent Okt3 Lymphocyte Counts
1660,Optical density units,Amniotic Fluid Optical Density Measurements
1661,Orthochromic normoblast (cell),Bm Ortho.Normoblast Test
1662,Osmolitic Fragility,Direct Osmotic Fragility Test
1663,Osmolitic Fragility,Hemolysin acid test
1664,Osmolitic Fragility,Indirect Osmotic Fragility Test
1665,Osmolitic Fragility,Osmotic Fragility test
1666,Pain:behavior,Assessment of Family Behavior Related to Pain
1667,Pain:behavior,Assessment of Patient Behavior Related to Pain
1668,Pain:knowledge,Assessment of Family Knowledge Related to Pain
1669,Pain:knowledge,Assessment of Patient Knowledge Related to Pain
1670,Pain:status,Assessment of Family Status Related to Pain
1671,Pain:status,Assessment of Patient Status Related to Pain
1672,Pancreatic-Islet Antibodies,Pancreatic-Islet Antibodies Test
1673,Parainfluenza virus Ab,Intravascular Parainfluenza Ab Test
1674,Parainfluenza virus Ab,Intravascular Parainfluenza Ab Test
1675,Parainfluenza virus Ab,Intravascular Parainfluenza Type 1 Ab Measurements
1676,Parainfluenza virus Ab,Intravascular Parainfluenza Type 2 Ab Measurements
1677,Parainfluenza virus Ab,Intravascular Parainfluenza Type 3 Ab Measurements
1678,Parainfluenza virus Ab,Intravascular Parainfluenza Types Ab Test
1679,Parainfluenza virus Ab,Blood Parainfluenza Antibody Test
1680,Parainfluenza virus Ab,Blood Parainfluenza Antibody Test
1681,Aspergillus Antibody (substance),Intravascular Aspergillus Antibody Test
1682,Aspergillus Antibody (substance),Intravascular Aspergillus Flavus Ab Test
1683,Aspergillus Antibody (substance),Intravascular Aspergillus Fumigatus (2) Ab Test
1684,Aspergillus Antibody (substance),Intravascular Aspergillus Niger Ab Test
1685,carboxyl-terminal parathyroid hormone,Intravascular Pth C-Terminal Test
1686,carboxyl-terminal parathyroid hormone,Serum Pth C-Terminal/Midregion Test
1687,amino-terminal parathyroid hormone,Intravascular Pth N-Terminal Test
1688,amino-terminal parathyroid hormone,Serum Pth N-Terminal Test
1689,parathyroid hormone-related protein,Serum Pth Related Protein Test
1690,Human parvovirus B19 antibody,Parvovirus B19 IgG Test
1691,Human parvovirus B19 antibody,Parvovirus B19 IgM measurement
1692,Human parvovirus B19 antibody,Parvovirus B19 Test
1693,Pentacarboxylporphyrin,Random Urine Pentacarboxyporphyrin Test
1694,Pentacarboxylporphyrin,24 Hours Urine Pentacarboxyporphyrin Test
1695,Personal Hygiene:behavior,Assessment of Family Behavior Related to Personal Hygiene
1696,Personal Hygiene:behavior,Assessment of Patient Behavior Related to Personal Hygiene
1697,Personal Hygiene:knowledge,Assessment of Family Knowledge Related to Personal Hygiene
1698,Personal Hygiene:knowledge,Assessment of Patient Knowledge Related to Personal Hygiene
1699,Personal Hygiene:status,Assessment of Family Status Related to Personal Hygiene
1700,Personal Hygiene:status,Assessment of Patient Status Related to Personal Hygiene
1701,Physical activity behavior,Assessment of Family Behavior Related to Physical Activity
1702,Physical activity behavior,Assessment of Patient Behavior Related to Physical Activity
1703,Physical Activity:knowledge,Assessment of Family Knowledge Relate to Physical Activity
1704,Physical Activity:knowledge,Assessment of Patient Knowledge Related to Physical Activity
1705,Physical Activity:status,Assessment of Family Status Related to Physical Activity
1706,Physical Activity:status,Assessment of Patient Status Related to Physical Activity
1707,Plasma Clot Lysis,Intravascular Euglobulin Lysis Test
1708,Platelet Size,Mean Platelet Volume Test
1709,Platelet Size,Platelet Size Measurements
1710,Pneumocystis Carinii Antibodies,Pneumocystis Carinii Antibodies Test
1711,Polychromatocyte,Whole Blood Polychromatocyte Counts
1712,Polychromic Normoblast,Bm Poly.Normoblast Test
1713,Post-trauma response,Assessment of Patient Status Related to Post-trauma Response
1714,Prescribed Medication Regimen:behavior,Assessment of Family Behavior Related to Prescribed Medication Regimen
1715,Prescribed Medication Regimen:behavior,Assessment of Patient Behavior Related to Prescribed Medication Regimen
1716,Prescribed Medication Regimen:knowledge,Assessment of Family Knowledge Related to Prescribed Medication Regimen
1717,Prescribed Medication Regimen:knowledge,Assessment of Patient Knowledge Related to Prescribed Medication Regimen
1718,Prescribed Medication Regimen:status,Assessment of Family Status Related to Prescribed Medication Regimen
1719,Prescribed Medication Regimen:status,Assessment of Patient Status Related to Prescribed Medication Regimen
1720,At risk of pressure ulcer,Braden Pressure Ulcer Risk Assessment
1721,Antigen to protein S (substance),Protein S antigen measurement
1722,Protein S,Protein s Activitiy Test
1723,Coxiella burnetii antibody,Q Fever Antibodies Test
1724,Reagins,Indirect Serologic Test for Syphilis (Reagin / VDRL Test)
1725,Reagins,Rapid Plasma Reagin (Rpr) Measurement
1726,Reagins,CSF VDRL Test
1727,Red Blood Cell Casts in Urine,Urine Erythrocyte Cast Test
1728,Red blood cell morphology result,Red Blood Cell Morphology Test
1729,Residence:behavior,Assessment of Family Behavior Related to Residence
1730,Residence:behavior,Assessment of Patient Behavior Related to Residence
1731,Residence:knowledge,Assessment of Family Knowledge Related to Residence
1732,Residence:knowledge,Assessment of Patient Knowledge Related to Residence
1733,Residence:status,Assessment of Family Status Related to Residence
1734,Residence:status,Assessment of Patient Status Related to Residence
1735,Respiration:behavior,Assessment of Family Behavoir Related to Respiration
1736,Respiration:behavior,Assessment of Patient Behavoir Related to Respiration
1737,Respiration:knowledge,Assessment of Family Knowledge Related to Respiration
1738,Respiration:knowledge,Assessment of Patient Knowledge Related to Respiration
1739,Respiration:status,Assessment of Family Status Related to Respiration
1740,Respiration:status,Assessment of Patient Status Related to Respiration
1741,Respiratory syncytial virus antigen,RSV antigen level
1742,Reticulin antibody,Reticulin antibody measurement
1743,Antigen in Rh blood group system,Whole Blood ABO & Rh Test
1744,Antigen in Rh blood group system,Whole Blood Rh-Antigen Test
1745,Ristocetin induced platelet aggregation,Platelet aggregation with ristocetin test
1746,Role Change:behavior,Assessment of Family Behavior Related to Role Change
1747,Role Change:behavior,Assessment of Patient Behavior Related to Role Change
1748,Role Change:knowledge,Assessment of Family Knowledge Related to Role Change
1749,Role Change:knowledge,Assessment of Patient Knowledge Related to Role Change
1750,Role Change:status,Assessment of Family Status Related to Role Change
1751,Role Change:status,Assessment of Patient Status Related to Role Change
1752,rubella antibodies,Intravascular Rubella Antibody Test
1753,rubella antibodies,Rubella antibody screening
1754,rubella antibodies,Blood Rubella Antibodies Test
1755,Rubella IgG Antibody,Intravascular Rubella IgG Antibody Test
1756,Rubella IgG Antibody,Blood Rubella IgG Antibody Test
1757,Rubella IgM Antibody,Intravascular Rubella IgM Antibody Test
1758,Rubella IgM Antibody,Blood Rubella IgM Antibody Test
1759,Salmonella Agglutinin Antibody,Blood Salmonella Agglutinin Antibody Measurement
1760,Salmonella Group A Agglutinin Antibody,Blood Salmonella Group A Agglutinin Antibody Test
1761,Salmonella Group B Agglutinin Antibody,Blood Salmonella Group B Agglutinin Antibody Test
1762,Salmonella Group C Agglutinin Antibody,Blood Salmonella Group C Agglutinin Antibody Test
1763,Salmonella Group D Agglutinin Antibody,Blood Salmonella Group D Agglutinin Antibody Test
1764,Sanitation:behavior,Assessment of Family Behavior Related to Sanitation
1765,Sanitation:behavior,Assessment of Patient Behavior Related to Sanitation
1766,Sanitation:knowledge,Assessment of Family Knowledge Related to Sanitation
1767,Sanitation:knowledge,Assessment of Patient Knowledge Related to Sanitation
1768,Sanitation:status,Assessment of Family Status Related to Sanitation
1769,Sanitation:status,Assessment of Patient Status Related to Sanitation
1770,Schistosoma species antibody,Schistosomiasis Antibodies Test
1771,Total self-care deficit,Assessment of Patient Status Related to Self-care Deficit
1772,Self-esteem disturbance,Assessment of Patient Status Related to Self-concept Alteration
1773,Drepanocyte (cell),Whole Blood Sickle Cell Test
1774,Situational low self-esteem,Assessment of Patient Status Related to Situational Self-esteem Disturbance
1775,Skin Integrity Alteration,Assessment of Patient Status Related to Skin Integrity Alteration
1776,Sleep and Rest Pattern:behavior,Assessment of Family Behavior Related to Sleep and Rest Pattern
1777,Sleep and Rest Pattern:behavior,Assessment of Patient Behavior Related to Sleep and Rest Pattern
1778,Sleep and Rest Pattern:knowledge,Assessment of Family Knowledge Related to Sleep and Rest Pattern
1779,Sleep and Rest Pattern:knowledge,Assessment of Patient Knowledge Related to Sleep and Rest Pattern
1780,Sleep and Rest Pattern:status,Assessment of Family Status Related to Sleep and Rest Pattern
1781,Sleep and Rest Pattern:status,Assessment of Patient Status Related to Sleep and Rest Pattern
1782,Social Contact:behavior,Assessment of Family Behavior Related to Social Contact
1783,Social Contact:behavior,Assessment of Patient Behavior Related to Social Contact
1784,Social Contact:knowledge,Assessment of Family Knowledge Related to Social Contact
1785,Social Contact:knowledge,Assessment of Patient Knowledge Related to Social Contact
1786,Social Contact:status,Assessment of Family Status Related to Social Contact
1787,Social Contact:status,Assessment of Patient Status Related to Social Contact
1788,Speech and Language:behavior,Assessment of Family Behavior Related to Speech and Language
1789,Speech and Language:behavior,Assessment of Patient Behavior Related to Speech and Language
1790,Speech and Language:knowledge,Assessment of Family Knowledge Related to Speech and Language
1791,Speech and Language:knowledge,Assessment of Patient Knowledge Related to Speech and Language
1792,Speech and Language:status,Assessment of Family Status Related to Speech and Language
1793,Speech and Language:status,Assessment of Patient Status Related to Speech and Language
1794,Spiritual Distress:behavior,Assessment of Family Behavior Related to Spiritual Distress
1795,Spiritual Distress:behavior,Assessment of Patient Behavior Related to Spiritual Distress
1796,Spiritual Distress:knowledge,Assessment of Family Knowledge Related to Spiritual Distress
1797,Spiritual Distress:knowledge,Assessment of Patient Knowledge Related to Spiritual Distress
1798,Spiritual Distress:status,Assessment of Family Status Related to Spiritual Distress
1799,Spiritual Distress:status,Assessment of Patient Status Related to Spiritual Distress
1800,Sporothrix species antibody,Sporothrix Antibodies Test
1801,SS A antibodies,Serum Anti-SSA Test
1802,SS-B antibodies,Serum Anti-SSB Test
1803,Stippled Erythrocyte,Whole Blood Stippled Erythrocyte Counts
1804,Substance Use:behavior,Assessment of Family Behavior Related to Substance Use
1805,Substance Use:behavior,Assessment of Patient Behavior Related to Substance Use
1806,Substance Use:knowledge,Assessment of Family Knowledge Related to Substance Use
1807,Substance Use:knowledge,Assessment of Patient Knowledge Related to Substance Use
1808,Substance Use:status,Assessment of Family Status Related to Substance Use
1809,Substance Use:status,Assessment of Patient Status Related to Substance Use
1810,Anti-sulfatide antibody,Intravascular Anti-Sulfatide Test
1811,T-Lymphocyte,Intravascular T Cell Interpretation
1812,T-Lymphocyte,T-Cell Lymphocyte Lymphocyte Counts
1813,T-Lymphocyte,Whole Blood Absolute Cd3+ Cell Count
1814,T-Lymphocyte,Whole Blood Absolute Total T-Cell Lymphocyte Counts
1815,T-Lymphocyte,Whole Blood Percent Total T-Cell Lymphocyte Counts
1816,T-Lymphocyte,Whole Blood Percentage Cd3+ Cell Counts
1817,T-Lymphocyte,Whole Blood Total T-Cell Lymphocyte Counts
1818,T-Lymphocyte,Cd2 (T11) T-Cell Test
1819,TSH receptor antibody,Intravascular TSH Receptor Antibodies Test
1820,Tacrolimus (Fk 506),Intravascular Tacrolimus Test
1821,Tacrolimus (Fk 506),Whole Blood Tacrolimus Test
1822,Leptocyte,Whole Blood Target Cell Counts
1823,tartrate-resistant acid phosphatase,Intravascular Tar.Res. Acid P'Tase Test
1824,tartrate-resistant acid phosphatase,Whole Blood Tar.Res. Acid P'Tase Test
1825,Technical Procedure:behavior,Assessment of Family Behavior Related to Technical Procedure
1826,Technical Procedure:behavior,Assessment of Patient Behavior Related to Technical Procedure
1827,Technical Procedure:knowledge,Assessment of Family Knowledge Related to Technical Procedure
1828,Technical Procedure:knowledge,Assessment of Patient Knowledge Related to Technical Procedure
1829,Technical Procedure:status,Assessment of Family Status Related to Technical Procedure
1830,Technical Procedure:status,Assessment of Patient Status Related to Technical Procedure
1831,Teichoic acid antibody,Whole Blood Teichoic Acid Antibody Test
1832,Tetracarboxylporphyrin,Random Urine Tetracarboxyporphyrin Test
1833,Tetracarboxylporphyrin,24 Hours Urine Tetracarboxyporphyrin Test
1834,Altered thought processes,Assessment of Patient Status Related to Thought Process Alteration
1835,Tissue factor induced coagulation,Calculation of international normalized ratio
1836,Tissue factor induced coagulation,"Operating Room Misc Labs: Pt,Pt/Control"
1837,Tissue factor induced coagulation,Plasma Control Prothrombin Test
1838,Tissue factor induced coagulation,Plasma Patient Prothrombin Test
1839,Tissue factor induced coagulation,Prothrombin time assay
1840,Toxicopathic Erythrocyte,Whole Blood Toxicopathic Erythrocyte Counts
1841,Toxocara antibody,Toxocara antibody measurement
1842,Toxoplasma species antibody,Intravascular Toxoplasma Gondii Antibody Test
1843,Toxoplasma species antibody,Intravascular Toxoplasma Gondii Antibody Titer Test
1844,Toxoplasma species antibody,Blood Toxoplasma Gondii Antibody Test
1845,Toxoplasma species antibody,CSF Toxoplasma Antibody Test
1846,Immunoglobulin G antibody to Toxoplasma gondii,Intravascular Toxoplasma Gondii IgG Antibody Test
1847,Immunoglobulin G antibody to Toxoplasma gondii,Blood Toxoplasma Gondii IgG Antibody Test
1848,Immunoglobulin M antibody to Toxoplasma gondii,Intravascular Toxoplasma Gondii IgM Antibody Test
1849,Immunoglobulin M antibody to Toxoplasma gondii,Blood Toxoplasma Gondii IgM Antibody Test
1850,Treponema pallidum,NYH Lab Term: Treponema Pallidum
1851,Treponema pallidum,Treponema Pallidum Test
1852,Trichinella species antibody,Intravascular Trichinella Antibody Test
1853,Tularemia Agglutinin,Tularemia Agglutinin Test
1854,Carbonyldiamide,Intravascular Urea Nitrogen Test
1855,Carbonyldiamide,Random Urine Urea Nitrogen Test
1856,Carbonyldiamide,Serum Urea Nitrogen Test
1857,Carbonyldiamide,24 Hour Urine Urea Test
1858,Carbonyldiamide,"Urea nitrogen measurement, urine"
1859,Carbonyldiamide,Whole Blood Urea Nitrogen Test
1860,Carbonyldiamide,Body Fluid Urea Test
1861,Carbonyldiamide,CHEM-7 Urea Nitrogen Measurement
1862,Urine Casts,Nonspecific Urine Cast Observation Test
1863,Urine Casts,Urine Cast Observation Test
1864,Varicella Antibody,Serum Varicella Antibody Test
1865,Very long chain fatty acid,Intravascular Very Long Chain Fatty Acids Test
1866,Vision:behavior,Assessment of Family Behavior Related to Vision
1867,Vision:behavior,Assessment of Patient Behavior Related to Vision
1868,Vision:knowledge,Assessment of Family Knowledge Related to Vision
1869,Vision:knowledge,Assessment of Patient Knowledge Related to Vision
1870,Vision:status,Assessment of Family Status Related to Vision
1871,Vision:status,Assessment of Patient Status Related to Vision
1872,Von Willebrand antigen,Plasma Ristocetin Cofactor Test
1873,Von Willebrand antigen,Plasma Von Willebrand Factor Antigen Test
1874,WBC Casts in Urine,Urine Leukocyte Cast Test
1875,Yersinia species antibody,Intravascular Yersinia Antibody Test
1876,Yersinia species antibody,Blood Yersinia Antibody Measurement
1877,Yersinia Type 3 Antibody,Intravascular Yersinia Type 3 Antibody Test
1878,Yersinia Type 5 Antibody,Intravascular Yersinia Type 5 Antibody Test
1879,Yersinia Type 8 Antibody,Intravascular Yersinia Type 8 Antibody Test
1880,3-methylhistidine,Intravascular 3-Methyl-Histidine Test
1881,Hydroxyindoleacetic Acid,24 Hour Urine Hydroxyindoleacetic Acid-5 Test
1882,Phosphogluconate Dehydrogenase,Glucose-6-phosphate dehydrogenase Measurement
1883,ABO Antigens,Whole Blood ABO & Rh Test
1884,ABO Antigens,Blood ABO Antigen Test
1885,ART Antibody,Serum ART Antibody Test
1886,Abused Child/adult:behavior,Assessment of Family Behavior Related to Abused Child/adult
1887,Abused Child/adult:behavior,Assessment of Patient Behavior Related to Abused Child/adult
1888,Abused Child/adult:knowledge,Assessment of Family Knowledge Related to Abused Child/adult
1889,Abused Child/adult:knowledge,Assessment of Patient Knowledge Related to Abused Child/adult
1890,Atypical lymphocyte,Whole Blood Atypical Lymphocyte Counts
1891,B-Lymphocytes,Percent B-Cell Lymphocyte Counts
1892,B-Lymphocytes,Absolute B-Cell Lymphocyte Counts
1893,B-Lymphocytes,B-Cell Lymphocyte Counts
1894,B-Lymphocytes,Cd19 (B4) B-Cell Lymphocyte Counts
1895,B-Lymphocytes,Cd20 (B1) B-Cell Test
1896,B-Lymphocytes,Cd3-Cd19+ (B Cells) Counts
1897,Abused Child/adult:status,Assessment of Family Status Related to Abused Child/adult
1898,Abused Child/adult:status,Assessment of Patient Status Related to Abused Child/adult
1899,Band Form Leukocytes,Whole Blood Band Form Leukocyte Counts
1900,Band Form Leukocytes,Bm Band Test
1901,Band Form Leukocytes,Body Fluid Band Test
1902,Acetylcholine Receptor Antibody,Serum Acetylcholine Receptor Antibody Test
1903,Bartonella henselae antibody,Cat Scratch Disease Test
1904,Basophilic normoblast,Bm Baso.Normoblast Test
1905,Self-bathing/hygiene deficit,Assessment of Patient Status Related to Bathing/hygiene Deficit
1906,beta-Alanine,Intravascular Beta-Alanine Test
1907,beta-Alanine,Plasma Beta-Alanine Test
1908,beta-Alanine,Urine Beta-Alanine Test
1909,beta-Alanine,beta-Alanine measurement
1910,Beta-Amino-Iso-Butyric Acid,Intravascular Beta-Amino-Iso-Butyric Acid Test
1911,Beta-Amino-Iso-Butyric Acid,Plasma Beta-Amino-Iso-Butyric Acid Test
1912,Beta-Amino-Iso-Butyric Acid,Urine Beta-Amino-Iso-Butyric Acid Test
1913,Beta-Amino-Iso-Butyric Acid,Beta-Amino-Iso-Butyric Acid Test
1914,Blast Cell,Whole Blood Blast Cell Counts
1915,Blast Cell,Body Fluid Blast Test
1916,Blastomycosis Antibody,Intravascular Blastomycosis Antibody Test
1917,Actinomyces Antibodies,Actinomyces antibody assay
1918,Activity of daily living (ADL) alteration,Assessment of Patient Status Related to Activities of Daily Living (adls) Alteration
1919,Adenosine Diphosphate-Induced Platelet Aggregation,Platelet aggregation with ADP test
1920,Adenovirus antibody (substance),Intravascular Adenovirus Antibody Test
1921,"Alkaline phosphatase isoenzyme, bone fraction",Serum Bone Alkaline Phosphatase Test
1922,Bowel Function:behavior,Assessment of Family Behavior Related to Bowel Function
1923,Bowel Function:behavior,Assessment of Patient Behavior Related to Bowel Function
1924,Bowel Function:knowledge,Assessment of Family Knowledge Related to Bowel Function
1925,Bowel Function:knowledge,Assessment of Patient Knowledge Related to Bowel Function
1926,Bowel Function:status,Assessment of Family Status Related to Bowel Function
1927,Bowel Function:status,Assessment of Patient Status Related to Bowel Function
1928,Braden: Friction and Shear,Braden Pressure Ulcer Assessment Item: Friction and Shear
1929,Brucella species antibody (substance),Brucella Titer Test
1930,C5 Lymphocyte,Whole Blood Absolute Cd5 Lymphocyte Counts
1931,C5 Lymphocyte,Whole Blood C5 Lymphocyte Counts
1932,C5 Lymphocyte,Whole Blood Percent Cd5 Lymphocyte Counts
1933,C5 Lymphocyte,Cd5 (Leu 1) T-Cell Test
1934,Ca 19-9 Carbohydrate Ag,Intravascular Ca 19-9 Test
1935,CA 27-29 antigen,Intravascular Ca27.29 Test
1936,CA-125 Antigen,Serum Ca-125 Antigen Test
1937,Mucin-1 Antigen,Ca15-3 Test
1938,Cadmium/Creatinine Ratio,Urinary Cad/Creat Ratio Calculations
1939,Candida species antibody (substance),Intravascular Candida Antibody Test
1940,carbamazepine epoxide,"Intravascular Bound 10,11-Epoxide Test"
1941,carbamazepine epoxide,"Intravascular Carbamazepine 10,11-Epoxide Test"
1942,carbamazepine epoxide,"Intravascular Free 10,11-Epoxide Test"
1943,Antiplasmin,Intravascular Alpha 2 Anti-Plasmin Test
1944,Caretaking/parenting:behavior,Assessment of Family Behavior Related to Caretaking/parenting
1945,Caretaking/parenting:behavior,Assessment of Patient Behavior Related to Caretaking/parenting
1946,Caretaking/parenting:knowledge,Assessment of Family Knowledge Related to Caretaking/parenting
1947,Caretaking/parenting:knowledge,Assessment of Patient Knowledge Related to Caretaking/parenting
1948,Caretaking/parenting:status,Assessment of Family Status Related to Caretaking/parenting
1949,Caretaking/parenting:status,Assessment of Patient Status Related to Caretaking/parenting
1950,CD4 Positive T Lymphocytes,Whole Blood Absolute Cd4 Lymphocyte Counts
1951,CD4 Positive T Lymphocytes,Whole Blood Cd4 Lymphocyte Counts
1952,CD4 Positive T Lymphocytes,Whole Blood Percent Cd4 Lymphocyte Counts
1953,CD8-Positive T-Lymphocytes,Whole Blood Absolute Cd8 Lymphocyte Counts
1954,CD8-Positive T-Lymphocytes,Whole Blood Cd8 Lymphocyte Counts
1955,CD8-Positive T-Lymphocytes,Whole Blood Percent Cd8 Lymphocyte Counts
1956,American trypanosomiasis antibody,Chagas Disease Antibodies Test
1957,alpha-Fetoproteins,Intravascular Alpha Fetoprotein Test
1958,alpha-Fetoproteins,Maternal Alpha Fetoprotein Test
1959,alpha-Fetoproteins,Body Fluid Alpha Fetoproteins Test
1960,alpha-Fetoproteins,"Alpha Fetoprotein Test, Not Specified as Maternal"
1961,alpha-Fetoproteins,Alpha Fetoproteins Serum Chemistry Test
1962,Chlamydia DNA,Chlamydia DNA Probe Test
1963,Chlamydia trachomatis antibody,Measurement of Chlamydia trachomatis antibody
1964,Chronic low self-esteem,Assessment of Patient Status Related to Chronic Low Self-esteem Disturbance
1965,Circulating anticoagulants,Circulating anticoagulants measurement
1966,Circulation:behavior,Assessment of Family Behavior Related to Circulation
1967,Circulation:behavior,Assessment of Patient Behavior Related to Circulation
1968,Circulation:knowledge,Assessment of Family Knowledge Related to Circulation
1969,Circulation:knowledge,Assessment of Patient Knowledge Related to Circulation
1970,Circulation status,Assessment of Family Status Related to Circulation
1971,Circulation status,Assessment of Patient Status Related to Circulation
1972,Cognition:behavior,Assessment of Family Behavior Related to Cognition
1973,Cognition:behavior,Assessment of Patient Behavior Related to Cognition
1974,Cognition:knowledge,Assessment of Family Knowledge Related to Cognition
1975,Cognition:knowledge,Assessment of Patient Knowledge Related to Cognition
1976,Cognition:status,Assessment of Family Status Related to Cognition
1977,Cognition:status,Assessment of Patient Status Related to Cognition
1978,alpha 2-Glucoproteins,Intravascular Alpha-2 Macroglobulin Test
1979,cold agglutinins,Cold Agglutinating Antibody Test
1980,Collagen-Induced Patelet Aggregation,Platelet aggregation with collagen test
1981,Communication with Community Resources:behavior,Assessment of Family Behavior Related to Communication with Community Resources
1982,Communication with Community Resources:behavior,Assessment of Patient Behavior Related to Communication with Community Resources
1983,Communication with Community Resources:status,Assessment of Family Status Related to Communication with Community Resources
1984,Communication with Community Resources:status,Assessment of Patient Status Related to Communication with Community Resources
1985,alpha-aminobutyric acid,Intravascular Alpha-Amino-N-Butyric Acid Test
1986,alpha-aminobutyric acid,Plasma Alpha-Amino-N-Butyric Acid Test
1987,alpha-aminobutyric acid,Urine Alpha-Amino-N-Butyric Acid Test
1988,alpha-aminobutyric acid,Alpha-Amino-N-Butyric Acid Test
1989,Conglutinin Immune Complex,Intravascular Conglutinin Immune Complex Test
1990,Consciousness:behavior,Assessment of Family Behavior Related to Consciousness
1991,Consciousness:behavior,Assessment of Patient Behavior Related to Consciousness
1992,Consciousness:knowledge,Assessment of Family Knowledge Related to Consciousness
1993,Consciousness:knowledge,Assessment of Patient Knowledge Related to Consciousness
1994,Consciousness:status,Assessment of Family Status Related to Consciousness
1995,Consciousness:status,Assessment of Patient Status Related to Consciousness
1996,2-Aminoadipic Acid,Intravascular Alpha-Aminodipic Test
1997,2-Aminoadipic Acid,Plasma Alpha-Aminodipic Test
1998,2-Aminoadipic Acid,Urine Alpha-Aminodipic Test
1999,2-Aminoadipic Acid,Alpha-Aminoadipic Acid Test
2000,Creatine kinase isoenzyme,Intravascular CK Isoenzyme Test
2001,Creatine kinase isoenzyme,Serum Creatine Kinase Isoenzyme Test
2002,cryptococcal polysaccharide,Serum Cryptococcal Polysaccharide Test
2003,cryptococcal polysaccharide,CSF Cryptococcal Polysaccharide Test
2004,lactate dehydrogenase 1,Serum Lactate Dehydrogenase Isoenzyme 1 Test
2005,Legionella pneumophila antigen,Urine Legionella Antigen Test
2006,Cytomegalovirus IgG Antibody,Intravascular Cytomegalovirus IgG Antibody Test
2007,Cytomegalovirus IgG Antibody,Blood Cytomegalovirus IgG Test
2008,Cytomegalovirus IgG Antibody,CSF Cmv-IgG Test
2009,Family Planning:knowledge,Assessment of Family Knowledge Related to Family Planning
2010,Family Planning:knowledge,Assessment of Patient Knowledge Related to Family Planning
2011,Genito-urinary Function:behavior,Assessment of Family Behavior Related to Genito-urinary Function
2012,Genito-urinary Function:behavior,Assessment of Patient Behavior Related to Genito-urinary Function
2013,"Alkaline phosphatase isoenzyme, liver fraction",Serum Liver Alkaline Phosphatase Test
2014,Communication with Community Resources:knowledge,Assessment of Family Knowledge Related to Communication with Community Resources
2015,Communication with Community Resources:knowledge,Assessment of Patient Knowledge Related to Communication with Community Resources
2016,Cell Migration Inhibition function,Cell Migration Inhibition measurement
2017,vascular endothelial growth factor activity,Vascular Endothelial Growth Factor Measurement
2018,L-alanine:2-oxoglutarate aminotransferase activity,Alanine aminotransferase measurement
2019,Blood flow,Radiolabelled antifibrin study
2020,Blood flow,Pulmonary ventilation-perfusion study by radioactive krypton
2021,Lewis blood group system antigens,Blood group antigen A>1< Le^b^
2022,Blood flow,Radionuclide limb blood flow assessment
2023,Iron,Total iron binding capacity function
2024,Blood flow,Radiolabelled antiplatelet study
2025,Blood flow,Isotope phlebography
2026,Antigen in Kidd (JK) blood group system,Kidd antigen type
2027,Hemoglobin,Hemoglobinuria
2028,Blood flow,Radiolabelled HMPAO cerebral blood flow study
2029,Lewis blood group system antigens,Blood group antigen Le^ab^
2030,Blood flow,Xenon flow scan of cardiovascular system
2031,Blood flow,"Pulmonary perfusion imaging, gaseous, with ventilation, rebreathing and washout"
2032,Blood flow,Kidney imaging with vascular flow and function study
2033,Blood flow,Liver imaging with vascular flow
2034,Blood flow,Radionuclide venous blood pool study
2035,Blood flow,Brain imaging with vascular flow
2036,Blood Platelets,Platelet aggregation
2037,Blood flow,Liver and spleen imaging with vascular flow
2038,Blood flow,Radionuclide soft tissue blood pool study - early and delayed
2039,Blood flow,Kidney imaging with vascular flow
2040,Lewis blood group system antigens,Blood group antigen Le^bH^
2041,Blood flow,Radionuclide arteriogram
2042,Blood flow,Radionuclide venogram
2043,Reducing substances,Urine reducing substances NOS (finding)
2044,Blood flow,Lung perfusion study with Tc99m-albumin
2045,Erythrocytes,Erythrocyte sedimentation rate measurement
2046,Blood flow,Radionuclide thrombus-specific peptide study
2047,Lewis blood group system antigens,Blood group antigen Le^b^
2048,Blood flow,"Pulmonary perfusion imaging, gaseous"
2049,Blood flow,Spleen imaging with vascular flow
2050,Blood flow,Lung perfusion study with Krypton 81m
2051,Corneal curvature radius,Keratometry
2052,Blood Platelets,Collagen induced platelet aggregation
2053,Blood flow,Peritoneal venous shunt patency test for Leveen shunt
2054,Blood flow,"Radionuclide venogram, unilateral"
2055,Reducing substances,Finding of presence of urinary reducing substances
2056,Blood Platelets,Serotonin induced platelet aggregation
2057,Blood flow,Pulmonary ventilation-perfusion study by radioactive oxygen
2058,Blood flow,Pulmonary perfusion study
2059,Lewis blood group system antigens,Blood group antigen Le^a^
2060,Corneal curvature meridian,Keratometry
2061,Blood Platelets,Calcium ionophore induced platelet aggregation
2062,Lewis blood group system antigens,Lewis blood group system antigens
2063,Cold reacting blood group autoantibody,Cold agglutinin titer
2064,Blood flow,"Radionuclide venogram, unilateral"
2065,Blood Platelets,"Platelet adhesion, function"
2066,Blood Platelets,Arachidonic acid induced platelet aggregation
2067,Antigen in Kell (KEL) blood group system,Kell antigen type
2068,Blood Platelets,Induced platelet aggregation
2069,Blood flow,Pulmonary ventilation perfusion study
2070,Blood flow,Isotope brain angiography
2071,Blood flow,Radiolabelled Tc99m HSA cerebral blood flow study
2072,Blood flow,Testicular imaging with vascular flow
2073,Blood flow,Cerebral blood flow radionuclide study
2074,Reducing substances,Urine: no reducing substances
2075,Blood Platelets,Platelet mean volume determination (procedure)
2076,Blood flow,Scanning or imaging with vascular flow
2077,Lewis blood group system antigens,Blood group antigen BLe^b^
2078,Erythrocytes,Erythrocyte sediment rate NOS
2079,Erythrocytes,"Blood coagulation panel, DIC"
2080,Blood flow,Thyroid imaging with vascular flow
2081,Blood Platelets,Ristocetin induced platelet aggregation
2082,Blood flow,Pulmonary ventilation-perfusion study by radioactive nitrogen
2083,Antigen in Duffy (FY) blood group system,Duffy antigen type
2084,Blood Platelets,ADP induced platelet aggregation
2085,Blood flow,Pulmonary ventilation-perfusion study by radioactive carbon
2086,Blood flow,Radionuclide thrombus localization study
2087,Blood flow,Radionuclide venous first pass study
2088,Blood Platelets,Epinephrine induced platelet aggregation
2089,Blood flow,Radionuclide imaging of radioisotope labeled platelets
2090,Blood flow,Denver shunt patency test
2091,Blood flow,Cardiac flow imaging
2092,Blood Platelets,Prostaglandin induced platelet aggregation
2093,Blood Platelets,Norepinephrine induced platelet aggregation
2094,Blood Platelets,Thrombin induced platelet aggregation
2095,Blood flow,"Pulmonary perfusion imaging, particulate"
2096,Blood flow,Pulmonary ventilation-perfusion study by radioactive xenon
2097,Acetaminophen,Acetaminophen:SCnc:Pt:Ser/Plas:Qn
2098,Amitriptyline+Nortriptyline,Amitriptyline+Nortriptyline:PrThr:Pt:Ser/Plas:Ord
2099,Virus identified,Virus identified:Prid:Pt:Stool:Nom:Microscopy.electron
2100,Diameter.hilum-cortex,Diameter.hilum-cortex:Len:Pt:Kidney.left:Qn:US.measured
2101,Neutrophils.band form/100 leukocytes,Neutrophils.band form/100 leukocytes:NFr:Pt:CSF:Qn:Manual count
2102,2-Hydroxyisovalerate/Creatinine,2-Hydroxyisovalerate/Creatinine:MRto:Pt:Urine:Qn
2103,Beta aminoisobutyrate/Creatinine,Beta aminoisobutyrate/Creatinine:MRto:Pt:Urine:Qn
2104,Glucose,Glucose^1H post 100 g glucose PO:MCnc:Pt:Ser/Plas:Qn
2105,Cholesterol.in HDL,Cholesterol.in HDL:SCnc:Pt:Ser/Plas:Qn
2106,Color,Color:Type:Pt:Pericard fld:Nom
2107,Fagus grandifolia Ab.IgE.RAST class,Fagus grandifolia Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
2108,Bellis perennis Ab.IgE.RAST class,Bellis perennis Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
2109,Cefsulodin,Cefsulodin:Susc:Pt:Isolate:Qn:MLC
2110,U Ab,U Ab:PrThr:Pt:Ser/Plas^Donor:Ord
2111,Celtis occidentalis Ab.IgE.RAST class,Celtis occidentalis Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
2112,Beta-hemolytic streptococcus,Streptococcus.beta-hemolytic:PrThr:Pt:Genital:Ord:Organism specific culture
2113,urine sediment comments,Urine sediment comments:Find:Pt:Urine sed:Nar:Microscopy.light
2114,Femur length/Abdominal circumference,Femur length/Abdominal circumference:LenRto:Pt:^Fetus:Qn:US.derived
2115,ceforanide,Ceforanide:Susc:Pt:Isolate:OrdQn:MIC
2116,Silicon,Silicon:MCnc:Pt:Ser/Plas:Qn
2117,Blood group antigen Js^a^,J little s super little a Ag:PrThr:Pt:RBC:Ord
2118,ED procedure result type,ED procedure result type:Type:Point in time:^Patient:Nominal
2119,Date of last menstrual period,Deprecated Last menstrual period
2120,Oxalates,Oxalate^8th specimen post XXX challenge:MCnc:Pt:Urine:Qn
2121,Coxsackievirus A10 Ab,Deprecated Coxsackievirus A10 Ab [Units/volume] in Serum
2122,Serine/Creatinine,Serine/Creatinine:MRto:Pt:Urine:Qn
2123,Amphetamines,Amphetamines:PrThr:Pt:Urine:Ord:Screen>1000 ng/mL
2124,dronabinol,THC Ur Cfm-mCnc
2125,Quercus virginiana Ab.IgE.RAST class,Deprecated Virginia Live Oak IgE Ab RAST class in Serum
2126,Outpatient visits,History of outpatient visits:Finding:Point in time:^Patient:Nominal:Reported
2127,Symptoms & diseases,History of symptoms & diseases:Finding:Point in time:Allergic & Immunologic:Narrative:Reported
2128,Blasts.CD5/100 blasts,Blasts.CD5/100 blasts:NFr:Pt:Bld:Qn
2129,S' wave amplitude.lead V3,S' wave amplitude.lead V3:Elpot:Pt:Heart:Qn:EKG
2130,Physical findings,Physical findings:Finding:Point in time:Calf:Narrative:Observed
2131,Mesothelial cells/100 leukocytes,Mesothelial cells/100 leukocytes:NFr:Pt:Plr fld:Qn:Manual count
2132,Rhizopus nigricans Ab.IgE.RAST class,Rhizopus nigricans Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
2133,Erythrocytes.dual population,Erythrocytes.dual population:PrThr:Pt:Bld:Ord:Microscopy.light
2134,Leptocyte,Target cells:PrThr:Pt:Bld:Ord:Microscopy.light
2135,Physical findings,Physical findings:Finding:Point in time:Calf:Nominal:Observed
2136,"Pulsatility index, arterial velocity waveform",Pulsatility index:VelRto:Pt:^Patient:Qn:US.doppler
2137,Study observation,Study observation:Finding:Point in time:Aortic arch^Fetus:Narrative:ULTRASOUND
2138,Norepinephrine,Norepinephrine^6th specimen post XXX challenge:MCnc:Pt:Plas:Qn
2139,microscopic observation,Microscopic observation:Prid:Pt:Eye:Nom:Gram stain
2140,Mononuclear cells/100 leukocytes,Mononuclear cells/100 leukocytes:NFr:Pt:Periton fld:Qn:Manual count
2141,Physical findings,Physical findings:Finding:Point in time:Extremities:Narrative:Observed
2142,Botulinum Toxins,Clostridium botulinum toxin:ACnc:Pt:Stool:Qn
2143,"Hydrocarbons, Halogenated",Hydrocarbons.halogenated:Prid:Pt:Urine:Nom
2144,Epithelial Cells,Epithelial cells:PrThr:Pt:Semen:Ord:Microscopy.light
2145,Borrelia burgdorferi 25kD Ab,Borrelia burgdorferi 25kD Ab:PrThr:Pt:Body fld:Ord:IB
2146,Iron/Transferrin,Iron/Transferrin:MRto:Pt:Ser/Plas:Qn
2147,Carbonyldiamide,Urea nitrogen:MCnc:Pt:Gast fld:Qn
2148,Calcium,Calcium:SCnc:Pt:Synv fld:Qn
2149,Cryptococcus species antibody,Cryptococcus sp Ab:Titr:Pt:Ser:Qn
2150,Proerythroblasts,Pronormoblasts:NCnc:Pt:Bld:Qn
2151,Glucose,Glucose^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
2152,Sodium,Sodium:SCnc:Pt:RBC:Qn
2153,Valproate,Valproate:SCnc:Pt:Ser/Plas:Qn
2154,Estradiol.free/Estradiol.total,Estradiol.free/Estradiol.total:MFr:Pt:Ser/Plas:Qn
2155,Geotrichum candidum Ab.IgE.RAST class,Geotrichum candidum Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
2156,(Hordeum vulgare+Oryza sativa+Secale cereale+Triticum aestivum) Ab.IgE,(Hordeum vulgare+Oryza sativa+Secale cereale+Triticum aestivum) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk
2157,(Cynodon dactylon+Lolium perenne+Bromus inermis+Ambrosia elatior+Artemisia vulgaris+Plantago lanceolata) Ab.IgE,(Cynodon dactylon+Lolium perenne+Bromus inermis+Ambrosia elatior+Artemisia vulgaris+Plantago lanceolata) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk
2158,PHOSPHOFRUCTOKINASE,Phosphofructokinase:CCnc:Pt:RBC:Qn
2159,Blood group antigen P2,Deprecated P2 Ag [Presence] on Red Blood Cells from Donor
2160,Propylene glycol,Propylene glycol:PrThr:Pt:Ser/Plas:Ord
2161,ST slope.lead AVF,ST slope.lead AVF:ElpotRat:Pt:Heart:Qn:EKG
2162,Progress note.total,Deprecated Progress note.total:Finding:Point in time:^Patient:Narrative
2163,cyclohexanone,Cyclohexanone:MCnc:Pt:Bld:Qn
2164,Iron.microscopic observation,Iron.microscopic observation:Prid:Pt:Bone mar:Nom:Potassium ferrocyanide stain
2165,Aldosterone,Aldosterone:SCnc:Pt:Urine:Qn
2166,Amylase.S1/Amylase.total,Amylase.S1/Amylase.total:CFr:Pt:Ser/Plas:Qn
2167,Isopropyl Alcohol,Isopropanol:PrThr:Pt:Meconium:Ord
2168,Thickness.diastolic,Thickness.diastolic:Len:Pt:Heart.ventricle.posterior wall.left^Fetus:Qn:US.measured.real time two dimension
2169,Ciprofloxacin,Deprecated Ciprofloxacin [Mass/volume] in Serum or Plasma --trough
2170,Follicle Stimulating Hormone,Follitropin:ARat:24H:Urine:Qn
2171,BLV Antibodies,Bovine leukemia virus Ab:PrThr:Pt:Ser:Ord:IA
2172,Neutrophils.band form/100 cells,Neutrophils.band form/100 cells:NFr:Pt:Bone mar:Qn:Manual count
2173,Creatinine,Creatinine^12H post peritoneal dialysis:MCnc:Pt:Periton fld:Qn
2174,Fungus identified,Fungus identified:Prid:Pt:XXX:Nom:Environmental culture
2175,jka antibody,J little k super little a Ab:PrThr:Pt:Ser/Plas^BPU:Ord
2176,Chinchilla Ab.IgE,Chinchilla Ab.IgE:ACnc:Pt:Ser:Qn
2177,M little g Ab,M little g Ab:PrThr:Pt:Ser/Plas^Donor:Ord
2178,Epithelial Cells,Epithelial cells:PrThr:Pt:Vag:Ord:Wet preparation
2179,Sulfatide Ab.IgM,Deprecated Sulfatide Antibody.immunoglobulin M:Arbitrary Concentration:Point in time:Serum/Plasma:Quantitative or Ordinal
2180,Hepatitis B virus DNA,Deprecated Hepatitis B virus DNA [Presence] in Blood by Immunoblot (IB)
2181,Growth Hormone,Somatotropin^1.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
2182,Acacia longifolia Ab.IgE.RAST class,Acacia longifolia Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
2183,Glucose,Glucose^pre 75 g glucose PO:MCnc:Pt:Ser/Plas:Qn
2184,Castanea sativa Ab.IgE.RAST class,Castanea sativa Antibody.immunoglobulin E.RAST class:Arbitrary Concentration:Point in time:Serum:Ordinal
2185,Insulin,Insulin^post 12H CFst:MCnc:Pt:Ser/Plas:Qn
2186,Cefoperazone,Cefoperazone:Titr:Pt:Isolate+Ser:Qn:SBT
2187,Antiribosomal antibody,Ribosomal Ab:Titr:Pt:Ser:Qn
2188,ethylene glycol,Deprecated Ethylene glycol
2189,8-hydroxyamoxapine,8-Hydroxyamoxapine:SCnc:Pt:Ser/Plas:Qn
2190,Streptococcus pneumoniae Danish serotype 14 Ab,Deprecated Streptococcus pneumoniae 14 Ab [Units/volume] in Serum by Immunoassay --1st specimen
2191,Carboxy tetrahydrocannabinol cutoff,Carboxy tetrahydrocannabinol cutoff:MCnc:Pt:Urine:Qn:Screen
2192,Chlorpheniramine cutoff,Chlorpheniramine cutoff:MCnc:Pt:Urine:Qn:Confirm
2193,Carbon Dioxide,Carbon dioxide^post bronchodilation:PPres:Pt:BldC:Qn:Transcutaneous CO2 monitor
2194,CATALASE,Catalase:CCnc:Pt:RBC:Qn
2195,Glutamine,Glutamine:SCnc:Pt:CSF:Qn
2196,TCRD gene rearrangements,TCRD gene rearrangements:Arb:Pt:Bld/Tiss:Ord:Molgen
2197,Epstein Barr virus capsid IgA,Epstein Barr virus capsid Ab.IgA:Titr:Pt:Ser:Qn
2198,Infectious bronchitis virus Ab,Infectious bronchitis virus Ab:Titr:Pt:Ser:Qn:Neut
2199,Theileria mutans Ab,Theileria mutans Ab:Titr:Pt:Ser:Qn:IF
2200,Legionella pneumophila 1 IgM,Legionella pneumophila 1 Ab.IgM:ACnc:Pt:Ser:Qn
2201,Tetrahydrocannabinol cutoff,Tetrahydrocannabinol cutoff:Mass Concentration:Point in time:Urine:Quantitative:Screen
2202,Cell positive for CD3 antigen,Cells.CD3:NCnc:Pt:XXX:Qn
2203,Avian infectious laryngotracheitis virus Ag,Avian infectious laryngotracheitis virus Ag:PrThr:Pt:Trac:Ord:Immune diffusion
2204,Leishmania sp identified,Leishmania sp identified:Prid:Pt:Tiss:Nom:IF
2205,Lithium,Lithium:MCnc:Pt:Body fld:Qn
2206,Toxaphene,Toxaphene:MCnc:Pt:Ser/Plas:Qn
2207,Oxygen,Oxygen^post bronchodilation:PPres:Pt:BldC:Qn:Transcutaneous O2 monitor
2208,Cell positive for CD4 antigen,Deprecated CD4 cells [#/volume] in Unspecified specimen
2209,Lymphocytes.IgM/100 lymphocytes,Lymphocytes.IgM/100 lymphocytes:NFr:Pt:XXX:Qn
2210,1-methylhistidine,1-Methylhistidine:SCnc:Pt:Ser/Plas:Qn
2211,Asparagine,Asparagine:SCnc:Pt:Ser/Plas:Qn
2212,Cystine+Cysteine,Cystine+Cysteine:MCnc:Pt:Ser/Plas:Qn
2213,Leptospira interrogans serovar Grippotyphosa antibody,Leptospira interrogans serovar Grippotyphosa Ab:PrThr:Pt:Ser:Ord:Aggl
2214,Sulfonylurea Compounds,Sulfonylurea:MCnc:Pt:Urine:Qn
2215,Alpha 1 antitrypsin fecal clearance,Alpha 1 antitrypsin fecal clearance:VRat:24H:Ser/Plas+Stool:Qn
2216,Cephradine,Cephradine:Susc:Pt:Isolate:OrdQn
2217,CA-125 Antigen,Cancer Ag 125:PrThr:Pt:Ser/Plas:Ord
2218,Census tract certainty 1970&80&90,Census tract certainty 1970&80&90:Type:Point in time:Census tract:Nominal:*
2219,Lumpy skin disease virus Ab,Lumpy skin disease virus Ab:PrThr:Pt:Ser:Ord
2220,Views 2,Views 2:Finding:Point in time:Hand:Narrative:XR
2221,Dihydrocodeine.free,Dihydrocodeine.free:PrThr:Pt:Ser/Plas:Ord:Confirm
2222,Echinococcus sp Ab.IgM,Echinococcus sp Ab.IgM:ACnc:Pt:Ser:Qn
2223,Ethambutol,Ethambutol:Susc:Pt:Isolate:OrdQn
2224,Hydroxyethylflurazepam cutoff,Hydroxyethylflurazepam cutoff:MCnc:Pt:Urine:Qn:Confirm
2225,Pressure.inspiratory min setting,Pressure.inspiratory min setting:Pres:Pt:Ventilator.alarm:Qn
2226,Spermatozoa.motile/100 spermatozoa,Spermatozoa.motile/100 spermatozoa^4H post ejaculation:NFr:Pt:Semen:Qn
2227,CACNA1S gene.p.Arg1239Gly,CACNA1S gene.p.Arg1239Gly:PrThr:Pt:Bld/Tiss:Ord:Molgen
2228,Monosialoganglioside GM1 Ab.IgG+IgM,Deprecated Monosialoganglioside GM1 Ab.IgG+IgM
2229,Magnesium,Magnesium:SCnt:Pt:Hair:Qn
2230,Regan isoenzyme,Alkaline phosphatase.regan:CCnc:Pt:Ser/Plas:Qn
2231,Streptococcus pneumoniae 18c Ab.IgG,Deprecated Streptococcus pneumoniae 56 IgG Ab [Units/volume] in Serum
2232,Mesoridazine cutoff,Mesoridazine cutoff:MCnc:Pt:Urine:Qn:Confirm
2233,Aspergillus niger antibody,Aspergillus niger Ab:PrThr:Pt:CSF:Ord:Immune diffusion
2234,Stager.clinical,Stager.clinical:Type:Pt:Cancer.XXX:Nom
2235,Acetazolamide,Acetazolamide:ACnc:Pt:Ser/Plas:Qn
2236,Long acting metabolite of methadone,Methadone.long acting metabolite:MCnc:Pt:Ser/Plas:Qn
2237,2-methylpentane,2-Methylpentane:MCnc:Pt:Bld:Qn
2238,Methylenedioxymethamphetamine cutoff,Methylenedioxymethamphetamine cutoff:MCnc:Pt:Urine:Qn:Screen
2239,Crossection,Crossection:Area:Pt:Aorta.root:Qn:US.calculated
2240,Intravascular peak systolic.XXX,Intravascular peak systolic.XXX:Pres:Pt:Circulatory system.XXX:Qn:US
2241,Bromides,Bromide:MCnc:Pt:Ocular fld:Qn
2242,Measles virus IgM,Measles virus Ab.IgM:Titr:Pt:CSF:Qn:IF
2243,SCL-70 extractable nuclear Ab.IgG,SCL-70 extractable nuclear Ab.IgG:PrThr:Pt:Ser:Ord
2244,Sesamum indicum Ab.IgG.RAST class,Sesamum indicum Ab.IgG.RAST class:PrThr:Pt:Ser:Ord
2245,Source of protocol in which patient enrolled,Source of protocol in which patient enrolled:Type:Pt:Cancer.XXX:Nom
2246,Date last contact,Date last contact:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative
2247,Vesicular stomatitis virus serotype,Vesicular stomatitis virus serotype:Prid:Pt:Tiss:Nom:IA
2248,Alfentanil,Alfentanil:MCnc:Pt:Urine:Qn
2249,Tellurium,Tellurium:PrThr:Pt:Urine:Ord
2250,HLA-A24 Antigen,HLA-A24(9):PrThr:Pt:Bld/Tiss:Ord
2251,Length,Length:Len:Pt:Region of interest.XXX:Qn:US
2252,Androstenedione,Androstenedione^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
2253,Rifabutin,Deprecated Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC)
2254,Francisella tularensis IgA,Francisella tularensis Ab.IgA:PrThr:Pt:Ser:Ord:LA
2255,Pyridoxic Acid,4-Pyridoxate:MCnc:Pt:Ser/Plas:Qn
2256,Gas flow,Gas flow:VRat:Pt:Respiratory system.airway:Qn
2257,Pressure.support setting,Pressure.support setting:Pres:Pt:Ventilator:Qn
2258,Systole.mean/Systole 2.mean,Systole.mean/Systole 2.mean:VelRto:Pt:Circulatory system.XXX:Qn:US.doppler.calculated
2259,Streptococcus pneumoniae IgG,Streptococcus pneumoniae Ab.IgG^1st specimen/2nd specimen:Ratio:Pt:Ser:Qn
2260,Immunoglobulin M antibody to Toxoplasma gondii,Toxoplasma gondii Ab.IgM:Titr:Pt:Ser:Qn
2261,dalfopristin / quinupristin,Quinupristin+Dalfopristin:Susc:Pt:Isolate:OrdQn:MIC
2262,Deceleration 2,Deceleration 2:Vel:Pt:Circulatory system.XXX:Qn:US
2263,3-Hydroxybutyrylcarnitine (C4-OH),3-Hydroxybutyrylcarnitine (C4-OH):MCnc:Pt:Ser/Plas:Qn
2264,Oxazepam,Oxazepam:PrThr:Pt:Urine:Ord:Screen
2265,Magnesium,Magnesium:MCnc:Pt:Bld:Qn
2266,Rickettsia conorii IgM,Rickettsia conorii Ab.IgM:Titr:Pt:Ser:Qn
2267,CDH1 gene mutations tested for,CDH1 gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen
2268,Avian reovirus Ab,Avian reovirus Ab:PrThr:Pt:Ser:Ord
2269,Rabies virus DNA,Deprecated Rabies virus deoxyribonucleic acid:Arbitrary Concentration:Point in time:To be specified in another part of the message:Ordinal:DNA NUCLEIC ACID PROBE.amp.tar
2270,Nairobi sheep disease virus Antigen,Nairobi sheep disease virus Ag:PrThr:Pt:XXX:Ord:IA
2271,Paratuberculosis reaction wheal,Paratuberculosis reaction wheal^3D post 0.1 mL johnin ID:Diam:Pt:Skin:Qn
2272,Aflatoxins,Aflatoxin:MCnt:Pt:Feed:Qn
2273,Benzoylecgonine,Benzoylecgonine:PrThr:Pt:Ser/Plas:Ord:Confirm
2274,Bicarbonates,Bicarbonate:SCnc:Pt:Amnio fld:Qn
2275,Psilocybin cutoff,Psilocybin cutoff:MCnc:Pt:Urine:Qn:Confirm
2276,Temazepam,Temazepam:PrThr:Pt:Urine:Ord:Screen
2277,Stroke Volume,Stroke volume:Vol:Pt:Heart.ventricle.right:Qn:US.2D.pulmonic valve flow area.calculated
2278,RR interval,RR interval^at tricuspid flow measurement:Time:Pt:Heart:Qn:US
2279,Deceleration slope,Deceleration slope:Vel:Pt:Tricuspid valve:Qn:US
2280,Encephalitozoon cuniculi Ab,Encephalitozoon cuniculi Ab:PrThr:Pt:Ser:Ord
2281,Borrelia burgdorferi antibody,Borrelia burgdorferi Ab:PrThr:Pt:CSF:Ord
2282,Lead,Lead:MCnt:Pt:XXX:Qn
2283,hexachloroethane,Hexachloroethane:MCnc:Pt:Bld:Qn
2284,Pheniramine,Pheniramine:MCnc:Pt:Urine:Qn
2285,Diameter (qualifier value),Diameter:Len:Pt:Mitral valve.annulus:Qn:US
2286,Lactose,Lactose^3H post 50 g lactose PO:MCnc:Pt:Ser/Plas:Qn
2287,Aspergillus fumigatus Ab.IgG,Aspergillus fumigatus Ab.IgG:PrThr:Pt:Ser:Ord
2288,Velocity-time integral.XXX,Velocity-time integral.XXX:Length:Point in time:Circulatory system.To be specified in another part of the message:Quantitative:ULTRASOUND.doppler
2289,Escherichia coli K99,Escherichia coli K99:PrThr:Pt:Isolate:Ord:Aggl
2290,Leptospira interrogans serovar Canicola antibody,Leptospira interrogans serovar Canicola Ab:Titr:Pt:Ser:Qn
2291,Erythromycin,Erythromycin:Susc:Pt:Isolate:OrdQn:MIC
2292,Diameter.anterior-posterior.systole/Diameter.aorta root,Diameter.anterior-posterior.systole/Diameter.aorta root:LenRto:Pt:Heart:Qn:US
2293,Ejection time,Ejection time:Time:Pt:Aortic valve:Qn:US.doppler
2294,Cytologist,Cytologist:ID:Pt:Cvx/Vag:Nom:Cyto stain
2295,Carnitine.free (C0),Carnitine.free (C0):MCnc:Pt:Ser/Plas:Qn
2296,Bovine herpesvirus 4 Antigen,Bovine herpesvirus 4 Ag:PrThr:Pt:Tiss:Ord:IF
2297,Influenza A virus antibody,Influenza virus A Ab:PrThr:Pt:Ser:Ord:HAI
2298,Estradiol.unconjugated,Estradiol.unconjugated:MRat:24H:Urine:Qn
2299,Proline/Creatinine,Proline/Creatinine:SRto:Pt:Urine:Qn
2300,Gradient.systole.max,Gradient.systole.max:Pres:Pt:Tricuspid valve.regurgitant jet:Qn:US.doppler
2301,Minor axis.end systole,Minor axis.end systole:Len:Pt:Heart.ventricle.right:Qn:US.2D
2302,Western equine encephalomyelitis virus antibody,Western equine encephalitis virus Ab:PrThr:Pt:Ser:Ord:Comp fix
2303,Biotin,Biotin:MCnc:Pt:Ser/Plas:Qn
2304,Intermediate density lipoprotein cholesterol,Deprecated Cholesterol.in IDL [Mass/volume] in Serum or Plasma
2305,Chlamydophila pneumoniae IgG,Chlamydophila pneumoniae Ab.IgG:Titr:Pt:CSF:Qn
2306,Chlamydophila psittaci IgG,Chlamydophila psittaci Ab.IgG:Titr:Pt:Ser:Qn
2307,Equine herpesvirus 1+4 Ab,Equine herpesvirus 1+4 Ab:Titr:Pt:Ser:Qn:IA
2308,GQ1b IgG ganglioside antibody,Ganglioside GQ1b Ab.IgG:Titr:Pt:CSF:Qn:IA
2309,Segmental wall motion,Segmental wall motion:Find:Pt:Heart.ventricle.left.apical septum:Ord:US
2310,Diagnosis,Diagnosis:Imp:Stdy:Gastrointestinal tract.lower:Nom
2311,Toxoplasma gondii antibody,Toxoplasma gondii Ab:Imp:Pt:Ser:Nom
2312,Cells.CD33+CD44+/100 cells,Cells.CD33+CD44+/100 cells:NFr:Pt:Bld:Qn
2313,Very low density lipoprotein cholesterol,Cholesterol.in VLDL [Mass/volume] in Serum or Plasma
2314,Swine vesicular disease virus Ab,Swine vesicular disease virus Ab:PrThr:Pt:Ser:Ord:Neut
2315,Thickness.systole,Thickness.systole:Len:Pt:Heart.ventricle.right.anterior wall:Qn:US
2316,Cocaine,Deprecated Benzoylmethylecgonine [Mass/volume] in Urine
2317,Dextroamphetamine,Dextroamphetamine:MCnc:Pt:Urine:Qn:Confirm
2318,Alcelaphine herpesvirus 1 antibody,Alcelaphine herpesvirus 1 Ab:PrThr:Pt:Ser:Ord:IF
2319,Salmonella typhi H D Ab,Salmonella typhi H D Antibody:Arbitrary Concentration:Point in time:Serum:Ordinal:LATEX AGGLUTINATION
2320,Flucytosine,5-fluorocytosine:Susceptibility:Point in time:Isolate:Quantitative or Ordinal:MINIMUM INHIBITORY CONCENTRATION
2321,Ornithine,Ornithine:SCnc:24H:Urine:Qn
2322,alpha-hydroxyalprazolam,Alpha hydroxyalprazolam:MCnt:Pt:Hair:Qn
2323,Disopyramide,Disopyramide:MCnc:Pt:Gast fld:Qn
2324,Red green balance.binocular,Red green balance.binocular:Type:Pt:Eye:Nom:Phoropter
2325,Insulin,Insulin^4H post XXX challenge:ACnc:Pt:Ser/Plas:Qn
2326,Tryptophan,Tryptophan:PrThr:Pt:Ser/Plas:Ord
2327,Adenovirus antibody (substance),HAdV Ab Fld-aCnc
2328,Bladder tumor Ag,Bladder tumor Ag:PrThr:Pt:Urine:Ord
2329,Hepatitis B Virus Surface Antibody,Hepatitis B virus surface Ab:Titr:Pt:Ser:Qn
2330,Fasciola species antibody,Fasciola sp Ab:Titr:Pt:Ser:Qn:IF
2331,Trigonella foenum-graecum Ab.IgE.RAST class,Trigonella foenum-graecum Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
2332,Urea/Creatinine Ratio,Urea/Creatinine:SRto:24H:Urine:Qn
2333,Valine,Valine:SCnc:24H:Urine:Qn
2334,Prism base distance,Prism base distance:InvLen:Pt:LM glasses.lens.left:Qn
2335,Jamestown Canyon virus IgM,Jamestown canyon virus Ab.IgM:ACnc:Pt:Ser:Qn:IF
2336,Trivittatus virus Ab,Trivittatus virus Ab:Titr:Pt:XXX:Qn
2337,Mycoplasma haemofelis,Haemobartonella felis:PrThr:Pt:Bld:Ord:Microscopy.light
2338,Flurazepam,Flurazepam:MCnt:Pt:Meconium:Qn
2339,Hydrogen-Ion Concentration,pH:LsCnc:Pt:BldV:Qn
2340,"1,2,3-trichlorobenzene","1,2,3-Trichlorobenzene:MCnc:Pt:Ser/Plas:Qn"
2341,Axis distance,Axis distance:Angle:Pt:Glasses prescription.lens.left:Qn
2342,Proteins,Protein:MCnc:Pt:Synv fld:Qn
2343,Views oblique,View oblique:Find:Pt:Abdomen>Spine.lumbar:Doc:XR
2344,View lateral frog,View lateral frog:Find:Pt:Lower extremity>Hip:Doc:XR
2345,Secobarbital,Secobarbital:MCnt:Pt:Meconium:Qn
2346,Cytomegalovirus DNA,Cytomegalovirus DNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar
2347,Insulin,Insulin^2.3H post XXX challenge:ACnc:Pt:Ser/Plas:Qn
2348,Multisection,Multisection^WO & W contrast IV:Find:Pt:Head>Maxillofacial region:Doc:CT
2349,Campylobacter jejuni antibody,Campylobacter jejuni Ab:ACnc:Pt:Ser:Qn
2350,size,Size:Arb:Pt:Ear.left:Ord:Estimated
2351,drugs identified,Drugs identified:Prid:Pt:Hair:Nom:Screen
2352,Cells.hyperdiploid/100 cells,Cells.hyperdiploid/100 cells:NFr:Pt:XXX:Qn:Flow cytometry
2353,View,VIEWS^W CONTRAST.XXX INTRAVENOUS:FINDING:POINT IN TIME:VEIN.ADRENAL.BILATERAL:NARRATIVE:XR.FLUOR.ANGIO
2354,Canine parvovirus Ab.IgG,Canine parvovirus Ab.IgG:ACnc:Pt:Ser:Qn
2355,Coxiella burnetii phase 2 IgA,Coxiella burnetii phase 2 Ab.IgA:ACnc:Pt:Ser:Qn
2356,Cells.CD2+CD7+/100 cells,Cells.CD2+CD7+/100 cells:NFr:Pt:Bld:Qn
2357,Magnesium,Magnesium:MRat:Pt:Stool:Qn
2358,Multisection,Multisection:Find:Pt:Chest>Aortic arch & Neck>Neck vessels:Doc:MR.angio
2359,Coxsackievirus B5 Ab,Coxsackievirus B5 Ab:ACnc:Pt:CSF:Qn
2360,Xylose,Xylose:MCnc:Pt:Bld:Qn
2361,Cryptococcus sp Ag,Cryptococcus sp Ag:PrThr:Pt:CSF:Ord
2362,Multisection,Multisection:Find:Pt:Abdomen>Retroperitoneum:Doc:CT
2363,Somatomedins,Insulin-like growth factor^10th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn
2364,Framycetin,Framycetin:Susc:Pt:Isolate:Qn:MLC
2365,View,Views:Find:Pt:Upper extremity.bilateral>Finger:Doc:XR
2366,Reovirus antibody,Reovirus Ab:Titr:Pt:Body fld:Qn:Comp fix
2367,Copper/Creatinine,Copper/Creatinine:MRto:24H:Urine:Qn
2368,beta Globulin,Beta globulin:PrThr:24H:Urine:Ord
2369,lomefloxacin,Lomefloxacin:Susc:Pt:Isolate:OrdQn:MIC
2370,Multisection,Multisection^WO & W contrast IV:Find:Pt:Chest>Brachial plexus:Doc:MR
2371,Histoplasma species antibody,Deprecated Histoplasma capsulatum Ab [Presence] in Serum
2372,Comment,Comment:Imp:Pt:LM glasses.lens.right:Nom
2373,Pemphigus antibody,Intercellular substance Ab:ACnc:Pt:Ser:Qn
2374,Alpha-mannosidase,Alpha mannosidase:CCnt:Pt:Fibroblasts:Qn
2375,Multisection,Multisection^WO & W contrast IV:Find:Pt:Upper extremity>Elbow:Doc:MR
2376,Fosfomycin,Fosfomycin:Susc:Pt:Isolate:OrdQn:MIC
2377,Gastrin,Gastrin^3rd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn
2378,Views screening,Views screening:Find:Pt:Breast.right:Doc:MG
2379,phosphate ion,Phosphate:MCnc:Pt:Bld:Qn
2380,Pressure spot code,Pressure spot code:Find:Pt:Eye.left:Nom:Perimetry
2381,Platelet mean diameter,Platelet mean diameter:EntLen:Pt:Bld:Qn
2382,Phleum pratense recombinant (rPhl p) 7 Ab.IgE,Phleum pratense recombinant (rPhl p) 7 Ab.IgE:ACnc:Pt:Ser:Qn
2383,Trichophyton mentagrophytes var goetzii Ab.IgE,Trichophyton mentagrophytes var goetzii Ab.IgE:ACnc:Pt:Ser:Qn
2384,Rubella virus IgM,Rubella virus Ab.IgM:PrThr:Pt:Ser/Plas:Ord:IA
2385,Epstein Barr virus nuclear IgM,Epstein Barr virus nuclear Ab.IgM:Titr:Pt:Ser:Qn
2386,Threonine,Threonine:SCnc:Pt:Amnio fld:Qn
2387,dronabinol,Tetrahydrocannabinol:MCnc:Pt:Vitr fld:Qn
2388,Metamyelocytes/100 leukocytes,Metamyelocytes/100 leukocytes:Number Fraction:Point in time:Whole blood:Quantitative
2389,Saquinavir,Saquinavir:ACnc:Pt:Ser/Plas:Qn
2390,(Alnus incana+Corylus avellana+Ulmus americana+Salix caprea+Populus deltoides) Ab.IgE,Deprecated (Alnus incana+Corylus avellana+Ulmus americana+Salix caprea+Populus deltoides) Ab.IgE:ACnc:Pt:Ser:Ord:Multidisk
2391,Hydroxyproline/Creatinine,Hydroxyproline/Creatinine:SRto:Pt:Urine:Qn
2392,Rotavirus IgM,Rotavirus Ab.IgM:ACnc:Pt:Ser:Qn:IA
2393,Somatomedins,Insulin-like growth factor^7th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn
2394,Somatomedins,Insulin-like growth factor^8th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn
2395,Multisection,Multisection:Find:Pt:Lower extremity.right>Hip:Doc:US
2396,Multisection,Multisection:Find:Pt:XXX>Joint:Doc:MR
2397,Specimen volume,Specimen volume:Vol:Pt:Amnio fld:Qn
2398,Polio virus 3 Ab,Polio virus 3 Ab^2nd specimen:Titr:Pt:Ser:Qn:Neut
2399,Coxsackievirus B1 Ab,Coxsackievirus B1 Ab^1st specimen:Titr:Pt:Ser:Qn:Comp fix
2400,Coxsackievirus B5 Ab,Coxsackievirus B5 Ab^2nd specimen:Titr:Pt:Ser:Qn:Comp fix
2401,Clostridium perfringens IgM,Clostridium perfringens Ab.IgM:ACnc:Pt:Ser:Qn
2402,Ephedrine+Pseudoephedrine,Ephedrine+Pseudoephedrine:MCnt:Pt:Stool:Qn
2403,Flurazepam,Flurazepam:MCnt:Pt:Hair:Qn
2404,Ephedrine+Pseudoephedrine,Ephedrine+Pseudoephedrine:MCnc:Pt:Urine:Qn
2405,Brompheniramine,Brompheniramine:MCnc:Pt:Urine:Qn
2406,Amino beta guanidinopropionate/Creatinine,Deprecated Amino beta guanidinopropionate/Creatinine [Ratio] in Urine
2407,loracarbef,Loracarbef:Susc:Pt:Isolate:Qn:MLC
2408,Coxsackievirus B6 Ab,Coxsackievirus B6 Ab:ACnc:Pt:CSF:Qn
2409,Antiribosomal antibody,Ribosomal Ab:ACnc:Pt:Ser:Qn
2410,Rickettsia prowazekii IgM,Rickettsia prowazekii Ab.IgM:ACnc:Pt:Ser:Qn
2411,Note (document),Note:Finding:Point in time:{Setting}:Document:Psychiatry
2412,Lactate,Lactate:SCnc:Pt:Periton fld:Qn
2413,Ciprofloxacin,Ciprofloxacin:MCnc:Pt:XXX:Qn
2414,Cysteic Acid,Cysteate:SCnc:24H:Urine:Qn
2415,Beta aminoadipate/Creatinine,Beta aminoadipate/Creatinine:SRto:Pt:Urine:Qn
2416,Free T4 & TSH panel,Free T4 & TSH panel:-:Pt:Ser/Plas:Qn
2417,Alloisoleucine,Alloisoleucine:ACnc:Pt:Ser/Plas:Qn
2418,Add 1,Add 1:InvLen:Pt:Eye.right:Qn:Phoropter
2419,Cocaine,Cocaine:MCnc:Pt:Gast fld:Qn
2420,(Olea europaea+Salix caprea+Pinus strobus+Eucalyptus spp+Acacia longifolia+Melaleuca leucadendron) Ab.IgE,(Olea europaea+Salix caprea+Pinus strobus+Eucalyptus spp+Acacia longifolia+Melaleuca leucadendron) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk
2421,Cortisol.free/Creatinine,Cortisol.free/Creatinine:MRto:24H:Urine:Qn
2422,Intravascular peak systolic,Intravascular peak systolic^during MR max vel measurement:Pres:Pt:Arterial system.XXX:Qn
2423,Aspartate,Aspartate:SRat:24H:Urine:Qn
2424,Aspergillus versicolor Ab.IgE.RAST class,Aspergillus versicolor Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
2425,Neuronal nuclear type 3 Ab,Neuronal nuclear type 3 Ab:PrThr:Pt:Ser:Ord
2426,Guidance for change of dialysis catheter,Guidance for change of dialysis catheter^W contrast IV:Find:Pt:XXX:Doc:RF
2427,Coxiella burnetii phase 2 IgM,Coxiella burnetii phase 2 Ab.IgM:PrThr:Pt:Ser:Ord:IF
2428,Cells.CD55/100 cells,Cells.CD55/100 cells:NFr:Pt:Body fld:Qn
2429,Immature granulocyte,Granulocytes.immature:PrThr:Pt:Bld:Ord
2430,Ristocetin,Ristocetin:Susc:Pt:Isolate:Qn:MLC
2431,Complement 3,Complement C3:MCnc:Pt:Plr fld:Qn
2432,Lipoprotein (a),Lipoprotein (little a):SCnc:Pt:Ser/Plas:Qn
2433,Purine-Nucleoside Phosphorylase,Purine nucleoside phosphorylase:EntCat:Pt:WBC:Qn
2434,Morphine,Morphine:PrThr:Pt:Hair:Ord
2435,Salmonella gallinarum Ab,Salmonella gallinarum Ab:PrThr:Pt:Bld:Ord
2436,Pivampicillin,Pivampicillin:Susc:Pt:Isolate:OrdQn:MIC
2437,Thallium/Creatinine,Thallium/Creatinine:SRto:Pt:Urine:Qn
2438,SPL patient package insert section,SPL patient package insert section:-:-:^FDA package insert:Nar
2439,Flurazepam,Flurazepam:Mass:Pt:Dose:Qn
2440,Thrombomodulin factor B,Deprecated Properdin factor B:Mass Concentration:Point in time:Plasma:Quantitative
2441,HLA-B61(40),HLA-B61(40):PrThr:Pt:Bld/Tiss:Ord
2442,Tyrosine/Amino acids.total,Tyrosine/Amino acids.total:SFr:Pt:XXX:Qn
2443,Herpes virus 8 IgG,Herpes virus 8 Ab.IgG:PrThr:Pt:Ser:Ord
2444,lomefloxacin,Lomefloxacin:Susc:Pt:Isolate:OrdQn:Gradient strip
2445,oritavancin,Oritavancin:Susc:Pt:Isolate:OrdQn:Gradient strip
2446,View,Views^W gastrografin PR:Find:Pt:Abdomen+Pelvis>Colon:Doc:RF
2447,Acetylcholine receptor binding antibody,Acetylcholine receptor binding Ab:PrThr:Pt:Ser:Ord
2448,Bilirubin,Bilirubin:PrThr:24H:Urine:Ord:Test strip
2449,Blood pressure systolic & diastolic,Blood pressure systolic & diastolic^post phlebotomy:Pres:Pt:Arterial system:Qn
2450,Erythrocyte sedimentation rate measurement,Erythrocyte sedimentation rate:Vel:Pt:Bld:Qn:Westergren
2451,Propranolol,Propranolol:PrThr:Pt:Ser/Plas:Ord
2452,Sulbactam,Sulbactam:Susc:Pt:Isolate:OrdQn:MIC
2453,Dopamine/Creatinine,Dopamine/Creatinine:SRto:24H:Urine:Qn
2454,Erythrocyte sedimentation rate measurement,Erythrocyte sedimentation rate:Vel:Pt:Bld:Qn:Wintrobe
2455,Streptococcus pneumoniae Danish serotype 43 IgG,Deprecated Streptococcus pneumoniae 43 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
2456,Tetracaine,Tetracaine:MCnc:Pt:Ser/Plas:Qn
2457,Multisection,Multisection^WO contrast:Find:Pt:Head>Head vessels:Doc:CT.angio
2458,Cells.CD20+CD23+/100 cells,Cells.CD20+CD23+/100 cells:NFr:Pt:Bld:Qn
2459,Uranium.depleted cutoff,Uranium.depleted cutoff:MCnc:Pt:Urine:Qn
2460,Reagins,Reagin Ab:Titr:Pt:CSF:Qn
2461,Creatinine,Creatinine^1H pre XXX challenge:MCnc:Pt:Ser/Plas:Qn
2462,11-oxo-etiocholanolone,11-Oxo-Etiocholanolone:MRat:24H:Urine:Qn
2463,Pivampicillin,Pivampicillin:Susc:Pt:Isolate:OrdQn:Agar diffusion
2464,Bacteria identified,Bacteria identified:Prid:Pt:Sinus:Nom:Culture
2465,Betamethasone,Betamethasone:MCnc:Pt:Urine:Qn
2466,TCR alpha beta Ag,TCR alpha beta Ag:PrThr:Pt:Tiss:Ord:Immune stain
2467,Ehrlichia chaffeensis IgG,Ehrlichia chaffeensis Ab.IgG:Titr:Pt:Ser:Qn:IF
2468,Glucose,Glucose^8.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
2469,Protriptyline,Protriptyline^trough:MCnc:Pt:Ser/Plas:Qn
2470,Mezlocillin,Mezlocillin:Mass:Pt:Dose:Qn
2471,Multisection,Multisection^W Tc-99m glucoheptonate IV:Find:Pt:Abdomen>Kidney:Doc:NM.SPECT
2472,Trimethoprim,Trimethoprim:Mass:Pt:Dose:Qn
2473,Influenzavirus A antigen,Influenza virus A Ag:PrThr:Pt:Bronchial:Ord:IF
2474,Guidance for aspiration or injection of cyst,Guidance for aspiration or injection of cyst:Find:Pt:XXX:Doc:US
2475,Multisection,Multisection:Find:Pt:Upper extremity.right>Upper extremity artery:Doc:US
2476,Views post mortem,Views post mortem:Find:Pt:XXX:Doc:XR
2477,View scaphoid,View scaphoid:Find:Pt:Upper extremity.bilateral>Wrist:Doc:XR
2478,Cells.CD38+Kappa+/100 cells,Cells.CD38+Kappa+/100 cells:NFr:Pt:Bld:Qn
2479,PlA1 Ab,PlA1 Ab:PrThr:Pt:PRP:Ord
2480,Multisection limited,Multisection limited:Find:Pt:Extremity>Extremity artery:Doc:US
2481,Influenza B virus antibody,Influenza virus B Ab:PrThr:Pt:Ser:Ord:Comp fix
2482,CD8 Antigens,CD8 Ag:PrThr:Pt:Tiss:Ord:Immune stain
2483,Oxygen saturation test result,Deprecated Oxygen saturation^pre exercise: SFr: Pt: BldA: Qn: Oximetry
2484,Views magnification,View magnification:Find:Pt:Neck:Doc:XR
2485,Cells.CD138/100 cells,Cells.CD138/100 cells:NFr:Pt:Tiss:Qn
2486,Blood product units requested,Blood product units requested:Num:Pt:^BPU:Qn
2487,Views 2,Views 2:Find:Pt:Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar:Doc:XR
2488,Streptococcus pneumoniae 20 Ab.IgG,Deprecated Streptococcus pneumoniae 20 IgG Ab [Mass/volume] in Serum --1st specimen
2489,Creatinine,Creatinine^baseline:SCnc:Pt:Urine:Qn
2490,External rotation.active range of motion,External rotation.active range of motion:Angle:Pt:Hip:Qn
2491,Alnus rugosa Ab.IgG,Alnus rugosa Ab.IgG:ACnc:Pt:Ser:Qn
2492,Study observation.general 3rd trimester,Study observation.general 3rd trimester:Imp:Pt:^Fetus:Nar:US
2493,Phenylalanine/Creatinine,Phenylalanine/Creatinine:MRto:24H:Urine:Qn
2494,Influenza A virus H7 RNA,Influenza virus A H7 RNA:ACnc:Pt:XXX:Qn:Probe.amp.tar
2495,Multisection,Multisection^WO & W contrast IV:Find:Pt:Lower extremity.right>Lower extremity vessels:Doc:CT.angio
2496,Epstein Barr virus early IgA,Epstein Barr virus early Ab.IgA:Titr:Pt:Ser:Qn:IF
2497,History of procedures,History of procedures:Find:Pt:{Setting}:Doc:{Role}
2498,Glucose,Glucose^2.5H post XXX challenge:SCnc:Pt:Ser/Plas:Qn
2499,Glucose,Glucose^2M post XXX challenge:SCnc:Pt:Ser/Plas:Qn
2500,Extension.passive range of motion,Extension.passive range of motion:Angle:Pt:Shoulder:Qn
2501,Hantavirus antibody,Hantavirus Ab:PrThr:Pt:Ser:Ord
2502,Benzodiazepines,Benzodiazepines:PrThr:Pt:XXX:Ord
2503,Creatinine,Creatinine^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
2504,Total metabolism,Total metabolism:Mass:24H:^Patient:Qn
2505,VWF gene targeted mutation analysis,VWF GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NOM:MOLGEN
2506,Walking Speed,Walking speed:Vel:24H^mean:^Patient:Qn:Calculated
2507,Netilmicin,Netilmicin:Mass:Pt:Dose:Qn
2508,Sulfamethoxazole,Sulfamethoxazole:Mass:Pt:Dose:Qn
2509,Chlamydia species antigen,Chlamydia sp Ag:PrThr:Pt:Nph:Ord:IA
2510,Multisection,Multisection:Find:Pt:XXX>Artery:Doc:US
2511,Parvovirus B19 IgM,Parvovirus B19 Ab.IgM:PrThr:Pt:Ser:Ord:IA
2512,Blastomyces dermatitidis antibody,Deprecated Blastomyces dermatitidis Ab [Presence] in Body fluid
2513,Multiple tumors reported as single primary,Multiple tumors reported as single primary:Prid:Pt:Cancer.XXX:Nom
2514,Date of diagnosis of multiple tumors,Date of diagnosis of multiple tumors:TmStp:Pt:Cancer.XXX:Qn
2515,Norepinephrine,Norepinephrine^1H post 300 ug clonidine PO:SCnc:Pt:Plas:Qn
2516,HLA-B52(5),HLA-B52(5):PrThr:Pt:Bld/Tiss:Ord
2517,Hydrocortisone,Cortisol^1.5H post 1 ug/kg CRH IV:SCnc:Pt:Ser/Plas:Qn
2518,Creatinine,Creatinine^6H post XXX challenge:SCnc:Pt:Ser/Plas:Qn
2519,rubella antibodies,Rubella virus Ab:PrThr:Pt:CSF:Ord:LA
2520,Acebutolol,Acebutolol:Mass:Pt:Dose:Qn
2521,Methadone/Creatinine,Methadone/Creatinine:MRto:Pt:Urine:Qn
2522,Antigen of Cryptosporidium parvum,Cryptosporidium parvum Ag:PrThr:Pt:Stool:Ord:IA
2523,3rd course treatment.other therapy,3rd course treatment.other therapy:Prid:Pt:Subsequent cancer Rx:Nom
2524,Loxapine,Loxapine:Mass:Pt:Dose:Qn
2525,Bordetella pertussis filamentous hemagglutinin IgA,Bordetella pertussis.filamentous hemagglutinin Ab.IgA:PrThr:Pt:Ser:Ord
2526,Appearance,Appearance^post transfusion reaction:Aper:Pt:Ser:Nom
2527,Lactose,Lactose^30M post dose lactose PO:SCnc:Pt:Ser/Plas:Qn
2528,Febrile agglutinin Ab panel,Febrile agglutinin Ab panel:Titr:Pt:Ser:Qn
2529,Derived American Joint Committee on cancer conversion method,Derived American Joint Committee on cancer conversion method:Arbitrary:Point in time:Cancer.To be specified in another part of the message:Ordinal
2530,Palliative procedure at this facility,Palliative procedure at this facility:Type:Pt:Cancer.XXX:Nom
2531,Arbovirus IgG,Arbovirus Ab.IgG:PrThr:Pt:Ser:Ord
2532,Propionylglycine/Creatinine,Propionylglycine/Creatinine:MRto:24H:Urine:Qn
2533,Tyrosine/Creatinine,Tyrosine/Creatinine:MRto:24H:Urine:Qn
2534,Reason for transplant,Reason for transplant:Finding:Point in time:^Patient:Nominal
2535,Lymphocytic choriomeningitis virus IgM,Lymphocytic choriomeningitis virus Ab.IgM:PrThr:Pt:Ser:Ord
2536,Interleukin-4,Interleukin 4:ACnc:Pt:Ser/Plas:Qn
2537,Chlamydia trachomatis antigen,Chlamydia trachomatis Ag:PrThr:Pt:Body fld:Ord
2538,Medication or other side effects associated with HIV Rx,Medication or other side effects associated with HIV Rx:Type:Pt:^Patient:Nom:Reported
2539,Spironolactone,Spironolactone:Mass Concentration:Point in time:Urine:Quantitative
2540,Basophils,Basophils:Naric:Pt:Periton fld:Qn:Microscopy.light.HPF
2541,arachidate,Arachidate:SCnc:Pt:Ser/Plas:Qn
2542,Multisection limited,Multisection limited:Find:Pt:Lower extremity>Hip:Doc:CT
2543,Chlamydia species antibody (substance),Chlamydia sp Ab:PrThr:Pt:CSF:Ord
2544,VA C&P exam.extremity joints note,VA C&P exam.extremity joints note:Find:Pt:{Setting}:Doc:{Role}
2545,Ketones,Ketones:SCnc:Pt:Ser/Plas:Qn:Test strip
2546,Tuberculosis reaction wheal,Tuberculosis reaction wheal^1D post dose mammalian tuberculin ID:Diam:Pt:Skin:Qn
2547,Fibrinogen; antigen,Deprecated Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunologic method
2548,Date of last menstrual period,Last menstrual period:Date:Pt:^Patient:Qn:Estimated from EDD
2549,Blood group antibody E,E Antibody:Dilution Factor (Titer):Point in time:Serum/Plasma:Quantitative
2550,Corynebacterium diphtheriae toxin Ab,Corynebacterium diphtheriae toxin Ab:ACnc:Pt:Ser:Qn
2551,Escherichia coli O157:H7 Antigen,Escherichia coli O157:H7 Ag:PrThr:Pt:Mlk.raw:Ord:IA
2552,Multisection limited,Multisection limited:Find:Pt:Extremity:Doc:US
2553,Gestational Age,Gestational age:Time:Pt:^Fetus:Qn:US+Estimated from CRL.Daya 1993
2554,Gestational Age,Gestational age:Time:Pt:^Fetus:Qn:US+Estimated from FL.Jeanty 1982
2555,Chlorpheniramine,Chlorpheniramine:MCnc:Pt:Ser/Plas:Qn
2556,Multisection,Multisection^W contrast IV:Find:Pt:Lower extremity.right>Knee:Doc:MR
2557,Multisection,Multisection^WO contrast:Find:Pt:Head>Sinuses:Doc:CT
2558,Multisection stereotactic,Deprecated Unspecified body region CT stereotactic
2559,Chorionic Gonadotropin,Choriogonadotropin:MCnc:Pt:Ser/Plas:Qn
2560,phosphate ion,Phosphate [Mass or Molecules/volume] in Serum or Plasma
2561,Mersalyl,Mersalyl:MRat:24H:Urine:Qn
2562,View,Views^W contrast:Find:Pt:Abdomen>Jejunum:Doc:RF
2563,View,Views^W contrast intra lymphatic:Find:Pt:Abdomen>Abdominal lymphatic vessels & Pelvis>Pelvic lymphatic vessels:Doc:RF.angio
2564,Views limited,Views limited^W contrast IT:Find:Pt:Chest>Spine.thoracic:Doc:RF
2565,Views perfusion,Views perfusion^W stress+W Tl-201 IV:Find:Pt:Chest>Heart:Doc:NM
2566,Cyclic AMP,Adenosine monophosphate.cyclic:SCnc:24H:Urine:Qn
2567,Ampicillin Ab.IgG,Ampicillin Ab.IgG:ACnc:Pt:Ser:Qn
2568,Chlamydia sp rRNA,Chlamydia sp rRNA:PrThr:Pt:Thrt:Ord:Probe
2569,Coagulation factor VIII activity.X(little a) activator,Coagulation factor VIII activity.X(little a) activator:ACnc:Pt:PPP:Qn:Chromo
2570,Clarity,Clarity:Type:Pt:Urine:Nom
2571,Distance of carcinoma from deep margin,Distance of carcinoma from deep margin:Len:Pt:Specimen:Qn
2572,Extent of invasion deepest,Extent of invasion deepest:Type:Pt:Specimen:Ord
2573,Copper,Copper:SCnc:Pt:Urine:Qn
2574,Views 2,Views 2:Find:Pt:Upper extremity>Elbow:Doc:XR
2575,View Zanca,View Zanca:Find:Pt:Upper extremity.left>Acromioclavicular joint:Doc:XR
2576,Views 6,Views 6:Find:Pt:Upper extremity>Wrist:Doc:XR
2577,Glucose,Glucose^2D post XXX challenge:MCnc:Pt:Ser/Plas:Qn
2578,Color,Periwound color:Type:Point in time:Wound:Nominal
2579,Views diagnostic,Views diagnostic:Find:Pt:Breast:Doc:MG.FFD
2580,Canrenone,Canrenone:MRat:24H:Urine:Qn
2581,View,Views^W manual stress:Find:Pt:Lower extremity.right>Ankle:Doc:XR
2582,Interleukin-13,Interleukin 13:MCnc:Pt:Ser/Plas:Qn
2583,Lymphocytes.immunoblastic,Lymphocytes.immunoblastic:NCnc:Pt:Bld:Qn:Manual count
2584,cell type,Cell type:Type:Pt:XXX:Nom
2585,microscopic observation,Microscopic observation:Prid:Pt:Bld:Nom:Malaria thin smear
2586,Immune complex.IgE,Immune complex.IgE:ACnc:Pt:Ser/Plas:Qn
2587,Consultation note,Consultation note:Find:Pt:{Setting}:Doc:Speech-language pathology+Audiology
2588,Platelet aggregation.XXX induced,Platelet aggregation.XXX induced:RelACnc:Pt:PRP^Donor:Qn
2589,Views 3,Views 3:Find:Pt:Chest:Doc:XR
2590,Multisection,Multisection^WO contrast:Find:Pt:Abdomen+Pelvis>Spine.lumbosacral junction:Doc:CT
2591,Views magnification,Views magnification:Find:Pt:Breast:Doc:MG
2592,Influenza A virus H9 Ab,Influenza virus A H9 Ab:Titr:Pt:Ser:Qn:HAI
2593,Blood flow.max.kidney artery/Blood flow.max.aorta,Blood flow.max.kidney artery/Blood flow.max.aorta:VelRto:Pt:{Circulatory system}:Qn:US
2594,diethylene glycol,Diethylene glycol:MCnc:Pt:Ser/Plas:Qn
2595,Surgical operation note,Surgical operation note:Find:Pt:{Setting}:Doc:Orthopaedic surgery
2596,Post-operative evaluation and management note,Postoperative evaluation and management note:Find:Pt:{Setting}:Doc:Surgery.nurse
2597,Views 3,Views 3:Find:Pt:Lower extremity.left>Foot:Doc:XR
2598,Multisection,Multisection:Find:Pt:Upper extremity.left>Upper extremity joint:Doc:MR
2599,Multisection,Multisection:Find:Pt:Head>Mastoid:Doc:XR.tomography
2600,Simazine,Simazine:MCnc:Pt:Water:Qn
2601,Cells.CD3+CD8+CD45RO-CD45RA-/100 cells,Cells.CD3+CD8+CD45RO-CD45RA-/100 cells:NFr:Pt:Bld:Qn
2602,Multisection,Multisection^WO & W contrast IV:Find:Pt:Lower extremity.right>Foot:Doc:CT
2603,Multisection,Multisection^WO & W contrast IV:Find:Pt:Upper extremity.left>Forearm:Doc:MR
2604,Multisection,Multisection:Finding:Point in time:Ovary:Narrative:MRI
2605,Multisection,Multisection:Find:Pt:Head>Temporomandibular joint.bilateral:Doc:MR
2606,Views 2,Views 2:Find:Pt:Upper extremity.right>Shoulder:Doc:XR
2607,Views perfusion,Deprecated Views perfusion^at rest & W stress & W 99m Tc Sestamibi IV:Find:Pt:Heart:Nar:Radnuc
2608,Hydrocortisone,Cortisol^1H post XXX challenge:SCnc:Pt:Ser/Plas:Qn
2609,Follicle Stimulating Hormone,Follitropin^baseline:ACnc:Pt:Ser/Plas:Qn
2610,DNA index 3,DNA index 3:ACnc:Pt:XXX:Qn:Flow cytometry
2611,LACROSSE VIRUS ANTIBODY,La Crosse virus Ab:Titr:Pt:Body fld:Qn
2612,View Zanca,View Zanca:Find:Pt:Upper extremity>Acromioclavicular joint:Doc:XR
2613,Mycobacterium tuberculosis complex rRNA,Deprecated Mycobacterium tuberculosis complex rRNA [Presence] in Unspecified specimen by DNA probe
2614,Color,Color:Type:Pt:Amnio fld:Nom
2615,Hematocrit procedure,Hematocrit:VFr:Pt:BldA:Qn
2616,Prothrombin antigen,Prothrombin Ag:ACnc:Pt:PPP:Qn:IA
2617,Chromosome 7 uniparental disomy,Chromosome 7 uniparental disomy:Arb:Pt:Bld/Tiss:Ord:Cytogenetics
2618,Multisection,Multisection:Find:Pt:Upper extremity>Humerus:Doc:XR.tomography
2619,View,Views:Find:Pt:Upper extremity>Humerus.bicipital groove:Doc:XR
2620,Views 5,Views 5:Find:Pt:Head>Sinuses:Doc:XR
2621,Legionella antibody,Legionella sp Ab:PrThr:Pt:Ser:Ord
2622,Oxacillin,Oxacillin:MCnc:Pt:Ser/Plas:Qn
2623,Multisection,Multisection:Find:Pt:Lower extremity>Lower extremity artery:Doc:US.doppler
2624,Urea,Urea^pre dialysis:SCnc:Pt:Ser/Plas:Qn
2625,West Nile virus Ag,West Nile virus Ag:PrThr:Pt:Tiss:Ord:Immune stain
2626,Recession,Recession:Len:Pt:{Tooth}.{probe site}:Qn:Measured
2627,Lymphocytes.variant,Lymphocytes.variant:NCnc:Pt:Plr fld:Qn
2628,Blastomyces dermatitidis IgM,Blastomyces dermatitidis Ab.IgM:PrThr:Pt:Ser:Ord:IA
2629,Calcium,Calcium^3D post XXX challenge:MCnc:Pt:Ser/Plas:Qn
2630,Trifluoperazine,Trifluoperazine:SCnc:Pt:Ser/Plas:Qn
2631,Physical findings,Physical findings:Find:Pt:Larynx:Nom:Observed
2632,Hepatitis B virus little e Ab.IgG,Hepatitis B virus little e Ab.IgG:PrThr:Pt:Ser:Ord:IA
2633,Note (document),Note:Find:Pt:{Setting}:Doc:Radiation oncology
2634,Patient History,Patient history:-:Point in time:^Patient:-
2635,Multisection,Multisection:Find:Pt:Lower extremity>Knee:Doc:XR.tomography
2636,Multisection,Multisection:Finding:Point in time:Neck:Narrative:Computerized Tomography
2637,Multisection,Multisection^WO contrast:Find:Pt:Upper extremity.left>Elbow:Doc:MR
2638,CFTR gene.c.1078delT,CFTR gene.c.1078delT:PrThr:Pt:Bld/Tiss:Ord:Molgen
2639,LITAF gene targeted mutation analysis,LITAF GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NAR:MOLGEN
2640,HTLV-I Antibodies,HTLV I Ab:PrThr:Pt:CSF:Ord
2641,Stable status,Stability:Imp:Pt:{Dental arch}.denture.complete:Ord:Reported
2642,Acetaminophen,Acetaminophen:PrThr:Pt:Urine:Ord
2643,Kelp Ab.IgE.RAST class,Kelp Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
2644,Methane/Expired gas,Methane/Expired gas^3H post dose lactose PO:VFr:Pt:Exhl gas:Qn
2645,HIV 1 p65+p66 Ab,HIV 1 p65+p66 Ab:PrThr:Pt:Ser:Ord:IB
2646,Clarity,Clarity:Type:Pt:XXX:Nom
2647,Multisection,Multisection:Find:Pt:Lower extremity>Lower extremity veins:Doc:MR.angio
2648,Multisection,Multisection^W contrast IS:Find:Pt:Upper extremity>Wrist:Doc:MR
2649,Multisection,Multisection^WO contrast:Find:Pt:Upper extremity>Wrist:Doc:CT
2650,VA C&P exam.miscellaneous arteries &or veins note,VA C&P exam.miscellaneous arteries &or veins note:Find:Pt:{Setting}:Doc:{Role}
2651,Platelet aggregation.arachidonate induced,Platelet aggregation.arachidonate induced:RelACnc:Pt:PRP^Control:Qn
2652,Diameter.biparietal outer to inner,Diameter.biparietal outer to inner:Len:Pt:Head^Fetus:Qn:US.estimated from Chitty 1994
2653,Methadone cutoff,Methadone cutoff:MCnc:Pt:Saliva:Qn:Confirm
2654,Carnitine biosynthesis intermediates panel,Carnitine biosynthesis intermediates panel:-:Pt:CSF:-
2655,Cardiolipin IgM,Deprecated Cardiolipin IgM Ab [Units/volume] in Serum by Immunoassay
2656,Actin.filamentous Ab,Actin.filamentous Ab:PrThr:Pt:Ser:Ord:Line blot
2657,Latex recombinant (rHev b) 11 Ab.IgE.RAST class,Latex recombinant (rHev b) 11 Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
2658,Phencyclidine,Phencyclidine:MCnc:Pt:Unk sub:Qn
2659,Collagen induced platelet aggregation,Platelet aggregation.collagen induced:ACnc:Pt:Bld:Qn
2660,Surgical operation note,Surgical operation note:Find:Pt:{Setting}:Doc:Obstetrics and Gynecology
2661,trimethyllysine,Trimethyllysine:SCnc:Pt:CSF:Qn
2662,Cells,Cells:Num:Pt:Anterior chamber.right:Qn:Slit lamp biomicroscopy
2663,Enhanced encounter note - recommended CDP Set 1 R1.0 & R1.1 sections,Enhanced encounter note - recommended CDP Set 1 R1.0 & R1.1 sections:-:Pt:{Setting}:-
2664,Verified side &or site of procedure,Verified side &or site of procedure:Find:Pt:^Patient:Ord
2665,Antiribosomal P protein antibody,Deprecated Ribosomal P Ab [Presence] in Cerebral spinal fluid by Immunoblot
2666,Service comment 12,Service comment 12:Impression/interpretation of study:Point in time:To be specified in another part of the message:Nominal
2667,Service comment 19,Service comment 19:Impression/interpretation of study:Point in time:To be specified in another part of the message:Nominal
2668,St. Louis encephalitis virus antibody,Saint Louis encephalitis virus Ab:Titr:Pt:CSF:Qn:IF
2669,Electroretinography (ERG) measurements panel,Electroretinography (ERG) measurements panel:-:Pt:Eye:-:Electroretinogram
2670,Objective refraction measurements panel,Objective refraction measurements panel:-:Pt:Eye:-:Objective refraction
2671,Pressure half time.diastole,Pressure half time.diastole:Time:Pt:Mitral valve:Qn:US.doppler
2672,Orifice area/Body surface area,Orifice area/Body surface area:ArArea:Pt:Aortic valve:Qn:US.2D+Measured by planimetry
2673,Sjogrens syndrome-A extractable nuclear 52kD Ab,Deprecated Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Cerebral spinal fluid by Immunoblot
2674,Body Temperature,Body temperature:Temp:12H^max:XXX:Qn
2675,Body Temperature,Body temperature:Temp:10H:XXX:Qn
2676,Fluid intake.intravascular,Fluid intake.intravascular:VRat:12H:Vascular system:Qn
2677,Urine volume finding,Fluid output.urine:VRat:8H:Urinary tract:Qn
2678,Borrelia burgdorferi 39kD IgG,Borrelia burgdorferi 39kD Ab.IgG:PrThr:Pt:Ser:Ord:IB
2679,Aluminum,Aluminum:SCnc:Pt:Water:Qn
2680,Norovirus genogroup I+II orf1-orf2 junction region,Norovirus genogroup I+II orf1-orf2 junction region:PrThr:Pt:Stool:Ord:Probe.amp.tar
2681,Cefixime,Cefixime:Susc:Pt:Isolate:Qn:MLC
2682,PISA velocity.diastole,PISA velocity.diastole:Vel:Pt:Aortic valve:Qn:US.doppler
2683,Immunoglobulin light chains.lambda.free,Immunoglobulin light chains.lambda.free:MCnc:Pt:Ser:Qn:Nephelometry
2684,Consultation note,Consultation note:Find:Pt:{Setting}:Doc:Surgical oncology
2685,Discharge teaching note,Discharge teaching note:Find:Pt:{Setting}:Doc:Geriatric medicine
2686,Intrachamber diastolic,Intrachamber diastolic:Pres:Pt:Heart.ventricle.left:Qn
2687,Stizostedion vitreum Ab.IgE,Stizostedion vitreum Ab.IgE:ACnc:Pt:Ser:Qn
2688,End-systolic volume,End-systolic volume:Vol:Pt:Heart.atrium.left:Qn:US.2D.A2C+Calc by single plane method of disks
2689,Distance of tumor from circumferential resection margin,Distance of tumor from circumferential resection margin:Len:Pt:Specimen:Qn:Microscopy.light
2690,(Chicken feather+Cow dander+Goose feather+Horse dander) Ab.IgE.RAST class,(Chicken feather+Cow dander+Goose feather+Horse dander) Ab.IgE.RAST class:PrThr:Pt:Ser:Ord:Multidisk
2691,Blood group antibody screen.cell III,Blood group antibody screen.cell III:PrThr:Pt:Ser/Plas:Ord:Prewarmed
2692,Coxsackievirus A16 Ab,Coxsackievirus A16 Ab:Titr:Pt:CSF:Qn:Comp fix
2693,HPD gene full mutation analysis,HPD gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing
2694,Measles antibody,Measles virus Ab:ACnc:Pt:Ser:Qn
2695,Blood velocity-time integral.systole,Blood velocity-time integral.systole:Len:Pt:Heart.ventricle.left.outflow tract:Qn:US.doppler
2696,Guidance for biopsy.vacuum,Guidance for biopsy.vacuum:Find:Pt:Breast.left:Doc:US
2697,Consultation note,Consultation note:Find:Pt:{Setting}:Doc:Clinical pharmacology
2698,Airway resistance,Resistance.airway^pre bronchodilation:FldResist:Pt:Respiratory system.airway:Qn
2699,RMRP gene targeted mutation analysis,RMRP gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen
2700,Calorie intake.total,Calorie intake.total:Power = Energy/Time:Point in time:^Patient:Quantitative
2701,Effective regurgitant orifice area.systole,Effective regurgitant orifice area.systole:Area:Pt:Mitral valve:Qn:US.doppler+Calculated by PISA method
2702,Cerebral ventricle drain site,Cerebral ventricle drain site:Anatomy:Point in time:*^Patient:Nominal
2703,Cells.aneuploid.S phase population/100 cells,Cells.aneuploid.S phase population/100 cells:NFr:Pt:Cells.XXX:Qn:Flow cytometry
2704,Cells.aneuploid.S phase population 2/100 cells,Cells.aneuploid.S phase population 2/100 cells:NFr:Pt:Cells.XXX:Qn:Flow cytometry
2705,Aneuploid G1 phase cell population peak channel,Aneuploid G1 phase cell population peak channel:Num:Pt:Cells.XXX:Qn:Flow cytometry
2706,Sensory or speech status,Sensory or speech status:Finding:Point in time:^Patient:Nominal
2707,formate,Formate:SCnc:Pt:Ser/Plas:Qn:Confirm
2708,Inosine triphosphate pyrophosphatase,Inosine triphosphate pyrophosphatase:CSub:Pt:RBC:Qn
2709,Transfer summary note,Transfer summary note:Find:Pt:{Setting}:Doc:Cardiac surgery
2710,P' wave amplitude.lead V5,P' wave amplitude.lead V5:Elpot:Pt:Heart:Qn:EKG
2711,QRS terminal amplitude.lead V2,QRS terminal amplitude.lead V2:Elpot:Pt:Heart:Qn:EKG
2712,Condition- or population-specific panel,Condition- or population-specific panel:-:Pt:^Patient:-:APTA
2713,Amphetamine,Amphetamine:MCnt:Pt:Hair:Qn:Confirm
2714,A2 antigen,A2 Ag:PrThr:Pt:RBC:Ord
2715,Comparison.study,Comparison.study:Impression/interpretation of study:Point in time:Heart:Nominal:EKG
2716,Wound drain site,Wound drain site:Anatomy:Point in time:*^Patient:Nominal
2717,output.stool,Output.stool:MRat:8H:Lower GI tract:Qn
2718,B variant NOS Ag,Deprecated B variant NOS Ag [Presence] on Red Blood Cells
2719,Rickettsia typhus group IgG,Rickettsia typhus group Ab.IgG:ACnc:Pt:Ser:Qn
2720,phosphate ion,Phosphate:SCnc:XXX:Urine:Qn
2721,Fat intake panel,Fat intake panel:-:-:^Patient:-
2722,Study observation.overall,Study observation.overall:Finding:Point in time:Heart:Nominal:EKG
2723,DLD gene targeted mutation analysis,DLD gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
2724,Spermatozoa morphology normal,Spermatozoa.normal morphology:Num:Pt:Semen:Qn:Automated count
2725,Views for therapy,Views for therapy^W I-131 PO:Find:Pt:Neck>Thyroid gland:Doc:NM
2726,Childhood diseases,History of childhood diseases:Finding:Point in time:^Patient:Nominal:Reported
2727,Amikacin.free,Amikacin.free:MCnc:Pt:Ser/Plas:Qn
2728,Homocysteine intake,Homocysteine intake:MRat:24H:^Patient:Qn:Measured
2729,Blood group antigen A3,A3 Ag:PrThr:Pt:RBC:Ord
2730,Phencyclidine cutoff,Phencyclidine cutoff:MCnc:Pt:Saliva:Qn:Confirm
2731,Referral note,Referral note:Find:Pt:{Setting}:Doc:Neonatal perinatal medicine
2732,HIV 1 RNA tropism,human immunodeficiency virus 1 ribonucleic acid tropism:Presence or Identity:Point in time:Plasma:Nominal
2733,Lymphocyte proliferation.Interleukin 2.maximum/CD45,Lymphocyte proliferation.Interleukin 2.maximum/CD45:NFr:Pt:Bld:Qn:Flow cytometry
2734,Surgical operation note preoperative Dx,Operative note preoperative Dx:Impression/interpretation of study:Point in time:^Patient:Nominal
2735,Borates,Borate:MCnc:Pt:XXX:Qn
2736,Propoxyphene+Norpropoxyphene,Propoxyphene+Norpropoxyphene:SCnc:Pt:XXX:Qn
2737,Indocyanine Green,Indocyanine green^15M post dose indocyanine green:MCnc:Pt:Plas:Qn
2738,Nitrogen,Nitrogen:MCnt:24H:Stool:Qn
2739,Human immunodeficiency virus 1 RNA,HIV 1 RNA:PrThr:Pt:Semen:Ord:Probe.amp.tar
2740,Schistosoma mansoni+haematobium+intercalatum,Schistosoma mansoni+haematobium+intercalatum:Titr:Pt:Ser:Qn:HA
2741,Admission history and physical note,Admission history and physical note:Find:Pt:{Setting}:Doc:Cardiovascular disease+Pulmonary disease
2742,Admission history and physical note,Admission history and physical note:Find:Pt:{Setting}:Doc:Oral and maxillofacial surgery
2743,cold agglutinins,Cold agglutinin^24H post incubation:Titr:Pt:Ser:Qn:4 deg C incubation
2744,Murmur quality,Murmur quality:Type:Pt:Heart:Nom:Auscultation
2745,Cells.CD27+CD45RA+/100 Cells.CD3+CD8+,Cells.CD27+CD45RA+/100 Cells.CD3+CD8+:NFr:Pt:Bld:Qn
2746,Biotin intake,Vitamin B7 intake:MRat:24H:^Patient:Qn:Estimated
2747,Complex carbohydrate intake,Complex carbohydrate intake:MRat:24H:^Patient:Qn:Measured
2748,"Human immunodeficiency virus, type II antibody",HIV 2 Ab:PrThr:Pt:Ser/Plas/Bld:Ord:IA.rapid
2749,Artemisia vulgaris native (nArt v) 3 Ab.IgE.RAST class,Artemisia vulgaris native (nArt v) 3 Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
2750,Dermatophagoides pteronyssinus recombinant (rDer p) 10 Ab.IgE.RAST class,Dermatophagoides pteronyssinus recombinant (rDer p) 10 Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
2751,Cocaine,Cocaine:PrThr:Pt:Unk sub:Ord:Screen
2752,Stroke volume/Body surface area,Stroke volume/Body surface area:ArVol:Pt:Heart.ventricle.left:Qn:Angiography.biplane
2753,Morphine,Morphine:Arbitrary Concentration:Point in time:Gastric fluid/contents:Ordinal
2754,Discharge instructions,Discharge instructions:Find:Pt:{Setting}:Doc:Pediatrics
2755,4-Hydroxycyclohexylacetate/creatinine,4-Hydroxycyclohexylacetate/creatinine:SRto:Pt:Urine:Qn
2756,Congenital cranial dysinnervation syndrome (CCDS) suspected,Congenital cranial dysinnervation syndrome (CCDS) suspected:Type:Pt:^Patient:Nom
2757,Vertical diameter,Vertical diameter:Len:Pt:Cornea.right:Qn
2758,Suspected organism,Suspected organism:Prid:Pt:XXX:Nom
2759,Hemodynamic resistance,Hemodynamic resistance:Resis:Pt:Systemic vasculature:Qn:Fick
2760,HLA-B Antigens,HLA-B:Type:Pt:Bld/Tiss:Nom:Low resolution
2761,Past employer address,Past employer address:Address:Point in time:^Patient:Nominal
2762,Percutaneous coronary intervention individual lesion procedure results panel,Percutaneous coronary intervention individual lesion procedure results panel:-:Pt:Heart:-
2763,Frequency of muscle-strengthening physical activity,Frequency of muscle-strengthening physical activity:Number = Count/Time:Reporting period:^Patient:Quantitative
2764,CPT2 gene.p.R549DC,Deprecated CPT2 gene p.R549DC [Presence] in Blood by Molecular genetics method
2765,Pregnenolone,Pregnenolone^baseline:MCnc:Pt:Ser/Plas:Qn
2766,Leptospira sp DNA,Leptospira sp DNA:PrThr:Pt:Urine:Ord:Probe.amp.tar
2767,desoxycorticosterone,11-Deoxycorticosterone:SCnc:Pt:Bld.dot:Qn
2768,CACT gene targeted mutation analysis,CACT gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen
2769,Rh Factors,Rh:Type:Pt:Bld^Fetus:Nom
2770,Whole blood pediatric units given,Whole blood pediatric units given:Num:Pt:^BPU:Qn
2771,Phleum pratense Ab.IgG4,Phleum pratense Ab.IgG4:MCnc:Pt:Ser:Qn
2772,Piromidate,Piromidate:Susc:Pt:Isolate:OrdQn:Agar diffusion
2773,Tinidazole,Tinidazole:Susc:Pt:Isolate:OrdQn:Gradient strip
2774,Aluminum,Aluminum:MCnc:Pt:Ser/Plas:Qn
2775,Catecholamines,Catecholamines:Impression/interpretation of study:Point in time:Urine:Narrative
2776,SH3TC2 gene targeted mutation analysis,SH3TC2 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
2777,Poa pratensis Ab.IgG,Poa pratensis Ab.IgG:MCnc:Pt:Ser:Qn
2778,Lupinus albus seed Ab.IgE,Lupinus albus seed Ab.IgE:ACnc:Pt:Ser:Qn
2779,Cytomegalovirus antibody,Cytomegalovirus Ab:ACnc:Pt:Ser/Plas:Qn:IF
2780,NPM1 gene targeted mutation analysis,NPM1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
2781,Genetic analysis summary panel,"Genetic analysis summary panel:-:Point in time:Whole blood/Tissue, unspecified:-:Molecular Genetics"
2782,HBB gene.c.251G>A,HBB gene.c.251G>A:PrThr:Pt:Bld:Ord:Molgen
2783,EGFR gene.c.2573T>G,EGFR gene.c.2573T>G:PrThr:Pt:Bld/Tiss:Ord:Molgen
2784,Poa pratensis leukotriene release,Poa pratensis leukotriene release:MCnc:Pt:WBC:Qn
2785,Minor determinant mixture leukotriene release,Minor determinant mixture leukotriene release:MCnc:Pt:WBC:Qn
2786,Plasmodium ovale IgG,Plasmodium ovale Ab.IgG:Titr:Pt:Ser:Qn:IF
2787,Pyruvate,Pyruvate:SCnc:Pt:BldV:Qn
2788,Tobramycin,Tobramycin:MCnc:Pt:CSF:Qn
2789,Licensed minimally manipulated cells label,Licensed minimally manipulated cells label:-:-:^FDA product label:Nar
2790,No change notification,No change notification:-:-:^FDA product label:Nar
2791,fibroblast growth factor 23,Fibroblast growth factor 23.intact ^4th specimen post XXX challenge:MCnc:Pt:Plas:Qn:IA
2792,Food colorant mix II leukotriene release,Food colorant mix II leukotriene release:MCnc:Pt:WBC:Qn
2793,Sperm evaluation by cervical mucus penetration test,Spermatozoa evaluation.cervical mucus penetration test:Impression/interpretation of study:Point in time:Seminal fluid:Narrative
2794,Ketones,Ketones:MCnc:Pt:Urine:Qn
2795,Tetracycline,Tetracycline:Susc:Pt:Isolate:OrdQn:Agar diffusion
2796,Magnolia grandiflora Ab.IgE,Magnolia grandiflora Ab.IgE:ACnc:Pt:Ser:Qn
2797,Creatine kinase.MB/Creatine kinase.total,Creatine kinase.total/Creatine kinase.MB:CRto:Pt:Bld:Qn
2798,Cells.CD42/100 cells,Cells.CD42/100 cells:NFr:Pt:CSF:Qn
2799,Maximum clot firmness.intrinsic coagulation system activated.heparin insensitive,Maximum clot firmness.intrinsic coagulation system activated.heparin insensitive:Len:Pt:Bld:Qn:Thromboelastography.rotational
2800,Carnitine palmitoyltransferase 2,Carnitine palmitoyltransferase 2:CCnt:Pt:Amnio fld cells:Qn
2801,Estradiol,Estradiol:MCnc:Pt:Body fld:Qn
2802,Histidine,Histidine:SCnt:Pt:Hair:Qn
2803,Streptococcus pneumoniae serogroup 23 antibody,Deprecated Streptococcus pneumoniae 23 Ab [Units/volume] in Serum by Immunoassay --1st specimen
2804,Glucose,Glucose^5th specimen:MCnc:Pt:Ser/Plas:Qn
2805,risk factors,Risk factors:Find:Pt:{Setting}:Doc:{Role}
2806,CD81 antigen,Deprecated CD81:Arbitrary Concentration:Point in time:Leukocytes:Quantitative
2807,VIM gene methylation,VIM gene methylation:Arb:Pt:Stool:Ord:Molgen
2808,Cortolone,Alpha cortolone:MCnc:24H:Urine:Qn
2809,ALPHA-D-GALACTOSIDASE ENZYME,Alpha galactosidase A:CCnc:Pt:Bld.dot:Qn
2810,Hydrocortisone,Cortisol^post dose dexamethasone:Mass Concentration:Point in time:Serum/Plasma:Quantitative
2811,Norvenlafaxine,Norvenlafaxine:SCnc:Pt:Ser/Plas:Qn
2812,Collagen type 1 Ab,Collagen type 1 Ab:ACnc:Pt:Ser:Qn
2813,Heparin Ab.IgE,Heparin Ab.IgE:ACnc:Pt:Ser:Qn
2814,HLA-Dw15,HLA-Dw15:PrThr:Pt:Bld/Tiss:Ord
2815,Organic acids panel,Organic acids panel:-:Pt:Urine:-
2816,Neural tube defect risk,Neural tube defect risk:Likelihood:Pt:^Fetus:Qn
2817,3-Hydroxybutyrylcarnitine (C4-OH)/Creatinine,3-Hydroxybutyrylcarnitine (C4-OH)/Creatinine:SRto:Pt:Urine:Qn
2818,Arsenic/Creatinine,Arsenic/Creatinine:SRto:24H:Urine:Qn
2819,Beryllium,Beryllium:SRat:24H:Urine:Qn
2820,Cells.terminal deoxyribonucleotidyl transferase/100 cells,Cells.terminal deoxyribonucleotidyl transferase/100 cells:NFr:Pt:Tiss:Qn:Flow cytometry
2821,microscopic observation,Microscopic observation:Prid:Pt:Bronchial:Nom:Rhodamine-auramine fluorochrome stain
2822,Nuclear Ab pattern.atypic speckled,Nuclear Ab pattern.atypic speckled:PrThr:Pt:Ser:Ord:IF
2823,Neopterin,Neopterin:SCnc:Pt:Urine:Qn
2824,John Cunningham virus DNA,JC virus DNA:NCnc:Pt:Urine:Qn:Probe.amp.tar
2825,SMN1 gene+SMN2 gene targeted mutation analysis,SMN1 gene+SMN2 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen
2826,Tetracycline,Tetracycline:Titr:Pt:Isolate+Ser:Qn:SBT
2827,Novocaine Ab.IgE,Novocaine Ab.IgE:ACnc:Pt:Ser:Qn
2828,Sodium,Sodium^^corrected for glucose:SCnc:Pt:Ser/Plas:Qn
2829,Lysozyme antibody,Lysozyme Ab:PrThr:Pt:Ser:Ord
2830,West Nile virus Ab.IgG & IgM panel,West Nile virus Ab.IgG & IgM panel:-:Pt:Ser:Qn
2831,PhenX measure - birth weight,PhenX measure - birth weight:-:Point in time:^Patient:-:PhenX
2832,Glutamate decarboxylase 65 antibody,Glutamate decarboxylase 65 Ab:ACnc:Pt:Ser:Qn:IA
2833,Growth Hormone,Somatotropin^2H post dose ornithine:ACnc:Pt:Ser/Plas:Qn
2834,Multisection,Multisection^WO & W contrast IT:Find:Pt:Neck>Spine.cervical:Doc:MR
2835,temafloxacin,Temafloxacin:Susc:Pt:Isolate:OrdQn:MIC
2836,Anaplasma phagocytophilum IgM,Anaplasma phagocytophilum Ab.IgM:Titr:Pt:Body fld:Qn:IF
2837,Streptococcus pneumoniae capsular polysaccharide IgG,Streptococcus pneumoniae capsular polysaccharide Ab.IgG:MCnc:Pt:Ser:Qn
2838,14-3-3 Proteins,Deprecated 14-3-3 protein [Presence] in Cerebral spinal fluid by Immunoblot
2839,CD43 Antigen,Deprecated CD43 cells/100 cells in Blood
2840,Naproxen Ab.IgE,Naproxen Ab.IgE:ACnc:Pt:Ser:Qn
2841,Birth plan,Birth plan:Finding:Point in time:^Patient:Narrative
2842,Thyrotropin,Thyrotropin^1.5H post dose lutenizing releasing hormone IV:ACnc:Pt:Ser/Plas:Qn
2843,Tin,Tin:SCnt:Pt:Hair:Qn
2844,Vancomycin,Vancomycin:SCnc:Pt:Body fld:Qn
2845,Mycoplasma pneumoniae antibody,Mycoplasma pneumoniae Ab:ACnc:Pt:Ser:Qn:LA
2846,Anti-striated muscle antibody,Striated muscle Ab:Titr:Pt:Ser:Qn:IF
2847,Newborn hearing screen,Deprecated Newborn hearing screen
2848,Double stranded anti DNA antibody,DNA double strand Ab:ACnc:Pt:Ser:Qn:IF
2849,Bupropion,Bupropion:SCnc:Pt:Ser/Plas:Qn
2850,MVK gene targeted mutation analysis,MVK gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen
2851,Calcium oxalate monohydrate/Total,Calcium oxalate monohydrate/Total:MFr:Pt:Calculus:Qn:Infrared spectroscopy
2852,Glucose,Glucose:SCnc:Pt:Flu.nonbiological:Qn
2853,Mycobacterium sp identified,Mycobacterium sp identified:Prid:Pt:Bone mar:Nom:Organism specific culture
2854,Method of best overall fetal weight estimate,Method of best overall fetal weight estimate:Finding:Point in time:^Fetus:Nominal:Reported
2855,Tissue transglutaminase Ab,Tissue transglutaminase Ab:Titr:Pt:Ser:Qn:IF
2856,ricinine,Ricinine:MCnc:Pt:Urine:Qn
2857,Reverse primer,Reverse primer:Seq:Pt:Bld/Tiss:Nom:Molgen
2858,Influenza A virus H3 RNA,Influenza virus A H3 RNA:PrThr:Pt:Isolate:Ord:Probe.amp.tar
2859,Growth Hormone,Somatotropin^11 PM specimen:ACnc:Pt:Ser/Plas:Qn
2860,Adenine Phosphoribosyltransferase,Adenine phosphoribosyltransferase:CCnt:Pt:CVS:Qn
2861,Coccidioides immitis antibody,Coccidioides immitis Ab:ACnc:Pt:Ser:Qn:IA
2862,Phosphoethanolamine Ab.IgG,Phosphoethanolamine Ab.IgG:PrThr:Pt:Ser/Plas:Ord
2863,Streptobacillus moniliformis antibody,Streptobacillus moniliformis Ab:ACnc:Pt:Ser:Qn
2864,Lymphocyte antigen CD50,Deprecated CD50 cells/100 cells in Blood
2865,hydroxybupropion,Hydroxybupropion:SCnc:Pt:Ser/Plas:Qn
2866,PKLR gene targeted mutation analysis,PKLR gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
2867,TSC2 gene targeted mutation analysis,TSC2 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
2868,Immune complex.IgG,Immune complex.IgG:MCnc:Pt:Body fld:Qn:C1q binding assay
2869,Growth Hormone,Somatotropin^5.30 AM specimen:ACnc:Pt:Ser/Plas:Qn
2870,Corticotropin,Corticotropin^40M post 100 ug CRH IV:MCnc:Pt:Plas:Qn
2871,posaconazole,Posaconazole:MCnc:Pt:Ser/Plas:Qn
2872,Strongyloides species antibody,Strongyloides sp Ab:ACnc:Pt:Ser:Qn:HA
2873,Cholesterol in intermediate density lipoprotein subfraction 1,Cholesterol.in IDL 1:SCnc:Pt:Ser/Plas:Qn
2874,Giardia lamblia+Cryptosporidium sp Ag,Giardia lamblia+Cryptosporidium sp Ag:PrThr:Pt:Stool:Ord:IA
2875,Coxiella burnetii antibody,Coxiella burnetii Ab:Titr:Pt:Ser:Qn:Comp fix
2876,Clot formation.intrinsic coagulation system activated,Clot formation.intrinsic coagulation system activated:Time:Pt:Bld:Qn:Thromboelastography.rotational
2877,Taenia solium adult Ab,Taenia solium adult Ab:ACnc:Pt:Ser:Qn:IA
2878,Drug screen comment,Drug screen comment:Imp:Pt:Urine:Nom
2879,Urea,Urea:SCnc:XXX:Urine:Qn
2880,Aspergillus niger Ab.IgG4,Aspergillus niger Ab.IgG4:MCnc:Pt:Ser:Qn
2881,Calcidiol & Calciferol,Calcidiol & Calciferol:Imp:Pt:Ser/Plas:Nar
2882,rubella antibodies,Rubella virus Ab:Titr:Pt:Ser:Qn:HAI
2883,Follicle Stimulating Hormone,Follitropin^8th specimen:ACnc:Pt:Ser/Plas:Qn
2884,Blasts.CD123/100 blasts,Blasts.CD123/100 blasts:NFr:Pt:XXX:Qn
2885,Influenza A virus RNA,Influenza virus A RNA:NCnc:Pt:XXX:Qn:Probe.amp.tar
2886,Chromium panel,Chromium panel:-:Pt:Urine:-
2887,glycolate,Glycolate:SCnc:Pt:CSF:Qn
2888,"Antigens, CD79b",Deprecated CD79b cells/100 cells in Blood
2889,Cefamandole+Sulbactam,Cefamandole+Sulbactam:Susc:Pt:Isolate:OrdQn:Gradient strip
2890,Phragmites communis Ab.IgG4,Phragmites communis Ab.IgG4:MCnc:Pt:Ser:Qn
2891,Hydrogen/Expired gas,Hydrogen/Expired gas^15M post dose lactose PO:VFr:Pt:Exhl gas:Qn
2892,SCA10 gene allele 2.ATTCT repeats,SCA10 gene allele 2.ATTCT repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen
2893,(Arachis hypogaea+Bean white+Glycine max+Lens esculenta+Pisum sativum) Ab.IgE,(Arachis hypogaea+Bean white+Glycine max+Lens esculenta+Pisum sativum) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk
2894,Blasts.CD14/100 blasts,Blasts.CD14/100 blasts:NFr:Pt:Bone mar:Qn
2895,Blasts.CD14/100 blasts,Blasts.CD14/100 blasts:NFr:Pt:XXX:Qn
2896,Epstein Barr virus capsid IgM,Epstein Barr virus capsid Ab.IgM:ACnc:Pt:Ser:Qn:IA
2897,La Crosse virus IgM,La Crosse virus Ab.IgM:PrThr:Pt:CSF:Ord:IA
2898,Chloroamphetamine,Chloroamphetamine:MCnc:Pt:Ser:Qn
2899,Risperidone & 9-Hydroxyrisperidone panel,Risperidone & 9-Hydroxyrisperidone panel:-:Pt:Ser/Plas:Qn
2900,Human T-lymphotrophic virus recombinant glycoprotein 21 antibody,HTLV I rgp21 Ab:PrThr:Pt:Ser:Ord:IB
2901,HIV nucleoside reverse transcriptase susceptibility panel,HIV nucleoside reverse transcriptase susceptibility panel:-:Pt:Isolate:-:Phenotyping
2902,Advanced Oxidation Protein Products,Advanced oxidation protein products:SCnc:Pt:Ser/Plas:Qn
2903,Hemicystine/Amino acids.total,Hemicystine/Amino acids.total:SFr:Pt:Bld.dot:Qn
2904,VFD Type C medicated feed animal drug label,VFD Type C medicated feed animal drug label:-:-:^FDA product label:Nar
2905,Blasts.CD24/100 blasts,Blasts.CD24/100 blasts:NFr:Pt:XXX:Qn
2906,Corynebacterium diphtheriae antibody,Corynebacterium diphtheriae Ab:ACnc:Pt:Ser:Qn:IA
2907,Hepatitis D antibody,Hepatitis D virus Ab:PrThr:Pt:Body fld:Ord
2908,Rotavirus antibody,Rotavirus Ab:ACnc:Pt:Ser:Qn:CIE
2909,Pipecolate,Pipecolate:SCnc:Pt:Amnio fld:Qn
2910,Zygosity,Zygosity:Prid:Pt:Buccal:Nom:Molgen
2911,Isoniazid 10.0 ug/mL,Isoniazid 10.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria
2912,Human leukocyte antigen Cw9(w3),HLA-Cw9(w3):PrThr:Pt:Bld/Tiss:Ord
2913,Pancytokeratin Ag,Pancytokeratin Ag:PrThr:Pt:Tiss:Ord:Immune stain
2914,Nordiazepam/Creatinine,Nordiazepam/Creatinine:MRto:Pt:Urine:Qn
2915,Corticotropin,Corticotropin^pre dose metyraPONE:MCnc:Pt:Plas:Qn
2916,Cells.CD19+CD38+,Cells.CD19+CD38+:NCnc:Pt:Bld:Qn
2917,"Do you ever have to stop for breath after walking about 100 yards, or after a few Ms, on the level","Do you ever have to stop for breath after walking about 100 yards, or after a few Ms, on the level:Find:Pt:^Patient:Ord:PhenX"
2918,Franseria acanthicarpa Ab.IgG,Franseria acanthicarpa Ab.IgG:MCnc:Pt:Ser:Qn
2919,Macrophages/100 cells,Macrophages/100 cells:NFr:Pt:Bone mar:Qn:Manual count
2920,KIR gene allele 3DL2,KIR gene allele 3DL2:PrThr:Pt:Bld/Tiss:Ord:Molgen
2921,At what age was diabetes first treated,At what age was diabetes first treated:Time:Pt:^Patient:Qn:PhenX
2922,When did you last eat or drink anything other than plain water,When did you last eat or drink anything other than plain water:TmStp:Pt:^Patient:Qn:PhenX
2923,Sit and reach stretch distance,Sit and reach stretch distance:Len:Pt:^Patient:Qn:PhenX
2924,Adjudication date by MD fracture coordinator,Adjudication date by MD fracture coordinator:Date:Pt:^Patient:Qn:PhenX
2925,Date abstracted,Date abstracted:Date:Pt:^Patient:Qn:PhenX
2926,11-ketoetiocholanolone,11-Ketoetiocholanolone^pre dose dexamethasone:MRat:24H:Urine:Qn
2927,Cortodoxone,11-Deoxycortisol^2D post dose metyraPONE:SCnc:Pt:Ser/Plas:Qn
2928,Hydrocortisone,Cortisol^4 AM specimen:MCnc:Pt:Saliva:Qn
2929,3-Hydroxybutyrate,Beta hydroxybutyrate:SCnc:Pt:Vitr fld:Qn
2930,ST amplitude.derived lead V6,ST amplitude.derived lead V6:Elpot:Pt:Heart:Qn:EKG
2931,"How often did you take garlic, as a pill, tablet, or capsule","How often did you take garlic, as a pill, tablet, or capsule:Find:Pt:^Patient:Ord:PhenX"
2932,microarray platform version number,Microarray platform version number:ID:Pt:Bld/Tiss:Nar:Molgen
2933,Nonesterified Fatty Acids,Fatty acids.nonesterified^9th specimen post CFst:SCnc:Pt:Ser/Plas:Qn
2934,Sigmoidoscopy or colonoscopy,Sigmoidoscopy or colonoscopy:Find:Pt:^Patient:Ord:PhenX
2935,Multiple polyps in specimen jar,Multiple polyps in specimen jar:Find:Pt:^Patient:Ord:PhenX
2936,Non-advanced adenomas,Non-advanced adenomas:Num:Pt:^Patient:Qn:PhenX
2937,Prunus avium Ab.IgE,Prunus avium Ab.IgE:ACnc:Pt:Ser:Qn
2938,Lymphocyte proliferation. 0.5 ug phytohemagglutinin stimulation actual/Normal,Lymphocyte proliferation. 0.5 ug phytohemagglutinin stimulation actual/Normal:RelRto:Pt:Bld:Qn
2939,Derived post treatment-7 stage group,Derived post treatment-7 stage group:Prid:Pt:Cancer.XXX:Nom
2940,Apnea interval,Apnea interval:Time:Pt:Ventilator.alarm:Qn
2941,Piper nigrum Ab.IgG,Piper nigrum Ab.IgG:MCnc:Pt:Ser:Qn
2942,Rumex acetosella Ab.IgE,Rumex acetosella Ab.IgE:ACnc:Pt:Ser:Qn
2943,About how long has it been since you completely quit smoking cigarettes,About how long has it been since you completely quit smoking cigarettes:Time:Pt:^Patient:Qn:TUS-CPS
2944,Did you continue to use marijuana after you knew it caused this problem,Did you continue to use marijuana after you knew it caused this problem:Find:Pt:^Patient:Ord:SSAGA II
2945,Which best describes the way you usually treat severe headaches,Which best describes the way you usually treat severe headaches:Find:Pt:^Patient:Ord:PhenX
2946,Right or left ear,Right or left ear:Find:Pt:Ear:Nom:PhenX
2947,My child's ability to make grown up sentences is,My child's ability to make grown up sentences is:Find:Pt:^Patient:Ord:PhenX
2948,Testosterone,Testosterone:SCnc:Pt:Body fld:Qn
2949,Dengue virus 4 RNA,Dengue virus 4 RNA:PrThr:Pt:Ser:Ord:Probe.amp.tar
2950,Enflurane gas delivered.total,Enflurane gas delivered.total:Vol:RptPeriod:Gas delivery system:Qn
2951,Keratin Ab,Keratin Ab:PrThr:Pt:Ser:Ord:IF
2952,Effect this medication has on your child,Effect this medication has on your child:Find:Pt:^Patient:Nom:PhenX
2953,Booster date,Booster date:Date:Pt:^Patient:Qn:PhenX
2954,6-alpha hydroxytetrahydro-11-deoxycortisol,6-Alpha hydroxytetrahydro-11-Deoxycortisol^pre dose dexamethasone:MCnc:24H:Urine:Qn
2955,Velocity-time integral.pulmonary vein A wave/Velocity-time integral.mitral valve A wave,Velocity-time integral.pulmonary vein A wave/Velocity-time integral.mitral valve A wave:LenFr:Pt:Pulmonary vein:Qn:US
2956,lacosamide,Lacosamide:MCnc:Pt:Bld:Qn
2957,Liver kidney microsomal 1 Ab,Liver kidney microsomal 1 Ab:Titr:Pt:CSF:Qn:IF
2958,"Over the past 4W when you had sexual stimulation or intercourse, how often did you ejaculate","Over the past 4W when you had sexual stimulation or intercourse, how often did you ejaculate:Find:4W:^Patient:Ord:PhenX"
2959,"When you urinate, pass water, do you usually feel like you have not completely emptied your bladder","When you urinate, pass water, do you usually feel like you have not completely emptied your bladder:Find:Pt:^Patient:Ord:PhenX"
2960,"When you wake up in the morning or from a nap, do you feel out of it and confused","When you wake up in the morning or from a nap, do you feel out of it and confused:Find:Pt:^Patient:Ord:PhenX"
2961,Luteinizing Hormone,Lutropin^10M post XXX challenge:ACnc:Pt:Ser/Plas:Qn
2962,Luteinizing Hormone,Lutropin^3H post XXX challenge:ACnc:Pt:Ser/Plas:Qn
2963,Corticotropin,Corticotropin^2H post XXX challenge:MCnc:Pt:Plas:Qn
2964,Human antihuman Ab,Human antihuman Ab:MCnc:Pt:Plas:Qn
2965,Waxy casts (substance),Waxy casts:Naric:Pt:Urine sed:Qn:Microscopy.light.LPF
2966,Coxsackievirus B IgG,Coxsackievirus B Ab.IgG:Titr:Pt:Ser:Qn
2967,Do you still have chronic bronchitis,Do you still have chronic bronchitis:Find:Pt:^Patient:Ord:PhenX
2968,I sympathize with others problems,I sympathize with others problems:Find:Pt:^Patient:Ord:PhenX
2969,I don't like being away from my family,I don't like being away from my family:Find:Pt:^Patient:Ord:SCARED-R
2970,"What is the longest period of time that you have felt this overwhelming desire to go to sleep, on most Ds","What is the longest period of time that you have felt this overwhelming desire to go to sleep, on most Ds:Time:Pt:^Patient:Qn:PhenX"
2971,During what part of the night do these events most often occur,During what part of the night do these events most often occur:Find:Pt:^Patient:Nom:PhenX
2972,Lab or imaging sequence,Lab or imaging sequence:Find:Pt:^Patient:Nom:PhenX
2973,Gold,Gold:MCnc:Pt:Bld:Qn
2974,Pentachlorophenol,Pentachlorophenol:Mass Concentration:Point in time:Urine:Quantitative
2975,Protein.monoclonal.beta,Deprecated Protein.monoclonal.beta [Mass/volume] in Urine by Electrophoresis
2976,Ever diagnosed by a doctor as having an abdominal aortic aneurysm,Ever diagnosed by a doctor as having an abdominal aortic aneurysm:Finding:Point in time:^Patient:Ordinal
2977,Mononuclear cells/100 leukocytes,Mononuclear cells/100 leukocytes:NFr:Pt:Dial fld prt:Qn
2978,Desethylvardenafil,Desethylvardenafil:MCnc:Pt:Urine:Qn
2979,Corticotropin,Corticotropin^5M post XXX challenge:SCnc:Pt:Plas:Qn
2980,Ribosomal ribonucleoprotein antibody,Ribonucleoprotein extractable nuclear Ab:PrThr:Pt:Body fld:Ord:Immune diffusion
2981,Echinococcus species antibody,Echinococcus sp Ab:ACnc:Pt:Ser:Qn:IA
2982,Screening for cancer,Cancer screening:Find:Pt:^Patient:Nom:PLCO
2983,Other relative,Other relative:Find:Pt:^Patient:Nom:PhenX
2984,Other drugs or medications occurring with insomnia,Other drugs or medications occurring with insomnia:Find:Pt:^Patient:Ord:PhenX
2985,Hydrocortisone,Cortisol^9th specimen:MCnc:Pt:Saliva:Qn
2986,Hydrocortisone,Cortisol^6th specimen:MCnc:Pt:Saliva:Qn
2987,Sample condition,Sample condition:Type:Point in time:Blood filter paper:Nominal
2988,Hydrocortisone,Cortisol^20th specimen:MCnc:Pt:Ser/Plas:Qn
2989,Finding of Mean Corpuscular Hemoglobin,Erythrocyte mean corpuscular hemoglobin:EntSub:Pt:RBC:Qn
2990,Severe acute respiratory syndrome coronavirus RNA,SARS coronavirus RNA:PrThr:Pt:Ser/Plas:Ord:Probe.amp.tar
2991,Assembly or installation instructions,Assembly or installation instructions:-:-:^FDA package insert:Nar
2992,Budgerigar feather Ab.IgE,Deprecated Budgerigar feather IgE Ab [Units/volume] in Serum
2993,PhenX measure - general distress screener,PhenX measure - general distress screener:-:Point in time:^Patient:-:PhenX
2994,Date of major illness or surgery,Date of major illness or surgery:Date:Pt:^Patient:Qn:PhenX
2995,"While you were having numbness, tingling and loss of sensation, did any of these things occur","While you were having numbness, tingling and loss of sensation, did any of these things occur:Find:Pt:^Patient:Ord:PhenX"
2996,17-alpha-Hydroxyprogesterone,17-Hydroxyprogesterone^10M post XXX challenge:MCnc:Pt:Ser/Plas:Qn
2997,Growth Hormone,Somatotropin^28th specimen:MCnc:Pt:Ser/Plas:Qn
2998,Collaborative staging post treatment extension,Collaborative staging post treatment extension:Prid:Pt:Cancer.XXX:Nom
2999,Nordazepam,Nordiazepam:MCnt:Pt:Stool:Qn:Confirm
3000,Indium,Indium:MCnc:Pt:RBC:Qn
3001,Protein C Antigen,Protein C Ag:ACnc:Pt:PPP:Qn:IA
3002,"Does your child now take vitamins with fluoride in them or any other kind of fluoride tablets, drops or supplements","Does your child now take vitamins with fluoride in them or any other kind of fluoride tablets, drops or supplements:Find:Pt:^Patient:Ord:PhenX"
3003,Sometimes I do impulsive things that I later regret,Sometimes I do impulsive things that I later regret:Finding:Point in time:^Patient:Ordinal:UPPS
3004,Trimipramine & Nortrimipramine panel,Trimipramine & Nortrimipramine panel:-:Pt:Ser/Plas:Qn
3005,Cortodoxone,11-Deoxycortisol^20M post XXX challenge:MCnc:Pt:Ser/Plas:Qn
3006,Chicken droppings Ab.IgG,Chicken droppings Ab.IgG:MCnc:Pt:Ser:Qn
3007,Fusarium culmorum Ab.IgE,Fusarium culmorum Ab.IgE:ACnc:Pt:Ser:Qn
3008,Enterovirus 71 RNA,Enterovirus 71 RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar
3009,Tooth site - periodontal,Tooth site - periodontal:Find:Pt:Tooth:Nom:PhenX
3010,Admission evaluation note,Admission evaluation note:Find:Pt:Hospital:Doc:Thoracic and cardiac surgery
3011,"How many times in the last Y have you sold marijuana or hashish, pot, grass, hash","How many times in the last Y have you sold marijuana or hashish, pot, grass, hash:NRat:1Y:^Patient:Qn:Denver Youth Survey"
3012,Have you done anything else in the past year that could have gotten you in trouble with the police,Have you done anything else in the past year that could have gotten you in trouble with the police:Find:Pt:^Patient:Ord:Denver Youth Survey
3013,Insulin,Insulin^1D post XXX challenge:MCnc:Pt:Ser/Plas:Qn
3014,Topoisomerase-1 antibody,SCL-70 extractable nuclear Ab:PrThr:Pt:Ser:Ord:IB
3015,Lead,Deprecated Lead:Mass Concentration:Point in time:Whole blood:Ordinal
3016,prasterone,Dehydroepiandrosterone^pre dose dexamethasone:MCnc:24H:Urine:Qn
3017,HEDIS 2010 Codes to identify LDLc screening (CDC-H),HEDIS 2010 Codes to identify LDLc screening (CDC-H):-:Point in time:^Patient:-
3018,HEDIS 2010 panel,HEDIS 2010 panel:-:Point in time:^Patient:-
3019,Flag for Hospital admission.first contact not populated,Flag for Hospital admission.first contact not populated:Prid:Pt:Cancer.XXX:Nom
3020,People often tell me that I keep going on and on about the same thing,People often tell me that I keep going on and on about the same thing:Find:Pt:^Patient:Ord:AQ
3021,Herpes simplex virus 2 Antigen,Herpes simplex virus 2 Ag:PrThr:Pt:Genital:Ord:IF
3022,House dust Allergopharma Ab.IgE,House dust Allergopharma Ab.IgE:ACnc:Pt:Ser:Qn
3023,Alternaria alternata Ab.IgE,Alternaria alternata Antibody.immunoglobulin E:Arbitrary Concentration:Point in time:Serum:Quantitative
3024,Blatella germanica Ab.IgE,Blatella germanica Antibody.immunoglobulin E:Arbitrary Concentration:Point in time:Serum:Quantitative
3025,Indexing - Indication,Indexing - Indication:-:-:^FDA product label:Nar
3026,pregabalin,Pregabalin:PrThr:Pt:Urine:Ord:Screen
3027,Your child finds it easy to do more than one thing at once,Your child finds it easy to do more than one thing at once:Find:Pt:^Patient:Ord:AQ Adolescent
3028,Your child is a good diplomat,Your child is a good diplomat:Find:Pt:^Patient:Ord:AQ Adolescent
3029,Do you have an unreasonably strong fear or avoid this social situation,Do you have an unreasonably strong fear or avoid this social situation:Find:Pt:^Patient:Ord:CIDI-SF
3030,Allium ampeloprasum Ab.IgE,Allium ampeloprasum Ab.IgE:ACnc:Pt:Ser:Qn
3031,Factor VIII antibody,Coagulation factor VIII Ab:PrThr:Pt:PPP:Ord:IA
3032,C-Peptide,C peptide^15M post dose glucose:MCnc:Pt:Ser/Plas:Qn
3033,Coagulation surface induced normal/Actual,Coagulation surface induced normal/Actual:RelTime:Pt:PPP:Qn:Coag
3034,Legionella sp identified,Legionella sp identified:Prid:Pt:Sputum:Nom:Organism specific culture
3035,Benzoylecgonine,Benzoylecgonine:MCnc:Pt:Ser/Plas:Qn:Confirm
3036,Hydrogen/Expired gas,Hydrogen/Expired gas^3H post dose fructose PO:VFr:Pt:Exhl gas:Qn
3037,Cells counted,"Cells counted:Number:Point in time:Whole blood/Tissue, unspecified:Quantitative:Molecular Genetics"
3038,Dermatophagoides farinae Ab.IgG,Dermatophagoides farinae Ab.IgG:MCnc:Pt:Ser:Qn
3039,Coxiella burnetii phase 1 IgM,Coxiella burnetii phase 1 Ab.IgM:PrThr:Pt:Ser:Ord:IF
3040,"If disabled from walking by any condition other than heart or lung disease, please describe nature of conditions","If disabled from walking by any condition other than heart or lung disease, please describe nature of conditions:Find:Pt:^Patient:Nom:PhenX"
3041,"Does your child like to do things over and over again, in the same way all the time","Does your child like to do things over and over again, in the same way all the time:Find:Pt:^Patient:Ord:CAST"
3042,Have you ever been nearby when an explosion or a blast occurred,Have you ever been nearby when an explosion or a blast occurred:Find:Pt:^Patient:Ord:PhenX
3043,"If more injuries with LOC, longest knocked out","If more injuries with LOC, longest knocked out:Time:Pt:^Patient:Qn:PhenX"
3044,Hands resting in lap for 15S,Hands resting in lap for 15S:Find:Pt:^Patient:Ord:PhenX
3045,Has anyone ever damaged or destroyed something on purpose that belonged to you or to someone who you lived with,Has anyone ever damaged or destroyed something on purpose that belonged to you or to someone who you lived with:Find:Pt:^Patient:Ord:LTVH
3046,ED transferring provider,ED transferring provider:Identifier:Point in time:Provider:Nominal
3047,phosphate ion,Phosphate:MCnc:12H:Urine:Qn
3048,ADNFLE gene targeted mutation analysis,ADNFLE gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
3049,CACNA1S+SCN4A gene targeted mutation analysis,CACNA1S+SCN4A gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
3050,Calcium,Calcium:MCnc:Pt:Flu.nonbiological:Qn
3051,C-Peptide,C peptide^4H post dose glucose:MCnc:Pt:Ser/Plas:Qn
3052,Estazolam,Estazolam:MCnc:Pt:Bld:Qn:Confirm
3053,Chest operations you had,Chest operations you had:Find:Pt:^Patient:Nom:PhenX
3054,I see myself as someone who is curious about many different things,I see myself as someone who is curious about many different things:Find:Pt:^Patient:Ord:BFI
3055,I see myself as someone who is generally trusting,I see myself as someone who is generally trusting:Find:Pt:^Patient:Ord:BFI
3056,Disease Progression,Course of disorder:Finding:Point in time:^Patient:Nominal
3057,Blunted affect,Blunted affect:Find:Pt:^Patient:Ord:DI-PAD CGP V 1.4
3058,Strychnine,Strychnine:PrThr:Pt:Ser/Plas:Ord
3059,Corticotropin,Corticotropin^1st specimen post XXX challenge:SCnc:Pt:Plas:Qn
3060,A wave.max,A wave.max:Vel:Pt:Heart.valve.XXX:Qn:US
3061,Brompheniramine,Brompheniramine:SCnc:Pt:XXX:Qn
3062,Blastomyces dermatitidis antigen,Blastomyces dermatitidis Ag:PrThr:Pt:Ser:Ord:IA
3063,Micropterus salmoides Ab.IgG,Micropterus salmoides Ab.IgG:MCnc:Pt:Ser:Qn
3064,House dust Hollister Stier Ab.IgG,House dust Hollister Stier Ab.IgG:MCnc:Pt:Ser:Qn
3065,Where was your mother's mother born,Where was your mother's mother born:Find:Pt:^Patient:Nom:PhenX
3066,"On a typical weekday in the summer, about how many H did you generally spend in the mid-day sun","On a typical weekday in the summer, about how many H did you generally spend in the mid-day sun:NRat:Pt:^Patient:Qn:NHL"
3067,"During the past 30D, about how often did you feel worthless","During the past 30D, about how often did you feel worthless:Find:30D:^Patient:Ord:Kessler 6 Distress"
3068,microscopic observation,"Microscopic observation:Presence or Identity:Point in time:Tissue, unspecified:Nominal:Dark field examination"
3069,Pathology biopsy report,Pathology biopsy report:Find:Pt:Breast:Nar
3070,How many times in the last Y have you been drunk in a public place,How many times in the last Y have you been drunk in a public place:NRat:1Y:^Patient:Qn:Denver Youth Survey
3071,(Ambrosia elatior+Artemisia vulgaris+Chrysanthemum leucathemum+Taraxacum vulgare+Solidago virgaurea) Ab.IgE,(Ambrosia elatior+Artemisia vulgaris+Chrysanthemum leucathemum+Taraxacum vulgare+Solidago virgaurea) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk
3072,Muscle specific receptor tyrosine kinase Ab.IgG,Muscle specific receptor tyrosine kinase Ab.IgG:MCnc:Pt:Ser:Qn:IA
3073,I like to stop and think things over before I do them,I like to stop and think things over before I do them:Finding:Point in time:^Patient:Ordinal:UPPS
3074,"When I am in a great mood, I tend to do things that could cause me problems","When I am in a great mood, I tend to do things that could cause me problems:Find:Pt:^Patient:Ord:UPPS-R-C"
3075,eosinophil,Eosinophils:NCnc:Pt:Bld^Fetus:Qn:Manual count
3076,Coagulation surface induced.lupus sensitive.factor substitution,Coagulation surface induced.lupus sensitive.factor substitution^immediately after addition of normal plasma:Time:Pt:PPP:Qn:Coag
3077,Medicago sativa Ab.IgG,Medicago sativa Ab.IgG:ACnc:Pt:Ser:Qn
3078,Enalapril induced platelet Ab.IgG,Enalapril induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
3079,Respiratory syncytial virus RNA,Respiratory syncytial virus RNA:PrThr:Pt:BAL:Ord:Probe.amp.tar
3080,Multisection,Multisection:Find:Pt:Extremity.right>Extremity artery:Doc:US
3081,Bipolanis curvularia Ab.IgE,Bipolanis curvularia Ab.IgE:ACnc:Pt:Ser:Qn
3082,Trimethoprim induced platelet Ab.IgG,Trimethoprim induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
3083,1p36 deletion prior risk,1p36 deletion prior risk:Likelihood:Pt:^Fetus:Qn:Based on general population risk
3084,Pinus ponderosa Ab.IgE,Pinus ponderosa Ab.IgE:ACnc:Pt:Ser:Qn
3085,Basophils/leukocytes,Basophils/leukocytes:NFr.DF:Pt:Pericard fld:Qn:Manual count
3086,Nail assessment panel,Nail assessment panel:-:Point in time:Nail:-
3087,Wound dressing panel,Wound dressing panel:-:Point in time:Wound:-
3088,Signs and Symptoms,Clinical finding:Find:Pt:^Family member:Nom
3089,Phenytoin,Phenytoin^trough:MCnc:Pt:Ser/Plas:Qn
3090,Sesamum indicum basophil bound Ab,Sesamum indicum basophil bound Ab:ACnc:Pt:Bld:Qn:LHR
3091,Note (document),Note:Find:Pt:{Setting}:Doc:Pediatric otolaryngology
3092,Platelets.reticulated/platelets.total,Deprecated Platelets reticulated in Blood by Automated count
3093,Monocytes/leukocytes,Monocytes/leukocytes:NFr.DF:Pt:Synv fld:Qn:Manual count
3094,Chloride & sodium panel,Chloride & sodium panel:SCnc:Pt:Sweat:Qn
3095,Electrolytes 3 panel,Electrolytes 3 panel:-:Pt:CSF:Qn
3096,Mononuclear cells,Mononuclear cells:Num:Pt:CSF:Qn:Manual count
3097,Secretory Immunoglobulin A,IgA.secretory:MCnc:Pt:Tear:Qn
3098,Eosinophils/leukocytes,Eosinophils/leukocytes:NFr.DF:Pt:CSF:Qn:Manual count
3099,Racial group,Race:Type:Pt:^Patient:Nom:OMB.1997
3100,Discase Ab.IgE,Discase Ab.IgE:ACnc:Pt:Ser:Qn
3101,Simethicone induced platelet Ab.IgG,Simethicone induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
3102,danofloxacin,Danofloxacin:Susc:Pt:Isolate:OrdQn:MIC
3103,3-Hydroxymyristoleylcarnitine (C14:1-OH),3-Hydroxymyristoleylcarnitine (C14:1-OH):CCnt:Pt:Fibroblasts:Qn
3104,Cells.CD158e/100 cells,Cells.CD158e/100 cells:NFr:Pt:XXX:Qn
3105,Cancer related large scale gene targeted mutation analysis,Cancer related large scale gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen
3106,Citrobacter sp (ompA+mrkC) genes,Deprecated Citrobacter sp (ompA+mrkC) genes [Presence] by Nucleic acid capture and probe detection in Positive blood culture
3107,Cancer detection basis,Cancer detection basis:Type:Point in time:^Patient:Nominal
3108,Do you feel that your tinnitus problem has placed stress on your relationship with members of your family and friends,Do you feel that your tinnitus problem has placed stress on your relationship with members of your family and friends:Find:Pt:^Patient:Ord:PhenX
3109,My voice sounds creaky and dry,My voice sounds creaky and dry:Find:Pt:^Patient:Ord:PhenX
3110,Acetohexamide,Acetohexamide:MCnc:Pt:XXX:Qn
3111,Activation of the destination healthcare facility team,Activation of the destination healthcare facility team:Find:Pt:^Patient:Ord:NEMSIS
3112,Burkholderia mallei antigen,Burkholderia mallei Ag:PrThr:Pt:XXX:Ord:IF
3113,Ictalurus punctatus Ab.IgE,Ictalurus punctatus Ab.IgE:ACnc:Pt:Ser:Qn
3114,Rosiglitazone induced platelet Ab.IgG,Rosiglitazone induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
3115,Father identifier,Father identifier:ID:Pt:^Father:Nom
3116,Cryptococcus sp Ag,Cryptococcus sp Ag:PrThr:Pt:Ser:Ord:IA.rapid
3117,Prunus armeniaca Ab.IgG,Prunus armeniaca Ab.IgG:ACnc:Pt:Ser:Qn
3118,Rotavirus IgG,Rotavirus Ab.IgG:Titr:Pt:Ser:Qn:IA
3119,Acetoacetates,Acetoacetate^post meal:SCnc:Pt:Bld:Qn
3120,Candida sp 6 panel,Candida sp 6 panel:-:Pt:Vag:-:Probe.amp.tar
3121,Octanoylcarnitine (C8),Octanoylcarnitine (C8):CCnt:Pt:Fibroblasts:Qn
3122,Butyrylcarnitine (C4),Butyrylcarnitine (C4):CCnt:Pt:Fibroblasts:Qn
3123,Fatty acids pattern,Fatty acids pattern:Imp:Pt:RBC:Nar
3124,Stroke Volume,Stroke volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by cube method
3125,Turnip Ab.IgE,Turnip Ab.IgE:ACnc:Pt:Ser:Qn
3126,Have you ever had heart surgery,Have you ever had heart surgery:Hx:Pt:^Patient:Ord:PhenX
3127,Bacteria antigenic formula,Bacteria antigenic formula:ID:Pt:Isolate:Nom
3128,Ancillary eye tests,Ancillary eye tests:Finding:Point in time:^Patient:Narrative
3129,CYP2D6 gene drug metabolism analysis overall interpretation,CYP2D6 gene drug metabolism analysis overall interpretation:Imp:Pt:Bld/Tiss/Sal:Ord:Molgen
3130,Glycosaminoglycans/Creatinine,Glycosaminoglycans/Creatinine:Ratio:24H:Urine:Qn
3131,deoxyinosine,Deoxyinosine:SCnc:Pt:CSF:Qn
3132,Guidance for percutaneous biopsy,Guidance for percutaneous biopsy:Find:Pt:XXX>Intervertebral disc:Doc:RF
3133,Trifluoperazine,Trifluoperazine:PrThr:Pt:Bld/Urine:Ord:Screen
3134,heart rate,Heart rate^standing:NRat:Pt:Arterial system:Qn
3135,Granulocytes.immature/100 leukocytes,Granulocytes.immature/100 leukocytes:NFr:Pt:Synv fld:Qn
3136,Dicarboxytetradecenoylcarnitine (C14:1-DC),Dicarboxytetradecenoylcarnitine (C14:1-DC):SCnc:Pt:CSF:Qn
3137,Drug induced neutrophil Ab panel,Drug induced neutrophil Ab panel:-:Pt:Ser/Plas:-
3138,Moxifloxacin induced platelet Ab.IgG,Moxifloxacin induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
3139,Albuterol induced platelet Ab.IgG,Albuterol induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
3140,Drug induced platelet antibody,Drug induced platelet Ab:Imp:Pt:Ser/Plas:Nar
3141,Mesothelin Ag,Mesothelin Ag:PrThr:Pt:Tiss:Ord:Immune stain
3142,Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10),Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10):SRto:Pt:Bld.dot:Qn
3143,Glutarylcarnitine (C5-DC)/Malonylcarnitine (C3-DC),Glutarylcarnitine (C5-DC)/Malonylcarnitine (C3-DC):SRto:Pt:Bld.dot:Qn
3144,Progress note,Progress note:Find:Pt:{Setting}:Doc:Urology
3145,Current severity of limitation,Current severity of limitation:Find:Pt:^Patient:Ord
3146,Projected goal of limitation,Projected goal of limitation:Find:Pt:^Patient:Ord
3147,People have acted as if they think you are not smart,People have acted as if they think you are not smart:Find:Pt:^Patient:Ord:PhenX
3148,Dicarboxytetradecenoylcarnitine (C14:1-DC),Dicarboxytetradecenoylcarnitine (C14:1-DC):SCnc:Pt:Urine:Qn
3149,Midazolam induced platelet Ab.IgG,Midazolam induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
3150,RR interval.coefficient of variation,RR interval.coefficient of variation:TRto:Procedure dur:Heart:Qn:EKG
3151,Teachers at my school help us children with our problems,Teachers at my school help us children with our problems:Find:Pt:^Patient:Ord:PhenX
3152,Glutamate decarboxylase 65 antibody,Glutamate decarboxylase 65 Ab:PrThr:Pt:Ser/Plas:Ord:IF
3153,raltegravir,Raltegravir:Susc:Pt:Isolate:Ord:Genotyping
3154,Tacrolimus induced neutrophil Ab.IgM,Tacrolimus induced neutrophil Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
3155,ceftaroline,Ceftaroline:Susc:Pt:Isolate:OrdQn:Agar diffusion
3156,Methadone panel,Methadone panel:-:Pt:Saliva:-:Screen
3157,Inspiration/Inspiration+Expiration,Inspiration/Inspiration+Expiration:TimeFr:Pt:Respiratory system:Qn
3158,End-diastolic volume,End-diastolic volume:Vol:Pt:Heart.ventricle.left:Qn:US.M-mode+Calculated by cube method
3159,Stroke Volume,Stroke volume:Vol:Pt:Heart.ventricle.left:Qn:US.M-mode+Calculated by Gibson method
3160,EMS physical assessment,EMS physical assessment:-:Pt:^Patient:Nar:NEMSIS
3161,Progress note,Progress note:Find:Pt:Hospital:Doc:Cardiovascular disease.medical student
3162,"inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript","inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript:Arb:Pt:Bld/Tiss:Ord:Molgen"
3163,Levodopa induced platelet Ab.IgM,Levodopa induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
3164,Blasts assessment,Blasts assessment:Find:Pt:Bone mar:Nar
3165,Blood group antigens present,Blood group antigens present:Prid:Pt:Bld:Nom:Immediate spin
3166,Other cells/100 leukocytes,Other cells/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count
3167,Pseudomonas aeruginosa regA gene,Pseudomonas aeruginosa regA gene:PrThr:Pt:XXX.swab:Ord:Probe.amp.tar
3168,Length-based tape measure category,Deprecated Length-based tape measure category NEMSIS
3169,2-hydroxyisovalerate,2-Hydroxyisovalerate:SCnc:Pt:CSF:Qn
3170,Minocycline,Minocycline:Susc:Pt:Isolate:OrdQn:Gradient strip
3171,Rotavirus dsRNA,Rotavirus dsRNA:Prid:Pt:Stool:Nom:PAGE
3172,Beta globulin/Protein.total,Beta globulin/Protein.total:MFr.DF:Pt:Ser/Plas:Qn:Electrophoresis
3173,albumin/protein.total,Albumin/Protein.total:MFr.DF:Pt:CSF:Qn:Electrophoresis
3174,Ketorolac induced platelet Ab.IgM,Ketorolac induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
3175,Ipratropium induced platelet Ab.IgM,Ipratropium induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
3176,(Ambrosia elatior+Ambrosia psilostachya+Ambrosia trifida) Ab.IgE,(Ambrosia elatior+Ambrosia psilostachya+Ambrosia trifida) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk
3177,Personal belief,Personal belief:Finding:Point in time:^Patient:Nominal
3178,Consultation note,Consultation note:Find:Pt:Hospital:Doc:Ophthalmology
3179,Letter [Publication Type],Letter:Find:Pt:Hospital:Doc:Ophthalmology
3180,Chlamydia trachomatis IgA,Chlamydia trachomatis Ab.IgA:Titr:Pt:Ser:Qn:IF
3181,Methylsuccinate,Methylsuccinate:SCnc:Pt:Amnio fld:Qn
3182,rivaroxaban,Rivaroxaban:MCnc:Pt:Ser/Plas:Qn
3183,MICA*036 Ab.IgG,MICA*036 Ab.IgG:PrThr:Pt:Ser:Ord
3184,Temperature,Temperature:Temp:Pt:Transcutaneous monitor sensor:Qn
3185,Proteins,Protein^2nd tube:MCnc:Pt:CSF:Qn
3186,Proteins,Protein^4th tube:MCnc:Pt:CSF:Qn
3187,Lymphocyte,Lymphocytes:NCnc:Pt:Plr fld^Fetus:Qn
3188,Discharge summary note,Discharge summary note:Find:Pt:{Setting}:Doc:Allergy+Immunology
3189,Note (document),Note:Find:Pt:{Setting}:Doc:Allergy+Immunology
3190,Mianserin,Mianserin^trough:MCnc:Pt:Ser/Plas:Qn
3191,Citalopram induced neutrophil Ab.IgM,Citalopram induced neutrophil Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
3192,Celecoxib induced neutrophil Ab.IgM,Celecoxib induced neutrophil Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
3193,Immunoglobulin kappa-Chains,Immunoglobulin light chains.kappa:PrThr:Pt:Ser:Ord:IA
3194,Pre-operative evaluation and management note,Preoperative evaluation and management note:Find:Pt:{Setting}:Doc:Clinical genetics
3195,Letter [Publication Type],Letter:Find:Pt:Hospital:Doc:Clinical genetics
3196,Cryptococcus terreus Ab.IgE,Cryptococcus terreus Ab.IgE:ACnc:Pt:Ser:Qn
3197,Human immunodeficiency virus 1 proviral DNA,HIV 1 proviral DNA:LnCnc:Pt:XXX:Qn:Probe.amp.tar
3198,Note (document),Note:Find:Pt:Outpatient:Doc:Urology
3199,Aspergillus sp DNA,Aspergillus sp DNA:PrThr:Pt:BAL:Ord:Probe.amp.tar
3200,Epinephrine,Epinephrine^2H post 300 ug cloNIDine PO:MCnc:Pt:Plas:Qn
3201,Glucose,Glucose^2H post 50 g lactose PO:MCnc:Pt:Ser/Plas:Qn
3202,Institution inventory number,Institution inventory number:ID:Pt:IO tube:Nom
3203,3-methoxytyrosine,3-O-Methyldopa:MCnc:Pt:Ser/Plas:Qn
3204,Diameter (qualifier value),Diameter:Len:Pt:Small bowel^Fetus:Qn:US.measured
3205,Immunoglobulin M antibody to Toxoplasma gondii,Toxoplasma gondii Ab.IgM:Titr:Pt:Ser:Qn:IA
3206,Cells.CD3-CD19+/100 cells,Cells.CD3-CD19+/100 cells:NFr:Pt:Bld:Qn
3207,Bean kidney red Ab.IgE.RAST class,Bean kidney red Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
3208,Prolactin,Prolactin^30 minutes post dose insulin Intravenous:Mass Concentration:Point in time:Serum/Plasma:Quantitative
3209,microscopic observation,Microscopic observation:Prid:Pt:Tiss:Nom:Acetate esterase stain
3210,Diameter.max,Diameter.max:Len:Pt:Ovary.left.largest follicle:Qn:US
3211,Corticotropin-Releasing Hormone,Corticotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn
3212,Diuretics,Diuretics:Prid:Pt:Urine:Nom
3213,Insulin-Like Growth-Factor Binding Protein 1,Insulin-like growth factor binding protein 1:MCnc:Pt:Ser/Plas:Qn
3214,Azelate/Creatinine,Azelate/Creatinine:MRto:Pt:Urine:Qn
3215,Citrulline/Creatinine,Citrulline/Creatinine:MRto:Pt:Urine:Qn
3216,Pseudotsuga taxifolia Ab.IgE.RAST class,Pseudotsuga taxifolia Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
3217,microscopic observation,Microscopic observation:Prid:Pt:Tiss:Nom:Silver impregnation stain.Dieterle
3218,microscopic observation,Microscopic observation:Prid:Pt:Tiss:Nom:Silver stain.Grimelius
3219,Hematocrit procedure,Hematocrit:VFr:Pt:BldCo:Qn:Automated count
3220,Cyclohexane,Cyclohexane:MCnc:Pt:Bld:Qn
3221,Thiothixene,Thiothixene:PrThr:Pt:Urine:Ord
3222,Glyoxylate/Creatinine,Glyoxylate/Creatinine:MRto:Pt:Urine:Qn
3223,2-Methylcitrate/Creatinine,2-Methylcitrate/Creatinine:MRto:Pt:Urine:Qn
3224,Horse epithelium Ab.IgE.RAST class,Horse epithelium Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
3225,Feeding and dietary status,Feeding and dietary status:Finding:Point in time:^Patient:Nominal:Reported
3226,Dihydrocodeine.free,Dihydrocodeine.free:MCnc:Pt:Ser/Plas:Qn
3227,Glucose,Glucose:SCnc:Pt:BldC:Qn:Glucometer
3228,Glucose,Glucose^2H post meal:SCnc:Pt:Ser/Plas:Qn
3229,Glucose,Glucose^30M post 50 g lactose PO:SCnc:Pt:Ser/Plas:Qn
3230,Mucor racemosus Ab.IgE.RAST class,Mucor racemosus Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
3231,Leishmania braziliensis IgM,Leishmania braziliensis Ab.IgM:ACnc:Pt:Ser:Qn
3232,Phosphoserine,Phosphoserine:MCnc:Pt:Amnio fld:Qn
3233,"V antigen, unspecified",V Ag:PrThr:Pt:RBC^Donor:Ord
3234,Free fractionated catecholamine,Catecholamines.free fractionated^1H post 300 ug cloNIDine PO:MCnc:Pt:Plas:Qn
3235,C-Peptide,C peptide^5M post 1 mg glucagon IV:MCnc:Pt:Ser/Plas:Qn
3236,Squamous Epithelial Cells,Epithelial cells.squamous:PrThr:Pt:Sputum:Ord:Microscopy.light
3237,Para-aminosalicylate,Para aminosalicylate:Susc:Pt:Isolate:OrdQn:MIC
3238,Low-Density Lipoproteins,Lipoprotein.beta:SCnc:Pt:Ser/Plas:Qn:Electrophoresis
3239,S wave duration.lead AVR,S wave duration.lead AVR:Time:Pt:Heart:Qn:EKG
3240,Amyloid P component antigen,Amyloid P component Ag:PrThr:Pt:Tiss:Ord:Immune stain
3241,"Human immunodeficiency virus, type II glycoprotein 125 antibody",HIV 2 gp125 Ab:PrThr:Pt:Ser:Ord:IB
3242,Immunization,History of immunization:Finding:Point in time:^Patient:Narrative:Reported
3243,Immunization status,Immunization status:Find:Pt:^Patient:Nom:Reported
3244,Position.placenta,Position.placenta:Finding:Point in time:Uterus:Narrative:ULTRASOUND.measured
3245,demoxepam,Demoxepam:MCnc:Pt:Ser/Plas:Qn
3246,Clozapine+Norclozapine,Clozapine+Norclozapine:SCnc:Pt:Ser/Plas:Qn
3247,Norepinephrine,Norepinephrine^10M post standing:MCnc:Pt:Plas:Qn
3248,Gastrin Ag,Gastrin Ag:PrThr:Pt:Tiss:Ord:Immune stain
3249,Blood group antigen KEL 1,K Antigen:Arbitrary Concentration:Point in time:Erythrocytes^Blood product unit (Pack):Ordinal
3250,Study observation,Study observation:Finding:Point in time:Aorta descending^Fetus:Nominal:ULTRASOUND
3251,Borrelia burgdorferi 29kD Ab,Borrelia burgdorferi 29kD Ab:PrThr:Pt:Body fld:Ord:IB
3252,microscopic observation,Microscopic observation:Prid:Pt:Vag:Nom:Gram stain
3253,phosphate ion,Phosphate:SRat:24H:Urine:Qn
3254,Phleum pratense Ab.IgE.RAST class,Phleum pratense Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
3255,Trichophyton Ab.IgE.RAST class,Trichophyton Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
3256,Psychiatric findings,Psychiatric findings:Finding:Point in time:^Patient:Narrative:Observed
3257,Clostridium tetani immunization status,Clostridium tetani immunization status:History:Point in time:^Patient:Nominal
3258,Bacillus anthracis antibody,Bacillus anthracis Ab:ACnc:Pt:XXX:Qn:IF
3259,microscopic observation,Microscopic observation:Prid:Pt:Stool:Nom:Acid fast stain
3260,calcium/albumin,Calcium/Albumin:MRto:Pt:Ser/Plas:Qn
3261,Xylene,Dimethylbenzene:MCnc:Pt:Bld:Qn
3262,Carbonyldiamide,Urea nitrogen:MCnc:Pt:Amnio fld:Qn
3263,Carbonyldiamide,Urea nitrogen:MCnc:Pt:Plr fld:Qn
3264,Calcium,Calcium:SCnc:Pt:Gast fld:Qn
3265,Bartonella henselae IgM,Bartonella henselae Ab.IgM:PrThr:Pt:CSF:Ord
3266,(Amylase+Glycine max+Sitophilus granarius+Triticum sativum) Ab.IgE,(Amylase+Glycine max+Sitophilus granarius+Triticum sativum) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk
3267,(Aspergillus fumigatus+Aspergillus niger) Ab.IgE,(Aspergillus fumigatus+Aspergillus niger) Ab.IgE:ACnc:Pt:Ser:Qn
3268,C-reactive protein,C reactive protein:PrThr:Pt:Ser/Plas:Ord
3269,M1 Ag,M1 Ag:PrThr:Pt:RBC^BPU:Ord
3270,Lipids,Lipids:MCnc:Pt:Body fld:Qn
3271,Monoamine Oxidase,Monoamine oxidase:CCnc:Pt:Bld:Qn
3272,P2 Ab,Deprecated P2 Antibody:Arbitrary Concentration:Point in time:Serum/Plasma^Donor:Ordinal:AGGLUTINATION RBC
3273,Aldosterone/Creatinine,Aldosterone/Creatinine:MRto:Pt:Urine:Qn
3274,phosphate ion,Phosphate:Substance Concentration:Point in time:Urine:Quantitative
3275,Ionized calcium,Calcium.ionized:SCnc:Pt:Ser/Plas:Qn:Calculated
3276,Zingiber officinale Ab.IgE.RAST class,Zingiber officinale Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
3277,Leptospira interrogans serovar Grippotyphosa antibody,Leptospira interrogans serovar Grippotyphosa Ab:Titr:Pt:Ser:Qn:Aggl
3278,Cotinine,Cotinine:MCnc:Pt:Urine:Qn
3279,ALPHA-N-ACETYLGALACTOSAMINIDASE,Alpha-N-acetylgalactosaminidase:CCnc:Pt:Ser/Plas:Qn
3280,HDL Cholesterol to LDL Cholesterol Ratio Measurement,Cholesterol.in LDL/Cholesterol.in HDL:Mass Concentration Ratio:Point in time:Serum/Plasma:Quantitative
3281,Triose-Phosphate Isomerase,Triosephosphate isomerase:CCnc:Pt:RBC:Qn
3282,Hydrogen-Ion Concentration,pH:LsCnc:Pt:Bld:Qn
3283,Cadmium/Creatinine,Cadmium/Creatinine:MRto:24H:Urine:Qn
3284,Platelet associated Ab.IgA,Deprecated Platelet associated IgA Ab [Units/volume] in Blood
3285,CD3+CD8+ cell,Cells.CD3+CD8+:NCnc:Pt:Bld:Qn
3286,Gastrin,Gastrin^5M post 0.2 U/kg secretin:MCnc:Pt:Ser/Plas:Qn
3287,Leishmania mexicana IgG,Leishmania mexicana Ab.IgG:Titr:Pt:Ser:Qn
3288,Catecholamines,Catecholamines^7th specimen post XXX challenge:MCnc:Pt:Urine:Qn
3289,Erythroblasts,Erythrocytes.nucleated:NCnc:Pt:Body fld:Qn:Manual count
3290,"2,3-Diphosphoglycerate","2,3-Diphosphoglycerate:SCnc:Pt:RBC:Qn"
3291,Width,Width:Len:Pt:Prostate:Qn:US.measured
3292,Codeine,Codeine:MCnc:Pt:Urine:Qn:Confirm
3293,ST wave displacement.mid.lead AVR,ST wave displacement.mid.lead AVR:Elpot:Pt:Heart:Qn:EKG
3294,ST wave displacement.mid.lead V3,ST wave displacement.mid.lead V3:Elpot:Pt:Heart:Qn:EKG
3295,ceforanide,Ceforanide:Susc:Pt:Isolate:OrdQn:Agar diffusion
3296,Cervical mucous arborization,Ferning:Type:Pt:Cvm:Nom
3297,Germ cells.immature,Germ cells.immature:NCnc:Pt:Semen:Qn
3298,Biophysical profile.breathing movement,Biophysical profile.breathing movement:Fcn:Pt:^Fetus:Ord:US
3299,Systolic flow/Diastolic flow,Systolic flow/Diastolic flow:VelRto:Pt:Cerebral artery anterior^Fetus:Qn:US.doppler
3300,C-Peptide,C peptide^6H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
3301,Gentamicin,Gentamicin:MCnc:Pt:Body fld:Qn
3302,cyclobenzaprine,Cyclobenzaprine:PrThr:Pt:Urine:Ord
3303,Lithium.saliva/Lithium.serum,Lithium.saliva/Lithium.serum:Relative Ratio:Point in time:Serum+Saliva:Quantitative
3304,Blood flow.mean,Blood flow.mean:Vel:Pt:Pulmonary valve:Qn:US.doppler
3305,Blood flow.mean,Blood flow.mean:Vel:Pt:Umbilical artery.between fetus and placenta^Fetus:Qn:US.doppler
3306,Creatinine,Creatinine^2H post peritoneal dialysis:MCnc:Pt:Periton fld:Qn
3307,Asialoganglioside GM1 Ab,Deprecated Asialoganglioside GM1 Ab
3308,Monosialoganglioside GM1 Ab.IgA,Deprecated Monosialoganglioside GM1 Antibody.immunoglobulin A:Arbitrary Concentration:Point in time:Serum/Plasma:Quantitative or Ordinal
3309,Theophylline,Theophylline:MCnc:Pt:CSF:Qn
3310,Cyclosporine,Cyclosporine:SCnc:Pt:Ser:Qn
3311,Mental state,Mental status:Finding:Point in time:^Patient:Narrative:Observed
3312,Physical findings,Physical findings:Finding:Point in time:Neurologic system:Narrative:Observed
3313,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes:Number Fraction:Point in time:Cerebral spinal fluid:Quantitative:Manual count
3314,Glucose,Glucose^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
3315,Glucose,Glucose^50M post XXX challenge:MCnc:Pt:Ser/Plas:Qn
3316,Insulin,Insulin^2.5H post 75 g glucose PO:MCnc:Pt:Ser/Plas:Qn
3317,Color,Color:Type:Pt:Gast fld:Nom
3318,Growth Hormone,Somatotropin^40M post XXX challenge:MCnc:Pt:Ser/Plas:Qn
3319,Rubella virus antigen,Rubella virus Ag:PrThr:Pt:Penis:Ord:IF
3320,Cheese swiss Ab.IgE.RAST class,Cheese swiss Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
3321,Human papilloma virus (antigen),Human papilloma virus Ag:PrThr:Pt:Tiss:Ord:Immune stain
3322,Diameter (qualifier value),Diameter:Len:Pt:Bowel:Qn:US.measured
3323,Diameter (qualifier value),Diameter:Len:Pt:Cervical canal.external os:Qn:US.measured
3324,Neutrophils/100 leukocytes,Neutrophils Fr Fld Manual
3325,Populus deltoides Ab.IgG,Populus deltoides Ab.IgG:ACnc:Pt:Ser:Qn
3326,Spermatozoa.motile/100 spermatozoa,Deprecated Spermatozoa Motile/100 spermatozoa in Semen
3327,Carnitine esters/Creatinine,Carnitine esters/Creatinine:MRto:Pt:Urine:Qn
3328,Blastomyces dermatitidis exoantigen identification,Blastomyces dermatitidis exoantigen identification:Prid:Pt:Isolate:Nom
3329,Chlorpheniramine,Chlorpheniramine:MCnc:Pt:Urine:Qn:Confirm
3330,hepatitis A virus antibodies,Hepatitis A virus Ab:ACnc:Pt:Ser:Qn
3331,Colistin,Colistin:MCnc:Pt:Ser/Plas:Qn
3332,Hydrocortisone,Cortisol^70M post XXX challenge:MCnc:Pt:Ser/Plas:Qn
3333,Transfer summary note,Transfer summary note:Find:Pt:{Setting}:Doc:{Role}
3334,Oxyhemoglobin/Hemoglobin.total,Deprecated Fractional oxyhemoglobin by Pulse oximetry --pre physiotherapy
3335,Cells.CD34/100 cells,Cells.CD34/100 cells:NFr:Pt:XXX:Qn
3336,17-alpha-Hydroxyprogesterone,17-Hydroxyprogesterone:MCnc:Pt:Ser/Plas:Qn
3337,Testosterone,Testosterone^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
3338,cholesterol/triglyceride,Cholesterol/Triglyceride:MRto:Pt:Ser/Plas:Qn
3339,Thallium,Thallium:MCnt:Pt:Tiss:Qn
3340,"Cells.t(5;12)(q33.1;p13)(PDGFRB,ETV6)/Cells.total","Cells.t(5;12)(q33.1;p13)(PDGFRB,ETV6)/Cells.total:NFr:Pt:Bld/Tiss:Qn:Molgen"
3341,Avian pox virus Ab,Avian pox virus Ab:PrThr:Pt:Ser:Ord:IA
3342,Magnesium,Magnesium:SRat:24H:Stool:Qn
3343,Parakeet serum Ab.IgE.RAST class,Parakeet serum Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
3344,Cells.CD48/100 cells,Cells.CD48/100 cells:NFr:Pt:Bld:Qn
3345,Triamterene,Triamterene:ACnc:Pt:Urine:Qn
3346,Cinoxacin,Cinoxacin:Susc:Pt:Isolate:OrdQn
3347,Peak inspiratory flow rate,Deprecated Peak inspiratory flow Respiratory system airway opening by Airway pressure monitor --at 2.0 liter per second on ventilator
3348,Border disease virus RNA,Border disease virus RNA:PrThr:Pt:Tiss^Fetus:Ord:Probe.amp.tar
3349,tungsten,Tungsten:MCnc:Pt:Ser/Plas:Qn
3350,Oxytetracycline,Oxytetracycline:Susc:Pt:Isolate:OrdQn
3351,Piper nigrum Ab.IgG.RAST class,Piper nigrum Ab.IgG.RAST class:PrThr:Pt:Ser:Ord
3352,SEER summary stage 1977,SEER summary stage 1977:Type:Pt:Cancer.XXX:Nom
3353,Polio virus 2 Ab,Polio virus 2 Ab:Titr:Pt:CSF:Qn
3354,Mareks disease virus Ab,Mareks disease virus Ab:PrThr:Pt:Ser:Ord:Immune diffusion
3355,Acetaminophen,Acetaminophen:ACnc:Pt:Urine:Qn
3356,Creatinine/Protein,Creatinine/Protein:MRto:Pt:Urine:Qn
3357,Emetine,Emetine:ACnc:Pt:Ser/Plas:Qn
3358,Cells.FMC7/100 cells,Cells.FMC7/100 cells:NFr:Pt:Bld:Qn
3359,Menthol,Menthol:MCnc:Pt:Bld:Qn
3360,"Alkaline phosphatase isoenzyme, liver fraction",Alkaline phosphatase.liver:CCnc:Pt:Ser/Plas:Qn
3361,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes:NFr:Pt:Body fld:Qn
3362,BETA-N-ACETYLHEXOSAMINIDASE,Beta-N-acetylhexosaminidase:CCnt:Pt:Tiss:Qn
3363,Volume,Volume:Vol:Pt:Breathing bag:Qn
3364,Ammonia,Ammonia:MCnc:Pt:Urine:Qn
3365,Fraxinus pennsylvanica Ab.IgE,Fraxinus pennsylvanica Ab.IgE:ACnc:Pt:Ser:Qn
3366,Bovine herpesvirus 1 Antigen,Bovine herpesvirus 1 Ag:PrThr:Pt:Tiss:Ord:Immune stain
3367,Low-Density Lipoproteins,Lipoprotein.beta:PrThr:Pt:Ser/Plas:Ord
3368,Ureaplasma urealyticum,Ureaplasma urealyticum:PrThr:Pt:XXX:Ord:Organism specific culture
3369,Carbamoyl-Phosphate Synthase (Ammonia),Carbamoyl phosphate synthetase(ammonia):CCnt:Pt:Tiss:Qn
3370,Brucella abortus antibody,Brucella abortus Ab:PrThr:Pt:Milk:Ord:Aggl.serial ring test
3371,Secale cereale Ab.IgG.RAST class,Deprecated Rye IgG Ab RAST class in Serum
3372,Measles virus IgM,Measles virus Ab.IgM:Titr:Pt:Ser:Qn
3373,Mycoplasma gallisepticum antigen,Mycoplasma gallisepticum Ag:PrThr:Pt:XXX:Ord:IF
3374,Vesicular stomatitis Indiana virus Ab,Vesicular stomatitis Indiana virus Ab:PrThr:Pt:Ser:Ord:Comp fix
3375,Myelin basic protein antibody,Myelin basic protein Ab:MCnc:Pt:Ser:Qn
3376,Bile Acids,Bile acid:MCnc:Pt:Ser:Qn
3377,Gradient.max,Gradient.max:Pres:Pt:Mitral valve.regurgitant jet:Qn:US+Calculated
3378,Brucella abortus antibody,Brucella abortus Ab:PrThr:Pt:Ser:Ord:EIA.RST
3379,Choriogonadotropin.beta subunit (pregnancy test),Choriogonadotropin.beta subunit (pregnancy test):PrThr:Pt:Urine:Ord
3380,Snapper red Ab.IgG.RAST class,Snapper red Ab.IgG.RAST class:PrThr:Pt:Ser:Ord
3381,Salmonella enterica subspecies enterica serovar Paratyphi B O antibody,Salmonella paratyphi B O Ab:PrThr:Pt:Ser:Ord
3382,Brucella sp Antigen,Brucella sp Ag:PrThr:Pt:Placenta:Ord:Immune stain
3383,Viral hemorrhagic disease virus Ag,Viral hemorrhagic disease virus Ag:PrThr:Pt:Tiss:Ord:IF
3384,Bacteria identified,Bacteria identified^^^3:Prid:Pt:Tiss:Nom:Anaerobic culture
3385,Blood flow 2.mean,Blood flow 2.mean:Vel:Pt:Tricuspid valve.regurgitant jet:Qn:US
3386,Acceleration slope,Acceleration slope:Vel:Pt:Pulmonary artery:Qn:US
3387,Immunoglobulin G antibody to Toxoplasma gondii,Toxoplasma gondii Ab.IgG:PrThr:Pt:Ser:Ord:Dye test
3388,Correction comments battery,Correction comments battery:Complex:Point in time::Multi
3389,"Dicarboxylate, C6-C8-C10",Dicarboxylate C6-C8-C10:MCnc:Pt:Urine:Qn
3390,Immunoglobulin G antibody to Toxoplasma gondii,Toxoplasma gondii Ab.IgG:Titr:Pt:CSF:Qn
3391,Myxoma virus Ag,Myxoma virus Ag:PrThr:Pt:XXX:Ord:IF
3392,Azithromycin,Azithromycin:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria
3393,Doxycycline,Deprecated Doxycycline [Susceptibility] by Method for Slow-growing mycobacteria
3394,Streptomycin,Deprecated Streptomycin [Susceptibility] by Method for Slow-growing mycobacteria
3395,Glucose,Glucose^6th specimen post XXX challenge:PrThr:Pt:Urine:Ord
3396,Tube number,Tube number:ID:Pt:CSF:Nom
3397,p-Hydroxyamphetamine,Para hydroxyamphetamine:PrThr:Pt:Urine:Ord:Confirm
3398,Stroke Volume,Stroke volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by bullet method
3399,Varicella zoster virus IgM,Varicella zoster virus Ab.IgM:Titr:Pt:CSF:Qn:IF
3400,Avian encephalomyelitis virus antibody,Avian encephalomyelitis virus Ab:PrThr:Pt:Ser:Ord
3401,Trichinella spiralis IgM,Deprecated Trichinella spiralis IgM Ab [Presence] in Serum
3402,Bluetongue virus 2 Ab,Bluetongue virus 2 Ab:Titr:Pt:Ser:Qn:Neut
3403,benzthiazide,Benzthiazide:MCnc:Pt:Ser/Plas:Qn
3404,Free prostate specific antigen,Prostate specific Ag.free:SCnc:Pt:Semen:Qn
3405,Bicarbonates,Bicarbonate^^standard:SCnc:Pt:BldMV:Qn
3406,Psilocybin,Deprecated Psilocybin [Mass/volume] in Urine
3407,Flow,Flow:Area:Pt:Tricuspid valve:Qn:US.calculated
3408,Blood flow.max,Blood flow.max:Vel:Pt:Circulatory system.XXX:Qn:US.doppler
3409,regional,Region:Area:Pt:Heart.valve.XXX:Qn:US.doppler.VTI+Diameter.calculated
3410,Peste des petits ruminants virus Ab,Peste des petits ruminants virus Ab:PrThr:Pt:Ser:Ord:IA
3411,Peste des petits ruminants virus Ag,Peste des petits ruminants virus Ag:PrThr:Pt:Tiss:Ord:IA
3412,Deceleration,Deceleration:Time:Pt:Aortic valve.regurgitant jet:Qn:US.doppler
3413,Defect.gradient.systole.max,Defect.gradient.systole.max:Pres:Pt:Heart.ventricle.septum:Qn:US.doppler
3414,Amphetamine or methamphetamine Assay,AMPHETAMINES TESTED FOR:PRID:PT:UR:NOM:SCREEN
3415,Urobilinogen,Urobilinogen:MCnc:Pt:Urine:Qn:Test strip
3416,CFTR gene.p.Phe508del,CFTR gene.p.Phe508del:PrThr:Pt:Bld/Tiss:Ord:Molgen
3417,Ejection fraction (finding),Ejection fraction:VFr:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by single-plane ellipse method
3418,QT interval feature (observable entity),QT interval:Time:Pt:Lead V5:Qn:EKG
3419,Pigeon serum Ab.IgG,Pigeon serum Ab.IgG:PrThr:Pt:Ser:Ord
3420,General categories,General categories:Imp:Pt:Cvx/Vag:Nom:Cyto stain
3421,PRSS1 gene targeted mutation analysis,PRSS1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
3422,Leptospira interrogans serovar Icterohaemorrhagiae antibody,Leptospira interrogans serovar Icterohaemorrhagiae Ab:Titr:Pt:Ser:Qn
3423,Estriol,Estriol:MRat:24H:Urine:Qn
3424,Brucella canis IgG,Brucella canis Ab.IgG:ACnc:Pt:Ser:Qn
3425,Dopamine,Dopamine:MCnc:Pt:Ser/Plas:Qn
3426,Etiocholanolone,Etiocholanolone:MRat:24H:Urine:Qn
3427,Rift valley fever virus Ag,Rift valley fever virus Ag:PrThr:Pt:Bld:Ord:Neut
3428,Chlorphentermine,Chlorphentermine:ACnc:Pt:Bld:Qn
3429,Gradient.systole.max,Gradient.systole.max:Pres:Pt:Heart.ventricle.left.outflow tract:Qn:US.doppler
3430,Ketamine,Ketamine:MCnc:Pt:Urine:Qn:Screen
3431,Cells.CD16+CD57+/100 cells,Cells.CD16+CD57-/100 cells:NFr:Pt:XXX:Qn
3432,Cerebroside-Sulfatase,Cerebroside sulfatase:Arbitrary Concentration:Point in time:Serum/Plasma:Ordinal
3433,Epithelial Cells,Epithelial cells:PrThr:Pt:Urine sed:Ord:Microscopy.light
3434,Leukocytes,Leukocytes:PrThr:Pt:Urine sed:Ord:Microscopy.light
3435,Bacteria identified,Bacteria identified:Prid:Pt:Milk:Nom:Aerobic culture
3436,Leucine,Leucine:SCnc:Pt:XXX:Qn
3437,Equine arteritis virus antibody,Equine arteritis virus Ab:PrThr:Pt:Ser:Ord:IF
3438,All-Trans-Retinol,Retinol^6H post dose:MCnc:Pt:Ser/Plas:Qn
3439,Salmonella gallinarum Ab,Deprecated Salmonella gallinarum Ab [Presence] in Serum
3440,Salmonella enterica enterica serovar Gallinarum DNA,Salmonella gallinarum DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar
3441,GQ1b ganglioside antibody,Ganglioside GQ1b Antibody:Arbitrary Concentration:Point in time:Serum:Ordinal
3442,Study observation.overall,Study observation.overall:Impression/interpretation of study:Point in time:Cardiovascular.central:Narrative:ULTRASOUND
3443,Ciprofloxacin,Ciprofloxacin:Susc:Pt:Isolate:OrdQn:Agar diffusion
3444,Echovirus 4 Ab,Echovirus 4 Ab:Titr:Pt:Ser:Qn
3445,Foot and mouth disease virus serotype,Foot and mouth disease virus serotype:Prid:Pt:Tiss:Nom:Comp fix
3446,Theileria equi antibody,Theileria equi Ab:PrThr:Pt:Ser:Ord:IF
3447,(Cynodon dactylon+Lolium perenne+Phleum pratense+Poa pratensis+Sorghum halepense) Ab.IgE,(Cynodon dactylon+Lolium perenne+Phleum pratense+Poa pratensis+Sorghum halepense) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk
3448,Specimen volume,Specimen volume:Vol:24H:Stool:Qn
3449,5-Hydroxyindoleacetate,5-Hydroxyindoleacetate:SCnc:24H:Urine:Qn
3450,Views 2,Views 2:Find:Pt:Upper extremity.bilateral>Humerus:Doc:XR
3451,Betula verrucosa Ab.IgG4.RAST class,Betula verrucosa Ab.IgG4.RAST class:PrThr:Pt:Ser:Ord
3452,C-Peptide,C peptide^40M post XXX challenge:MCnc:Pt:Ser/Plas:Qn
3453,Warfarin,Warfarin:MCnc:Pt:Urine:Qn
3454,Echovirus 30 Ab,Echovirus 30 Ab:PrThr:Pt:Ser:Ord:Comp fix
3455,Multisection,Multisection^WO contrast:Find:Pt:Upper extremity>Shoulder:Doc:MR
3456,Tryptophan,Deprecated Tryptophan [Mass/volume] in Serum or Plasma
3457,Canine distemper virus Ab,Canine distemper virus Ab:PrThr:Pt:Ser:Ord
3458,Cyanides,Cyanide:SCnc:Pt:Ser/Plas:Qn
3459,Taurine/Creatinine,Taurine/Creatinine:SRto:24H:Urine:Qn
3460,Lactalbumin alpha Ab.IgG4,Lactalbumin alpha Ab.IgG4:ACnc:Pt:Ser:Qn
3461,Axis N 2,Axis N 2:Angle:Pt:LM glasses.lens.right:Qn
3462,loracarbef,Loracarbef:Susc:Pt:Isolate:OrdQn:Agar diffusion
3463,Free tryptophan,Tryptophan.free:MCnc:Pt:Ser/Plas:Qn
3464,Bovine diarrhea virus Antigen,Bovine diarrhea virus Ag:PrThr:Pt:Stool:Ord
3465,Bovine herpesvirus 2 Ag,Bovine herpesvirus 2 Ag:PrThr:Pt:Exudate:Ord
3466,Respiratory syncytial virus antigen,Respiratory syncytial virus Ag:PrThr:Pt:Nose:Ord:IF
3467,Herpes virus 6 IgG,Herpes virus 6 Ab.IgG:Titr:Pt:Ser:Qn:IF
3468,Glycine,Glycine:SRat:24H:Urine:Qn
3469,Monocytes/100 leukocytes,Monocytes/100 leukocytes:NFr:Pt:Bld:Qn
3470,Sphere N 1,Sphere N 1:InvLen:Pt:Glasses prescription:Qn
3471,Sphere N 2,Sphere N 2:InvLen:Pt:Glasses prescription.lens.left:Qn
3472,Neutrophils.segmented/100 leukocytes,Neutrophils.segmented/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count
3473,View,Views^W standing:Find:Pt:Lower extremity.bilateral>Knee:Doc:XR
3474,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes:NFr:Pt:CSF:Qn
3475,Thyroxine measurement,Thyroxine:MCnc:Pt:Saliva:Qn
3476,Canary serum proteins Ab,Canary serum proteins Ab:PrThr:Pt:Ser:Ord
3477,Pentacarboxylporphyrin,Pentacarboxylporphyrins:SRat:24H:Urine:Qn
3478,View,Views:Find:Pt:Lower extremity.right>Acetabulum:Doc:XR
3479,Chlamydia trachomatis D+K Ab.IgA,Chlamydia trachomatis D+K Ab.IgA:ACnc:Pt:Ser:Qn
3480,Amobarbital,Amobarbital:MCnc:Pt:Vitr fld:Qn
3481,Phencyclidine,Phencyclidine:MCnt:Pt:Meconium:Qn
3482,Beta alanine/Creatinine,Beta alanine/Creatinine:SRto:Pt:Urine:Qn
3483,phosphate ion,Phosphate:Mass Concentration:Point in time:Serum/Plasma:Quantitative
3484,Glucose,Glucose^2H post 1.2 g/kg lactose PO:MCnc:Pt:Ser/Plas:Qn
3485,Coxsackievirus B4 Ab,Coxsackievirus B4 Ab:ACnc:Pt:Body fld:Qn
3486,Epstein Barr virus early IgG,Epstein Barr virus early Ab.IgG:Titr:Pt:CSF:Qn:IF
3487,Pyridoxine congeners,Pyridoxine congeners:MCnc:Pt:Ser/Plas:Qn
3488,Equine arteritis virus antibody,Equine arteritis virus Ab:ACnc:Pt:Ser:Qn
3489,Feline herpesvirus Ab,Feline herpesvirus Ab:ACnc:Pt:Ser:Qn
3490,Blatta orientalis Ab.IgE.RAST class,Blatta orientalis Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
3491,Leishmania donovani antibody,Leishmania donovani Ab:Titr:Pt:Ser:Qn
3492,Phenylalanine,Phenylalanine:MRat:24H:Urine:Qn
3493,Tetrahydrodeoxycortisol,Tetrahydrodeoxycortisol:MRat:24H:Urine:Qn
3494,Lymphocytes.variant/100 leukocytes,Lymphocytes.variant/100 leukocytes:NFr:Pt:Body fld:Qn
3495,Bordetella pertussis filamentous hemagglutinin IgA,Bordetella pertussis.filamentous hemagglutinin Ab.IgA:ACnc:Pt:Ser:Qn:IA
3496,Glucose,Glucose^4.5H post dose glucose:SCnc:Pt:Ser/Plas:Qn
3497,Multisection,Multisection^WO & W contrast IV:Find:Pt:Lower extremity.bilateral>Ankle:Doc:MR
3498,Legionella pneumophila 3 Ab,Legionella pneumophila 3 Ab:ACnc:Pt:Ser:Qn
3499,Multisection,Multisection:Find:Pt:Chest>Brachial plexus.right:Doc:MR
3500,Physical findings,Physical findings:Find:Pt:Eye lid.right:Nar
3501,Pyruvate dehydrogenase (cytochrome),Pyruvate dehydrogenase.cytochrome:CCnc:Pt:Ser/Plas:Qn
3502,Somatostatin,Somatostatin:PrThr:Pt:Plas:Ord
3503,3-hydroxyglutarate,3-Hydroxyglutarate:PrThr:Pt:Urine:Ord
3504,Lymphocytic choriomeningitis virus IgM,Lymphocytic choriomeningitis virus Ab.IgM:ACnc:Pt:CSF:Qn
3505,4-Hydroxyphenylacetate/Creatinine,4-Hydroxyphenylacetate/Creatinine:SRto:Pt:Urine:Qn
3506,Plasmodium species antibody,Plasmodium sp Ab:Titr:Pt:Ser:Qn:IF
3507,Midomafetamine,Methylenedioxymethamphetamine:MCnc:Pt:Vitr fld:Qn
3508,Argon laser trabeculoplasty Rx,Argon laser trabeculoplasty Rx:EngRat:Pt:Eye.left:Qn
3509,Metanephrine,Metanephrine:MCnc:Pt:Ser/Plas:Qn
3510,Neisseria gonorrhoeae antigen,Neisseria gonorrhoeae Ag:PrThr:Pt:XXX:Ord
3511,View,Views:Finding:Point in time:Elbow:Narrative:XR
3512,Free thyroxin,Thyroxine.free^4th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn
3513,Free thyroxin,Thyroxine.free^5th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn
3514,Streptococcus pneumoniae Danish serotype 3 IgG,Deprecated Streptococcus pneumoniae 3 IgG Ab [Mass/volume] in Serum by Immunoassay
3515,para-Aminohippurate renal clearance,Para aminohippurate renal clearance:VRat:24H:Urine+Ser/Plas:Qn
3516,Gerbil epithelium Ab.IgE.RAST class,Gerbil epithelium Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
3517,Amikacin,Amikacin^trough post extended interval dosing:MCnc:Pt:Ser/Plas:Qn
3518,Rickettsia spotted fever group IgG,Rickettsia spotted fever group Ab.IgG^1st specimen:Titr:Pt:Ser:Qn:IF
3519,Staphylococcus aureus enterotoxin C Ab.IgE,Staphylococcus aureus enterotoxin C Ab.IgE:ACnc:Pt:Ser:Qn
3520,Amino beta guanidinopropionate/Creatinine,Amino beta guanidinopropionate/Creatinine:Relative Density:Point in time:Urine:Quantitative
3521,Alpha aminobutyrate/Creatinine,Alpha aminobutyrate/Creatinine:Ratio:24H:Urine:Qn
3522,Rickettsia sibirica Ab,Rickettsia sibirica Ab:Titr:Pt:Ser:Qn
3523,Gerbil hair Ab.IgE.RAST class,Gerbil hair Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
3524,Vanillylmandelate,Vanillylmandelate:MRat:24H:Urine:Qn
3525,Ethanol,Ethanol:SCnc:Pt:XXX:Qn
3526,LACROSSE VIRUS ANTIBODY,La Crosse virus Ab^1st specimen:Titr:Pt:Ser:Qn:IF
3527,Multisection,Multisection:Find:Pt:Head>Internal auditory canal+Posterior fossa:Doc:MR
3528,Guidance for placement of peripherally-inserted central venous catheter,Guidance for placement of peripherally-inserted central venous catheter:Find:Pt:XXX>Vein.right:Doc:RF.angio
3529,Arginine,Arginine:SCnc:Pt:Urine:Qn
3530,Fetal Hemoglobin,Hemoglobin F:PrThr:Pt:Bld:Ord:Kleihauer-Betke
3531,Respiratory syncytial virus antigen,Respiratory syncytial virus Ag:PrThr:Pt:Thrt:Ord
3532,Rubella virus antigen,Rubella virus Ag:PrThr:Pt:Urethra:Ord
3533,Guidance for injection,Guidance for injection:Find:Pt:Pelvis>Sacroiliac joint.left:Doc:CT
3534,Methyltestosterone,Methyltestosterone:MCnc:Pt:Urine:Qn
3535,Invertase,Deprecated Beta fructofuranosidase [Enzymatic activity/volume] in Red Blood Cells
3536,Color,Deprecated Color of Unspecified specimen
3537,Physical findings,Physical findings:Finding:Point in time:Integumentary system:Narrative:Observed
3538,Dispensing medication,Medication dispensed:Type:Point in time:^Patient:Nominal
3539,View,Views^W radionuclide IV:Find:Pt:Lower extremity>Knee:Doc:NM
3540,Insulin Antibodies,Insulin Ab:PrThr:Pt:Ser:Ord
3541,Multisection,Multisection^W Tc-99m IV:Find:Pt:Abdomen>Liver:Doc:NM.SPECT
3542,Macroglobulins,Macroglobulin:MCnc:Pt:Ser/Plas:Qn
3543,Oxazepam,Oxazepam:MCnc:Pt:Vitr fld:Qn
3544,6-O-monoacetylmorphine,6-Monoacetylmorphine:MCnt:Pt:Meconium:Qn
3545,Gentamicin,Gentamicin^peak post extended interval dosing:MCnc:Pt:Ser/Plas:Qn
3546,microscopic observation,Microscopic observation:Prid:Pt:Neck mass.FNA:Nom:Cyto stain
3547,Vesicular stomatitis Indiana virus Ab,Vesicular stomatitis Indiana virus Ab:ACnc:Pt:Ser:Qn
3548,Western equine encephalomyelitis virus antigen,Western equine encephalitis virus Ag:PrThr:Pt:Ser:Ord
3549,Chlamydia species antigen,Chlamydia sp Ag:PrThr:Pt:Urine:Ord:IA
3550,Xanthurenates,Xanthurenate:MCnc:Pt:Ser/Plas:Qn
3551,Guidance for placement of tube,Guidance for placement of tube:Find:Pt:Chest:Doc:US
3552,Babesia microti antibody,Babesia microti Ab:PrThr:Pt:Ser:Ord
3553,CV2 Ab.IgG,CV2 Ab.IgG:ACnc:Pt:Ser:Qn
3554,Porphyrin fractions,Porphyrins fractionated:Impression/interpretation of study:24 hours:Urine:Nominal
3555,Platelet mean volume finding,Platelet mean volume:EntVol:Pt:BldCo:Qn
3556,Brucella abortus Ab.IgG & IgM panel,Brucella abortus Ab.IgG & IgM panel:-:Pt:Ser:-
3557,Dissolved solids,Dissolved solids:MCnc:Pt:Water:Qn
3558,Nitrogen,Nitrogen:SRat:24H:Urine:Qn
3559,Cells.CD4/100 cells,Deprecated CD4 cells/100 cells in Cerebral spinal fluid
3560,Centromere antibody,Centromere Ab:Titr:Pt:Body fld:Qn
3561,Coxsackievirus A6 Ab,Deprecated Coxsackievirus A6 Ab [Titer] in Serum
3562,Uroporphyrin 3 isomer,Uroporphyrin 3 isomer:SCnt:Pt:Stool:Qn
3563,Growth Hormone,Somatotropin^pre dose glucagon:ACnc:Pt:Ser/Plas:Qn
3564,Porphyrins,Porphyrins:SRat:24H:Urine:Qn
3565,Views 2,Views 2:Find:Pt:Pelvis & Lower extremity.left>Hip:Doc:XR
3566,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68+70 DNA,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68+70 DNA:PrThr:Pt:Anal:Ord:Probe.amp.sig
3567,Time of analysis,Time of analysis:TmStp:Pt:XXX:Qn
3568,coproporphyrin I,Coproporphyrin 1:SRat:24H:Urine:Qn
3569,Trichophyton reaction wheal,Trichophyton reaction wheal [Diameter] --2 days post dose trichophyton intradermal
3570,ramoplanin,Ramoplanin:Susc:Pt:Isolate:OrdQn:Gradient strip
3571,Malignant cells/100 cells,Malignant cells/100 cells:NFr:Pt:Plr fld:Qn
3572,Hemoglobin C/Hemoglobin.total,Hemoglobin C/Hemoglobin.total:MFr:Pt:Bld:Qn:HPLC
3573,Streptococcus pneumoniae Danish serotype 5 IgG,Deprecated Streptococcus pneumoniae 5 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
3574,Multisection,Multisection^W radionuclide IV:Find:Pt:Abdomen>Kidney:Doc:NM.SPECT
3575,ceftobiprole,Ceftobiprole:Susc:Pt:Isolate:OrdQn:MLC
3576,Cells.CD3/Cells.CD4,Cells.CD3/Cells.CD4:NRto:Pt:XXX:Qn
3577,Powassan virus polyvalent E Ab,Powassan virus polyvalent E Ab:PrThr:Pt:XXX:Ord:IA
3578,Influenza virus A hemagglutinin H5 RNA,Deprecated Influenza virus A hemagglutinin H5 RNA [Presence] in Unspecified specimen by Probe & target amplification method
3579,Leukocytes,Leukocytes:Naric:Pt:Vag:Qn:Wet preparation
3580,Neisseria meningitidis,Neisseria meningitidis:Prid:Pt:Isolate:Nom:Organism specific culture
3581,Australian cervix cytology code,Australian cervix cytology code:Imp:Pt:XXX:Nom
3582,Sisomicin,Sisomicin:Titr:Pt:Isolate+Ser:Qn:SBT
3583,Phosphate crystals.amorphous,Phosphate crystals.amorphous:Naric:Pt:Urine sed:Qn:Microscopy.light.LPF
3584,Homovanillate,Homovanillate:SCnc:Pt:CSF:Qn
3585,Leishmania sp Ab.IgG,Leishmania sp Ab.IgG:ACnc:Pt:Ser:Qn
3586,Voltage-gated calcium channel Ab.IgG,Voltage-gated calcium channel Ab.IgG:SCnc:Pt:Ser:Qn
3587,AKT1 gene targeted mutation analysis,AKT1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
3588,Multisection,Multisection^W contrast IV:Find:Pt:Lower extremity.bilateral>Lower extremity vessels:Doc:MR.angio
3589,Jamestown Canyon virus IgM,Jamestown canyon virus Ab.IgM:Titr:Pt:Ser:Qn:Neut
3590,Cells.CD11c+CD19+/100 cells,Cells.CD11c+CD19+/100 cells:NFr:Pt:Body fld:Qn
3591,Yeasts,Yeast:PrThr:Pt:CSF:Ord:Microscopy.light
3592,Xylose,Xylose^2H post 25 g xylose PO:MCnc:Pt:Urine:Qn
3593,Triamcinolone Acetonide,Triamcinolone acetonide:MCnc:Pt:Ser/Plas:Qn
3594,Multisection,Multisection^W In-111 tagged WBC IV:Find:Pt:XXX>Bone:Doc:NM.SPECT
3595,Immune complex.C3d,Immune complex.C3d:ACnc:Pt:Ser/Plas:Qn
3596,Protriptyline,Protriptyline:Mass:Pt:Dose:Qn
3597,HLA-A33(19),HLA-A33(19):PrThr:Pt:Bld/Tiss^Donor:Ord
3598,Monocytes/100 leukocytes,Monocytes/100 leukocytes:NFr:Pt:Dial fld prt:Qn:Manual count
3599,Uranium 235/Uranium 238,Uranium 235/Uranium 238:MRto:Pt:Urine:Qn
3600,Multisection limited,Multisection limited:Find:Pt:Upper extremity>Upper extremity artery:Doc:US
3601,Multisection endorectal,Multisection endorectal:Find:Pt:Pelvis>Prostate:Doc:MR
3602,Rat epithelium+Serum proteins+Urine proteins Ab.IgE.RAST class,Rat epithelium+Serum proteins+Urine proteins Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
3603,Casts body substance,Casts:Naric:Pt:Urine sed:Qn:Automated count
3604,Legionella pneumophila 10 IgM,Legionella pneumophila 10 Ab.IgM:Titr:Pt:Ser:Qn
3605,Creatinine,Creatinine^45M post XXX challenge:SCnc:Pt:Ser/Plas:Qn
3606,Tobramycin,Tobramycin [Mass/volume] in Serum or Plasma --trough
3607,Internal rotation.active range of motion,Internal rotation.active range of motion:Angle:Pt:Shoulder.right:Qn
3608,External rotation.active range of motion,External rotation.active range of motion:Angle:Pt:Shoulder.right:Qn
3609,Glucose,Glucose^15M pre XXX challenge:SCnc:Pt:Ser/Plas:Qn
3610,Blast Cell,Deprecated Blasts [#/volume] in Blood by Automated count
3611,Campylobacter sp Ab.IgA,Campylobacter sp Ab.IgA:PrThr:Pt:Ser:Ord:IA
3612,Ricin,Ricin toxin:PrThr:Pt:XXX:Ord:IF
3613,Passive range of motion panel,Passive range of motion panel:Angle:Pt:^Patient:Qn
3614,Abduction.active range of motion,Abduction.active range of motion:Angle:Pt:Hip:Qn
3615,Chlamydia trachomatis DNA,Deprecated Chlamydia trachomatis DNA [Presence] in Penis by Probe and target amplification method
3616,LOINC class types,Class:Type:Pt:Oxygen saturation device:Nom
3617,Herpes simplex virus 1 IgG,Herpes simplex virus 1 Ab.IgG:PrThr:Pt:CSF:Ord
3618,Isovalerylcarnitine (C5),Isovalerylcarnitine (C5):SCnc:Pt:Bld.dot:Qn
3619,Histologic type,Histologic type:Type:Pt:Prostate tumor:Nom
3620,Chlamydia species antigen,Chlamydia sp Ag:PrThr:Pt:Cvx:Ord:IA
3621,Hemoglobin H/Hemoglobin.total,Hemoglobin H/Hemoglobin.total:MFr:Pt:Bld:Qn:Electrophoresis
3622,Gentamicin,Gentamicin:SCnc:Pt:Ser/Plas:Qn
3623,Bicarbonates,Bicarbonate:SRat:24H:Urine:Qn
3624,Fenfluramine,Fenfluramine:Mass:Pt:Dose:Qn
3625,Multisection,Multisection^WO & W contrast IV:Find:Pt:Neck>Spine.cervical & Chest>Spine.thoracic:Doc:MR
3626,Coccidioides sp Ab.IgG,Coccidioides sp Ab.IgG:PrThr:Pt:Ser:Ord:IA
3627,Multisection,Multisection:Find:Pt:Lower extremity.bilateral>Lower extremity vein:Doc:US
3628,HTLV I+II Ab,HTLV I+II Ab:Titr:Pt:Ser:Qn
3629,Lesion size.max.dimension,Lesion size.max.dimension:Len:Pt:Skin:Qn
3630,Intact parathyrin,Parathyrin.intact^baseline:SCnc:Pt:Ser/Plas:Qn
3631,Ribosomal ribonucleoprotein antibody,Ribonucleoprotein extractable nuclear Ab:MCnc:Pt:Ser:Qn
3632,lopinavir,Lopinavir:Susc:Pt:Isolate:Ord:Genotyping
3633,COC site & type override flag,COC site & type override flag:Arb:Pt:Cancer case.XXX:Ord
3634,Collaborative staging regional nodes evaluation,Collaborative staging regional nodes evaluation:Prid:Pt:Cancer.XXX:Nom
3635,Contributing factor.patient-related,Contributing factor.patient-related:Find:Pt:^Patient:Nom:Observed.MERSTH
3636,Contributing factor.technical,Contributing factor.technical:Find:Pt:^Patient:Nom:Observed.MERSTH
3637,Feline leukemia virus Ab,Feline leukemia virus Ab:Titr:Pt:Ser:Qn
3638,Purkinje cell antibody,Purkinje cells Ab:ACnc:Pt:Ser:Qn:IF
3639,Egg whole Ab.IgG,Egg whole Ab.IgG:MCnc:Pt:Ser:Qn
3640,Hemosiderin,Hemosiderin:MCnc:Pt:Urine:Qn
3641,Follicle Stimulating Hormone,Follitropin^2.5H post 100 ug lutenizing releasing hormone IV:ACnc:Pt:Ser/Plas:Qn
3642,Glutamate,Glutamate:SCnc:Pt:Bld.dot:Qn
3643,HLA-DRB3 Chains,HLA-DRB3:PrThr:Pt:Bld/Tiss:Ord
3644,Somatotropin/Creatinine,Somatotropin/Creatinine:MRto:Pt:Urine:Qn
3645,Disialylganglioside GD1b Ab.IgG,Deprecated Disialylganglioside GD1b IgG Ab [Presence] in Serum
3646,Neuronal nuclear Ab.IgG,Neuronal nuclear Ab.IgG:Titr:Pt:Ser:Qn:IF
3647,Cyclic AMP,Adenosine monophosphate.cyclic^2nd specimen post XXX challenge:SCnc:Pt:Urine:Qn
3648,procollagen Type I N-terminal peptide,Procollagen type I.N-terminal propeptide:MCnc:Pt:Ser:Qn
3649,Insulin,Insulin^20M post dose glucose:ACnc:Pt:Ser/Plas:Qn
3650,Insulin,Insulin^pre-meal:ACnc:Pt:Ser/Plas:Qn
3651,Prolactin,Prolactin^30M post dose triple bolus:MCnc:Pt:Ser/Plas:Qn
3652,Discharge summary note,Discharge summarization note:Finding:Point in time:Hospital:Document:Physician
3653,fatty acid oxidation,Fatty acid oxidation:Prid:Pt:Fibroblasts:Nom
3654,Potassium,Potassium:Sub:XXX:Urine:Qn
3655,Gestational Age,Gestational age:Time:Pt:^Fetus:Qn:US+Estimated from AC.Lessoway 1998
3656,Doxepin,Doxepin:MCnc:Pt:Ser/Plas:Qn:Screen
3657,Multisection,Multisection^W contrast IS:Find:Pt:Lower extremity.right>Ankle:Doc:MR
3658,Multisection,Multisection^WO contrast:Find:Pt:Lower extremity.right>Hip:Doc:MR
3659,Multisection,Multisection^W contrast intradisc:Find:Pt:Abdomen>Spine.lumbar:Doc:CT
3660,Ampicillin / Sulbactam,Ampicillin+Sulbactam:Susc:Pt:Isolate:OrdQn:Agar diffusion
3661,Gestational Age,Gestational age:Time:Pt:^Fetus:Qn:US+Estimated from HC measured.Chitty 1997
3662,Diameter product,Diameter product:Len:Pt:Abdomen^Fetus:Qn:US.estimated from Shinozuka 1996
3663,Gamma globulin/Protein.total,Gamma globulin/Protein.total:MFr:24H:Urine:Qn
3664,View,Views:Find:Pt:Upper extremity.bilateral>Finger.fourth:Doc:XR
3665,Multisection perfusion,Multisection perfusion^W radionuclide IV:Find:Pt:Chest>Heart:Doc:NM.SPECT
3666,Cells.G0+G1 phase/100 cells,Cells.G0+G1 phase/100 cells:NFr:Pt:XXX:Qn:Flow cytometry
3667,View,Views^W contrast IA:Find:Pt:Neck>Carotid artery.common.right:Doc:RF.angio
3668,Asbestos,Asbestos:MCnc:Pt:Air:Qn
3669,VA C&P exam.thyroid &or parathyroid diseases note,VA C&P exam.thyroid &or parathyroid diseases note:Find:Pt:{Setting}:Doc:{Role}
3670,View,Views^W contrast intra lymphatic:Find:Pt:Pelvis>Pelvic lymphatic vessels.bilateral:Doc:RF.angio
3671,Multisection,Multisection:Find:Pt:Pelvis>Penis:Doc:US
3672,Protection,Protection:Type:Pt:Skin:Nom
3673,Platelets.large,Platelets.large:PrThr:Pt:Bld:Ord:Microscopy.light
3674,Cells,Cells:NCnc:Pt:Synv fld:Qn:Manual count
3675,Cefaclor Ab.IgG,Cefaclor Ab.IgG:ACnc:Pt:Ser:Qn
3676,cefditoren,Cefditoren:Susc:Pt:Isolate:OrdQn:Agar diffusion
3677,Hexachlorobenzene,Hexachlorobenzene:MCnc:Pt:Air:Qn
3678,Color,Color:Type:Pt:Wound.base:Nom
3679,Oral assessment panel,Oral assessment panel:-:Point in time:^Patient:-
3680,Silicone Ab.IgM,Silicone Ab.IgM:ACnc:Pt:Ser:Qn:IA
3681,Calcium,Calcium^1st specimen post XXX challenge:SCnc:Pt:Urine:Qn
3682,Lead,Lead:SCnc:24H:Urine:Qn
3683,Cefotaxime+Clavulanate,Cefotaxime+Clavulanate:Susc:Pt:Isolate:OrdQn
3684,Multisection,Multisection^W contrast IV:Find:Pt:Neck>Neck vessels:Doc:CT.angio
3685,Braden scale skin assessment panel,Braden scale skin assessment panel:-:Point in time:^Patient:-
3686,"1,3-butadiene","1,3-Butadiene:MCnc:Pt:Air:Qn"
3687,View,Views:Find:Pt:Chest>Sternoclavicular joint.bilateral:Doc:XR
3688,View,Views:Find:Pt:Upper extremity.right>Hand:Doc:XR
3689,Cannabinoids,Cannabinoids:MCnt:Pt:Meconium:Qn:Confirm
3690,Treponema pallidum Ab.IgG & IgM panel,Treponema pallidum Ab.IgG & IgM panel:-:Pt:Ser:Qn
3691,Vitamin D+Metabolites,Vitamin D+Metabolites:MCnc:Pt:Ser/Plas:Qn
3692,DMPK gene allele 1.CTG repeats,DMPK gene allele 1.CTG repeats:PrThr:Pt:Bld/Tiss:Ord:Molgen
3693,Trospectinomycin,Trospectinomycin:Susc:Pt:Isolate:OrdQn:MIC
3694,dimazine,"1,1-Dimethylhydrazine:MCnc:Pt:Air:Qn"
3695,phosphate ion,Phosphate:MCnc:Pt:Air:Qn
3696,Perca spp Ab.IgG.RAST class,Perca spp Ab.IgG.RAST class:PrThr:Pt:Ser:Ord
3697,Enterovirus RNA,Enterovirus RNA:PrThr:Pt:Tiss:Ord:Probe.amp.tar
3698,Views 4,Views 4:Finding:Point in time:Chest:Document:XR
3699,Tetrachlorodibenzodioxin,Dioxin:MCnc:Pt:Water:Qn
3700,"1,3-dichloro-1-propene","1,3-Dichloropropene:MCnc:Pt:Air:Qn"
3701,Methylenedianiline,Methylenedianiline:MCnc:Pt:Air:Qn
3702,View,Views^W Ga-67 IV:Find:Pt:XXX:Doc:NM
3703,Views perfusion,Views perfusion^W Tc-99m Sestamibi IV:Find:Pt:Chest>Heart:Doc:NM
3704,Coagulation factor XI activity,Coagulation factor XI activity:ACnc:Pt:PPP:Qn:Chromo
3705,Acetone,Acetone:SCnc:Pt:Urine:Qn
3706,benzodiazepines positive,Benzodiazepines positive:Presence or Identity:Point in time:Urine:Nominal
3707,Coagulation tissue factor induced.factor substitution,Coagulation tissue factor induced.factor substitution^2H post incubation after 1:4 addition of normal plasma:Time:Pt:PPP:Qn:Coag
3708,Chlamydia sp DNA,Chlamydia sp DNA:PrThr:Pt:Nose:Ord:Probe.amp.tar
3709,Herpes simplex virus 1 IgG,Herpes simplex virus 1 Ab.IgG^1st specimen/2nd specimen:Ratio:Pt:Ser:Qn:IA
3710,s ANTIBODY,S Antibody:Dilution Factor (Titer):Point in time:Serum/Plasma:Quantitative
3711,Multisection,Multisection:Find:Pt:Breast.left:Doc:MR
3712,Multisection,Multisection^WO & W contrast IV:Find:Pt:Lower extremity.right>Knee:Doc:CT
3713,Complement C3.nephritic,Complement C3.nephritic:PrThr:Pt:Ser/Plas:Ord
3714,View,Deprecated UE aa-R XRA W contr IA
3715,Herpes virus 6 deoxyribonucleic acid,Herpes virus 6 DNA:PrThr:Pt:Bld:Ord:Probe.amp.tar
3716,Multisection,Multisection^WO & W contrast IV:Find:Pt:Abdomen>Spleen:Doc:MR
3717,Multisection,Multisection^W contrast IV:Find:Pt:Pelvis>Ovary:Doc:MR
3718,Multisection,Multisection^W contrast IV:Find:Pt:Head>Head vessels:Doc:CT.angio
3719,Multisection,Multisection^WO contrast:Find:Pt:Head>Brain & Head+Neck>Larynx:Doc:MR
3720,Parainfluenza virus I antigen,Parainfluenza virus 1 Ag:PrThr:Pt:Nose:Ord:IF
3721,Pheniramine,Pheniramine:MCnc:Pt:Ser/Plas:Qn
3722,Cefotiam,Cefotiam:Susc:Pt:Isolate:OrdQn
3723,Reflex irritability,Reflex irritability^5M post birth:Fcn:Pt:^Patient:Ord:Apgar
3724,Respiratory therapy goal,Respiratory therapy goal:Type:Point in time:Respiratory therapy:Nominal
3725,lymphoblast,Lymphoblasts:NCnc:Pt:Bld:Qn
3726,Multisection,Multisection:Finding:Point in time:Hip:Narrative:MRI
3727,Fluorouracil,Fluorouracil:MCnc:Pt:Ser/Plas:Qn
3728,Multisection,Multisection^WO & W contrast IV:Find:Pt:Head>Orbit.right:Doc:MR
3729,Multisection,Multisection^WO & W contrast IV:Find:Pt:Lower extremity.right>Lower extremity veins:Doc:MR.angio
3730,View,Views^W contrast IA:Find:Pt:Chest>Bronchial artery:Doc:RF.angio
3731,Views oblique,View oblique:Find:Pt:Upper extremity>Thumb:Doc:XR
3732,Multisection,Multisection:Find:Pt:Extremity.right>Extremity vein:Doc:US.doppler
3733,Views delayed,Views delayed^W In-111 Satumomab IV:Find:Pt:Whole body:Doc:NM
3734,Triglycerides,Triglyceride:SCnc:Pt:Plr fld:Qn
3735,Symptoms & diseases,Symptoms & diseases:Hx:Pt:Kidney:Nom
3736,Bile acid pattern,Bile acid pattern:Impression/interpretation of study:Point in time:Urine:Nominal
3737,Organic acids pattern,Organic acids pattern:Impression/interpretation of study:Point in time:Cerebral spinal fluid:Nominal
3738,Treatment urgency,Treatment urgency:Find:Pt:{Diagnosis}:Ord
3739,Basophils,Basophils:NCnc:Pt:Periton fld:Qn
3740,Basophils,Basophils:NCnc:Pt:Synv fld:Qn
3741,Large granular lymphocyte,Lymphocytes.large granular:NCnc:Pt:Bld:Qn
3742,Second trimester triple maternal screen panel,Second trimester triple maternal screen panel:-:Pt:Ser/Plas:-
3743,Acyclovir,Acyclovir^peak:MCnc:Pt:Ser/Plas:Qn
3744,Multisection,Multisection^WO contrast:Find:Pt:Upper extremity.right>Elbow:Doc:CT
3745,Views AP,View AP:Find:Pt:Upper extremity.bilateral>Shoulder:Doc:XR
3746,Methotrexate,Methotrexate^1-2w post dose:MCnc:Pt:Ser/Plas:Qn
3747,Aesthetics (quality),Aesthetics:Imp:Pt:{Dental arch}.denture.partial:Ord:Reported
3748,Glucose,Glucose^pre or post dose glucagon:SCnc:Pt:Ser/Plas:Qn
3749,Contraindications section,Contraindications section:-:-:^FDA package insert:Nar
3750,Cell count & Differential panel,Cell count & Differential panel:-:Pt:Body fld:Qn
3751,Coagulation dilute Russell viper venom induced.factor substitution,Coagulation dilute Russell viper venom induced.factor substitution^immediately after 1:2 addition of normal plasma:Time:Pt:PPP:Qn:Coag
3752,Multisection,Multisection:Find:Pt:Upper extremity.left>Shoulder:Doc:XR.tomography
3753,View,Views^W contrast IV:Find:Pt:Head>Sinus vein:Doc:RF.angio
3754,Multisection,Multisection:Finding:Point in time:Kidney:Narrative:Ultrasound
3755,VA C&P exam.acromegaly note,VA C&P exam.acromegaly note:Find:Pt:{Setting}:Doc:{Role}
3756,Cells.CD3+CD8+/100 cells,Cells.CD3+CD8+/100 cells:NFr:Pt:Bone mar:Qn
3757,Ristocetin induced platelet aggregation,Platelet aggregation.ristocetin induced^600 ug/mL:RelACnc:Pt:PRP:Qn
3758,Color,Color:Type:Pt:Dial fld prt:Nom
3759,Jo-1 extractable nuclear Ab,Jo-1 extractable nuclear Ab:PrThr:Pt:Ser:Ord
3760,West Nile virus Kunjin strain Ab.IgM,West Nile virus Kunjin strain Ab.IgM:PrThr:Pt:Ser:Ord
3761,Gadolinium,Gadolinium:MRat:24H:Urine:Qn
3762,Arterial pulse intensity,Arterial pulse intensity:Force:Pt:Radial artery.right:Ord:Palpation
3763,Study observation,Study observation:Prid:Pt:Eyelid & Lashes & Adnexa:Nom:Slit lamp biomicroscopy
3764,Visual Acuity,Visual acuity^best corrected:LenRto:Pt:Eye.left:Qn:Snellen eye chart
3765,Study observation,Study observation:Find:Pt:Visual pathway.right:Ord:VEP
3766,Enhanced procedure note - recommended CDP Set 1 R1.0 & R1.1 sections,Enhanced procedure note - recommended CDP Set 1 R1.0 & R1.1 sections:-:Pt:{Setting}:-
3767,Medical equipment or product list,Medical equipment or product list:Find:Pt:{Setting}:Doc:Community health care
3768,Multisection,Multisection^WO & W contrast IV:Find:Pt:Lower extremity.right>Hindfoot+Midfoot:Doc:CT
3769,View,Deprecated Hindfoot - right and Midfoot - right X-ray
3770,Views 2,Deprecated Hindfoot - right and Midfoot - right X-ray 2 views
3771,Discharge instructions,Discharge instructions:Find:Pt:{Setting}:Doc:Obstetrics and Gynecology
3772,Blood flow velocity.diastole.max,Blood flow velocity.diastole.max:Vel:Pt:Mitral valve:Qn:US.doppler
3773,Tissue velocity.A wave.max,Tissue velocity.A wave.max:Vel:Pt:Tricuspid valve.annulus:Qn:US.tissue doppler
3774,Blood flow velocity.diastole.max,Blood flow velocity.diastole.max:Vel:Pt:Tricuspid valve:Qn:US.doppler
3775,Body Temperature,Body temperature:Temp:1H^max:XXX:Qn
3776,Body Temperature,Body temperature:Temp:8H^min:XXX:Qn
3777,HIV 1 RNA+proviral DNA,HIV 1 RNA+proviral DNA:PrThr:Pt:Plas:Ord:Probe.amp.tar
3778,Catecholamine metabolites pattern,Catecholamine metabolites pattern:Imp:Pt:CSF:Nar
3779,Time to peak displacement.systole,Time to peak displacement.systole:Time:Pt:Heart.interventricular septum:Qn:US.M-mode+ECG
3780,History and physical note,History and physical note:Find:Pt:{Setting}:Doc:Geriatric medicine
3781,Initial evaluation note,Initial evaluation note:Find:Pt:{Setting}:Doc:Geriatric medicine
3782,(Carum carvi+Elettaria cardamomum+Mace+Syzygium aromaticum) Ab.IgE.RAST class,(Carum carvi+Elettaria cardamomum+Mace+Syzygium aromaticum) Ab.IgE.RAST class:PrThr:Pt:Ser:Ord:Multidisk
3783,Intravascular diastolic,Intravascular diastolic:Pres:Pt:Renal artery.right:Qn
3784,Pyridostigmine,Pyridostigmine:MCnc:Pt:Ser/Plas:Qn
3785,"t(6;9)(p22;q34)(DEK,NUP214) fusion transcript","t(6;9)(p22;q34)(DEK,NUP214) fusion transcript:Find:Pt:Bld/Tiss:Doc:FISH"
3786,Platelet mean diameter,Platelet mean diameter:EntLen:Pt:Bld:Qn:Rees-Ecker
3787,Minor axis.end diastole/Body surface area,Minor axis.end diastole/Body surface area:ArLen:Pt:Heart.ventricle.left:Qn:US.2D
3788,Myocardial mass.end diastole/Body surface area,Myocardial mass.end diastole/Body surface area:ArMass:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by area-length method
3789,Duodenum length,Duodenum length:Len:Pt:Specimen:Qn
3790,Cardiac output/Body surface area,Cardiac output/Body surface area:ArVRat:Pt:Heart.ventricle.left:Qn:Angiography.single plane
3791,sodium intake,Sodium intake:SRat:12H:^Patient:Qn
3792,Toxocara canis IgA,Toxocara canis Ab.IgA:ACnc:Pt:Ser:Qn:IA
3793,Coxsackievirus B3 Ab,Coxsackievirus B3 Ab:Titr:Pt:CSF:Qn:Comp fix
3794,Vendor FISH product name,Vendor FISH product name:ID:Pt:Bld/Tiss:Nom
3795,BCL2 Gene Rearrangement,BCL2 gene rearrangements:PrThr:Pt:Bld/Tiss:Ord:FISH
3796,Promyelocytes/100 leukocytes,Deprecated Promyelocytes/100 leukocytes in Blood by Automated count
3797,Mirtazapine,Mirtazapine:PrThr:Pt:Urine:Ord:Confirm
3798,Myocardial mass.end diastole,Myocardial mass.end diastole:Mass:Pt:Heart.ventricle.left:Qn:US.M-mode+Calculated by dimension method
3799,Gradient.systole.max,Gradient.systole.max:PressDiff:Pt:Mitral valve:Qn:US.doppler+Calculated by simplified Bernoulli
3800,CTNS gene targeted mutation analysis,CTNS gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen
3801,Western equine encephalitis virus IgG,Western equine encephalitis virus Ab.IgG:Titr:Pt:CSF:Qn:IF
3802,Intravascular systolic,Intravascular systolic^inspiration:Pres:Pt:Arterial system:Qn
3803,Intravascular diastolic,Intravascular diastolic:Pres:24H^mean:Arterial system:Qn
3804,protein intake,Protein intake:MRat:10H:^Patient:Qn
3805,Hydrocortisone,Cortisol [Mass/volume] in Serum or Plasma --AM peak specimen
3806,Education note,Education note:Find:Pt:{Setting}:Doc:Colon and rectal surgery
3807,OPC3373,OPC3373:MCnc:Pt:Urine:Qn:Confirm
3808,Time to max tissue velocity.systole,Time to max tissue velocity.systole:Time:Pt:Heart.ventricle.left.basal inferior:Qn:US.tissue doppler
3809,Diameter.end diastole,Diameter.end diastole:Len:Pt:Tricuspid valve.annulus:Qn:US.2D.A4C
3810,ALDH3A2 gene full mutation analysis,ALDH3A2 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing
3811,(Cynodon dactylon+Lolium perenne+Bromus inermis+Ambrosia elatior+Artemisia vulgaris+Plantago lanceolata) Ab.IgE.RAST class,(Cynodon dactylon+Lolium perenne+Bromus inermis+Ambrosia elatior+Artemisia vulgaris+Plantago lanceolata) Ab.IgE.RAST class:PrThr:Pt:Ser:Ord:Multidisk
3812,dbSNP version,dbSNP version:Identifier:Point in time:^Patient:Nominal
3813,COSMIC structural variant,COSMIC structural variant:ID:Pt:^Patient:Nom
3814,Intravascular systolic,Intravascular systolic:Pres:8H^mean:Arterial system:Qn
3815,total fluid intake,Fluid intake.total:VRat:8H:^Patient:Qn
3816,Fluid output.cerebral ventricle drain,Fluid output.cerebral ventricle drain:Vol:Pt:Cerebral ventricles:Qn
3817,Rhythm segment,Rhythm segment:Impression/interpretation of study:Point in time:Heart:Narrative:EKG
3818,FGFR1 Gene Rearrangement,FGFR1 gene rearrangements:PrThr:Pt:Bld/Tiss:Ord:FISH
3819,Cells.FGFR1 gene rearrangements/Cells counted,Cells.FGFR1 gene rearrangements/Cells counted:NFr:Pt:Bld/Tiss:Qn:FISH
3820,Varicella zoster virus surveillance panel,Varicella zoster virus surveillance panel:-:Point in time:^Patient:-
3821,Intravascular systolic,Intravascular systolic:Pres:Pt:Digital artery.right:Qn
3822,Fluid output.gastric tube,Fluid output.gastric tube:Aper:Pt:Upper GI tract:Nom
3823,MLH1+MSH2+MSH6+PMS2 gene deletion+duplication & full mutation analysis,MLH1+MSH2+MSH6+PMS2 gene deletion+duplication & full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen
3824,Start coordinates,Start coordinates:Type:Pt:Coronary arteries.segment:Nom
3825,Bifurcated lesion end segment position,Bifurcated lesion end segment position:Type:Pt:Coronary arteries:Nom
3826,output.stool,Output.stool:Mass:Pt:Lower GI tract:Qn
3827,Zirconium/Creatinine,Zirconium/Creatinine:SRto:Pt:Urine:Qn
3828,"WFDC2 protein, human",Deprecated Human epididymis protein 4 [Moles/volume] in Serum or Plasma by Immunoassay
3829,S-Adenosylmethionine,S-adenosylmethionine:SCnc:Pt:Ser/Plas:Qn
3830,Other genomic reference sequence coding system OID,Other genomic reference sequence coding system OID:Uniform Resource Identifier:Point in time:^Patient:Nominal
3831,Output.ileostomy,Output.ileostomy:MRat:10H:Lower GI tract:Qn
3832,Dispensing of blood product (procedure),Blood product dispensed:Vol:Pt:^BPU:Qn
3833,Ethyl glucuronide cutoff,Ethyl glucuronide cutoff:MCnc:Pt:Urine:Qn:Confirm
3834,R- & S-beta aminoisobutyrate & D- & L-serine panel,R- & S-beta aminoisobutyrate & D- & L-serine panel:-:Pt:CSF:-
3835,Xanthopterin,Xanthopterin:SCnc:Pt:CSF:Qn
3836,Influenza virus A & B identified,Influenza virus A & B identified:Prid:Pt:Nph:Nom:Shell vial culture
3837,"1,1'-Sulfonylbis-2-Methylthioethane","1,1'-Sulfonylbis-2-Methylthioethane:MCnc:Pt:Urine:Qn"
3838,Gadolinium,Gadolinium:MCnt:Pt:Tiss:Qn
3839,Anti-somatotropin antibody,Somatotropin Ab:ACnc:Pt:Ser/Plas:Qn
3840,Additional pathological findings,Additional pathological findings:Prid:Pt:Specimen:Nom
3841,Amino acid.essential intake,Amino acid.essential intake:MRat:24H:^Patient:Qn:Measured
3842,Hospital discharge disposition,Hospital discharge disposition:Type:Point in time:^Patient:Narrative
3843,cis-11-Eicosenoate,cis-11-Eicosenoate:EntSub:Pt:RBC:Qn
3844,Eicosadienoate,Eicosadienoate:EntSub:Pt:RBC:Qn
3845,A wave amplitude,A wave amplitude:Pres:Pt:Pulmonary artery.wedge:Qn:Cardiac catheterization
3846,Consultation note,Consultation note:Find:Pt:{Setting}:Doc:Vascular neurology
3847,Views for glomerular filtration rate,Views for glomerular filtration rate^W radionuclide IV:Find:Pt:Abdomen>Kidney:Doc:NM
3848,Vitamin B1 Intake,Vitamin B1 intake:MRat:24H:^Patient:Qn:Measured
3849,Tyrosine intake,Tyrosine intake:MRat:24H:^Patient:Qn:Measured
3850,Vibrio cholerae DNA,Vibrio cholerae DNA:PrThr:Pt:Stool:Ord:Non-probe.amp.tar
3851,History source,History source:Type:Point in time:Interviewee:Nominal:*
3852,Bumetanide,Bumetanide:MCnc:Pt:Ser/Plas:Qn
3853,Manganese intake,Manganese intake:MRat:24H:^Patient:Qn:Estimated
3854,Platanus acerifolia recombinant (rPla a) 1 Ab.IgE.RAST class,Platanus acerifolia recombinant (rPla a) 1 Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
3855,Chromosome region 16p13.3 deletion,Chromosome region 16p13.3 deletion:Find:Pt:Bld/Tiss:Doc:FISH
3856,Chromosome region 7q11.23 deletion,Chromosome region 7q11.23 deletion:Find:Pt:Amnio fld/CVS:Doc:FISH
3857,A3 B Ab,Deprecated A3 B Antibody:Arbitrary Concentration:Point in time:Serum:Ordinal:AGGLUTINATION RBC
3858,Heptacarboxylporphyrin,Heptacarboxylporphyrin:MRat:XXX:Stool:Qn
3859,Howell-Jolly Bodies,Howell-Jolly bodies:PrThr:Pt:Bld:Ord:Microscopy.light
3860,CYP2C9 gene product metabolic activity interpretation,CYP2C9 gene product metabolic activity interpretation:Imp:Pt:Bld/Tiss:Ord:CPIC
3861,Murmur radiating to body location,Murmur radiating to body location:Anat:Pt:^Patient:Nom:Auscultation
3862,CYTOMEGALOVIRUS ANTIGEN,Cytomegalovirus Ag:PrThr:Pt:BAL:Ord:IF
3863,Smudge cell,Smudge cells:PrThr:Pt:Bld:Ord:Microscopy.light
3864,Creatinine,Creatinine^4H dwell specimen:SCnc:Pt:Dial fld prt:Qn
3865,Docosahexaenoate intake,Docosahexaenoate intake:MRat:24H:^Patient:Qn:Estimated
3866,Tissue perfusion assessment panel,Tissue perfusion assessment panel:-:Point in time:^Patient:-
3867,Triticum aestivum recombinant (rTri a) 19 Ab.IgE.RAST class,Triticum aestivum recombinant (rTri a) 19 Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
3868,ABO & Rh group,ABO & Rh group:Type:Pt:Bld:Nom
3869,Hemodynamic resistance,Hemodynamic resistance:Resistance:Point in time:Pulmonary vasculature:Quantitative
3870,Heptachlor,Heptachlor:MCnc:Pt:Ser/Plas:Qn
3871,Human papilloma virus 18 DNA,Human papilloma virus 18 DNA:PrThr:Pt:Anorectal:Ord:Probe.amp.tar
3872,Education note,Education note:Find:Pt:{Setting}:Doc:Critical Care Medicine
3873,Growth Hormone,Somatotropin^1.5H post dose arginine+insulin:MCnc:Pt:Ser/Plas:Qn
3874,Amobarbital,Amobarbital:MCnc:Pt:Body fld:Qn
3875,ISCEV standard protocol used,ISCEV standard protocol used:Type:Pt:^Patient:Nom:Electroretinogram
3876,Visual field defects,Visual field defects:Find:Pt:Eye.left:Nom
3877,Hexosaminidase A,Beta-N-acetylhexosaminidase.A:CCnc:Pt:Bld.dot:Qn
3878,Actinidia deliciosa native (nAct d) 1 Ab.IgE.RAST class,Actinidia deliciosa native (nAct d) 1 Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
3879,Phencyclidine,Phencyclidine:PrThr:Pt:Gast fld:Ord:Screen
3880,Oxygen saturation test result,Oxygen saturation:MFr:Pt:Pulmonary artery.left:Qn
3881,California encephalitis virus Ab.IgG,California encephalitis virus Ab.IgG:ACnc:Pt:Ser:Qn
3882,2-Aminoadipate,Alpha aminoadipate:SCnc:Pt:Body fld:Qn
3883,Boron,Boron:SCnc:Pt:Ser/Plas:Qn
3884,Arachis hypogaea Ab.IgG4,Arachis hypogaea Ab.IgG4:MCnc:Pt:Ser:Qn
3885,(Acer negundo+Betula verrucosa+Corylus avellana+Quercus alba+Platanus acerifolia) Ab.IgE,(Acer negundo+Betula verrucosa+Corylus avellana+Quercus alba+Platanus acerifolia) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk
3886,Brucella abortus antibody,Brucella abortus Ab:Titr:Pt:Ser:Qn:LA
3887,Cells.CD10/100 cells,Cells.CD10/100 cells:NFr:Pt:Bone mar:Qn
3888,Pregnenolone,Pregnenolone^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
3889,Pregnenolone,Pregnenolone^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
3890,Cheese swiss Ab.IgG4,Cheese swiss Ab.IgG4:MCnc:Pt:Ser:Qn
3891,Glucose-6-Phosphate dehydrogenase phenotype,Glucose-6-phosphate dehydrogenase phenotype:Impression/interpretation of study:Point in time:Erythrocytes:Narrative
3892,5-Hydroxyindoleacetate,5-Hydroxyindoleacetate:SCnc:Pt:Ser/Plas:Qn
3893,Antineutrophil Cytoplasmic Antibodies,Neutrophil cytoplasmic Antibody:Arbitrary Concentration:Point in time:Serum:Quantitative
3894,Alpha aminobutyrate/Amino acids.total,Alpha aminobutyrate/Amino acids.total:SFr:Pt:Ser/Plas:Qn
3895,Beef Ab.IgG4,Beef Ab.IgG4:MCnc:Pt:Ser:Qn
3896,Amino acid pattern,Amino acids:Impression/interpretation of study:Point in time:Cerebral spinal fluid:Narrative
3897,Glycine,Glycine:SCnt:Pt:Hair:Qn
3898,Arsenic,Arsenic:MRat:24H:Urine:Qn
3899,reboxetine,Reboxetine:SCnc:Pt:Ser/Plas:Qn
3900,Rickettsia sp identified,Rickettsia sp identified:Prid:Pt:XXX:Nom:Sequencing
3901,Human polyomavirus 1 DNA,BK virus DNA:NCnc:Pt:CSF:Qn:Probe.amp.tar
3902,Ehrlichia chaffeensis Ab.IgG+IgM,Ehrlichia chaffeensis Ab.IgG+IgM:PrThr:Pt:Ser/Plas:Ord
3903,Bacteria identified,Bacteria identified:Prid:Pt:Anal:Nom:Culture
3904,Glucose,Glucose^4 AM specimen:SCnc:Pt:Ser/Plas:Qn
3905,Staphylococcus aureus Panton-Valentine leukocidin gene,Staphylococcus aureus Panton-Valentine leukocidin gene:PrThr:Pt:XXX:Ord:Probe.amp.tar
3906,Herpes virus 6 deoxyribonucleic acid,Herpes virus 6 DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar
3907,Specimen drawn,Specimen drawn^1st specimen:TmStp:Pt:Ser/Plas:Qn
3908,17-Hydroxycorticosteroids,17-Hydroxycorticosteroids^post dose dexamethasone:MRat:24H:Urine:Qn
3909,Nonesterified Fatty Acids,Fatty acids.nonesterified^4th specimen post CFst:SCnc:Pt:Ser/Plas:Qn
3910,View,Views:Find:Pt:Upper extremity.left>Wrist+Hand:Doc:XR
3911,Oleoylcarnitine (C18:1),Oleoylcarnitine (C18:1):SCnc:Pt:Amnio fld:Qn
3912,Ribitol/Creatinine,Ribitol/Creatinine:SRto:Pt:Urine:Qn
3913,"Respiratory allergen panel, US - Central midwest a","Respiratory allergen panel, US - Central midwest a:-:Pt:Ser:-"
3914,"Respiratory allergen panel, US - Southern coastal California","Respiratory allergen panel, US - Southern coastal California:-:Pt:Ser:-"
3915,"Respiratory allergen panel, US - Alaska a","Respiratory allergen panel, US - Alaska a:-:Pt:Ser:-"
3916,dechloroethylifosfamide,2-Dechloroethylifosfamide^2D post dose ifosfamide:MCnc:Pt:Bld:Qn
3917,Chromium,Chromium:SCnt:Pt:Hair:Qn
3918,Cobalt,Cobalt:SCnt:Pt:Hair:Qn
3919,Protons,Hydrogen ion:SCnc:Pt:BldC:Qn
3920,Cardiac ejection fraction method,Cardiac ejection fraction method:Type:Pt:Heart.ventricle.left:Nom
3921,Calories burned,Calories burned:EngRat:XXX:^Patient:Qn:Pedometer
3922,phosphate ion,Phosphate:SCnc:Pt:Periton fld:Qn
3923,Mixed cellular casts,Mixed cellular casts:PrThr:Pt:Urine:Ord:Computer assisted
3924,nickel,Nickel:SCnt:Pt:Tiss:Qn
3925,Hydrogen-Ion Concentration,pH:LsCnc:Pt:Plr fld:Qn:Test strip
3926,Selenium,Selenium:SCnc:Pt:Urine:Qn
3927,Hepatitis D virus IgG,Hepatitis D virus Ab.IgG:ACnc:Pt:Ser:Qn
3928,HEDIS 2009-2013 Codes to identify anticonvulsant serum concentration monitoring tests - Valproate (MPM-E),HEDIS 2009-2013 Codes to identify anticonvulsant serum concentration monitoring tests - Valproate (MPM-E):-:Point in time:^Patient:-
3929,Cortodoxone,11-Deoxycortisol^1H post dose corticotropin:SCnc:Pt:Ser/Plas:Qn
3930,Cholesterol in low density lipoprotein pattern A,Cholesterol.in LDL pattern A:PrThr:Pt:Ser/Plas:Ord
3931,Rickettsia africae IgM,Rickettsia africae Ab.IgM:Titr:Pt:Body fld:Qn:IF
3932,POU3F4 gene targeted mutation analysis,POU3F4 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen
3933,Budgerigar serum proteins+feathers+droppings Ab.IgG,Budgerigar serum proteins+feathers+droppings Ab.IgG:PrThr:Pt:Ser:Ord
3934,HEDIS 2009 Tests used in early prenatal care - Toxoplasma (PPC-C),HEDIS 2009 Tests used in early prenatal care - Toxoplasma (PPC-C):-:Point in time:^Patient:-
3935,Chloral Hydrate,Chloral hydrate:SCnc:Pt:Ser/Plas:Qn
3936,Clopenthixol,Clopenthixol:SCnc:Pt:Ser/Plas:Qn
3937,Platelet aggregation.adenosine diphosphate induced ATP secretion,Platelet aggregation.adenosine diphosphate induced ATP secretion^10 umol/L:RelACnc:Pt:Bld:Qn
3938,Pyrazinamide 300.0 ug/mL,Pyrazinamide 300.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria
3939,fondaparinux,Fondaparinux:MCnc:Pt:Ser/Plas:Qn
3940,Cells.CD81/100 cells,Cells.CD81/100 cells:NFr:Pt:Bone mar:Qn
3941,Levodopa,Levodopa:SCnc:Pt:CSF:Qn
3942,"Antigens, CD1",Deprecated CD1 cells/100 cells in Blood
3943,Thiamphenicol,Thiamphenicol:Susc:Pt:Isolate:OrdQn
3944,PhenX measure - current age,PhenX measure - current age:-:Point in time:^Patient:-:PhenX
3945,Views GE 3,Views GE 3:Find:Pt:Lower extremity.right>Foot:Doc:XR
3946,Views GE 3,Views GE 3:Find:Pt:Head>Facial bones:Doc:XR
3947,Midazolam,Midazolam:MCnc:Pt:XXX:Qn
3948,Propoxyphene,Propoxyphene:MCnc:Pt:XXX:Qn
3949,DCX gene targeted mutation analysis,DCX gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen
3950,Alpha-1-Microglobulin.placental,Alpha-1-Microglobulin.placental:PrThr:Pt:Vag:Ord
3951,ADENOSINE DEAMINASE,Adenosine deaminase:CCnt:Pt:CVS:Qn
3952,Width.transverse,Width.transverse:Len:Pt:Head.lateral cerebral ventricle.right^Fetus:Qn:US.measured
3953,Antistreptolysin O,Streptolysin O Ab:Titr:Pt:Ser:Qn:LA
3954,Para-aminosalicylate,Para aminosalicylate:Susc:Pt:Isolate:OrdQn:Agar diffusion
3955,Prednisone,Prednisone:SCnc:Pt:Ser/Plas:Qn
3956,Asparagine/Creatinine,Asparagine/Creatinine:Ratio:24H:Urine:Qn
3957,Knee height (observable entity),Knee height:Length:Point in time:^Patient:Quantitative
3958,Hand dominance - holding a toothbrush,Hand dominance - holding a toothbrush:Find:Pt:^Patient:Nom:ALSPAC
3959,Platelet glycoprotein Ia-IIa Ab.IgG,Platelet glycoprotein Ia-IIa Ab.IgG:PrThr:Pt:Bld:Ord:IA
3960,Fibrillarin Ab,Fibrillarin Ab:PrThr:Pt:Ser:Ord
3961,Blood pressure systolic & diastolic,Blood pressure systolic & diastolic^pre transfusion:Pres:Pt:Arterial system:Qn
3962,Protein.abnormal band/Protein.total,Protein.abnormal band/Protein.total:MFr:Pt:Urine:Qn:Electrophoresis
3963,Echovirus 5 Ab,Echovirus 5 Ab:Titr:Pt:Ser:Qn
3964,Parietal cell antibody,Parietal cell Ab:Titr:Pt:Ser:Qn:IF
3965,3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0),3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0):SRto:Pt:Bld.dot:Qn
3966,3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8),3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8):SRto:Pt:Bld.dot:Qn
3967,Neural tube defect risk cutoff,Neural tube defect risk cutoff:Find:Pt:^Fetus:Qn
3968,3-methoxytyramine,3-Methoxytyramine:SCnc:Pt:CSF:Qn
3969,Blasts.CD10,Blasts.CD10:ACnc:Pt:Bld:Qn
3970,Blasts.CD10,Blasts.CD10:ACnc:Pt:XXX:Qn
3971,vasoactive intestinal peptide,Vasoactive intestinal peptide:PrThr:Pt:Ser/Plas:Ord
3972,Penicillium roqueforti antibody,Penicillium roqueforti Ab:ACnc:Pt:Ser:Qn
3973,Prekallikrein,Deprecated Prekallikrein (Fletcher Factor) in Platelet poor plasma
3974,CEH volatile organic compounds panel,CEH volatile organic compounds panel:MCnc:Pt:Ser/Plas:-
3975,SmIg-CD79,Deprecated SmIg-CD79:Arbitrary Concentration:Point in time:Leukocytes:Quantitative
3976,Cholesterol.in HDL/Cholesterol.in HDL+Cholesterol.in VLDL,Cholesterol.in HDL/Cholesterol.in HDL+Cholesterol.in VLDL:SRto:Pt:Ser/Plas:Qn
3977,Protein feed time,Protein feed time:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative
3978,Views AP & lateral,Deprecated Views AP & lateral:Finding:Point in time:Abdomen:Narrative:XR
3979,Polio virus 1 Ab,Polio virus 1 Ab:Titr:Pt:Ser:Qn:Neut
3980,Carnitine.free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18),Carnitine.free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18):SRto:Pt:Bld.dot:Qn
3981,Enterovirus RNA,Enterovirus RNA:NCnc:Pt:XXX:Qn:Probe.amp.tar
3982,Glucose,Glucose^2H post dose ornithine alpha-ketoglutarate:SCnc:Pt:Ser/Plas:Qn
3983,Glutarylcarnitine (C5-DC),Glutarylcarnitine (C5-DC):SCnc:Pt:Amnio fld:Qn
3984,Ulmus pumila Ab.IgG4,Ulmus pumila Ab.IgG4:MCnc:Pt:Ser:Qn
3985,Arbovirus Ab.IgG & IgM panel,Arbovirus Ab.IgG & IgM panel:-:Pt:CSF:-:IF
3986,HLA-Dw5 antigen,HLA-Dw5:PrThr:Pt:Bld/Tiss^Donor:Ord
3987,Muscle sarcolemma antibody,Muscle sarcolemma Ab:Titr:Pt:Plr fld:Qn:IF
3988,Bartonella henselae IgM,Bartonella henselae Ab.IgM:ACnc:Pt:Ser:Qn
3989,Aldosterone & renin activity panel,Aldosterone & renin activity panel:-:Pt:Plas:Qn
3990,Flunitrazepam & 7-Aminoflunitrazepam panel,Flunitrazepam & 7-Aminoflunitrazepam panel:MCnc:Pt:Urine:Qn
3991,Astacus astacus Ab.IgG4,Astacus astacus Ab.IgG4:MCnc:Pt:Ser:Qn
3992,Chrysops flavidus (whole body) Ab.IgG4,Chrysops flavidus (whole body) Ab.IgG4:MCnc:Pt:Ser:Qn
3993,Solenopsis invicta Ab.IgG4,Solenopsis invicta Ab.IgG4:MCnc:Pt:Ser:Qn
3994,HLA-Dw6 antigen,HLA-Dw6:PrThr:Pt:Bld/Tiss^Donor:Ord
3995,Rickettsia prowazekii IgM,Rickettsia prowazekii Ab.IgM:Titr:Pt:Body fld:Qn
3996,Blasts.cytoplasmic CD3/100 blasts,Blasts.cytoplasmic CD3/100 blasts:NFr:Pt:Bld:Qn
3997,Blood product unit 4 expiration,Blood product unit 4 expiration:TmStp:Pt:^BPU:Qn
3998,"t(9;22)(q34.1;q11)(ABL1,BCR) transcript detection panel","t(9;22)(q34.1;q11)(ABL1,BCR) transcript detection panel:-:Pt:Bld/Tiss:-:Molgen"
3999,Platinum,Platinum:SCnc:Pt:Urine:Qn
4000,Beta 2 globulin+Gamma globulin/Protein.total,Beta 2 globulin+Gamma globulin/Protein.total:MFr:Pt:Urine:Qn:Electrophoresis
4001,Sodium urate crystal,Sodium urate crystals:PrThr:Pt:XXX:Ord:Microscopy.light
4002,Ciprofloxacin 1.0 ug/mL,Ciprofloxacin 1.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria
4003,Exercise duration,Exercise duration:Time:Point in time:^Patient:Quantitative
4004,Acetone,Acetone:MCnc:Pt:Ser/Plas:Qn
4005,Paromomycin,Deprecated Paramomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
4006,Cucumis melo spp Ab.IgG4,Deprecated Melon IgG4 Ab [Mass/volume] in Serum
4007,Melaleuca leucadendron Ab.IgG4,Melaleuca leucadendron Ab.IgG4:MCnc:Pt:Ser:Qn
4008,Citrus sinensis leukotriene release,Citrus sinensis leukotriene release:MCnc:Pt:WBC:Qn
4009,Coxiella burnetii phase 2 IgM,Coxiella burnetii phase 2 Ab.IgM:Titr:Pt:Body fld:Qn
4010,Cells.CD5+CD23+/100 cells,Cells.CD5+CD23+/100 cells:NFr:Pt:Bld:Qn
4011,Borrelia burgdorferi Ab.IgG+IgM with reflex to immune blot panel,Borrelia burgdorferi Ab.IgG+IgM with reflex to immune blot panel:-:Pt:Ser:-
4012,Chromosome analysis panel,Chromosome analysis panel:-:Pt:Bld^Fetus:-:G-banded
4013,Decreased appetite in past 7D,Decreased appetite in past 7D:Finding:Point in time:^Patient:Ordinal:PhenX
4014,"Are these dreams very intense, detailed and vivid, like watching a movie","Are these dreams very intense, detailed and vivid, like watching a movie:Find:Pt:^Patient:Ord:PhenX"
4015,Have you ever had gallbladder surgery,Have you ever had gallbladder surgery:Find:Pt:^Patient:Ord:PhenX
4016,Coxiella burnetii IgG,Coxiella burnetii Ab.IgG:PrThr:Pt:Ser:Ord:IF
4017,Cortodoxone,11-Deoxycortisol^1D post dose dexamethasone:MCnc:Pt:Ser/Plas:Qn
4018,Hexacarboxylporphyrin,Hexacarboxylporphyrin:SCnc:Pt:Ser/Plas:Qn
4019,Mesoridazine,Mesoridazine:SCnc:Pt:XXX:Qn
4020,Cancer pagurus Ab.IgE,Cancer pagurus Ab.IgE:ACnc:Pt:Ser:Qn
4021,HLA-DQB1*06:02 antigen,HLA-DQB1*06:02:PrThr:Pt:Bld/Tiss:Ord
4022,My cough hurts,My cough hurts:Find:Pt:^Patient:Ord:PhenX
4023,Adenoma dysplasia,Adenoma dysplasia:Find:Pt:^Patient:Ord:PhenX
4024,AJCC cancer staging manual,AJCC cancer staging manual:Find:Pt:^Patient:Nom:PhenX
4025,Phencyclidine,Phencyclidine:PrThr:Pt:Bld:Ord:Confirm
4026,Mycoplasma pneumoniae Ab.IgG & IgM panel,Mycoplasma pneumoniae Ab.IgG & IgM panel:-:Pt:Ser:-
4027,Carbonyldiamide,Urea nitrogen [Mass/volume] in Dialysis fluid
4028,Proteins,Protein:MCnc:Pt:Dial fld:Qn
4029,gamma-Tocopherol,Gamma tocopherol:SCnc:Pt:Ser/Plas:Qn
4030,Taraxacum vulgare Ab.IgE,Taraxacum vulgare Ab.IgE:ACnc:Pt:Ser:Qn
4031,Perfusion (procedure),Perfusion:Pres:Pt:Cerebrum:Qn
4032,"Which cigarette would, or did, you hate most to give up","Which cigarette would, or did, you hate most to give up:Find:Pt:^Patient:Ord:FTND"
4033,"Has your child experienced periods of several Ds or more when he or she was unable to sit still, and had to keep moving or jumping from one activity to another","Has your child experienced periods of several Ds or more when he or she was unable to sit still, and had to keep moving or jumping from one activity to another:Find:Pt:^Patient:Ord:P-GBI"
4034,Date participant returned actigraph to clinic,Date participant returned actigraph to clinic:Date:Pt:^Patient:Qn:PhenX
4035,Iron/Creatinine,Iron/Creatinine:MRto:24H:Urine:Qn
4036,Chlorpheniramine,Chlorpheniramine:SCnc:Pt:Ser/Plas:Qn
4037,CYTOMEGALOVIRUS ANTIGEN,Cytomegalovirus Ag:PrThr:Pt:Ser/Plas:Ord:IA
4038,View of myself in past 7D,View of myself in past 7D:Find:7D:^Patient:Nom:QIDS
4039,Cow milk Ab,Cow milk Ab:PrThr:Pt:Ser:Ord:Immune diffusion
4040,didesethylflurazepam,N-desalkylflurazepam:PrThr:Pt:Urine:Ord
4041,"3,4-methylenedioxyethamphetamine",Methylenedioxyethylamphetamine:PrThr:Pt:XXX:Ord
4042,norfentanyl,Norfentanyl:PrThr:Pt:XXX:Ord
4043,Palinurus spp Ab.IgE,Palinurus spp Ab.IgE:ACnc:Pt:Ser:Qn
4044,Antimitochondrial antibody,Mitochondria Ab:Titr:Pt:CSF:Qn:IF
4045,Has there been renovation in your home during the past 12Mo,Has there been renovation in your home during the past 12Mo:Find:12Mo:^Patient:Ord:FEAS
4046,Is the wall material in your home plastic,Is the wall material in your home plastic:Find:Pt:^Patient:Ord:FEAS
4047,What is your normal work or school and sleep schedule,What is your normal work or school and sleep schedule:Find:Pt:^Patient:Nom:PhenX
4048,Do you prefer to keep a regular sleep schedule - one that does not change much from one night to the next,Do you prefer to keep a regular sleep schedule - one that does not change much from one night to the next:Find:Pt:^Patient:Ord:PhenX
4049,How strong is your preference,How strong is your preference:Find:Pt:^Patient:Ord:PhenX
4050,Apolipoprotein B/Apolipoprotein A-I,Deprecated Apolipoprotein B/Apolipoprotein A-I [Mass ratio] in Serum or Plasma
4051,Dehydroepiandrosterone Sulfate,Dehydroepiandrosterone sulfate^30M post XXX challenge:MCnc:Pt:Ser/Plas:Qn
4052,Fluorides,Fluoride:MRat:24H:Urine:Qn
4053,C-Peptide,C peptide^70M pre XXX challenge:SCnc:Pt:Ser/Plas:Qn
4054,Erythrocytes,Erythrocytes:Morph:Pt:Body fld:Nom:Microscopy.light
4055,Dinorsibutramine,Dinorsibutramine:MCnc:Pt:Urine:Qn
4056,tapentadol,Tapentadol:MCnc:Pt:Body fld:Qn
4057,Ethanol,Ethanol:PrThr:Pt:XXX:Ord:Screen
4058,Number of the largest bead that is at least as large as the right testis,Number of the largest bead that is at least as large as the right testis:Find:Pt:^Patient:Nom:PhenX
4059,Cornea thickness,Cornea thickness:Len:Pt:Eye.right:Qn:PhenX
4060,Activity that usually makes you feel breathless these days,Activity that usually makes you feel breathless these days:Find:Pt:^Patient:Nom:PhenX
4061,Volume expired during 6.0 s of forced expiration,Volume^at 6.0 s post forced expiration:Volume Ratio:Point in time:Respiratory system:Quantitative
4062,Epstein-Barr virus nuclear 1 IgG,Epstein Barr virus nuclear 1 Ab.IgG:ACnc:Pt:Ser:Qn
4063,Legionella pneumophila IgG,Legionella pneumophila Ab.IgG^1st specimen:PrThr:Pt:Ser:Ord:IF
4064,Adenovirus Antigen,Adenovirus Ag:PrThr:Pt:Stool:Ord:IF
4065,Specific gravity measurement,Specific gravity:Rden:Pt:Pericard fld:Qn
4066,didesethylflurazepam,N-desalkylflurazepam:PrThr:Pt:Gast fld:Ord
4067,During the last 12Mo has your child appeared to have difficulty seeing,During the last 12Mo has your child appeared to have difficulty seeing:Find:12Mo:^Patient:Ord:PhenX
4068,"Have you ever had a crossed or wandering eye, amblyopia","Have you ever had a crossed or wandering eye, amblyopia:Find:Pt:^Patient:Ord:PhenX"
4069,"While you were having your episode of change in speech, did any of these things occur","While you were having your episode of change in speech, did any of these things occur:Find:Pt:^Patient:Ord:PhenX"
4070,Have you been told by a rheumatologist that you have psoriatic arthritis,Have you been told by a rheumatologist that you have psoriatic arthritis:Find:Pt:^Patient:Ord:PhenX
4071,Congenital adrenal hyperplasia newborn screening comment-discussion,Congenital adrenal hyperplasia newborn screening comment-discussion:Text:Point in time:Blood filter paper:Narrative
4072,Chest discomfort ever or since last exam or medical history update,Chest discomfort ever or since last exam or medical history update:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative
4073,Virus identified,Virus identified:Prid:Pt:Bld:Nom:Culture
4074,PhenX measure - posttraumatic stress disorder (PTSD),PhenX measure - posttraumatic stress disorder (PTSD):-:Point in time:^Patient:-:PhenX
4075,Entamoeba histolytica DNA,Entamoeba histolytica DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar
4076,Elastase antibody,Elastase Ab:ACnc:Pt:Ser:Qn:IA
4077,Nuclear Ab.IgG,Nuclear Ab.IgG:Titr:Pt:Ser:Qn:IF
4078,Referral note,Referral note:Find:Pt:{Setting}:Doc:Psychology
4079,Collaborative staging post treatment tumor size,Collaborative staging post treatment tumor size:Prid:Pt:Cancer.XXX:Nom
4080,Dichlorvos,Dichlorvos:MCnc:Pt:Bld:Qn
4081,Flounder Ab.IgG,Flounder Ab.IgG:MCnc:Pt:Ser:Qn
4082,Solenopsis invicta Ab.IgE,Solenopsis invicta Antibody.immunoglobulin E:Arbitrary Concentration:Point in time:Serum:Quantitative
4083,Linum usitatissimum Ab.IgG,Linum usitatissimum Ab.IgG:MCnc:Pt:Ser:Qn
4084,I am breathless when I bend over,I am breathless when I bend over:Find:Pt:^Patient:Ord:PhenX
4085,"When frightened, I feel like passing out","When frightened, I feel like passing out:Find:Pt:^Patient:Ord:SCARED-R"
4086,"When frightened, I feel like going crazy","When frightened, I feel like going crazy:Find:Pt:^Patient:Ord:SCARED-R"
4087,Did you have trouble seeing,Did you have trouble seeing:Find:Pt:^Patient:Ord:PhenX
4088,Pathology biopsy report,Pathology biopsy report:Find:Pt:Cervix:Nar
4089,Pathology biopsy report,Pathology biopsy report:Find:Pt:Rectum:Nar
4090,Scarring chronic alopecia,Scarring chronic alopecia:Hx:Pt:^Patient:Ord:PhenX
4091,I can solve most problems if I invest the necessary effort,I can solve most problems if I invest the necessary effort:Find:Pt:^Patient:Ord:GSE
4092,Pain severity,Pain severity:Find:Pt:^Patient:Ord:Reported.FPS-R
4093,Norvenlafaxine,Norvenlafaxine:MCnc:Pt:Body fld:Qn
4094,Spermatozoa.bent midpiece/100 spermatozoa,Spermatozoa.bent midpiece/100 spermatozoa:NFr:Pt:Semen:Qn
4095,View,Views^W radionuclide intra lymphatic:Find:Pt:Breast.left>Lymphatic vessels:Doc:NM
4096,I don't like being in a hospital,I don't like being in a hospital:Find:Pt:^Patient:Ord:SCARED-R
4097,Corylus avellana recombinant (rCor a) 1.0101 Ab.IgE,Corylus avellana recombinant (rCor a) 1.0101 Ab.IgE:ACnc:Pt:Ser:Qn
4098,View,Deprecated Sagittal sinus and Jugular veins - right Fluoroscopic angiogram W contrast IV
4099,microscopic observation,Microscopic observation:Prid:Pt:Tiss:Nom:Methylene blue stain.Loeffler
4100,Testosterone free & total panel,Testosterone free & total panel:MCnc:Pt:Ser/Plas:Qn
4101,Bilevel positive airway pressure,Pressure.bilevel positive airway:Pres:Pt:Ventilator:Qn
4102,pentane,Pentane:MCnc:Pt:Urine:Qn
4103,phensuximide,Phensuximide:MCnc:Pt:Bld:Qn
4104,I enjoy social chit-chat,I enjoy social chit-chat:Find:Pt:^Patient:Ord:AQ
4105,Admission request,Admission request:Find:Pt:^Patient:Doc
4106,Erythrocytes,Erythrocytes:NCnc:Pt:Periton fld:Qn:Automated count
4107,Carisoprodol,Carisoprodol:SCnc:Pt:XXX:Qn
4108,Carbonyldiamide,Urea nitrogen:SCnc:Pt:Bld:Qn
4109,Sulfamethizole,Sulfamethizole:MCnc:Pt:Bld:Qn
4110,Potassium,Potassium:SCnc:Pt:Bld:Qn
4111,Dyspnea,Dyspnea^post exercise:Find:Pt:Respiratory system:Ord
4112,Your child is fascinated by dates,Your child is fascinated by dates:Find:Pt:^Patient:Ord:AQ Adolescent
4113,microscopic observation,Microscopic observation:Prid:Pt:Tiss:Nom:Warthin-Starry stain
4114,How much does he or she appreciate you,How much does he or she appreciate you:Find:Pt:^Patient:Ord:MIDUS II
4115,C-Peptide,C peptide^100M post XXX challenge:SCnc:Pt:Ser/Plas:Qn
4116,Estradiol,Estradiol^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn:High sensitivity
4117,Minimum alveolar concentration sum,Minimum alveolar concentration sum^^corrected for age:VFr:Pt:Anesthetic agent.XXX+Nitrous oxide:Qn
4118,PhenX measure - birthplace of parents,PhenX measure - birthplace of parents:-:Point in time:^Patient:-:PhenX
4119,Have you ever had chronic bronchitis,Have you ever had chronic bronchitis:Find:Pt:^Patient:Ord:PhenX
4120,Have you ever smoked cigarettes,Have you ever smoked cigarettes:Find:Pt:^Patient:Ord:PhenX
4121,How old were you when you started smoking cigars regularly,How old were you when you started smoking cigars regularly:Time:Pt:^Patient:Qn:PhenX
4122,Streptococcus pyogenes antigen,Deprecated Streptococcus pyogenes Ag [Presence] in Throat by Immunoassay
4123,Motor symptoms - legs,Motor symptoms - legs:Find:Pt:^Patient:Ord:PhenX
4124,Psychological stressor notes,Psychological stressor notes:Txt:Pt:^Patient:Nom:DI-PAD CGP V 1.4
4125,Reduced need for sleep,Reduced need for sleep:Find:Pt:^Patient:Ord:DI-PAD CGP V 1.4
4126,Excessive activity,Excessive activity:Find:Pt:^Patient:Ord:DI-PAD CGP V 1.4
4127,"Troponin T, Cardiac Muscle",Troponin T.cardiac:MCnc:Pt:Ser/Plas:Qn
4128,Have you ever seen or heard another person be threatened with a weapon - a gun or a knife,Have you ever seen or heard another person be threatened with a weapon - a gun or a knife:Find:Pt:^Patient:Ord:LTVH
4129,Modified dukes - astler-coller,Modified dukes - astler-coller:Find:Pt:^Patient:Ord:PhenX
4130,Episode unique identifier,Episode unique identifier:Identifier:Point in time:^Patient:nom
4131,Corticotropin,Corticotropin^1.5H post dose glucose:MCnc:Pt:Plas:Qn
4132,Coagulation Russell viper venom induced,Coagulation Russell viper venom induced:Time:Pt:PPP:Qn:Coag
4133,ST amplitude.lead AI,ST amplitude.lead AI:Elpot:Pt:Heart:Qn:EKG
4134,"Antigens, CD55",Complement decay accelerating factor:PrThr:Pt:RBC:Ord
4135,Fagopyrum esculentum Ab.IgG,Fagopyrum esculentum Ab.IgG:MCnc:Pt:Ser:Qn
4136,Negative formal thought disorder,Negative formal thought disorder:Find:Pt:^Patient:Ord:DI-PAD CGP V 1.4
4137,How many times in the last Y have you gone into or tried to go into a building to steal something,How many times in the last Y have you gone into or tried to go into a building to steal something:NRat:1Y:^Patient:Qn:Denver Youth Survey
4138,Presenting problem,Presenting problem:Finding:Point in time:^Patient:Nominal
4139,Corticotropin,Corticotropin^30M post XXX challenge:SCnc:Pt:Plas:Qn
4140,Aspergillus terreus Ab.IgE,Aspergillus terreus Ab.IgE:ACnc:Pt:Ser:Qn
4141,Phoenix dactylifera Ab.IgG,Phoenix dactylifera Ab.IgG:MCnc:Pt:Ser:Qn
4142,Where was your biological mother born,Where was your biological mother born:Find:Pt:^Patient:Nom:PhenX
4143,"Compared to other children, does this child give close attention to detail and avoid careless mistakes","Compared to other children, does this child give close attention to detail and avoid careless mistakes:Find:Pt:^Patient:Ord:SWAN ADHD"
4144,Pathology biopsy report,Pathology biopsy report:Finding:Point in time:Bone marrow:Narrative
4145,Your work is boring and repetitive,Your work is boring and repetitive:Find:Pt:^Patient:Ord:PhenX
4146,Cardiac rhythm monitoring,Cardiac rhythm monitoring:Complex:-:^Patient:Set
4147,Glucose,Glucose^4th specimen post dose lactose:MCnc:Pt:Ser/Plas:Qn
4148,Musa spp Ab.IgE,Musa spp Ab.IgE:ACnc:Pt:Ser:Qn
4149,Imipramine,Imipramine:PrThr:Pt:Urine:Ord:Confirm
4150,norhydrocodone,Norhydrocodone:MCnc:Pt:Urine:Qn:Confirm
4151,Penicillium brevicompactum Ab.IgG,Penicillium brevicompactum Ab.IgG:MCnc:Pt:Ser:Qn
4152,I have taken money from someone's purse or wallet without asking,I have taken money from someone's purse or wallet without asking:Find:Pt:^Patient:Ord:PhenX
4153,I'm afraid of far fewer things than most people,I'm afraid of far fewer things than most people:Find:Pt:^Patient:Ord:PhenX
4154,I never worry about making a fool of myself with others,I never worry about making a fool of myself with others:Find:Pt:^Patient:Ord:PhenX
4155,I have stolen something out of a vehicle,I have stolen something out of a vehicle:Find:Pt:^Patient:Ord:PhenX
4156,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.glucuronidated+Bilirubin.albumin bound:MCnc:Pt:Periton fld:Qn
4157,Spermatozoa.progressive.grade 3/100 spermatozoa,Spermatozoa.progressive.grade 3/100 spermatozoa^post concentration:NFr:Pt:Semen:Qn
4158,Legionella pneumophila 1+3+4+5+6+8 Ab,Legionella pneumophila 1+3+4+5+6+8 Ab:PrThr:Pt:Ser:Ord
4159,Guidance for biopsy.needle,Deprecated US Guidance for needle biopsy of Muscle
4160,Valdecoxib induced platelet Ab.IgG,Valdecoxib induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
4161,Doxycycline induced platelet Ab.IgG,Doxycycline induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
4162,Cortolone,Alpha cortolone:SCnc:24H:Urine:Qn
4163,Steroid fractions panel,Steroid fractions panel:-:24H:Urine:-
4164,Trisomy 13 prior risk,Trisomy 13 prior risk:Likelihood:Point in time:^Fetus:Quantitative:Based on maternal age
4165,Carbon Dioxide,Carbon dioxide^during inspiration:VFr/PPres:Pt:Gas delivery system.inspiratory limb:Qn
4166,Spermatozoa.motile/100 spermatozoa,Spermatozoa.motile/100 spermatozoa:Number Fraction:Point in time:Seminal fluid:Quantitative
4167,Transfer summary note,Transfer summary note:Find:Pt:{Setting}:Doc:Pediatric gastroenterology
4168,Citrulline,Citrulline:MRat:24H:Urine:Qn
4169,GALACTOKINASE,Galactokinase:CCnt:Pt:WBC:Qn
4170,Citalopram,Deprecated Citalopram [Mass/volume] in Serum or Plasma --trough
4171,Progress note,Progress note:Find:Pt:Hospital:Doc:Pediatrics
4172,"Allergen specific antibody interpretation, semi-quantitative",RAST class:PrThr:Pt:Ser:Ord
4173,Cladosporium herbarum Ab.IgG,Cladosporium herbarum Ab.IgG:ACnc:Pt:Ser:Qn
4174,Clavulanate induced platelet Ab.IgG,Clavulanate induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
4175,Citalopram induced platelet Ab.IgG,Citalopram induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
4176,Glucose,Glucose^15M post 50 g lactose PO:SCnc:Pt:Ser/Plas:Qn
4177,Oxygen therapy was given,Oxygen therapy was given:Find:Pt:^Patient:Ord:NTDS
4178,Streptococcus sp tuf gene,Deprecated Streptococcus sp tuf gene [Presence] by Nucleic acid capture and probe detection in Positive blood culture
4179,Hydroxychloroquine,Hydroxychloroquine^trough:MCnc:Pt:Ser/Plas:Qn
4180,norketamine,Norketamine:MCnc:Pt:Urine:Qn:Confirm
4181,Anethum graveolens Ab.IgE,Anethum graveolens Ab.IgE:ACnc:Pt:Ser:Qn
4182,Buprenorphine,Buprenorphine:PrThr:Pt:Saliva:Ord:Screen
4183,Lactalbumin basophil bound Ab,Lactalbumin basophil bound Ab:ACnc:Pt:Bld:Qn:LHR
4184,Carnitine O-Palmitoyltransferase,Deprecated Carnitine acyltransferase I [Enzymatic activity/mass] in Leukocytes
4185,Note (document),Note:Find:Pt:{Setting}:Doc:Pediatric transplant hepatology
4186,Albumin/Globulin,Albumin/Globulin:MRto:Pt:CSF:Qn:Electrophoresis
4187,Clindamycin,Clindamycin:Susc:Pt:Isolate:OrdQn:Gradient strip
4188,Hantavirus saaremaa Ab.IgG,Hantavirus saaremaa Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IF
4189,Hantavirus seoul Ab.IgG,Hantavirus seoul Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IF
4190,Burkholderia mallei DNA,Burkholderia mallei DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar
4191,"Influenza A Virus Antigen, B",Influenza virus A & B Ag:Prid:Pt:Nose:Nom:IA.rapid
4192,plazomicin,Plazomicin:Susc:Pt:Isolate:OrdQn
4193,Sildenafil citrate induced platelet Ab.IgM,Sildenafil citrate induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
4194,Von Willebrand factor activity (finding),von Willebrand factor.activity:ACnc:Pt:PPP:Qn:IA
4195,Manufacturer Name,Manufacturer name:ID:Pt:Syringe:Nom
4196,Acceleration index,Acceleration index:Accel:Pt:Aorta:Qn
4197,Jugular vein distension,Jugular vein distension:Finding:Point in time:^Patient:Ordinal
4198,Neutrophil Ab.IgM,Neutrophil Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
4199,Periodontal attachment - recommended CDA set,Periodontal attachment - recommended CDA set:-:Pt:{Setting}:-
4200,How close are you to this person,How close are you to this person:Find:Pt:^Patient:Ord:PhenX
4201,Note (document),Note:Find:Pt:{Setting}:Doc:Neurology w special qualifications in child neuro
4202,Dantu Ab,Dantu Ab:PrThr:Pt:Ser/Plas:Ord
4203,Guidance for percutaneous vertebroplasty,Guidance for percutaneous vertebroplasty:Find:Pt:Neck>Spine.cervical:Doc:RF
4204,Vision Tests,Vision testing:Finding:Point in time:^Patient:Narrative
4205,3-Hydroxybutyrate,Beta hydroxybutyrate^pre-meal:SCnc:Pt:Bld:Qn
4206,didesmethylcitalopram,Didesmethylcitalopram:MCnc:Pt:Ser/Plas:Qn
4207,Fumarate Hydratase,Fumarase:CCnt:Pt:Fibroblasts:Qn
4208,Docosahexaenoate,Docosahexaenoate:EntSub:Pt:RBC:Qn
4209,Raphanus sativus Ab.IgE,Raphanus sativus Ab.IgE:ACnc:Pt:Ser:Qn
4210,Fluconazole,Fluconazole:Susc:Pt:Isolate:OrdQn:Gradient strip
4211,Cannabinoids,Cannabinoids:PrThr:Pt:Urine:Ord:Screen>20 ng/mL
4212,NDC labeler code request.animal drug,NDC labeler code request.animal drug:-:-:^FDA product label:Nar
4213,Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH),Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH):SCnc:Pt:Ser/Plas:Qn
4214,Monoclonal band 3 observed,Monoclonal band 3 observed:Prid:Pt:Ser/Plas:Nom:Immunofixation
4215,How many of your brothers or sisters have hearing difficulties,How many of your brothers or sisters have hearing difficulties:Num:Pt:^Patient:Qn:PhenX
4216,Ear with hearing difficulty,Ear with hearing difficulty:Find:Pt:Ear:Nom:PhenX
4217,Nuclear antibody,Nuclear Ab:Titr:Pt:Plr fld:Qn:IF
4218,Lactose tolerance panel,Lactose tolerance panel^dosage unspecified:SCnc:Pt:Ser/Plas:-
4219,PMI - Common side effects section,PMI - Common side effects section:-:-:^FDA package insert:Nar
4220,HNA 4a-4a Ab,HNA 4a-4a Ab:PrThr:Pt:Ser:Ord:IA
4221,Granulocytes/100 leukocytes,Granulocytes/100 leukocytes:NFr:Pt:Body fld:Qn
4222,Monoclonal band observed,Monoclonal band observed:Prid:Pt:Urine:Nom:Immunofixation
4223,Cocaine metabolite,Cocaine+Metabolites:PrThr:Pt:Saliva:Ord:Confirm
4224,Chlorinated solvents,Chlorinated solvents:PrThr:Pt:Urine:Ord
4225,Ambrosia dumosa Ab.IgE,Ambrosia dumosa Ab.IgE:ACnc:Pt:Ser:Qn
4226,ghrelin,Ghrelin:MCnc:Pt:Ser/Plas:Qn
4227,Scene delay,Scene delay:Type:Pt:^Patient:Nom:NEMSIS
4228,Chief complaint per dispatch,Chief complaint per dispatch:Find:Pt:^Patient:Nom:Reported.dispatch
4229,You have been treated with less respect than other people,You have been treated with less respect than other people:Find:Pt:^Patient:Ord:PhenX
4230,Nuclear antibody,Nuclear Ab:Titr:Pt:Body fld:Qn:IF
4231,Methadone panel,Methadone panel:-:Pt:Saliva:-:Confirm
4232,Magnesium.ionized,Magnesium.ionized:SCnc:Pt:Bld:Qn:ISE
4233,RR interval,RR interval:Time:Stdy^max:Heart:Qn:EKG
4234,The rules of the school are fair,The rules of the school are fair:Find:Pt:^Patient:Ord:PhenX
4235,Monocytes,Monocytes:NCnc:Pt:Pericard fld:Qn:Manual count
4236,CFTR gene.c.394delTT,CFTR gene.c.394delTT:PrThr:Pt:Bld/Tiss:Ord:Molgen
4237,Myelopoiesis assessment,Myelopoiesis assessment:Find:Pt:Bone mar:Nar
4238,End-systolic volume,End-systolic volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by cube method
4239,Admission evaluation note,Admission evaluation note:Find:Pt:Hospital:Doc:Cardiovascular disease
4240,Cell count panel,Cell count panel:-:Pt:Pericard fld:Qn
4241,"t(11;17)(q23;q21.1)(ZBTB16,RARA) fusion transcript","t(11;17)(q23;q21.1)(ZBTB16,RARA) fusion transcript:Arb:Pt:Bld/Tiss:Ord:Molgen"
4242,Creatine kinase.MM/Creatine kinase.total,Creatine kinase.MM/Creatine kinase.total:CFr.DF:Pt:Ser/Plas:Qn:Electrophoresis
4243,Valproate,Valproate^peak:MCnc:Pt:Ser/Plas:Qn
4244,Additional cause of injury,Additional cause of injury:Find:Pt:^Patient:Nom:NTDS
4245,Acetylcholinesterase,Acetylcholinesterase:Imp:Pt:Amnio fld:Nar
4246,Apolipoprotein A-I,Apolipoprotein A-I:SCnc:Pt:Ser/Plas:Qn
4247,Have you ever smoked regularly,Have you ever smoked regularly:Find:Pt:^Patient:Ord:PhenX
4248,Diagram of device,Diagram of device:-:-:^FDA package insert:Nar
4249,2-hydroxyphenylacetate,2-Hydroxyphenylacetate:SCnc:Pt:Ser/Plas:Qn
4250,17-alpha-Hydroxyprogesterone,17-Hydroxyprogesterone:SCnc:Pt:Amnio fld:Qn
4251,norcocaine,Norcocaine:PrThr:Pt:Meconium:Ord
4252,Pupil reaction,Pupil reaction:Time:Pt:Eye.right:Qn
4253,Snapper red Ab.IgE,Snapper red Ab.IgE:ACnc:Pt:Ser:Qn
4254,methylethyl ketone,Methyl ethyl ketone:MCnc:Pt:Body fld:Qn
4255,dechloroethylifosfamide,2-Dechloroethylifosfamide^4D post dose ifosfamide:MCnc:24H:Urine:Qn
4256,PAX5 & CD5 Ag,PAX5 & CD5 Ag:Prid:Pt:Tiss:Nom:Immune stain
4257,Air delivered.case,Air delivered.case:Vol:Procedure dur:Gas delivery system:Qn
4258,Process variables for assays,Process variables for assays:-:Pt:^Patient:-:PhenX
4259,Extrinsic coagulation factor activity 4 panel,Extrinsic coagulation factor activity 4 panel:-:Pt:PPP:-
4260,7-aminoflunitrazepam,7-Aminoflunitrazepam:MCnc:Pt:Ser/Plas/Bld:Qn
4261,Snowshoe hare virus IgM Ab,Snowshoe hare virus Ab.IgM:PrThr:Pt:Ser:Ord:IF
4262,Education note,Education note:Find:Pt:{Setting}:Doc:Primary care
4263,Transfer summary note,Transfer summary note:Find:Pt:{Setting}:Doc:Multi-specialty program
4264,C-reactive protein,C reactive protein:MCnc:Pt:Bld:Qn:High sensitivity
4265,Base excess.100% oxygenated,Base excess.100% oxygenated^^standard:SCnc:Pt:BldA:Qn:Calculated
4266,Alpha-cortol,Alpha cortol:SCnc:24H:Urine:Qn
4267,Iva xanthifolia Ab.IgG,Iva xanthifolia Ab.IgG:ACnc:Pt:Ser:Qn
4268,Note (document),Note:Find:Pt:Telehealth:Doc:{Role}
4269,Lupus anticoagulant two screening tests W Reflex panel,Lupus anticoagulant two screening tests W Reflex panel:-:Pt:PPP:-:Coag
4270,Adenovirus DNA,Adenovirus DNA:PrThr:Pt:Nph:Ord:Probe.amp.tar
4271,microscopic observation,Microscopic observation:PrThr:Pt:BAL:Ord:Acid fast stain.Ziehl-Neelsen
4272,Aldosterone,Aldosterone:SCnc:Pt:Ser/Plas:Qn
4273,Immunoglobulin A,IgA:PrThr:Pt:Ser:Ord:Immunoelectrophoresis
4274,Budgerigar serum proteins Ab.IgE.RAST class,Budgie Serum Prot IgE RAST Ql
4275,Populus tremula Ab.IgE.RAST class,Populus tremula Antibody.immunoglobulin E.RAST class:Arbitrary Concentration:Point in time:Serum:Ordinal
4276,Institution inventory number,Institution inventory number:ID:Pt:Oral tube:Nom
4277,F little y super little b Ab,F little y super little b Ab:PrThr:Pt:Ser/Plas^BPU:Ord
4278,Vendor model number,Vendor model number:Prid:Pt:GI tube:Nom
4279,Vendor serial number,Vendor serial number:ID:Pt:Chest tube:Nom
4280,Diameter (qualifier value),Diameter:Len:Pt:Umbilical vein^Fetus:Qn:US.measured
4281,Hydrocortisone,Cortisol^pre 250 ug corticotropin IM:MCnc:Pt:Ser/Plas:Qn
4282,Cotinine,Cotinine:PrThr:Pt:Urine:Ord
4283,Tranylcypromine,Tranylcypromine:MCnc:Pt:Ser/Plas:Qn
4284,microscopic observation,Microscopic observation:Prid:Pt:Tiss:Nom:Methyl green-pyronine Y stain
4285,Gestational Age,Gestational age:Time:Pt:^Fetus:Qn:Estimated from ovulation date
4286,Benzyl Alcohol,Benzyl alcohol:PrThr:Pt:Ser/Plas:Ord
4287,Insulin,Insulin^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
4288,Toxoplasma gondii antibody,Toxoplasma gondii Ab:ACnc:Pt:CSF:Qn
4289,Norepinephrine/Creatinine,Norepinephrine/Creatinine:MRto:Pt:Urine:Qn
4290,Hydrocortisone,Cortisol^50H post 500 ug dexamethasone PO 2.5 day low dose q6h:MCnc:Pt:Ser/Plas:Qn
4291,Follicle Stimulating Hormone,Follitropin^1H post dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn
4292,Carya tomentosa Ab.IgE.RAST class,Carya tomentosa Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
4293,Honeysuckle Ab.IgE.RAST class,Honeysuckle Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
4294,Inject varicella zoster virus immune globulin,Inject varicella zoster virus immune globulin:Vol:Pt:^Patient:Qn
4295,Rh immune globulin given,Rh immune globulin given:Vol:Pt:^Patient:Qn
4296,Urate crystals.microscopic observation,Urate crystals.microscopic observation:Prid:Pt:Tiss:Nom:De Galantha stain
4297,ED procedure practitioner profession,ED procedure practitioner profession:Type:Point in time:Provider:Nominal
4298,IgM Ab.IgM,IgM Ab.IgM:ACnc:Pt:Ser/Plas:Qn
4299,Packed erythrocytes units available,Packed erythrocytes units available:Num:Pt:^BPU:Qn
4300,Haemophilus influenzae B Ag,Haemophilus influenzae B Ag:PrThr:Pt:CSF:Ord:LA
4301,Glucose,Glucose^30M post dose glucose:SCnc:Pt:Ser/Plas:Qn
4302,Homarus gammarus Ab.IgE.RAST class,Homarus gammarus Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
4303,Octopus vulgaris Ab.IgE.RAST class,Octopus vulgaris Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
4304,Transfuse whole blood autologous,Transfuse whole blood autologous:Vol:Pt:^Patient:Qn
4305,phosphate ion,Phosphate:MCnt:Pt:Stool:Qn
4306,Free prostate specific antigen,Prostate specific Ag.free:MCnc:Pt:Ser/Plas:Qn
4307,Proteins,Protein:MCnc:12H:Urine:Qn
4308,Blasts.CD33/100 blasts,Blasts.CD33/100 blasts:NFr:Pt:Bld:Qn
4309,Lymphocytes.CD3+CD26+/100 lymphocytes,Deprecated CD3+CD26+ cells/100 cells in Blood
4310,Ethanol,Ethanol:MCnc:Pt:Ser/Plas:Qn:GC
4311,Insulin,Insulin:SCnc:Pt:Ser/Plas:Qn
4312,Ipomoea batatas Ab.IgE.RAST class,Ipomoea batatas Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
4313,S wave amplitude.lead V3,S wave amplitude.lead V3:Elpot:Pt:Heart:Qn:EKG
4314,Horse serum proteins Ab.IgE,Horse serum proteins Ab.IgE:ACnc:Pt:Ser:Qn
4315,Triglycerides,"Triglyceride:Mass Concentration:Point in time:Body fluid, unsp:Quantitative"
4316,Cucurbita pepo seed Ab.IgE.RAST class,Cucurbita pepo seed Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
4317,Physical findings,Physical findings:Finding:Point in time:Genitalia.female:Nominal:Observed
4318,"Human immunodeficiency virus, type II protein 41 antibody",HIV 2 p41 Ab:PrThr:Pt:Ser:Ord:IB
4319,Testes Ab.IgG,Testes Ab.IgG:Titr:Pt:Ser:Qn
4320,Loligo sp Ab.IgE.RAST class,Loligo sp Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
4321,Swine epithelium Ab.IgE.RAST class,Swine epithelium Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
4322,Tetramin Ab.IgE.RAST class,Tetramin Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
4323,Cryptococcus sp Ag,Cryptococcus sp Ag:Titr:Pt:XXX:Qn
4324,Myelin-Associated Glycoprotein Antibody,Myelin associated glycoprotein Ab:PrThr:Pt:CSF:Ord:IB
4325,thyrotropin-binding inhibitory immunoglobulin,Thyrotropin binding inhibitory immunoglobulins:PrThr:Pt:Ser:Ord
4326,Helicobacter pylori IgA,Helicobacter pylori Ab.IgA:PrThr:Pt:Ser:Ord
4327,Amyl ether,Amyl ether:MCnc:Pt:Bld:Qn
4328,Acanthamoeba sp identified,Acanthamoeba sp identified:Prid:Pt:Eye:Nom:Organism specific culture
4329,microscopic observation,Microscopic observation:Prid:Pt:Tiss:Nom:Argentaffin stain
4330,Surgical operation note anesthesia duration,Surgical operation note anesthesia duration:Time:Duration of procedure:Surgical procedure:Quantitative
4331,Factor VIII Coagulant Antigen,Coagulation factor VIII Ag:PrThr:Pt:Tiss:Ord:Immune stain
4332,Study observation,Study observation:Finding:Point in time:Mitral valve^Fetus:Nominal:ULTRASOUND
4333,Magnesium/Creatinine,Magnesium/Creatinine:MRto:Pt:Urine:Qn
4334,18-Hydroxydeoxycortisol/Creatinine,18-Hydroxydeoxycortisol/Creatinine:MRto:Pt:Urine:Qn
4335,Free cortisol,Cortisol.free^pre 2 mg dexamethasone PO 2.5 day high dose q6h:MCnc:24H:Urine:Qn
4336,Alpha 1 globulin/Protein.total,Alpha 1 globulin/Protein.total:MFr:Pt:CSF:Qn:Electrophoresis
4337,Albumin/Globulin,Albumin/Globulin:MRto:Pt:CSF:Qn
4338,Cholesterol,Deprecated Cholesterol [Mass/volume] in Pleural fluid
4339,Zinc,Zinc:SCnc:Pt:Ser/Plas:Qn
4340,Formaldehyde Ab.IgE.RAST class,Formaldehyde Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
4341,Spermatozoa.motile with IgA/100 spermatozoa,Spermatozoa.motile with IgA/100 spermatozoa:NFr:Pt:Semen:Qn:Immunobead
4342,Amorphous urate crystals,Urate crystals.amorphous:NCnc:Pt:Urine sed:Qn
4343,Muromonab-CD3,OKT3:MCnc:Pt:Ser/Plas:Qn
4344,Study observation,Study observation:Finding:Point in time:Kidney.left^Fetus:Nominal:ULTRASOUND
4345,Hexobarbital,Hexobarbital:MCnc:Pt:Ser/Plas:Qn
4346,Carbonyldiamide,Urea nitrogen:MCnc:Pt:BldV:Qn
4347,Rubella virus antigen,Rubella virus Ag:PrThr:Pt:Cvx:Ord:IF
4348,ST initial amplitude 6 ms.lead V6,ST initial amplitude 6 ms.lead V6:Elpot:Pt:Heart:Qn:EKG
4349,Brucella canis antibody,Brucella canis Ab:ACnc:Pt:Ser:Qn
4350,Gestational Age,Gestational age:Time:Pt:^Fetus:Qn:US.estimated from BPC
4351,Erythromycin / Sulfisoxazole,Erythromycin+Sulfisoxazole:Susc:Pt:Isolate:OrdQn:Gradient strip
4352,C-Peptide,C peptide^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
4353,Prolactin,Prolactin^45M post dose insulin IV:MCnc:Pt:Ser/Plas:Qn
4354,ST wave displacement.mid.lead AVL,ST wave displacement.mid.lead AVL:Elpot:Pt:Heart:Qn:EKG
4355,Hydrocortisone,Cortisol^10th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
4356,Platelet Ab.circulating,Deprecated Platelet Ab [Units/volume] in Serum
4357,dezocine,Dezocine:PrThr:Pt:Urine:Ord
4358,Hydrocortisone,Cortisol^1M post 1 ug/kg CRH IV:MCnc:Pt:Ser/Plas:Qn
4359,Bacteria identified,Bacteria identified:Prid:Pt:Cvx:Nom:Aerobic culture
4360,Oxalates,Oxalate:SCnc:Pt:Urine:Qn
4361,estrone sulfate,Estrone sulfate:MCnc:Pt:Ser/Plas:Qn
4362,Varicella zoster virus immunoglobulin G antibody,Varicella zoster virus Ab.IgG:PrThr:Pt:Ser:Ord:IA
4363,Coagulation surface induced,Coagulation surface induced:Time:Pt:Bld^Control:Qn:Coag.saline 1:1
4364,Albumin/Globulin,Albumin/Globulin:MRto:Pt:Body fld:Qn
4365,Glucose,Glucose^pre dialysis:MCnc:Pt:Dial fld prt:Qn
4366,Beta tubulin Ab.IgM,Deprecated Beta tubulin Ab.IgM
4367,Porphyrins,Porphyrins:SRat:24H:Stool:Qn
4368,Uroporphyrins,Uroporphyrin:SRat:24H:Urine:Qn
4369,Digitoxin,Digitoxin:SCnc:Pt:Ser/Plas:Qn
4370,Midazolam,Midazolam:SCnc:Pt:Ser/Plas:Qn
4371,Acremonium sp Ab.IgE.RAST class,Acremonium sp Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
4372,Cortisol/Creatinine,Cortisol/Creatinine:MRto:Pt:Urine:Qn
4373,Blood flow.systolic.max,Blood flow.systolic.max:Vel:Pt:Cerebral artery middle:Qn:US.doppler
4374,Blood flow.systolic.max,Blood flow.systolic.max:Vel:Pt:Mitral valve:Qn:US.doppler
4375,Chymopapain Ab.IgE.RAST class,Chymopapain Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
4376,Trichosporon pullulans Ab.IgE,Trichosporon pullulans Ab.IgE:ACnc:Pt:Ser:Qn
4377,P Blood group antibodies,Deprecated P NOS Ab [Presence] in Serum or Plasma
4378,C-Peptide,C peptide^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
4379,Coagulation thrombin induced,Deprecated Thrombin time in Platelet poor plasma from control by Coagulation assay
4380,Dinoprost,Prostaglandin F2 alpha:MCnc:Pt:Ser/Plas:Qn
4381,Hemoglobin.gastrointestinal,Hemoglobin.gastrointestinal^3rd specimen:PrThr:Pt:Stool:Ord
4382,Cortodoxone,11-Deoxycortisol:SCnc:Pt:Ser/Plas:Qn
4383,Aldosterone,Aldosterone:MCnc:Pt:Bld:Qn
4384,Streptococcus pneumoniae IgG,Streptococcus pneumoniae Ab.IgG^1st specimen:ACnc:Pt:Ser:Qn:IA
4385,Butorphanol cutoff,Butorphanol cutoff:MCnc:Pt:Urine:Qn:Screen
4386,Invertase,Beta fructofuranosidase:CCnc:Pt:Ser:Qn
4387,Diffusion capacity/Alveolar volume,Diffusion capacity/Alveolar volume:Inverse VI:Pt:Respiratory system:Qn:Predicted
4388,Chlamydophila psittaci antibody,Chlamydophila psittaci Ab:PrThr:Pt:Ser:Ord:Immune diffusion
4389,COLLAGENASE,Collagenase:CCnc:Pt:Ser:Qn
4390,Japanese encephalitis virus Antigen,Japanese encephalitis virus Ag:PrThr:Pt:XXX:Ord:HAI
4391,Hydrocortisone,Cortisol^1M post XXX challenge:MCnc:Pt:Ser/Plas:Qn
4392,Dextromethamphetamine,Dextromethamphetamine:PrThr:Pt:Urine:Ord:Screen
4393,Tritrichomonas foetus Ag,Tritrichomonas foetus Ag:PrThr:Pt:Placenta:Ord:Immune stain
4394,EKG impression,EKG impression:Impression/interpretation of study:Point in time:Heart:Narrative:EKG
4395,Beta-glucuronidase,Beta glucuronidase:CCnc:Pt:Urine:Qn
4396,ethylamphetamine,Ethylamphetamine:PrThr:Pt:Urine:Ord:Screen
4397,Oxygen,Oxygen^on room air and asleep:PPres:Stdy^max:BldC:Qn:Transcutaneous O2 monitor
4398,"t(6;9)(p22;q34)(DEK,NUP214) fusion transcript","t(6;9)(p22;q34)(DEK,NUP214) fusion transcript:Arb:Pt:Bld/Tiss:Ord:Molgen"
4399,La Crosse virus IgG,La Crosse virus Ab.IgG:Titr:Pt:CSF:Qn
4400,Histoplasma species antibody,Deprecated Histoplasma capsulatum Ab [Presence] in Serum by Immune diffusion (ID)
4401,malaoxon,Malaoxon:MCnc:Pt:Bld:Qn
4402,Dehydroepiandrosterone Sulfate,Dehydroepiandrosterone sulfate^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
4403,"Acid phosphatase isoenzyme, prostatic fraction",Acid phosphatase.prostatic:CCnc:Pt:Vag:Qn
4404,Hydroxyalprazolam,Hydroxyalprazolam:PrThr:Pt:Urine:Ord:Confirm
4405,Peak inspiratory flow rate,Deprecated Peak inspiratory flow Respiratory system airway opening by Airway pressure monitor --at 1.0 liter per second on ventilator
4406,Myelin-Associated Glycoprotein Antibody,Myelin associated glycoprotein Ab.IgM:Titr:Pt:Ser:Qn
4407,Sequence number central.patient,Sequence number central.patient:Arb:Pt:Cancer.XXX:Ord
4408,Coding system.original,Coding system.original:Type:Pt:Cancer.XXX.anatomic site:Nom
4409,Leptospira sp subtype,Leptospira sp subtype:Prid:Pt:XXX:Nom
4410,Calcium,Calcium^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
4411,Dieldrin,Dieldrin:MCnc:Pt:Bld:Qn
4412,Echovirus 1 Ab,Echovirus 1 Ab:ACnc:Pt:Ser:Qn:Comp fix
4413,Varicella zoster virus immunoglobulin G antibody,Varicella zoster virus Ab.IgG:ACnc:Pt:Ser:Qn:IF
4414,Ova & parasites identified,Ova & parasites identified:Prid:Pt:Stool:Nom:Iron hematoxylin stain
4415,CACNA1S gene targeted mutation analysis,CACNA1S gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
4416,CACNA1S gene.p.Arg1239His,CACNA1S gene.p.Arg1239His:PrThr:Pt:Bld/Tiss:Ord:Molgen
4417,3-Hydroxydodecanedioate/Creatinine,3-Hydroxydodecanedioate/Creatinine:MRto:Pt:Urine:Qn
4418,Nephrogenous cyclic AMP (substance),Adenosine monophosphate.cyclic.nephrogenous:SCnc:Pt:Urine+Ser/Plas:Qn
4419,Extension,Extension:Type:Pt:Cancer.XXX:Nom
4420,Bordetella bronchiseptica Ab,Bordetella bronchiseptica Ab:PrThr:Pt:Ser:Ord
4421,Erythromycin,Erythromycin:Titr:Pt:Isolate+Ser:Qn:SBT
4422,Lymphocytic choriomeningitis virus IgM,Lymphocytic choriomeningitis virus Ab.IgM:Titr:Pt:CSF:Qn
4423,Study report,Deprecated NM Thyroid gland Study report
4424,Propylene glycol,Propylene glycol:MCnc:Pt:Urine:Qn
4425,temafloxacin,Temafloxacin:Susc:Pt:Isolate:OrdQn
4426,Volume expired during 1.0 s of forced expiration,Volume expired during 1.0 s of forced expiration^post bronchodilation:Vol:Pt:Respiratory system:Qn
4427,Ampicillin,Ampicillin:MCnc:Pt:XXX:Qn
4428,Immunoglobulin G antibody to Rickettsia typhi,Rickettsia typhi Ab.IgG:Titr:Pt:Ser:Qn
4429,Mycobacterium avium subspecies paratuberculosis DNA,Mycobacterium avium subspecies paratuberculosis DNA:PrThr:Pt:Stool:Ord:Probe.amp.tar
4430,Biperiden,Biperiden:MCnc:Pt:Ser/Plas:Qn
4431,Clindamycin,Clindamycin:Titr:Pt:Isolate+Ser:Qn:SBT
4432,Methyprylon cutoff,Methyprylon cutoff:MCnc:Pt:Urine:Qn:Screen
4433,Measles virus IgM,Measles virus Ab.IgM:Titr:Pt:CSF:Qn
4434,Alpha-aminoisobutyrate,Alpha aminoisobutyrate:PrThr:Pt:Plas:Ord
4435,Cephalothin,Cephalothin:Titr:Pt:Isolate+Ser:Qn:SBT
4436,Alanine,Alanine:MCnc:Pt:CSF:Qn
4437,Parvovirus B19 Ab.IgG+IgM,Parvovirus B19 Ab.IgG+IgM:ACnc:Pt:Ser:Qn
4438,Alpha-amino acid nitrogen,Alpha amino acid nitrogen:MRat:24H:Urine:Qn
4439,Curvularia lunata Ab.IgG,Curvularia lunata Ab.IgG:ACnc:Pt:Ser:Qn
4440,Nalbuphine cutoff,Nalbuphine cutoff:MCnc:Pt:Urine:Qn:Confirm
4441,Gradient 2.max,Gradient 2.max:Pres:Pt:Circulatory system.XXX:Qn:US+Calculated
4442,Brucella abortus antibody,Brucella abortus Ab:PrThr:Pt:Ser:Ord:Aggl.card
4443,Campylobacter fetus Ab,Campylobacter fetus Ab:PrThr:Pt:Genital muc:Ord:Aggl
4444,Mycoplasma mycoides subspecies mycoides large colony Ab,Mycoplasma mycoides subspecies mycoides large colony Ab:PrThr:Pt:Ser:Ord:Comp fix
4445,Glucosephosphate Dehydrogenase,Glucose-6-Phosphate dehydrogenase:CCnc:Pt:Ser:Qn
4446,Bacteria identified,Bacteria identified^^^5:Prid:Pt:Line:Nom:Intravascular line culture
4447,Methotrimeprazine,L-Mepromazine Ur Ql Cfm
4448,norfluoxetine,Norfluoxetine:PrThr:Pt:Urine:Ord:Confirm
4449,Systole.max/Systole 2.max,Systole.max/Systole 2.max:VelRto:Pt:Circulatory system.XXX:Qn:US.doppler
4450,Slope.XXX/Slope 2.XXX,Slope.XXX/Slope 2.XXX:VelRto:Pt:Circulatory system.XXX:Qn:US.M-mode+Calculated
4451,Toxoplasma gondii antibody,Toxoplasma gondii Ab:PrThr:Pt:Ser:Ord
4452,Choriogonadotropin.beta subunit.free,Choriogonadotropin.beta subunit.free:ACnc:Pt:Ser/Plas:Qn
4453,Q-wave to closure,Q-wave to closure:Time:Pt:Pulmonic valve:Qn:US.measured
4454,Carboxyhemoglobin/Hemoglobin.total,Carboxyhemoglobin/Hemoglobin.total:MFr:Pt:BldC:Qn
4455,Coliform bacteria,Coliform bacteria:NCnc:Pt:Envir:Qn:Viability count
4456,CDKN2B gene deletion,CDKN2B gene deletion:Arb:Pt:Bld/Tiss:Ord:Molgen
4457,Trypanosoma cruzi antibody,Trypanosoma cruzi Ab:Titr:Pt:Ser:Qn
4458,Ovine progressive pneumonia virus Ab,Deprecated Ovine progressive pneumonia virus Ab [Presence] in Serum
4459,Beryllium,Beryllium:PrThr:Pt:Urine:Ord
4460,Stemphylium botryosum Ab.IgG,Stemphylium botryosum Ab.IgG:ACnc:Pt:Ser:Qn
4461,Octenoylcarnitine (C8:1),Octenoylcarnitine (C8:1):MCnc:Pt:Ser/Plas:Qn
4462,Squamous cell carcinoma antigen,Squamous cell carcinoma Ag:ACnc:Pt:Ser/Plas:Qn
4463,Oxygen,Oxygen^^saturation adjusted to 0.5:PPres:Pt:BldV:Qn
4464,St. Louis encephalitis virus antibody,Saint Louis encephalitis virus Antibody:Arbitrary Concentration:Point in time:Serum:Ordinal
4465,ATP7B gene.c.2010_2016del,ATP7B gene.c.2010_2016del:PrThr:Pt:Bld/Tiss:Ord:Molgen
4466,Varicella zoster virus IgM,Varicella zoster virus Ab.IgM:Titr:Pt:Ser:Qn
4467,Canine distemper virus Ag,Canine distemper virus Ag:PrThr:Pt:Cnjt:Ord
4468,butyrate,Butyrate:MCnc:Pt:Stool:Qn
4469,Phenolphthalein,Phenolphthalein:MCnc:Pt:Bld:Qn
4470,Bicarbonates,Bicarbonate^^standard:SCnc:Pt:BldC:Qn
4471,CBS gene.p.G307S,Deprecated CBS gene p.G307S [Presence] in Blood or Tissue by Molecular genetics method
4472,Threonine,Threonine:SCnc:Pt:CSF:Qn
4473,Duck hepatitis virus 3 Ab,Duck hepatitis virus 3 Ab:PrThr:Pt:Ser:Ord:Neut
4474,Prion protein.abnormal,Prion protein.abnormal:PrThr:Pt:Brain:Ord:Immune stain
4475,Feline immunodeficiency virus Ab,Feline immunodeficiency virus Ab:PrThr:Pt:Ser:Ord
4476,Myelin associated glycoprotein Ab.IgA,Myelin associated glycoprotein Ab.IgA:ACnc:Pt:Ser:Qn
4477,Amylase.P1,Amylase.P1:CCnc:Pt:Ser/Plas:Qn
4478,Glucose,Glucose^3H post dose glucose:MCnc:Pt:Ser/Plas:Qn
4479,Deer hair Ab.IgE.RAST class,Deer hair Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
4480,Protoporphyrins,Protoporphyrin:MRat:XXX:Stool:Qn
4481,Isoleucine,Isoleucine:SCnc:Pt:CSF:Qn
4482,Rift valley fever virus Ab,Rift valley fever virus Ab:Titr:Pt:Ser:Qn:HAI
4483,Mycoplasma synoviae antibody,Mycoplasma synoviae Ab:Titr:Pt:Ser:Qn:HA
4484,Canary droppings Ab.IgE,Canary droppings Ab.IgE:ACnc:Pt:Ser:Qn
4485,Porphyrins,Porphyrins:ACnc:Pt:Stool:Qn
4486,Crossection,Crossection:Area:Pt:Pulmonary artery.main:Qn:US
4487,Study observation,Study observation:Finding:Duration of the study:Endoscopy procedure:Nominal
4488,Chlamydophila psittaci antibody,Chlamydophila psittaci Ab:Titr:Pt:Ser:Qn
4489,Chlamydia trachomatis IgA,Chlamydia trachomatis Ab.IgA:Titr:Pt:CSF:Qn
4490,Chlamydia trachomatis G+F+K Ab.IgG,Chlamydia trachomatis G+F+K Ab.IgG:Titr:Pt:Ser:Qn
4491,Creatinine,Creatinine:SCnc:Pt:XXX:Qn
4492,Rotavirus RNA,Rotavirus RNA:PrThr:Pt:XXX:Ord:Probe
4493,Histiocytes/100 cells,Histiocytes/100 cells:NFr:Pt:Body fld:Qn:Microscopy.light
4494,oleandrin,Oleandrin:MCnc:Pt:Urine:Qn
4495,Organochlorine pesticide,Organochlorine pesticides:PrThr:Pt:Tiss:Ord:Screen
4496,Gastrin,Gastrin^7M post 0.2 U/kg secretin:MCnc:Pt:Ser/Plas:Qn
4497,SNCA gene.p.Ala30Pro,SNCA gene.p.Ala30Pro:PrThr:Pt:Bld/Tiss:Ord:Molgen
4498,Swine vesicular disease virus Ag,Swine vesicular disease virus Ag:PrThr:Pt:XXX:Ord:IA
4499,Rhodococcus equi Ab,Rhodococcus equi Ab:Titr:Pt:Ser:Qn
4500,Cerebroside sulfatase B,Deprecated Cerebroside sulfatase B:Catalytic Concentration:Point in time:Leukocytes:Quantitative
4501,oxychlordane,Oxychlordane:MCnc:Pt:Ser/Plas:Qn
4502,Afipia felis IgM,Afipia felis Ab.IgM:Titr:Pt:Ser:Qn
4503,Echovirus 18 Ab,Echovirus 18 Ab:Titr:Pt:Ser:Qn
4504,Echovirus 3 Ab,Echovirus 3 Ab:Titr:Pt:Ser:Qn
4505,Theileria equi rRNA,Theileria equi rRNA:PrThr:Pt:Bld:Ord:Probe
4506,Coccidioides reaction wheal,Coccidioides reaction wheal:Diam:Pt:Skin:Qn
4507,Salmonella enterica subspecies enterica serovar Typhi O antibody,Salmonella typhi O Ab:PrThr:Pt:Ser:Ord
4508,Magnesium,Magnesium:SCnc:Pt:RBC:Qn
4509,Views 2,Views 2:Find:Pt:Lower extremity.right>Ankle:Doc:XR
4510,Potassium,Potassium:SCnc:Pt:Saliva:Qn
4511,Prostaglandins,Prostaglandin:MCnc:Pt:Ser/Plas:Qn
4512,Accommodation width.measured 2,Accommodation width.measured 2:Len:Pt:Eye:Qn
4513,Polarization.binocular,Polarization.binocular:Prid:Pt:Eye:Nom:Phoropter
4514,Accommodation width.measured 3,Accommodation width.measured 3:Len:Pt:Eye:Qn:Hand optometer
4515,Nordazepam,Nordiazepam:MCnc:Pt:Gast fld:Qn
4516,succinylacetone,Succinylacetone:PrThr:Pt:Urine:Ord
4517,Methacycline,Methacycline:Susc:Pt:Isolate:OrdQn:Agar diffusion
4518,Phosphatidylserine IgM,Phosphatidylserine Ab.IgM:ACnc:Pt:Ser:Qn:IA
4519,Myoglobin,Myoglobin:MCnc:Pt:Urine:Qn
4520,Cylinder N 2,Cylinder N 2:InvLen:Pt:LM glasses.lens.left:Qn
4521,Sphere N 1,Sphere N 1:InvLen:Pt:Glasses prescription.lens.right:Qn
4522,Cylinder N 1,Cylinder N 1:InvLen:Pt:Glasses prescription.lens.right:Qn
4523,Digoxin.free,Digoxin.free:SCnc:Pt:Ser/Plas:Qn
4524,Barbital,Barbital:PrThr:Pt:XXX:Ord
4525,butabarbital,Butabarbital:PrThr:Pt:XXX:Ord
4526,Malate Dehydrogenase,Malate dehydrogenase:CCnc:Pt:Ser:Qn
4527,Erythrocytes,Erythrocytes:NCnc:Pt:CSF:Qn
4528,Topoisomerase-1 antibody,SCL-70 extractable nuclear Ab:ACnc:Pt:Ser:Qn:IA
4529,Borrelia burgdorferi 58kD IgG,Borrelia burgdorferi 58kD Ab.IgG:PrThr:Pt:CSF:Ord:IB
4530,gamma hydroxybutyrate,Deprecated Gamma hydroxybutyrate [Mass/volume] in Urine
4531,Cylinder N 1,Cylinder N 1:InvLen:Pt:Glasses prescription.lens.left:Qn
4532,Proteins,Protein:MCnc:Pt:Ser/Plas:Qn
4533,Eastern equine encephalitis virus IgG,Eastern equine encephalitis virus Ab.IgG:PrThr:Pt:Ser:Ord
4534,3-Hydroxypalmitoylcarnitine (C16-OH),3OH-Palmitoylcarn SerPl-sCnc
4535,Aspergillus terreus Ab,Aspergillus terreus Ab:PrThr:Pt:Ser:Ord
4536,Lithium,Lithium:SCnc:Pt:Bld:Qn
4537,View,Views^W contrast IA:Find:Pt:Head+Neck>Carotid arteries.bilateral:Doc:RF.angio
4538,Bevel radius,Bevel radius:Len:Pt:Contact lens.right:Qn
4539,Lenticulation,Lenticulation:Arb:Pt:Contact lens.left:Ord
4540,Isovalerylglycine,Isovalerylglycine:PrThr:Pt:Urine:Ord
4541,Multisection,Multisection^W contrast IV:Find:Pt:Head>Maxillofacial region:Doc:CT
4542,Glycogen (Starch) Synthase,Glycogen synthase:CCnc:Pt:Ser:Qn
4543,(Quercus alba+Ulmus americana+Platanus acerifolia+Salix caprea+Populus deltoides) Ab.IgE.RAST class,(Quercus alba+Ulmus americana+Platanus acerifolia+Salix caprea+Populus deltoides) Ab.IgE.RAST class:PrThr:Pt:Ser:Ord:Multidisk
4544,Pigeon droppings Ab,Pigeon droppings Ab:PrThr:Pt:Ser:Ord:Immune diffusion
4545,Lactoferrin,Lactoferrin:MCnc:Pt:Ser:Qn
4546,Glutamine,Glutamine:SCnc:Pt:Urine:Qn
4547,Over refraction axis,Over refraction axis:Angle:Pt:Contact lens.left:Qn
4548,Materials,Material:Prid:Pt:Contact lens.prescription.left:Nom
4549,Torus,Torus:Prid:Pt:Contact lens.prescription.left:Nom
4550,Symptoms & diseases,History of symptoms & diseases:Finding:Point in time:Behavior:Nominal:Observed
4551,Transcobalamin,Transcobalamin:MCnc:Pt:Ser:Qn
4552,Chlamydia trachomatis B IgM,Chlamydia trachomatis B Ab.IgM:ACnc:Pt:Ser:Qn
4553,Cockatiel droppings Ab,Cockatiel droppings Ab:PrThr:Pt:Ser:Ord
4554,Coxsackievirus A10 Ab,Coxsackievirus A10 Ab:ACnc:Pt:Body fld:Qn
4555,Bartonella henselae IgM,Bartonella henselae Ab.IgM:Titr:Pt:CSF:Qn:IF
4556,Borrelia burgdorferi IgG,Borrelia burgdorferi Ab.IgG:Titr:Pt:CSF:Qn
4557,Multisection,Multisection:Find:Pt:Abdomen>Retroperitoneum:Doc:US
4558,Cells.CD3+CD56+,Cells.CD3+CD56+:NCnc:Pt:Bld:Qn
4559,Highlands J virus Ab,Highlands J virus Ab:ACnc:Pt:XXX:Qn
4560,Haemophilus influenzae B DNA,Haemophilus influenzae B DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar
4561,Fungus identified,Fungus identified:Prid:Pt:Bronchial:Nom:Culture
4562,Guidance for placement of stent,Guidance for placement of stent:Find:Pt:XXX>Artery:Doc:RF.angio
4563,Insulin,Insulin^8th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn
4564,C-Peptide,C peptide^1st specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn
4565,Babesia duncani Ab,Babesia duncani Ab:PrThr:Pt:Ser:Ord
4566,Cisapride,Cisapride:MCnc:Pt:Ser/Plas:Qn
4567,Multisection,Multisection:Find:Pt:Upper extremity>Upper extremity joint:Doc:MR
4568,Ethambutol,Ethambutol:Susc:Pt:Isolate:Qn:MLC
4569,Streptococcus pneumoniae Danish serotype 8 Ab,Deprecated Streptococcus pneumoniae 8 Ab [Mass/volume] in Serum
4570,Multisection,Multisection^W contrast IV:Find:Pt:XXX>Spine:Doc:CT
4571,Follicle Stimulating Hormone,Follitropin^2nd specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn:2nd IRP
4572,View,Views:Find:Pt:Head>Zygomatic arch.bilateral:Doc:XR
4573,Paracoccidioides brasiliensis antibody,Paracoccidioides brasiliensis Ab:PrThr:Pt:Ser:Ord
4574,Axis distance,Axis distance:Angle:Pt:Glasses prescription.lens.right:Qn
4575,Gold,Gold:MCnc:24H:Urine:Qn
4576,Mesothelial cells/100 leukocytes,Mesothelial cells/100 leukocytes:NFr:Pt:Plr fld:Qn
4577,Metamyelocytes,Metamyelocytes:NCnc:Pt:Bld:Qn
4578,Aluminum,Aluminum:MCnc:XXX:Urine:Qn
4579,Human herpesvirus 1 antibody,Herpes simplex virus 1 Ab:ACnc:Pt:CSF:Qn
4580,Infectious bursal disease virus antibody,Infectious bursal disease virus Ab:ACnc:Pt:Ser:Qn
4581,Views limited,Views limited:Find:Pt:Breast:Doc:MG
4582,Multisection,Multisection:Find:Pt:Head>Temporomandibular joint:Doc:MR
4583,Multisection,Multisection^WO & W contrast IV:Find:Pt:Lower extremity.left>Ankle:Doc:MR
4584,Oleate,Oleate:PrThr:Pt:Bld:Ord
4585,Neutrophils.segmented/100 leukocytes,Neutrophils.segmented/100 leukocytes:NFr:Pt:Body fld:Qn
4586,Vaccines due next,Vaccines due next:Complex:Point in time:^Patient:Set
4587,Aspergillus fumigatus recombinant (rAsp f) 2 Ab.IgE,Aspergillus fumigatus recombinant (rAsp f) 2 Ab.IgE:ACnc:Pt:Ser:Qn
4588,Legionella pneumophila 6 IgM,Legionella pneumophila 6 Ab.IgM:ACnc:Pt:Ser:Qn
4589,Multisection,Multisection^W contrast Intravenous:Finding:Point in time:Chest:Narrative:COMPUTERIZED TOMOGRAPHY
4590,Multisection,Multisection^WO & W contrast IV:Find:Pt:Lower extremity.left>Thigh:Doc:MR
4591,Methionine,Methionine:PrThr:Pt:Bld:Ord
4592,Gentamicin,Gentamicin:Susc:Pt:Isolate:Qn:MLC
4593,Bartonella quintana antibody,Bartonella quintana Ab:PrThr:Pt:Ser:Ord
4594,Multisection,Multisection:Imp:Pt:Eye.left:Nom:US.2D
4595,Myelin-Associated Glycoprotein Antibody,Myelin associated glycoprotein Ab.IgM:PrThr:Pt:Ser:Ord:IB
4596,Indinavir,Indinavir:MCnc:Pt:Ser/Plas:Qn
4597,Immunoglobulin G,IgG:MCnc:Pt:CSF:Qn
4598,Beta aminoisobutyrate/Creatinine,Beta aminoisobutyrate/Creatinine:Substance Concentration Ratio:Point in time:Urine:Quantitative
4599,Multisection,Multisection:Find:Pt:Lower extremity.left>Lower extremity joint:Doc:MR
4600,Protein S actual/Normal,Protein S actual/Normal:RelTime:Pt:PPP:Qn:Coag
4601,Mycobacterium DNA,Mycobacterium sp DNA:PrThr:Pt:Urine:Ord:Probe.amp.tar
4602,Borrelia burgdorferi IgM,Borrelia burgdorferi Ab.IgM:PrThr:Pt:Ser:Ord:IF
4603,Coxsackievirus B3 Ab,Coxsackievirus B3 Ab:Titr:Pt:Body fld:Qn:Comp fix
4604,Rumex acetosella Ab.IgG,Rumex acetosella Ab.IgG:ACnc:Pt:Ser:Qn
4605,Multisection,Multisection:Find:Pt:Extremity:Doc:US
4606,Follicle Stimulating Hormone,Follitropin^4th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn
4607,Growth Hormone,Somatotropin^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
4608,Hydrocortisone,Cortisol:PrThr:Pt:Urine:Ord
4609,Rickettsia honei Ab,Rickettsia honei Ab:Titr:Pt:Ser:Qn
4610,Casuarina equisetifolia Ab.IgE.RAST class,Casuarina equisetifolia Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
4611,Specimen mass,Deprecated Weight of Unspecified specimen
4612,Legionella pneumophila antibody,Legionella pneumophila Ab^2nd specimen:Titr:Pt:Ser:Qn:IF
4613,Guidance for placement of decompression tube,Guidance for placement of decompression tube:Find:Pt:Abdomen+Pelvis>Gastrointestinal tract:Doc:RF
4614,Staphylococcus aureus enterotoxin D Ab.IgE,Staphylococcus aureus enterotoxin D Ab.IgE:ACnc:Pt:Ser:Qn
4615,PHOSPHOFRUCTOKINASE,Phosphofructokinase:CCnc:Pt:Ser:Qn
4616,normeperidine,Normeperidine:PrThr:Pt:Urine:Ord
4617,Benzoate/Creatinine,Benzoate/Creatinine:Ratio:Pt:Urine:Qn
4618,Eastern equine encephalitis virus Antibody,Eastern equine encephalitis virus Ab^1st specimen:Titr:Pt:Ser:Qn:IF
4619,Isoniazid 0.1 ug/mL,Isoniazid 0.1 ug/mL:Susceptibility:Point in time:Isolate:Quantitative or Ordinal:Slow-growing Mycobacteria
4620,Rubella virus antigen,Rubella virus Ag:PrThr:Pt:Thrt:Ord
4621,Multisection,Multisection^W contrast IV:Find:Pt:Abdomen>Kidney.bilateral:Doc:XR.tomography
4622,Phencyclidine,Phencyclidine:MCnt:Pt:Meconium:Qn:Screen
4623,"2,4-DICHLOROPHENOXYACETATE","2,4-Dichlorophenoxyacetate:MCnc:Pt:Ser/Plas:Qn"
4624,Jamestown canyon virus Ab,Jamestown canyon virus Ab:PrThr:Pt:XXX:Ord:Neut
4625,Multisection,Multisection^W contrast IV:Find:Pt:Abdomen>Spine.lumbar:Doc:MR
4626,microscopic observation,Microscopic observation:Prid:Pt:Abdomen.FNA:Nom:Cyto stain
4627,14-3-3 Ag,14-3-3 Ag:ACnc:Pt:CSF:Qn
4628,Insulin-Like Growth Factor I,Insulin-Like growth factor-I [Mass/volume] in Serum or Plasma
4629,desmethyldoxepin,Deprecated Nordoxepin [Mass] of Dose
4630,Glucose,Glucose^12 AM specimen:SCnc:Pt:Ser/Plas:Qn
4631,Burkholderia species,Burkholderia sp:PrThr:Pt:XXX:Ord:Organism specific culture
4632,{HIV ART medication} doses missed yesterday,{HIV ART medication} doses missed yesterday:Num:Pt:^Patient:Qn:Reported.ACTG
4633,Cyclic AMP,Adenosine monophosphate.cyclic^1st specimen post XXX challenge:SCnc:Pt:Urine:Qn
4634,Views screening,Views screening:Find:Pt:Breast.bilateral:Doc:MG.FFD
4635,Number of specimens received,Number of specimens received:Num:Pt:XXX:Qn
4636,IgG subclass panel,IgG subclass panel:MCnc:Pt:Ser:Qn
4637,Phencyclidine,Phencyclidine:PrThr:Pt:Hair:Ord
4638,Ethambutol 10.0 ug/mL,Deprecated Ethambutol 10.0 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
4639,Ethambutol 5.0 ug/mL,Deprecated Ethambutol 5.0 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
4640,Borrelia burgdorferi antibody,Borrelia burgdorferi Ab:ACnc:Pt:CSF:Qn:IB
4641,Human herpesvirus 1,Herpes simplex virus 1:PrThr:Pt:Vag:Ord:Organism specific culture
4642,(Anacardium occidentale+Carya illinoinensis+Juglans spp+Pistacia vera) Ab.IgE,(Anacardium occidentale+Carya illinoinensis+Juglans spp+Pistacia vera) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk
4643,HTR2A gene+HTR2C gene targeted mutation analysis,HTR2A gene+HTR2C gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen
4644,Alkaline Phosphatase,Alkaline phosphatase:CCnc:Pt:Periton fld:Qn
4645,Histoplasma capsulatum antigen,Histoplasma capsulatum Ag:PrThr:Pt:CSF:Ord
4646,Malignant cells/100 cells,Malignant cells/100 cells:NFr:Pt:Periton fld:Qn:Manual count
4647,Views multiple areas,Views multiple areas^W In-111 Satumomab IV:Find:Pt:XXX:Doc:NM
4648,Aztreonam,Aztreonam:Susc:Pt:Isolate:OrdQn:Agar diffusion
4649,Creatinine,Creatinine^3.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
4650,Creatinine,Creatinine^7D post XXX challenge:MCnc:Pt:Ser/Plas:Qn
4651,Bromides,Bromide:MCnc:Pt:Bld:Qn
4652,Emetine,Emetine:Mass:Pt:Dose:Qn
4653,HTLV I+II Ab,HTLV I+II Ab:PrThr:Pt:Ser^Donor:Ord
4654,Trimethadione,Trimethadione:Mass:Pt:Dose:Qn
4655,Complement C3d-C3d+Gg-IC3b receptors,Deprecated Complement C3d-C3d+Gg-IC3b receptors [Presence] in Leukocytes
4656,Electrocardiograph lead,Electrocardiograph lead:Finding:Point in time:^Patient:Nominal
4657,Creatinine,Creatinine^4H specimen:SCnc:Pt:Dial fld:Qn
4658,Glucose,Glucose^110M post XXX challenge:MCnc:Pt:Ser/Plas:Qn
4659,Cells.CD3-CD57+/100 cells,Cells.CD3-CD57+/100 cells:Number Fraction:Point in time:Marrow (bone):Quantitative
4660,Chlamydia trachomatis D+K Ab.IgM,Chlamydia trachomatis D+K Ab.IgM:PrThr:Pt:Ser:Ord
4661,Chlamydia trachomatis D+K Ab.IgG,Chlamydia trachomatis D+K Ab.IgG:PrThr:Pt:Ser:Ord
4662,hemoglobin Yakima,Hemoglobin Yakima:PrThr:Pt:Bld:Ord
4663,Views AP,Views AP^WO & W L-bending:Find:Pt:Abdomen>Spine.lumbar:Doc:XR
4664,Morphine,Morphine:Mass:Pt:Dose:Qn
4665,Views AP,View AP^W standing:Find:Pt:Lower extremity.bilateral:Doc:XR
4666,Chlamydia trachomatis antibody,Chlamydia trachomatis Ab:PrThr:Pt:Ser:Ord:IF
4667,Multisection,Multisection^W contrast IV:Find:Pt:Whole body:Doc:CT
4668,Cryoglobulin.IgA,Cryoglobulin.IgA:MCnc:Pt:Ser:Qn:Cold incubation
4669,Inulin,Inulin:MCnc:Pt:Ser^Control:Qn
4670,Herpes simplex virus 2 Ab,Herpes simplex virus 2 Ab:ACnc:Pt:CSF:Qn:IF
4671,Views lateral,Deprecated Neck XR Lat
4672,HLA-A2 SBT,HLA-A2 SBT:Type:Pt:Bld/Tiss:Nom:High resolution
4673,Weight container+Specimen,Weight container+Specimen:Mass:Pt:Stool:Qn
4674,Streptococcus pneumoniae Danish serotype 1 IgG,Deprecated Streptococcus pneumoniae 1 IgG Ab [Mass/volume] in Serum --1st specimen
4675,Creatinine,Creatinine^4.5H post XXX challenge:SCnc:Pt:Urine:Qn
4676,Respiratory syncytial virus IgG,Respiratory syncytial virus Ab.IgG:PrThr:Pt:Ser:Ord:IA
4677,Group counseling note,Group counseling note:Finding:Point in time:{Setting}:Document:{Provider}
4678,Legionella pneumophila 13 IgM,Legionella pneumophila 13 Ab.IgM:Titr:Pt:Ser:Qn:IF
4679,Epstein Barr virus capsid IgG,Epstein Barr virus capsid Ab.IgG:Titr:Pt:Body fld:Qn:IF
4680,Rhinovirus+Enterovirus RNA,Rhinovirus+Enterovirus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar
4681,Acyclovir,Acyclovir:Mass:Pt:Dose:Qn
4682,Volume expired during 3.0 s of forced expiration,Volume expired during 3.0 s of forced expiration:Vol:Pt:Respiratory system:Qn:Predicted
4683,Vendor serial number,Vendor serial number:ID:Pt:Height device:Nom
4684,Ketamine,Ketamine:Mass:Pt:Dose:Qn
4685,Porphyrins/Creatinine,Porphyrins/Creatinine:MRto:24H:Urine:Qn
4686,Invasive component size.additional dimension 1,Invasive component size.additional dimension 1:Len:Pt:Breast tumor:Qn
4687,Chlamydia species antigen,Chlamydia sp Ag:PrThr:Pt:Cvx:Ord:IF
4688,Hemoglobin H/Hemoglobin.total,Hemoglobin H/Hemoglobin.total:MFr:Pt:Bld:Qn
4689,Multisection,Multisection^W reduced contrast volume IV:Find:Pt:Pelvis:Doc:CT
4690,Naproxen,naproxen:mass:point in time:dose med or substance:quantitative
4691,View,Views^during electroconvulsive shock treatment:Find:Pt:Head>Brain:Doc:NM
4692,Aspartate/Creatinine,Aspartate/Creatinine:MRto:24H:Urine:Qn
4693,Cortisol/Creatinine,Cortisol/Creatinine:MRto:24H:Urine:Qn
4694,Tissue cores.positive.carcinoma,Tissue cores.positive.carcinoma:Num:Pt:Tissue core:Qn
4695,T classification,Deprecated T classification in Prostate tumor by CAP cancer protocols
4696,Epinephrine,Epinephrine^3H post 300 ug cloNIDine PO:SCnc:Pt:Plas:Qn
4697,Growth Hormone,Somatotropin^1H post dose ornithine:ACnc:Pt:Ser/Plas:Qn
4698,Human coronavirus NL63 IgG,Human coronavirus NL63 Ab.IgG:PrThr:Pt:Ser:Ord
4699,Spermatozoa IgG binding location,Spermatozoa IgG binding location:Prid:Pt:Semen:Nom
4700,Guidance for placement of radiation therapy fields,Guidance for placement of radiation therapy fields:Find:Pt:XXX:Doc:US
4701,Views GE 3,Finger third - right Narrative X-ray GE 3 views
4702,BHD gene targeted mutation analysis,BHD gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen
4703,Norepinephrine,Norepinephrine^2H post XXX challenge:SCnc:Pt:Plas:Qn
4704,Stage.summary & TNM-M override flag,Stage.summary & TNM-M override flag:Arb:Pt:Cancer case.XXX:Ord
4705,Event description.general nursing care,Event description.general nursing care:Find:Pt:^Patient:Nom:Observed.MERSTH
4706,Lipoprotein.beta.subparticle.intermediate,Lipoprotein.beta.subparticle.intermediate:EntLen:Pt:Ser/Plas:Qn
4707,Estradiol,Estradiol^1H post dose corticotropin:MCnc:Pt:Ser/Plas:Qn
4708,Insulin,Insulin^1H post XXX challenge:SCnc:Pt:Ser/Plas:Qn
4709,PRX gene targeted mutation analysis,PRX GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NOM:MOLGEN
4710,Parainfluenza virus Ag panel,Parainfluenza virus Ag panel:-:Pt:XXX:-:IF
4711,Derived SEER summary stage 1977 conversion method,Derived SEER summary stage 1977 conversion method:Arb:Pt:Cancer.XXX:Ord
4712,Boost radiation treatment modality,Boost radiation treatment modality:Prid:Pt:Radiation.Rx:Nom
4713,Chlamydia trachomatis IgM,Chlamydia trachomatis Ab.IgM:Titr:Pt:CSF:Qn
4714,Chlamydia sp Ab.IgA,Chlamydia sp Ab.IgA:Titr:Pt:Ser:Qn
4715,Views 4,Deprecated Mandible - left X-ray 4 views
4716,Insulin,Insulin^pre dose glucagon:ACnc:Pt:Ser/Plas:Qn
4717,Growth Hormone,Somatotropin^15M post dose triple bolus:MCnc:Pt:Ser/Plas:Qn
4718,Phosphatidylethanolamine antibody,Phosphatidylethanolamine Ab:ACnc:Pt:Ser:Qn:IA
4719,Vaccenate,Vaccenate:SCnc:Pt:Ser/Plas:Qn
4720,arachidonate,Arachidonate:SCnc:Pt:Ser/Plas:Qn
4721,Eicosapentaenoate,Eicosapentaenoate:SCnc:Pt:Ser/Plas:Qn
4722,HIV 1 p40 Ab,HIV 1 p40 Ab:PrThr:Pt:Ser:Ord:IB
4723,Multisection,Multisection^WO contrast:Find:Pt:Head>Head vessels:Doc:MR.angio
4724,West Nile virus polyvalent E Ab,West Nile virus polyvalent E Ab:PrThr:Pt:XXX:Ord:IA
4725,Imipramine,Imipramine:PrThr:Pt:Ser/Plas:Ord
4726,View,Views^W contrast IA:Find:Pt:Upper extremity.left>Upper extremity arteries:Doc:RF.angio
4727,Carnitine.free (C0),Carnitine.free (C0):SCnc:Pt:Bld.dot:Qn
4728,Netilmicin,Netilmicin^peak:MCnc:Pt:Ser/Plas:Qn
4729,Multisection,Multisection:Find:Pt:Upper extremity.left>Upper extremity artery:Doc:US.doppler
4730,Coxiella burnetii antibody,Coxiella burnetii Ab:Titr:Pt:CSF:Qn
4731,Iron,Iron:MCnc:Pt:Stool:Qn
4732,cyclobenzaprine,Cyclobenzaprine:MCnc:Pt:Ser/Plas:Qn:Screen
4733,View,Views:Find:Pt:Upper extremity.bilateral>Finger.fifth:Doc:XR
4734,Sarcocystis neurona antibody,Sarcocystis neurona Ab:PrThr:Pt:Ser:Ord:IF
4735,FRANCISELLA TULARENSIS,Francisella tularensis:PrThr:Pt:Isolate:Ord:Organism specific culture
4736,Hemoglobin cast,Hemoglobin casts:PrThr:Pt:Urine sed:Ord:Microscopy.light
4737,desmethyldoxepin,Nordoxepin:MCnc:Pt:Ser/Plas:Qn:Screen
4738,Path report.final diagnosis section - text,Deprecated Pathology report final diagnosis section - text
4739,View,View^during surgery:Find:Pt:Lower extremity.left>Hip:Doc:XR
4740,Guidance for needle localization,Guidance for needle localization:Find:Pt:XXX:Doc:RF
4741,p-Hydroxyamphetamine,Para hydroxyamphetamine:MRat:24H:Urine:Qn
4742,Views multiple areas,Views multiple areas^W radionuclide IV:Find:Pt:XXX>Bone marrow:Doc:NM
4743,4-Aminobenzoate,Para aminobenzoate:MRat:24H:Urine:Qn
4744,Progesterone,Progesterone [Mass or Molecules/volume] in Serum or Plasma
4745,Testosterone,Testosterone [Mass or Molecules/volume] in Serum or Plasma
4746,Carbonyldiamide,Urea nitrogen [Mass or Molecules/volume] in Urine
4747,Colorado tick fever virus Ab.IgG & IgM panel,Colorado tick fever virus Ab.IgG & IgM panel:-:Pt:Ser:Qn
4748,View decubitus portable,Deprecated View decubitus portable
4749,View,Views^W manual stress:Find:Pt:Upper extremity.left>Thumb:Doc:XR
4750,View,Views^W contrast intra salivary duct:Find:Pt:Neck>Parotid gland.left:Doc:RF
4751,View,Views^W contrast IA:Find:Pt:Chest>Pulmonary arteries:Doc:RF.angio
4752,Glucose,Glucose^1.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
4753,Glucose,Glucose^4H post XXX challenge:SCnc:Pt:Ser/Plas:Qn
4754,Perphenazine,Perphenazine:PrThr:Pt:Urine:Ord
4755,Granular casts.fine (substance),Granular casts.fine:Naric:Pt:Urine sed:Qn:Microscopy.light.HPF
4756,Erythrocyte cast,Erythrocyte casts:Naric:Pt:Urine:Qn:Computer assisted
4757,Arsenic,Arsenic:SCnc:24H:Urine:Qn
4758,Views oblique,View oblique:Find:Pt:Upper extremity>Finger.third:Doc:XR
4759,View,Views^W contrast IA:Find:Pt:Head+Neck>Carotid artery.bilateral & Head>Cerebral artery.bilateral:Doc:RF.angio
4760,Basophils+Eosinophils+Monocytes/100 leukocytes,Basophils+Eosinophils+Monocytes/100 leukocytes:NFr:Pt:Bld:Qn:Automated count
4761,Catecholamines,Catecholamines:PrThr:24H:Urine:Ord
4762,"Polyp size, largest dimension",Polyp size greatest dimension:Len:Pt:Specimen:Qn
4763,Histone Ab.IgG,Histone Ab.IgG:PrThr:Pt:Ser:Ord
4764,RPS6KA3 gene targeted mutation analysis,RPS6KA3 GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NAR:MOLGEN
4765,Views 2,Views 2:Find:Pt:Lower extremity.left>Acetabulum:Doc:XR
4766,Parainfluenza virus 2 IgG,Parainfluenza virus 2 Ab.IgG:ACnc:Pt:Ser:Qn
4767,Motile spermatozoa,Spermatozoa.motile:Naric:Pt:Semen:Qn:Microscopy.light.HPF
4768,Coagulation factor X inhibitor,Coagulation factor X inhibitor:ACnc:Pt:PPP:Qn:Coag
4769,Hepatitis B e Antigens,Hepatitis B virus little e Ag:Titr:Pt:Ser:Qn
4770,Creatine Kinase MB Isoenzyme,Creatine kinase.MB:CCnc:Pt:Ser/Plas:Qn
4771,Cryptococcus sp Ag,Cryptococcus sp Ag:Titr:Pt:CSF:Qn
4772,Lactate,Lactate:SCnc:Pt:Bld:Qn
4773,Acidity.total,Acidity.total:SCnc:Pt:Gast fld:Qn
4774,Hexacarboxylporphyrin,Hexacarboxylporphyrins:MCnt:Pt:Stool:Qn
4775,TRYPSIN,Trypsin^2nd specimen post dose sincalide:CCnc:Pt:Body fld:Qn
4776,Disulfiram,Disulfiram:MCnc:Pt:Ser/Plas:Qn
4777,beta 1 globulin,Beta 1 globulin:MRat:24H:Urine:Qn:Electrophoresis
4778,View transthoracic,View transthoracic:Find:Pt:Upper extremity.right>Shoulder:Doc:XR
4779,Note (document),Note:Find:Pt:{Setting}:Doc:Pathology
4780,Consultation note,Consultation note:Find:Pt:{Setting}:Doc:Physical therapy
4781,Doxepin,Doxepin:PrThr:Pt:Urine:Ord
4782,chloromethyl methyl ether,Chloromethyl methyl ether:MCnc:Pt:Air:Qn
4783,Spermatozoa.tail tip Ab.IgM/100 spermatozoa,Spermatozoa.tail tip Ab.IgM/100 spermatozoa:NFr:Pt:XXX:Qn:Immunobead
4784,Cystathionine,Cystathionine:SCnc:Pt:Vitr fld:Qn
4785,Methionine,Methionine:SCnc:Pt:Vitr fld:Qn
4786,Miocamycin,Miocamycin:Susc:Pt:Isolate:Qn:MLC
4787,Karyotype (cell structure),Karyotype:Prid:Pt:Bone mar:Nom
4788,Interleukin-1,Interleukin 1:MCnc:Pt:Ser/Plas:Qn
4789,Multisection,Multisection^WO & W contrast IV:Find:Pt:Lower extremity.left:Doc:CT
4790,Views 3,Views 3:Find:Pt:Upper extremity.left>Finger:Doc:XR
4791,Columbid circovirus DNA,Columbid circovirus DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar
4792,hexachlorocyclopentadiene,Hexachlorocyclopentadiene:MCnc:Pt:Air:Qn
4793,Multisection for infection,Multisection for infection^W Ga-67 IV:Find:Pt:Whole body:Doc:NM.SPECT
4794,Minocycline,Minocycline:Susc:Pt:Isolate:OrdQn:MIC
4795,Sjogren's syndrome B antibody,Sjogrens syndrome-B extractable nuclear Ab:ACnc:Pt:Ser:Qn:IB
4796,Spore identification,Spore identification:Prid:Pt:XXX:Nom:Malachite green stain
4797,Counseling note,Counseling note:Find:Pt:{Setting}:Doc:Social worker
4798,Interventional procedure note,Interventional procedure note:Find:Pt:{Setting}:Doc:Gastroenterology
4799,Legionella pneumophila 1 IgG,Legionella pneumophila 1 Ab.IgG:PrThr:Pt:Ser:Ord
4800,Views 4,Views 4:Find:Pt:Breast:Doc:MG
4801,View,Views^W contrast IA:Find:Pt:Chest>Pulmonary arteries.right:Doc:RF.angio
4802,Views limited,Views limited^W Ga-67 IV:Find:Pt:XXX:Doc:NM
4803,Eastern equine encephalitis virus RNA,Eastern equine encephalitis virus RNA:PrThr:Pt:Bld:Ord:Probe.amp.tar
4804,Fibrinopeptide A,Deprecated Fibrinopeptide A Ag [Mass/volume] in Platelet poor plasma by EIA
4805,Leishmania tropica IgM,Leishmania tropica Ab.IgM:PrThr:Pt:Ser:Ord
4806,Views 4,Views 4:Find:Pt:Upper extremity.right>Shoulder:Doc:XR
4807,Nortriptyline,Nortriptyline^trough >12h post dose:MCnc:Pt:Ser/Plas:Qn
4808,Multisection,Multisection^WO contrast:Find:Pt:Abdomen>Kidney.bilateral:Doc:XR.tomography
4809,Multisection perfusion,Multisection perfusion^W Tc-99m Sestamibi IV:Find:Pt:Chest>Heart:Doc:NM.SPECT
4810,Monocyte+Macrophage/100 leukocytes,Monocytes+Macrophages/100 leukocytes:NFr:Pt:Bronchial:Qn
4811,Carbonyldiamide,Urea nitrogen:SCnc:24H:Urine:Qn
4812,Multisection,Multisection:Find:Pt:Head>Internal auditory canal:Doc:CT
4813,Multisection,Multisection:Find:Pt:Upper extremity>Elbow:Doc:XR.tomography
4814,Views AP,View AP^W R-bending:Find:Pt:Chest>Spine.thoracic:Doc:XR
4815,phendimetrazine,Phendimetrazine:MRat:24H:Urine:Qn
4816,Herpes virus 8 DNA,Herpes virus 8 DNA:PrThr:Pt:Ser/Plas:Ord:Probe.amp.tar
4817,SARS coronavirus Urbani ribonucleic acid,SARS coronavirus Urbani RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar
4818,clorprenaline,Clorprenaline:MRat:24H:Urine:Qn
4819,View Towne,View Towne:Find:Pt:Head>Skull:Doc:XR
4820,Immunoglobulin G,IgG:MCnc:Pt:Urine:Qn
4821,LOINC class types,Class:Type:Pt:Intubation tube:Nom
4822,Mesothelial cell,Mesothelial cells:NCnc:Pt:Synv fld:Qn
4823,Leukocytes other,Leukocytes other:NCnc:Pt:Plr fld:Qn
4824,View,Views^W contrast IA:Find:Pt:Head+Neck>Carotid arteries+Vertebral artery:Doc:RF.angio
4825,View,Deprecated RF Kidney - left Views W contrast retrograde via urethra
4826,Probenecid,Probenecid:MCnc:Pt:Urine:Qn
4827,methicillin,Methicillin:Susc:Pt:Isolate:OrdQn:Agar diffusion
4828,Physical findings,Physical findings:Find:Pt:Liver:Nom
4829,Clostridium tetani IgG,Clostridium tetani Ab.IgG:PrThr:Pt:Ser:Ord
4830,Furcation classification,Furcation classification:Class:Pt:{Tooth}:Ord:Glickman classification
4831,OB ultrasound panel,OB ultrasound panel:-:Point in time:^Patient:-
4832,Arterial patency,Arterial patency^pre arterial puncture:PrThr:Pt:Wrist artery:Ord
4833,Multisection,Multisection:Finding:Point in time:Larynx:Narrative:MRI
4834,MFN2 gene targeted mutation analysis,MFN2 GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NOM:MOLGEN
4835,Views static limited,Deprecated NM Bone Limited Static Views
4836,Views for endocrine tumor,Views for endocrine tumor^W I-131 MIBG IV:Find:Pt:Whole body:Doc:NM
4837,M8-nelfinavir,Nelfinavir M8:MCnc:Pt:Ser/Plas:Qn
4838,Multisection diffusion weighted,Deprecated Brain MR diffusion weighted
4839,View,Views^W contrast:Find:Pt:XXX>Visceral vessels:Doc:RF.angio
4840,West Nile virus RNA,West Nile virus RNA:PrThr:Pt:XXX:Ord:Probe
4841,Creatinine,Creatinine:SCnc:24H:Dial fld prt:Qn
4842,Cells.CD3+CD8+/100 cells,Cells.CD3+CD8+/100 cells:NFr:Pt:XXX:Qn
4843,Flowsheet,Flowsheet:Find:Pt:{Setting}:Doc:Speech-language pathology
4844,allysine,Alpha-aminoadipic semialdehyde:SCnc:Pt:Ser/Plas:Qn
4845,Strongyloides sp Ab.IgG,Strongyloides sp Ab.IgG:PrThr:Pt:Ser:Ord:IA
4846,creosol,Creosol:PrThr:Pt:XXX:Ord
4847,Treatment plan note,Deprecated Audiology Treatment plan note
4848,D- & L-2-hydroxyglutarate panel,D- & L-2-hydroxyglutarate panel:-:Pt:Bld.dot:-
4849,Cefmetazole,Cefmetazole:Susc:Pt:Isolate:OrdQn:Agar diffusion
4850,Legionella pneumophila 4 IgM,Legionella pneumophila 4 Ab.IgM:Titr:Pt:Ser:Qn:IF
4851,Blood group antibody C^w^,C little w Ab:PrThr:Pt:Ser/Plas:Ord
4852,Methylone cutoff,Methylone cutoff:MCnc:Pt:Urine:Qn:Confirm
4853,Pathologic casts,Pathologic casts:NCnc:Pt:Urine:Qn:Automated count
4854,Blood flow velocity.S wave.max,Blood flow velocity.S wave.max:Vel:Pt:Pulmonary vein:Qn:US.doppler.PW
4855,Education note,Education note:Find:Pt:{Setting}:Doc:Pulmonary disease
4856,Cardiac Output,Cardiac output:VRat:Pt:Heart.ventricle.left:Qn:US.3D
4857,alminoprofen,Alminoprofen:MCnc:Pt:Bld:Qn
4858,Regurgitant blood flow rate.diastole,Regurgitant blood flow rate.diastole:VRat:Pt:Aortic valve:Qn:US.doppler+Calculated by PISA method
4859,Transfer summary note,Transfer summary note:Find:Pt:{Setting}:Doc:Geriatric medicine
4860,Guidance for peripheral venous access,Guidance for peripheral venous access:Find:Pt:XXX>Vein:Doc:US
4861,Radial strain rate.diastole.max,Radial strain rate.diastole.max:ARat:Pt:Heart.ventricle.left:Qn:US.2D
4862,Eicosatrienoate,Eicosatrienoate:EntSub:Pt:Ser/Plas:Qn
4863,Intravascular diastolic,Intravascular diastolic:Pres:Pt:Splenic artery:Qn
4864,Intravascular end diastolic,Intravascular end diastolic:Pres:Pt:Heart.ventricle.right:Qn
4865,Insulin,Insulin^30M post 75 g glucose PO:MCnc:Pt:Ser/Plas:Qn
4866,pyridinoline,Pyridinoline:MRat:2H:Urine:Qn
4867,Taenia solium larva 21kD Ab,Taenia solium larva 21kD Ab:PrThr:Pt:Ser:Ord:IB
4868,8-hydroxyloxapine,8-Hydroxyloxapine:MCnc:Pt:Ser/Plas:Qn
4869,Pepsin A+Pepsinogen A,Pepsin A+Pepsinogen A:MCnc:Pt:Respiratory.lower:Qn:IA
4870,Skin-fold thickness (finding),Skin fold thickness:Len:Pt:Waist:Qn
4871,sodium intake,Sodium intake:SRat:8H:^Patient:Qn
4872,ACSF3 gene full mutation analysis,ACSF3 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing
4873,Extraocular retinoblastoma classification,Extraocular retinoblastoma classification^at final disease stage:Class:Pt:Eye.left:Ord:Reese-Ellsworth system
4874,Methylphenidate,Methylphenidate:MCnt:Pt:Hair:Qn
4875,Peritoneal tube site,Peritoneal tube site:Anatomy:Point in time:*^Patient:Nominal
4876,DFNB31 gene mutation analysis limited to known familial mutations,DFNB31 gene mutation analysis limited to known familial mutations:Find:Pt:Bld/Tiss:Doc:Molgen
4877,liver fibrosis score,Liver fibrosis score:Score:Pt:Ser/Plas:Qn:Calculated.HepaScore
4878,Time to max tissue velocity.systole,Time to max tissue velocity.systole:Time:Pt:Heart.ventricle.left.basal lateral:Qn:US.tissue doppler
4879,Checklist,Checklist:Finding:Point in time:{Setting}:Document:{Role}
4880,Certificate (record artifact),Certificate:Finding:Point in time:{Setting}:Document:{Role}
4881,Care plan - recommended C-CDA R2.0 & R2.1 sections,Care plan - recommended C-CDA R2.0 & R2.1 sections:-:Pt:{Setting}:-
4882,Intravascular diastolic,Intravascular diastolic:Pres:Pt:Femoral artery:Qn
4883,LOINC class types,Class:Type:Pt:Rate control device:Nom
4884,Ventricular morphology,Ventricular morphology:Impression/interpretation of study:Point in time::Narrative:EKG
4885,Coxsackievirus A7 Ab,Coxsackievirus A7 Ab:ACnc:Pt:Ser:Qn
4886,Hexadecenoate,Hexadecenoate:EntSub:Pt:RBC:Qn
4887,suberylglycine,Suberylglycine:SCnc:Pt:Ser/Plas:Qn
4888,N-acetyltyrosine,N-acetyltyrosine:SCnc:Pt:Ser/Plas:Qn
4889,Q wave depth.lead V2,Q wave depth.lead V2:Elpot:Pt:Heart:Qn:EKG
4890,HLA-DQ Ab.IgG,HLA-DQ Ab.IgG:Prid:Pt:Ser/Plas:Nom:IA
4891,Bacteria identified,Bacteria identified:Prid:Pt:Implanted device:Nom:Culture
4892,Parainfluenza virus 3 NP gene,Parainfluenza virus 3 NP gene:PrThr:Pt:Nph:Ord:Probe.amp.tar
4893,Respiratory syncytial virus B F gene,Respiratory syncytial virus B F gene:PrThr:Pt:Nph:Ord:Probe.amp.tar
4894,PSEN1 gene mutation analysis limited to known familial mutations,PSEN1 gene mutation analysis limited to known familial mutations:Find:Pt:Bld/Tiss:Doc:Molgen
4895,1-(3-chlorophenyl)piperazine,M-chlorophenylpiperazine:MCnc:Pt:Bld:Qn
4896,R- & S-beta aminoisobutyrate & D- & L-serine pattern,R- & S-beta aminoisobutyrate & D- & L-serine pattern:Imp:Pt:CSF:Nar
4897,Cholestanols,Bile alcohols:Imp:Pt:Urine:Ord
4898,Pterins pattern,Pterins pattern:Imp:Pt:Ser/Plas:Nar
4899,Azelate,Azelate:SCnc:Pt:Ser/Plas:Qn
4900,Hydantoin-5-propionate,Hydantoin-5-propionate:SCnc:Pt:Ser/Plas:Qn
4901,Discharge instructions,Discharge instructions:Find:Pt:{Setting}:Doc:Nephrology
4902,Discharge instructions,Discharge instructions:Find:Pt:{Setting}:Doc:Neurology
4903,Discharge instructions,Discharge instructions:Find:Pt:{Setting}:Doc:Nurse practitioner
4904,Beta alanine & Beta aminoisobutyrate & Gamma aminobutyrate pattern,Beta alanine & Beta aminoisobutyrate & Gamma aminobutyrate pattern:Imp:Pt:CSF:Nar
4905,Maprotiline+Normaprotiline,Maprotiline+Normaprotiline:MCnc:Pt:Ser/Plas:Qn
4906,View,Views^W radionuclide IV:Find:Pt:XXX>Lymph node:Doc:NM
4907,View,Views^W radionuclide IV:Find:Pt:XXX>Lymph node.bilateral:Doc:NM
4908,Mycoplasma hyopneumoniae Ab sample/Positive control,Mycoplasma hyopneumoniae Ab sample/Positive control:RelRto:Pt:Ser:Qn:IA
4909,Stenosis degree,Stenosis degree:LenFr:Pt:Posterolateral from right coronary artery:Qn
4910,"N,N-dimethylarginine","N,N-dimethylarginine:MCnc:Pt:Ser/Plas:Qn"
4911,Vitamin B1 Intake,Vitamin B1 intake:MRat:24H:^Patient:Qn:Estimated
4912,Operative Surgical Procedures,History of surgical procedures:Finding:Point in time:^Patient:Nominal:Reported
4913,Carbon Tetrachloride,Carbon tetrachloride:Mass Concentration:Point in time:Whole blood:Quantitative
4914,IgA subclass 1/IgA.total,immunoglobulin A subclass 1/immunoglobulin A.total:Mass Fraction:Point in time:Serum:Quantitative
4915,Flurazepam,Flurazepam:SCnc:Pt:XXX:Qn
4916,Multisection,Multisection^W contrast IV:Find:Pt:Abdomen:Doc:CT
4917,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA:PrThr:Pt:Urine:Ord:Probe.amp.tar
4918,Calcium Oxalate,Calcium oxalate:EngDiff:24H:Urine:Qn
4919,Chromosome region 17p13.3 deletion,Chromosome region 17p13.3 deletion:Find:Pt:Amnio fld/CVS:Doc:FISH
4920,Physical findings,Physical findings:Finding:Point in time:Rectum:Nominal:Observed
4921,cold agglutinins,Cold agglutinin^1H post incubation:Titr:Pt:Ser:Qn:37 deg C incubation
4922,Cold agglutinin panel,Cold agglutinin panel:-:Pt:Ser:-
4923,Alpha linolenate intake,Alpha linolenate intake:MRat:24H:^Patient:Qn:Measured
4924,Casein intake,Casein intake:MRat:24H:^Patient:Qn:Measured
4925,Copper intake,Copper intake:MRat:24H:^Patient:Qn:Measured
4926,Body Weight,Body weight^ante partum:Mass:Pt:^Patient:Qn:Measured
4927,Intravascular diastolic,Intravascular diastolic:Pres:Pt:Superior mesenteric artery:Qn
4928,Ambrosia artemisiifolia native (nAmb a) 1 Ab.IgE.RAST class,Ambrosia artemisiifolia native (nAmb a) 1 Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
4929,Pholcodine Ab.IgE.RAST class,Pholcodine Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
4930,Country of exposure to illness,Country of exposure to illness:Loc:Pt:^Patient:Nom
4931,Evidence supporting myopathy,Evidence supporting myopathy:Type:Pt:^Patient:Nom
4932,Intraocular retinoblastoma classification,Intraocular retinoblastoma classification^at initial diagnosis:Class:Pt:Eye.left:Ord:ICRB
4933,Tendon reflex assessment panel,Tendon reflex assessment panel:-:Pt:Neurologic deep tendon reflexes:-
4934,Skin assessment,Skin assessment:Imp:Pt:Skin:Nom
4935,Fructose intake,Fructose intake:MRat:24H:^Patient:Qn:Estimated
4936,Metabolic equivalent of task by population resting metabolic rate panel,Metabolic equivalent of task by population resting metabolic rate panel:-:1M^mean:^Patient:-
4937,Discharge teaching note,Discharge teaching note:Find:Pt:{Setting}:Doc:Physical therapy
4938,Flowsheet,Flowsheet:Find:Pt:{Setting}:Doc:Orthopaedic surgery
4939,Biotinidase,Biotinidase:CCnt:Pt:Ser/Plas:Qn
4940,Plan of care note,Plan of care note:Find:Pt:{Setting}:Doc:Dentistry
4941,heart rate,Heart rate:NRat:Pt:Capillary bed:Qn:Pulse oximetry
4942,Galactose,Galactose:MCnc:Pt:RBC:Qn
4943,Beta hydroxybutyrate/Acetoacetate,Beta hydroxybutyrate/Acetoacetate:SRto:Pt:CSF:Qn
4944,Hydrogen/Expired gas,Hydrogen/Expired gas^3.5H post XXX challenge:VFr:Pt:Exhl gas:Qn
4945,"Antigens, CD15",CD15 Ag:PrThr:Pt:Bone mar:Ord:Immune stain
4946,desoxycorticosterone,11-Deoxycorticosterone:MCnc:Pt:Bld.dot:Qn
4947,Cobalamins,Cobalamins:SCnc:Pt:Body fld:Qn
4948,Glucose,Glucose^4th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn
4949,Potassium/Creatinine,Potassium/Creatinine:SRto:24H:Urine:Qn
4950,Tinidazole,Tinidazole:Susc:Pt:Isolate:OrdQn:Agar diffusion
4951,Yersinia sp Ab.IgG & IgM panel,Yersinia sp Ab.IgG & IgM panel:-:Pt:Ser:-
4952,Leishmania mexicana IgM,Leishmania mexicana Ab.IgM:ACnc:Pt:Ser:Qn:IF
4953,prasterone,Dehydroepiandrosterone:MCnc:Pt:Saliva:Qn
4954,Festuca elatior Ab.IgG,Festuca elatior Ab.IgG:MCnc:Pt:Ser:Qn
4955,Cytomegalovirus antibody,Deprecated Cytomegalovirus Ab [Titer] in Serum by Latex agglutination
4956,Cells.CD13/100 cells,Cells.CD13/100 cells:NFr:Pt:CSF:Qn
4957,Mercury/Creatinine,Mercury/Creatinine:SRto:24H:Urine:Qn
4958,Calcium bilirubinate/Total,Calcium bilirubinate/Total:MFr:Pt:Calculus:Qn
4959,Leukocytes,Leukocytes^^corrected for nucleated erythrocytes:NCnc:Pt:Bone mar:Qn
4960,Rubus idaeus Ab.IgG4,Rubus idaeus Ab.IgG4:MCnc:Pt:Ser:Qn
4961,Sodium nitrite leukotriene release,Sodium nitrite leukotriene release:MCnc:Pt:WBC:Qn
4962,HLA-DPw4 antigen,HLA-DPw4:PrThr:Pt:Bld/Tiss^Donor:Ord
4963,Cocaine+Benzoylecgonine,Cocaine+Benzoylecgonine:PrThr:Pt:Ser/Plas:Ord:Screen
4964,3-hydroxypropionate,3-Hydroxypropionate:SCnc:Pt:Amnio fld:Qn
4965,Cells.CD3+CD16+/100 cells,"Cells.CD3+CD16+/100 cells:Number Fraction:Point in time:Body fluid, unsp:Quantitative"
4966,Oxygen saturation test result,Oxygen saturation:MFr:Pt:BldV:Qn:Calculated from oxygen partial pressure
4967,Heptaporphyrin/Creatinine,Deprecated Heptaporphyrin/Creatinine [Mass Ratio] in Urine
4968,Alpha 2 globulin/Protein.total,Alpha 2 globulin/Protein.total:MFr:Pt:Dial fld:Qn:Electrophoresis
4969,Heparin 10000 U per mL given,Heparin 10000 U per mL given:Vol:Pt:^Patient:Qn
4970,Plan of care note,Plan of care:Finding:Point in time:^Patient:Document
4971,Influenza A virus antibody,Influenza virus A Ab:Titr:Pt:Ser:Qn:Comp fix
4972,Integrin alpha5,Deprecated CD49e cells/100 cells in Blood
4973,Bacteroides melaninogenicus antigen,Bacteroides melaninogenicus Ag:PrThr:Pt:XXX:Ord:IF
4974,Dicarboxydodecanoylcarnitine (C12-DC)/Creatinine,Dicarboxydodecanoylcarnitine (C12-DC)/Creatinine:SRto:Pt:Urine:Qn
4975,Dicarboxypalmitoylcarnitine (C16-DC),Dicarboxypalmitoylcarnitine (C16-DC):SCnc:Pt:Ser/Plas:Qn
4976,Human leukocyte antigen B44(12),HLA-B44(12):PrThr:Pt:Bld/Tiss:Ord
4977,Chylomicrons/Lipoprotein.total,Chylomicrons/Lipoprotein.total:MFr:Pt:Ser/Plas:Qn
4978,Legionella sp rRNA,Legionella rRNA XXX Ql Prb
4979,Ganglioside GM2 Ab.IgG/Ganglioside GM2 Ab.IgM,Ganglioside GM2 Ab.IgG/Ganglioside GM2 Ab.IgM:Ratio:Pt:Ser:Qn:IA
4980,Mucin-1 Antigen,Cancer Ag 15-3:ACnc:Pt:Periton fld:Qn
4981,multiple sclerosis panel,Multiple sclerosis panel:-:Pt:Ser+CSF:-
4982,Trichinella spiralis IgG,Trichinella spiralis Ab.IgG:Titr:Pt:Ser:Qn:IF
4983,CD8 Antigens,Deprecated CD8 cells/100 cells in Blood
4984,anidulafungin,Anidulafungin:Susc:Pt:Isolate:OrdQn:MIC
4985,prasterone,Dehydroepiandrosterone^pre 250 ug corticotropin:MCnc:Pt:Ser/Plas:Qn
4986,HLA-Dw16 antigen,HLA-Dw16:PrThr:Pt:Bld/Tiss:Ord
4987,3-Hydroxyisobutyrate/Creatinine,3-Hydroxyisobutyrate/Creatinine:SRto:24H:Urine:Qn
4988,Antigen of Hepatitis C virus core,Hepatitis C virus core Ag:PrThr:Pt:Bld/Bone mar^Donor:Ord
4989,21-deoxycortisol,21-Deoxycortisol:SCnc:Pt:Ser/Plas:Qn
4990,Echovirus 19 Ab,Echovirus 19 Ab:Titr:Pt:Ser:Qn:Neut
4991,Leukocytes,Leukocytes:Naric:Pt:Stool:Qn:Microscopy.light.HPF
4992,HIV 2 Ab Signal/Cutoff,HIV 2 Ab Signal/Cutoff:RelACnc:Pt:Ser/Plas:Qn:IA
4993,Cholesterol crystals (substance),Cholesterol crystals:Naric:Pt:Urine:Qn:Computer assisted
4994,Hemoglobin D+G/Hemoglobin.total,Hemoglobin D+G/Hemoglobin.total:MFr:Pt:Bld:Qn
4995,Tubular basement membrane Ab.IgG,Tubular basement membrane Ab.IgG:ACnc:Pt:Ser:Qn:IF
4996,Bartonella elizabethae IgG,Bartonella elizabethae Ab.IgG:Titr:Pt:Ser:Qn:IF
4997,Urea renal clearance/1.73 sq M,Urea renal clearance/1.73 sq M:ArVRat:XXX:Urine+Ser/Plas:Qn
4998,3-Hydroxymyristoleylcarnitine (C14:1-OH),3-Hydroxymyristoleylcarnitine (C14:1-OH):SCnc:Pt:Bld.dot:Qn
4999,3-dechloroethylifosfamide,3-Dechloroethylifosfamide^2D post dose ifosfamide:MCnc:Pt:Bld:Qn
5000,Domperidone,Domperidone:SCnc:Pt:Ser/Plas:Qn
5001,Bartonella quintana IgM,Bartonella quintana Ab.IgM:ACnc:Pt:Ser:Qn:IA
5002,Adenovirus IgG,Adenovirus Ab.IgG:ACnc:Pt:Ser:Qn:IA
5003,Erythrocytes.Plasmodium sp infected/100 erythrocytes,Erythrocytes.Plasmodium sp infected/100 erythrocytes:NFr:Pt:Bld:Qn
5004,Multisection,Multisection^W contrast IV:Find:Pt:Head+Neck>Nasopharynx:Doc:CT
5005,Ehrlichia sp identified,Ehrlichia sp identified:Prid:Pt:XXX:Nom:Organism specific culture
5006,Blasts.CD33,Blasts.CD33:ACnc:Pt:Bld:Qn
5007,BCL10 Ag,BCL10 Ag:PrThr:Pt:Tiss:Ord:Immune stain
5008,Clusterin Ag,Clusterin Ag:PrThr:Pt:Tiss:Ord:Immune stain
5009,Iron,Iron:SCnt:Pt:Hair:Qn
5010,Muscle specific receptor tyrosine kinase Ab,Muscle specific receptor tyrosine kinase Ab:SCnc:Pt:Ser:Qn
5011,DNA marker analysis test coverage panel,"deoxyribonucleic acid marker analysis test coverage panel:-:Point in time:Whole blood/Tissue, unspecified:-:Molecular Genetics"
5012,17-alpha-Hydroxyprogesterone,17-Hydroxyprogesterone^30M post dose corticotropin:SCnc:Pt:Ser/Plas:Qn
5013,Multisection,Multisection^W contrast IV:Find:Pt:Chest>Clavicle.left:Doc:MR
5014,Adenosine monophosphate.cyclic/Creatinine,Adenosine monophosphate.cyclic/Creatinine^1st specimen post XXX challenge:Ratio:Pt:Urine:Qn
5015,Zinc/Creatinine,Zinc/Creatinine:SRto:24H:Urine:Qn
5016,Thyroid newborn screening panel,Thyroid newborn screening panel:Mass Concentration:Point in time:Blood filter paper:-
5017,Newborn hearing screen,Newborn hearing screen:Arb:Pt:Ear.right:Ord
5018,HLA-B73 antigen,HLA-B73:PrThr:Pt:Bld/Tiss:Ord
5019,11-hydroxy-delta(9)-tetrahydrocannabinol,11-Hydroxy delta-9 tetrahydrocannabinol:MCnc:Pt:XXX:Qn
5020,"Respiratory allergen panel, US - North Atlantic states b","Respiratory allergen panel, US - North Atlantic states b:-:Pt:Ser:-"
5021,Legionella sp Ab.IgG,Legionella sp Ab.IgG:PrThr:Pt:Ser:Ord
5022,Ribosomal ribonucleoprotein antibody,Ribonucleoprotein extractable nuclear Ab:ACnc:Pt:Ser:Qn:IA
5023,CD52 antigen,CD52 Ag:PrThr:Pt:Tiss:Ord:Immune stain
5024,Clotrimazole,Clotrimazole:Susc:Pt:Isolate:OrdQn:Gradient strip
5025,Muramidase,Lysozyme:ACnc:Pt:Urine:Qn
5026,Lactalbumin alpha Ab.IgG4,Lactalbumin alpha Ab.IgG4:MCnc:Pt:Ser:Qn
5027,Multisection limited,Multisection limited:Find:Pt:Neck:Doc:MR
5028,Views AP,View AP:Find:Pt:Lower extremity.right>Knee:Doc:XR
5029,Methadone,Methadone:MCnc:Pt:XXX:Qn
5030,Bisacodyl,Bisacodyl:MCnc:Pt:Stool:Qn
5031,Mycobacterium bovis tuberculin stimulated gamma interferon panel,Mycobacterium bovis tuberculin stimulated gamma interferon panel:-:Pt:Bld:-
5032,Pheniramine,Pheniramine:SCnc:Pt:Ser/Plas:Qn
5033,RHE gene targeted mutation analysis,RHE gene targeted mutation analysis:Type:Pt:Amnio fld:Nom:Molgen
5034,epinephrine and norepinephrine,Epinephrine+Norepinephrine:MCnc:Pt:Urine:Qn
5035,Hydrocortisone,Cortisol^5D post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn
5036,Coagulation thrombin induced.factor substitution,Coagulation thrombin induced.factor substitution^immediately after 1:4 addition of normal plasma:Time:Pt:PPP:Qn:Coag
5037,Lymphoma - CLL screen panel,Lymphoma - CLL screen panel:-:Pt:XXX:-:Flow cytometry
5038,Magnesium cutoff,Magnesium cutoff:MCnt:Pt:Stool:Qn
5039,reference lab test identifier and name,Reference lab test number and name:Identifier:time reported elsewhere:Reference lab test:Nominal
5040,HLA-DR14(6),HLA-DR14(6):PrThr:Pt:Bld/Tiss^Donor:Ord
5041,Blasts.CD1,Blasts.CD1:ACnc:Pt:XXX:Qn
5042,Aspergillus fumigatus recombinant (rAsp f) 1 Ab.IgE.RAST class,Aspergillus fumigatus recombinant (rAsp f) 1 Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
5043,Aspergillus fumigatus recombinant (rAsp f) 3 Ab.IgE.RAST class,Aspergillus fumigatus recombinant (rAsp f) 3 Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
5044,Hepatitis C Antibodies,Hepatitis C virus Ab:PrThr:Pt:Ser:Ord:IB
5045,Glucose,Glucose^4M post dose glucagon:SCnc:Pt:Ser/Plas:Qn
5046,Growth Hormone,Somatotropin^2.5H post dose glucagon:ACnc:Pt:Ser/Plas:Qn
5047,HLA-B14 antigen,HLA-B14:PrThr:Pt:Bld/Tiss:Ord
5048,Plasma cells/100 leukocytes,Plasma cells/100 leukocytes:NFr:Pt:CSF:Qn:Manual count
5049,Cichorium intybus Ab.IgG4,Cichorium intybus Ab.IgG4:MCnc:Pt:Ser:Qn
5050,Sonographer name,Sonographer name:Patient number:Point in time:^Patient:Nominal
5051,Blasts.CD179a,Blasts.CD179a:ACnc:Pt:XXX:Qn
5052,Transitional Epithelial Cells,Transitional cells:PrThr:Pt:Urine:Ord:Computer assisted
5053,Platelet aggregation.arachidonate induced,Platelet aggregation.arachidonate induced:ACnc:Pt:Bld:Qn
5054,Familial long QTS syndrome gene targeted mutation analysis,Familial long QTS syndrome gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen
5055,GQ1b ganglioside antibody,Deprecated Ganglioside GQ1b Ab [Units/volume] in Serum
5056,Hepatitis B virus precore codon 28,Deprecated Hepatitis B virus precore codon 28 [Identifier] in Serum by Probe and target amplification method
5057,California encephalitis virus Ab.IgM,California encephalitis virus Ab.IgM:Titr:Pt:CSF:Qn:IF
5058,Lymphocyte proliferation.10 umol beryllium stimulation,Lymphocyte proliferation.10 umol beryllium stimulation^7D post incubation:ACnc:Pt:Bld:Qn
5059,VFD Type B medicated feed animal drug label,VFD Type B medicated feed animal drug label:-:-:^FDA product label:Nar
5060,Gastric analysis panel,Gastric analysis panel:-:Pt:Gast fld:-
5061,Blasts.CD23/100 blasts,Blasts.CD23/100 blasts:NFr:Pt:Bone mar:Qn
5062,Blasts.cytoplasmic CD3,Blasts.cytoplasmic CD3:ACnc:Pt:Bld:Qn
5063,Blasts.CD34,Blasts.CD34:ACnc:Pt:Bld:Qn
5064,Macroblasts/100 cells,Macroblasts/100 cells:NFr:Pt:Bone mar:Qn:Manual count
5065,Mean sphered cell volume,Mean sphered cell volume:EntVol:Pt:RBC:Qn
5066,Selenium,Selenium:SRat:24H:Urine:Qn
5067,Triple phosphate crystals,Triple phosphate crystals:NCnc:Pt:Urine:Qn:Computer assisted
5068,Triple phosphate crystals,Triple phosphate crystals:Naric:Pt:Urine:Qn:Computer assisted
5069,Phosphoserine,Phosphoserine:SCnc:Pt:Bld.dot:Qn
5070,Paromomycin,Paromomycin:Susc:Pt:Isolate:OrdQn:Agar diffusion
5071,Bean green Ab.IgG4,Bean green Ab.IgG4:MCnc:Pt:Ser:Qn
5072,Homarus gammarus Ab.IgG4,Homarus gammarus Ab.IgG4:MCnc:Pt:Ser:Qn
5073,Albumin & Immunoglobulin Quotient,Albumin & Immunoglobulin Quotient:Imp:Pt:Ser+CSF:Nom
5074,Plasma cell Ag,Plasma cell Ag:PrThr:Pt:Tiss:Ord:Immune stain
5075,Streptococcus agalactiae DNA,Streptococcus agalactiae DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar
5076,Mycoplasma pneumoniae IgM,Mycoplasma pneumoniae Ab.IgM:PrThr:Pt:Ser:Ord:IF
5077,Immunoglobulin M,IgM:MRat:24H:Urine:Qn
5078,Varicella-zoster virus antigen,Varicella zoster virus Ag:PrThr:Pt:XXX:Ord:IF
5079,Hydrocortisone,Cortisol^12th specimen post XXX challenge:SCnc:Pt:Saliva:Qn
5080,Enterococcus species.vancomycin resistant,Enterococcus species.vancomycin resistant:PrThr:Pt:Urine:Ord:Organism specific culture
5081,Prunus avium Ab.IgG,Prunus avium Ab.IgG:MCnc:Pt:Ser:Qn
5082,Triazolam,Triazolam:MCnc:Pt:Body fld:Qn:Confirm
5083,Human reference sequence assembly release number,"Human reference sequence assembly release number:Identifier:Point in time:Whole blood/Tissue, unspecified:Nominal:Molecular Genetics"
5084,Taenia solium larva IgG,Taenia solium larva Ab.IgG:PrThr:Pt:Ser:Ord:IB
5085,"What did they make, or what service did they provide - what type of business was it","What did they make, or what service did they provide - what type of business was it:Find:Pt:^Patient:Nom:NHANES"
5086,How often do you take naps,How often do you take naps:NRat:Pt:^Patient:Ord:PhenX
5087,11-ketoetiocholanolone,11-Ketoetiocholanolone^2D post high dose dexamethasone:MCnc:24H:Urine:Qn
5088,desmethyldoxepin,Nordoxepin:PrThr:Pt:Urine:Ord
5089,Human papilloma virus 18 DNA,Human papilloma virus 18 DNA:PrThr:Pt:Cvx:Ord:Probe.amp.sig
5090,Epstein-Barr virus DNA,Epstein Barr virus DNA:PrThr:Pt:Body fld:Ord:Probe.amp.tar
5091,How often did you eat fruit in past 30D,How often did you eat fruit in past 30D:Finding:Point in time:^Patient:Ordinal:PhenX
5092,Cathepsin G antibody,Cathepsin G Ab:ACnc:Pt:Ser:Qn:IA
5093,Borrelia burgdorferi Ag,Borrelia burgdorferi Ag:ACnc:Pt:Ser:Qn
5094,Japanese encephalitis virus IgM,Japanese encephalitis virus Ab.IgM:PrThr:Pt:Ser:Ord:IA
5095,D little o super little b Ab,D little o super little b Ab:PrThr:Pt:Ser/Plas:Ord
5096,Derived post treatment-7 M,Derived post treatment-7 M:Prid:Pt:Cancer.XXX:Nom
5097,Duck meat Ab.IgE,Duck meat Ab.IgE:ACnc:Pt:Ser:Qn
5098,Ganglioside GD3 Ab.IgG+IgM,Ganglioside GD3 Ab.IgG+IgM:PrThr:Pt:Ser:Ord:IA
5099,About how much weight did you gain and lose,About how much weight did you gain and lose:Mass:Pt:^Patient:Qn:QIDS
5100,Kinds of physical activity you usually performed while on the job this last Y,Kinds of physical activity you usually performed while on the job this last Y:Find:1Y:^Patient:Nom:PhenX
5101,Aldosterone,Aldosterone^2H post XXX challenge:SCnc:Pt:Ser/Plas:Qn
5102,I little n super little b Ab,In^b Antibody:Arbitrary Concentration:Point in time:Serum/Plasma:Ordinal
5103,Discharge summary note,Discharge summary note:Find:Pt:Emergency department:Doc:{Role}
5104,Acetone,Acetone:SCnc:Pt:Gast fld:Qn
5105,Measles virus identified,Deprecated Measles virus identified in Unspecified specimen by Organism specific culture
5106,Halothane gas delivered.total,Halothane gas delivered.total:Vol:RptPeriod:Gas delivery system:Qn
5107,GQ1b IgG ganglioside antibody,Ganglioside GQ1b Ab.IgG:PrThr:Pt:Ser:Ord:IA
5108,Histone antibody,Histone Ab:PrThr:Pt:Body fld:Ord:IA
5109,At what age did you start living there,At what age did you start living there:Time:Pt:^Patient:Qn:NHEXAS
5110,Was the private well cased,Was the private well cased:Find:Pt:^Patient:Nom:Next-of-kin
5111,"Does anyone who lives here smoke cigarettes, cigars, or pipes anywhere inside this home","Does anyone who lives here smoke cigarettes, cigars, or pipes anywhere inside this home:Find:Pt:^Patient:Nom:NHANES"
5112,Booster age,Booster age:Time:Pt:^Patient:Qn:PhenX
5113,Main presenting symptom,Main presenting symptom:Find:Pt:^Patient:Nom:PhenX
5114,Births.stillborn,Births.stillborn:Number:Point in time:^Patient:Quantitative:Reported
5115,date of delivery (history),Delivery date:Date:Pt:^Patient:Qn:Estimated from quickening date
5116,Squamous cell carcinoma antigen,Squamous cell carcinoma Ag:MCnc:Pt:Periton fld:Qn
5117,Levamisole,Levamisole:MCnc:Pt:Body fld:Qn
5118,Levamisole,Levamisole:MCnc:Pt:Urine:Qn
5119,milnacipran,Milnacipran:MCnc:Pt:Urine:Qn
5120,Mexiletine,Mexiletine:SCnc:Pt:Urine:Qn
5121,Lymphocytes.large granular/100 leukocytes,Lymphocytes.large granular/100 leukocytes:NFr:Pt:Bld:Qn:Flow cytometry
5122,PhenX measure - environmental exposures - current environmental tobacco smoke exposure,PhenX measure - environmental exposures - current environmental tobacco smoke exposure:-:Point in time:^Patient:-:PhenX
5123,Liver kidney microsomal 2 Ab,Liver kidney microsomal 2 Ab:PrThr:Pt:Ser:Ord:IF
5124,"During the last 3Mo of your pregnancy, how many alcoholic drinks did you have in an average W","During the last 3Mo of your pregnancy, how many alcoholic drinks did you have in an average W:NRat:Pt:^Patient:Qn:PhenX"
5125,"Do you consider yourself to be a morning person - early bird, an evening person - night owl, or neither","Do you consider yourself to be a morning person - early bird, an evening person - night owl, or neither:Find:Pt:^Patient:Nom:PhenX"
5126,Urobilinogen,Urobilinogen:PrThr:Pt:Urine:Ord:Test strip
5127,tapentadol,Tapentadol:MCnt:Pt:Tiss:Qn
5128,Human papilloma virus 68 DNA,Human papilloma virus 68 DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar
5129,Liquidambar styraciflua Ab.IgE,Liquidambar styraciflua Ab.IgE:ACnc:Pt:Ser:Qn
5130,PM-SCL extractable nuclear antibody,PM-SCL extractable nuclear Ab:PrThr:Pt:CSF:Ord:IA
5131,Country,Country:Loc:Pt:Facility:Nom
5132,Asialoglycoprotein receptor Ab,Asialoglycoprotein receptor Ab:ACnc:Pt:Ser:Qn:IA
5133,PhenX measure - peripheral arterial disease,PhenX measure - peripheral arterial disease:-:Point in time:^Patient:-:PhenX
5134,Conalbumin native (nGal d) 3 Ab.IgE,Conalbumin native (nGal d) 3 Ab.IgE:ACnc:Pt:Ser:Qn
5135,Prunus persica recombinant (rPru p) 3 Ab.IgE,Prunus persica recombinant (rPru p) 3 Ab.IgE:ACnc:Pt:Ser:Qn
5136,Lactate Dehydrogenase,Lactate dehydrogenase:CCnc:Pt:CSF:Qn:Reaction: pyruvate to lactate
5137,Lactate Dehydrogenase,Lactate dehydrogenase:CCnc:Pt:CSF:Qn:Reaction: lactate to pyruvate
5138,Ribosomal ribonucleoprotein antibody,Ribonucleoprotein extractable nuclear Ab:PrThr:Pt:CSF:Ord:IA
5139,I get really frightened for no reason,I get really frightened for no reason:Find:Pt:^Patient:Ord:SCARED-R
5140,meropenem,Meropenem:Susc:Pt:Isolate:Qn:MLC
5141,How thick is an average spot of your psoriasis,How thick is an average spot of your psoriasis:Find:Pt:^Patient:Ord:PhenX
5142,17-alpha-Hydroxyprogesterone,17-Hydroxyprogesterone^15M post XXX challenge:MCnc:Pt:Ser/Plas:Qn
5143,Avena sativa Ab.IgE,Avena sativa Antibody.immunoglobulin E:Arbitrary Concentration:Point in time:Serum:Quantitative
5144,Would you say that in general your health is,Would you say that in general your health is:Find:Pt:^Patient:Ord:HRQOL
5145,I'll try anything once,I'll try anything once:Finding:Point in time:^Patient:Ordinal:UPPS
5146,desoxycorticosterone,11-Deoxycorticosterone^1.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
5147,PhenX measure - migraine,PhenX measure - migraine:-:Point in time:^Patient:-:PhenX
5148,PhenX measure - total physical activity - comprehensive,PhenX measure - total physical activity - comprehensive:-:Point in time:^Patient:-:PhenX
5149,Phaseolus limensis Ab.IgG,Phaseolus limensis Ab.IgG:MCnc:Pt:Ser:Qn
5150,How old were you when you first needed to wear glasses to see clearly in the distance,How old were you when you first needed to wear glasses to see clearly in the distance:Time:Pt:^Patient:Qn:PhenX
5151,"When I feel bad, I often do things I later regret in order to make myself feel better now","When I feel bad, I often do things I later regret in order to make myself feel better now:Find:Pt:^Patient:Ord:UPPS-R-C"
5152,Methyl formamide/Creatinine,Methyl formamide/Creatinine:Ratio:Pt:Urine:Qn
5153,TNFRSF13B gene mutations tested for,TNFRSF13B gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen
5154,Platelet factor 4 heparin complex induced Antibody,Platelet factor 4 heparin complex induced Ab:PrThr:Pt:Ser/Plas:Ord:IA
5155,tapentadol,Tapentadol:PrThr:Pt:Urine:Ord:Confirm
5156,Plasminogen activator tissue type Ag,Plasminogen activator tissue type Ag^20M post venistasis:MCnc:Pt:PPP:Qn:IA
5157,paramethadione,Paramethadione:MCnc:Pt:Bld:Qn
5158,Progress note,Progress note:Find:Pt:Hospital:Doc:Critical Care Medicine
5159,I get scared when I sleep away from home,I get scared when I sleep away from home:Find:Pt:^Patient:Ord:SCARED-R
5160,Arachis hypogaea recombinant (rAra h) 9 Ab.IgE,Arachis hypogaea recombinant (rAra h) 9 Ab.IgE:ACnc:Pt:Ser:Qn
5161,Cladosporium herbarum recombinant (rCla h) 8 Ab.IgE,Cladosporium herbarum recombinant (rCla h) 8 Ab.IgE:ACnc:Pt:Ser:Qn
5162,What kind of things did you do,What kind of things did you do:Find:Pt:^Patient:Nom:Denver Youth Survey
5163,Do you find it very difficult to follow a conversation if there is background noise,Do you find it very difficult to follow a conversation if there is background noise:Find:Pt:^Patient:Ord:PhenX
5164,How many times in the last Y have you skipped classes or school without an excuse,How many times in the last Y have you skipped classes or school without an excuse:NRat:1Y:^Patient:Qn:Denver Youth Survey
5165,Sodium benzoate Ab.IgE,Sodium benzoate Ab.IgE:ACnc:Pt:Ser:Qn
5166,"HEDIS 2010, 2011 Codes to identify anticonvulsant serum concentration monitoring tests (MPM-E)",HEDIS 2010 Codes to identify drug serum concentration monitoring tests (MPM-E):-:Point in time:^Patient:-
5167,Derived pre treatment-7 N,Derived pre treatment-7 N:Prid:Pt:Cancer.XXX:Nom
5168,Derived pre treatment-7 T descriptor,Derived pre treatment-7 T descriptor:Prid:Pt:Cancer.XXX:Nom
5169,pentane,Pentane:MCnc:Pt:Ser/Plas:Qn
5170,Penicillium brevicompactum Ab.IgE,Penicillium brevicompactum Ab.IgE:ACnc:Pt:Ser:Qn
5171,Double stranded anti DNA antibody,DNA double strand Ab:PrThr:Pt:CSF:Ord:IF
5172,I am not very good at remembering phone numbers,I am not very good at remembering phone numbers:Find:Pt:^Patient:Ord:AQ
5173,Adenovirus DNA,Adenovirus DNA:LnCnc:Pt:CSF:Qn:Probe.amp.tar
5174,Leukocytes,Leukocytes:NCnc:Pt:Dial fld:Qn:Manual count
5175,Phleum pratense recombinant (rPhl p) 5b Ab.IgE,Phleum pratense recombinant (rPhl p) 5b Ab.IgE:ACnc:Pt:Ser:Qn
5176,Tripelennamine,Tripelennamine:MCnc:Pt:Bld:Qn
5177,Isoflurane,Isoflurane^during expiration:VFr/PPres:Pt:Gas delivery system.expiratory limb:Qn
5178,Glycyphagus domesticus Ab.IgE,Glycyphagus domesticus Ab.IgE:ACnc:Pt:Ser:Qn
5179,PhenX measure - assessment of gallbladder disease and related conditions,PhenX measure - assessment of gallbladder disease and related conditions:-:Point in time:^Patient:-:PhenX
5180,Reason stopped or paused before 6M,Reason stopped or paused before 6M:Finding:Point in time:^Patient:Nominal
5181,"When your child is reading a story, your child can easily imagine what the characters might look like","When your child is reading a story, your child can easily imagine what the characters might look like:Find:Pt:^Patient:Ord:AQ Adolescent"
5182,Condition causing difficulty with breathing,Condition causing difficulty with breathing:Find:Pt:^Patient:Nom:PhenX
5183,During these episodes of overeating and loss of control did you eat alone because you were embarrassed by how much you were eating,During these episodes of overeating and loss of control did you eat alone because you were embarrassed by how much you were eating:Find:Pt:^Patient:Ord:EDDS
5184,How well can you give yourself a pep talk when you feel low,How well can you give yourself a pep talk when you feel low:Find:Pt:^Patient:Nom:SEQ-C
5185,Cucumis melo cantalupenisis basophil bound Ab,Cucumis melo cantalupenisis basophil bound Ab:ACnc:Pt:Bld:Qn:LHR
5186,Zolazepam,Zolazepam:MCnc:Pt:Ser/Plas:Qn
5187,Hydrogen/Expired gas,Hydrogen/Expired gas^2.25H post dose lactose PO:VFr:Pt:Exhl gas:Qn
5188,Carbon dioxide setting,Carbon dioxide setting^during inspiration:VFr/PPres:Pt:Gas delivery system:Qn
5189,Carbon dioxide.gastric-Carbon dioxide.BldA,Carbon dioxide.gastric-Carbon dioxide.BldA:PPresDiff:Pt:Stomach+BldA:Qn:Gastric tonometry
5190,Nuclei scored,Nuclei scored:Num:Pt:Tiss:Qn
5191,TOP2A gene 17q21-22 deletion+duplication,TOP2A gene 17q21-22 deletion+duplication:PrThr:Pt:Tiss:Ord:FISH
5192,CD3+CD4+ cell,Cells.CD3+CD4+:NCnc:Pt:CSF:Qn
5193,Do or did you inhale the cigarette smoke,Do or did you inhale the cigarette smoke:Find:Pt:^Patient:Nom:PhenX
5194,Does your child enjoy sports,Does your child enjoy sports:Find:Pt:^Patient:Ord:CAST
5195,Does your child have any unusual and repetitive movements,Does your child have any unusual and repetitive movements:Find:Pt:^Patient:Ord:CAST
5196,Immunoglobulin G antibody to Influenza A virus,Influenza virus A Ab.IgG^1st specimen:ACnc:Pt:Ser:Qn:IA
5197,Lymphocytes.cytoplasmic IgM/100 lymphocytes,Lymphocytes.cytoplasmic IgM/100 lymphocytes:NFr:Pt:Body fld:Qn
5198,"In the past 12Mo, have you had periods or episodes of cough with phlegm that lasted 1 W or more","In the past 12Mo, have you had periods or episodes of cough with phlegm that lasted 1 W or more:Finding:Point in time:^Patient:Ordinal:PhenX"
5199,Bizarre delusion,Bizarre delusions:Find:Pt:^Patient:Ord:DI-PAD CGP V 1.4
5200,Did you feel like there was nothing you could do to stop what was happening,Did you feel like there was nothing you could do to stop what was happening:Find:Pt:^Patient:Ord:LTVH
5201,Has anyone ever stolen something from you without your knowing it,Has anyone ever stolen something from you without your knowing it:Find:Pt:^Patient:Ord:LTVH
5202,Problem location,Problem location:Anatomy:Point in time:^Patient:Nominal
5203,Oxalates,Oxalate:MCnc:12H:Urine:Qn
5204,Herpes simplex virus identified,Herpes simplex virus identified:Prid:Pt:Genital:Nom:Organism specific culture
5205,Complement C3 Ag,Complement C3 Ag:PrThr:Pt:Tiss:Ord:IF
5206,25-Hydroxyvitamin D2+25-Hydroxyvitamin D3,25-Hydroxyvitamin D2+25-Hydroxyvitamin D3:MCnc:Pt:Ser/Plas:Qn
5207,Secale cereale pollen Ab.IgG,Secale cereale pollen Ab.IgG:MCnc:Pt:Ser:Qn
5208,What kind of business or industry did you work in for the longest period of time,What kind of business or industry did you work in for the longest period of time:Find:Pt:^Patient:Nom:NHANES
5209,Chlamydia trachomatis,Chlamydia trachomatis:PrThr:Pt:XXX:Ord:Organism specific culture
5210,Are you unable to recall important parts of the event,Are you unable to recall important parts of the event:Find:Pt:^Patient:Ord:PhenX
5211,"How many of your daughters have had, or were suspected of having this eye problem","How many of your daughters have had, or were suspected of having this eye problem:Num:Pt:^Patient:Qn:PhenX"
5212,How much difficulty do you have reading street signs or the names of stores,How much difficulty do you have reading street signs or the names of stores:Find:Pt:^Patient:Ord:PhenX
5213,Amount of dextrose solution administered,Amount of dextrose solution administered:Num:Pt:^Patient:Qn:PhenX
5214,A wave amplitude,A wave amplitude:Len:Pt:Heart.valve.XXX:Qn:US
5215,1-benzylpiperazine,Benzylpiperazine:MCnc:Pt:Urine:Qn:Confirm
5216,Chaetomium globosum Ab.IgG,Chaetomium globosum Ab.IgG:MCnc:Pt:Ser:Qn
5217,Centromere antibody,Centromere Ab:PrThr:Pt:Body fld:Ord:IF
5218,Bacteria identified,Bacteria identified:Prid:Pt:XXX:Nom:Anaerobic culture
5219,Did the need to drink a lot more before you got drunk increase 50 percent or more,Did the need to drink a lot more before you got drunk increase 50 percent or more:Find:Pt:^Patient:Ord:SSAGA II
5220,I have had problems at work because I was irresponsible,I have had problems at work because I was irresponsible:Find:Pt:^Patient:Ord:PhenX
5221,Was this the source of fracture confirmation,Was this the source of fracture confirmation:Find:Pt:^Patient:Ord:PhenX
5222,Mononuclear cells/100 leukocytes,Mononuclear cells/100 leukocytes:NFr:Pt:Plr fld^Fetus:Qn:Manual count
5223,Calcitriol,Calcitriol^3H post dose calcium:SCnc:Pt:Ser/Plas:Qn
5224,Basophils+Mast cells/100 leukocytes,Basophils+Mast cells/100 leukocytes:NFr:Pt:CSF:Qn
5225,(Beef+Chicken+Pork) Ab.IgE,(Beef+Chicken+Pork) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk
5226,Basophils/100 leukocytes,Basophils/100 leukocytes:NFr:Pt:BldCo:Qn
5227,Artemisia californica Ab.IgE,Artemisia californica Ab.IgE:ACnc:Pt:Ser:Qn
5228,PROCEDURE NOTE,Procedure note:Find:Pt:{Setting}:Doc:Pediatric hematology-oncology
5229,History and physical note,History and physical note:Find:Pt:{Setting}:Doc:Pediatric otolaryngology
5230,cefprozil,Cefprozil:Susc:Pt:Isolate:OrdQn:Gradient strip
5231,Vaccinium myrtillus Ab.IgE,Vaccinium myrtillus Ab.IgE:ACnc:Pt:Ser:Qn
5232,Newborn hearing screen reason not performed,Newborn hearing screen reason not performed:Find:Pt:Ear.right:Nom
5233,Monocytes/100 leukocytes,Monocytes/100 leukocytes:NFr:Pt:Bld:Qn:Manual count
5234,Xenon,Xenon^during expiration:VFr/PPres:Pt:Gas delivery system.expiratory limb:Qn
5235,Nitric Oxide,Nitric oxide:VFr/PPres:Pt:Gas delivery system:Qn
5236,Savinase Ab.IgE,Savinase Ab.IgE:ACnc:Pt:Ser:Qn
5237,Guidance for needle localization,Guidance for needle localization:Find:Pt:Breast.bilateral:Doc:MG
5238,Pre-operative evaluation and management note,Preoperative evaluation and management note:Find:Pt:Hospital:Doc:Pediatrics
5239,pyridoxine,Pyridoxine:SCnc:Pt:CSF:Qn
5240,Desflurane liquid delivered.case,Desflurane liquid delivered.case:Vol:Procedure dur:Gas delivery system:Qn
5241,Multisection,Multisection^WO contrast:Find:Pt:Upper extremity>Finger:Doc:MR
5242,Neutrophils/leukocytes,Neutrophils/leukocytes:NFr.DF:Pt:Pericard fld:Qn:Manual count
5243,Polymorphonuclear cells/leukocytes,Polymorphonuclear cells/leukocytes:NFr.DF:Pt:Plr fld:Qn:Manual count
5244,Ceftizoxime induced platelet Ab.IgM,Ceftizoxime induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
5245,Penicillium chrysogenum IgG,Penicillium notatum Ab.IgG:ACnc:Pt:Ser:Qn
5246,Carbon dioxide production/Ideal body weight,Carbon dioxide production/Ideal body weight:VRat:Pt:Respiratory system:Qn
5247,PMI - Directions for use section,PMI - Directions for use section:-:-:^FDA package insert:Nar
5248,zinc protoporphyrin,Protoporphyrin.zinc:SCnc:Pt:RBC:Qn
5249,Clover Ab.IgE,Clover Ab.IgE:ACnc:Pt:Ser:Qn
5250,Warfarin induced platelet Ab.IgM,Warfarin induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
5251,Linum usitatissimum Ab.IgE,Linum usitatissimum Antibody.immunoglobulin E:Arbitrary Concentration:Point in time:Serum:Quantitative
5252,Buspirone induced platelet Ab.IgM,Buspirone induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
5253,Date of autopsy,Date of autopsy:Date:Pt:^Patient:Qn
5254,Cryptococcus sp Ag,Cryptococcus sp Ag:PrThr:Pt:Tiss:Ord:Immune stain
5255,Pyruvate Kinase,Pyruvate kinase:CSub:Pt:RBC:Qn
5256,Milrinone induced platelet Ab.IgG,Milrinone induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
5257,Ezetimibe induced platelet Ab.IgM,Ezetimibe induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
5258,Pravastatin induced platelet Ab.IgM,Pravastatin induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
5259,Carya laciniosa Ab.IgE,Carya laciniosa Ab.IgE:ACnc:Pt:Ser:Qn
5260,Suberylcarnitine (C8-DC),Suberylcarnitine (C8-DC):CCnt:Pt:Fibroblasts:Qn
5261,Fatty acids.very long chain.C24:0,Fatty acids.very long chain.C24:0:EntSub:Pt:RBC:Qn
5262,Solea solea Ab.IgG,Solea solea Ab.IgG:ACnc:Pt:Ser:Qn
5263,Do you suffer from migraine,Do you suffer from migraine:Hx:Pt:^Patient:Ord:PhenX
5264,p27 antigen,P27 Ag:PrThr:Pt:Tiss:Ord:Immune stain
5265,Physical therapy provider specialty,Physical therapy provider specialty:Type:Pt:Provider:Nom:APTA
5266,Last oral intake,Last oral intake:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative
5267,First alternate healthcare agent,First alternate healthcare agent:Pn:Pt:^Patient:Nom:Reported
5268,Western equine encephalitis virus IgG,Western equine encephalitis virus Ab.IgG:Titr:Pt:Ser:Qn:IF
5269,TF gene full mutation analysis,TF gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing
5270,Zea mays pollen Ab.IgE,Zea mays pollen Ab.IgE:ACnc:Pt:Ser:Qn
5271,Egg whole basophil bound Ab,Egg whole basophil bound Ab:ACnc:Pt:Bld:Qn:LHR
5272,Poa compressa Ab.IgE,Poa compressa Ab.IgE:ACnc:Pt:Ser:Qn
5273,My teachers make it clear to me when I have misbehaved in class,My teachers make it clear to me when I have misbehaved in class:Find:Pt:^Patient:Ord:PhenX
5274,Latex glove extract ammoniated Ab.IgE,Latex glove extract ammoniated Ab.IgE:ACnc:Pt:Ser:Qn
5275,telavancin,Telavancin:Susc:Pt:Isolate:OrdQn:Agar diffusion
5276,Fluid need,Fluid need:VRat:24H:^Patient:Qn:Estimated
5277,Forecast of outcome,Prognosis:Find:Pt:^Patient:Nom
5278,Restraint note,Restraint note:Find:Pt:Hospital:Doc:Physician
5279,"t(1;11)(p32;q23)(EPS15,MLL) fusion transcript","t(1;11)(p32;q23)(EPS15,MLL) fusion transcript:Arb:Pt:Bld/Tiss:Ord:Molgen"
5280,Birth Certificates,Birth certificate:Finding:Point in time:{Setting}:Document:{Provider}
5281,Myrica spp Ab.IgE,Myrica spp Ab.IgE:ACnc:Pt:Ser:Qn
5282,Guidance for laser ablation,Guidance for laser ablation:Find:Pt:Extremity.left>Extremity vein:Doc:US
5283,Populus fremontii Ab.IgE,Populus fremontii Antibody.immunoglobulin E:Arbitrary Concentration:Point in time:Serum:Quantitative
5284,Lidocaine induced platelet Ab.IgM,Lidocaine induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
5285,Other cells/100 leukocytes,Other cells/100 leukocytes:NFr:Pt:Pericard fld:Qn:Manual count
5286,Hypersegmented neutrophil,Neutrophils.hypersegmented:PrThr:Pt:Bld:Ord:Microscopy.light
5287,Do you suffer from white finger syndrome or raynaud's syndrome caused by excessive vibration from pneumatic hammers or drills,Do you suffer from white finger syndrome or raynaud's syndrome caused by excessive vibration from pneumatic hammers or drills:Find:Pt:^Patient:Ord:PhenX
5288,Beta globulin/Protein.total,Beta globulin/Protein.total:MFr.DF:24H:Urine:Qn:Electrophoresis
5289,Metoclopramide induced neutrophil Ab.IgG,Metoclopramide induced neutrophil Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
5290,Lolium perenne Ab.IgE,LOLIUM PERENNE ANTIBODY.IMMUNOGLOBULIN E:ARBITRARY CONCENTRATION:POINT IN TIME:SERUM:QUANTITATIVE
5291,Bile acid panel,Bile acid panel:-:24H:Stool:-
5292,Diphenylmethane diisocyanate (MDI) Ab.IgE,Diphenylmethane diisocyanate (MDI) Ab.IgE:ACnc:Pt:Ser:Qn
5293,Airway resistance,Resistance.airway^during expiration:FldResist:Pt:Respiratory system.airway:Qn
5294,Ampicillin,Ampicillin:Susc:Pt:Isolate:OrdQn:Gradient strip
5295,Grass sorghum Ab.IgE,Grass sorghum Ab.IgE:ACnc:Pt:Ser:Qn
5296,Oidiodendrum spp Ab.IgE,Oidiodendrum spp Ab.IgE:ACnc:Pt:Ser:Qn
5297,Glasgow coma score.motor,Deprecated Glasgow coma score motor NEMSIS
5298,Alkaline phosphatase.intestinal 3,Alkaline phosphatase.intestinal 3:CCnc:Pt:Ser/Plas:Qn
5299,Legionella species,Legionella sp:Prid:Pt:Isolate:Nom:Aggl
5300,Cheese mozzarella Ab.IgG,Cheese mozzarella Ab.IgG:ACnc:Pt:Ser:Qn
5301,MARS2 gene full mutation analysis,MARS2 gene full mutation analysis:Prid:Pt:Bld/Tiss/Sal:Nom:Sequencing
5302,Cell positive for CD20 antigen,Cells.CD20:NCnc:Pt:XXX:Qn
5303,Plasma cells/100 cells,Plasma cells/100 cells:NFr:Pt:Lymph node:Qn:Manual count
5304,Delta dRVVT,Delta dRVVT:TimeDif:Pt:PPP:Qn:Coag
5305,PROCEDURE NOTE,Procedure note:Find:Pt:{Setting}:Doc:Developmental-behavioral pediatrics
5306,Venlafaxine+Norvenlafaxine,Venlafaxine+Norvenlafaxine^trough:MCnc:Pt:Ser/Plas:Qn
5307,Bacteria identified,Bacteria identified:Prid:Pt:Bone^Donor:Nom:Aerobic culture
5308,Normirtazapine,Normirtazapine:MCnc:Pt:Body fld:Qn
5309,Arginosuccinate,Argininosuccinate^post therapeutic diet:SCnc:Pt:Bld.dot:Qn
5310,Anisakis Ab.IgE.RAST class,Anisakis Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
5311,Fraxinus americana Ab.IgE.RAST class,Fraxinus americana Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
5312,Vendor model number,Vendor model number:Prid:Pt:Biliary drain:Nom
5313,Diameter (qualifier value),Diameter:Len:Pt:Heart.ventricle.right.outflow tract:Qn:US.measured
5314,C-Peptide,C peptide^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
5315,Corticotropin,Corticotropin^pre 1 ug/kg CRH IV:MCnc:Pt:Plas:Qn
5316,2-Oxoadipate/Creatinine,2-Oxoadipate/Creatinine:MRto:Pt:Urine:Qn
5317,4-Hydroxyphenylpyruvate/Creatinine,4-Hydroxyphenylpyruvate/Creatinine:MRto:Pt:Urine:Qn
5318,Rheumatoid Factor,Rheumatoid factor:Titr:Pt:Ser:Qn:Nephelometry
5319,Glycine max Ab.IgE.RAST class,Glycine max Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
5320,Beta-2 glycoprotein 1 IgG antibody,Beta 2 glycoprotein 1 Ab.IgG:ACnc:Pt:Ser:Qn
5321,Droperidol,Droperidol:PrThr:Pt:Ser/Plas:Ord
5322,Erythromycin,Erythromycin:PrThr:Pt:Urine:Ord
5323,Secretory Immunoglobulin A,IgA.secretory:ACnc:Pt:Ser/Plas:Qn
5324,Aspartate/Creatinine,Aspartate/Creatinine:MRto:Pt:Urine:Qn
5325,Benzoate/Creatinine,Benzoate/Creatinine:MRto:Pt:Urine:Qn
5326,Creatinine,Creatinine:SCnc:Pt:Ser/Plas:Qn
5327,Irregularly contracted cell,Irregularly contracted cells:PrThr:Pt:Bld:Ord:Microscopy.light
5328,microscopic observation,Microscopic observation:Prid:Pt:Tiss:Nom:Safranin stain
5329,Sporothrix schenckii Ab,Sporothrix schenckii Ab:PrThr:Pt:Ser:Ord
5330,Rubella virus IgM,Rubella virus Ab.IgM:ACnc:Pt:CSF:Qn
5331,Flurazepam,Flurazepam:SCnc:Pt:Ser/Plas:Qn
5332,Methyprylon,Methyprylon:PrThr:Pt:Urine:Ord:Confirm
5333,Lycopodium spp Ab.IgE.RAST class,Lycopodium spp Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
5334,microscopic observation,Deprecated Microscopic observation [Identifier] in Tissue by Wright Giemsa stain
5335,Gestational Age,Gestational age:Time:Pt:^Fetus:Qn:US.estimated from radius length
5336,Grade,Grade:Type:Point in time:Placenta^Fetus:Ordinal:ULTRASOUND
5337,heart rate,Heart rate:NRat:Pt:^Fetus:Qn:US.measured
5338,Long axis,Long axis:Len:Pt:Foot^Fetus:Qn:US.measured
5339,MNSs group Ag,MNSs group Ag:Type:Pt:RBC:Nom
5340,Herpes simplex virus 2 Ab,Herpes simplex virus 2 Ab:ACnc:Pt:Ser:Qn:IF
5341,Phenylpropionylglycine/Creatinine,Phenylpropionylglycine/Creatinine:MRto:Pt:Urine:Qn
5342,Follicle Stimulating Hormone,Follitropin^30M post dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn
5343,Cells.CD8+HLA-DR+/100 cells,Cells.CD8+HLA-DR+/100 cells:NFr:Pt:Bld:Qn
5344,Androstenedione,Androstenedione^30M post 250 ug corticotropin IM:MCnc:Pt:Ser/Plas:Qn
5345,Lithium,Lithium:SCnc:Pt:Ser/Plas:Qn
5346,17-Hydroxycorticosteroids,17-Hydroxycorticosteroids:SRat:24H:Urine:Qn
5347,Pigweed common Ab.IgE.RAST class,Pigweed common Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
5348,Free cortisol,Cortisol.free^48H post 40 ug corticotropin IM BID 3 day:MCnc:24H:Urine:Qn
5349,Methanol,Methanol:SCnc:Pt:Ser/Plas:Qn
5350,Toxoplasma gondii,Toxoplasma gondii:PrThr:Pt:Tiss:Ord:Organism specific culture
5351,Ambrosia elatior Ab.IgE.RAST class,Deprecated Common Ragweed IgE RAST Ql
5352,Origanum majorana Ab.IgE,Origanum majorana Ab.IgE:ACnc:Pt:Ser:Qn
5353,Physical findings,Physical findings:Finding:Point in time:Knee:Narrative:Observed
5354,Physical findings,Physical findings:Finding:Point in time:Hand:Nominal:Observed
5355,Promazine,Promazine:MCnc:Pt:Ser/Plas:Qn
5356,Borrelia burgdorferi 30kD Ab,Borrelia burgdorferi 30kD Ab:PrThr:Pt:CSF:Ord:IB
5357,Succinylcholine Ab.IgE.RAST class,Succinylcholine Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
5358,Blood group antigen H,Deprecated H NOS Ag [Presence] on Red Blood Cells
5359,Bacillus anthracis antibody,Bacillus anthracis Ab:ACnc:Pt:Ser:Qn:IB
5360,Cryptococcus neoformans antigen,Deprecated Cryptococcus neoformans Ag [Presence] in Unspecified specimen
5361,Creatinine dialysis fluid clearance,Creatinine dialysis fluid clearance:Volume Rate:Point in time:Dialysis fluid+Serum/Plasma:Quantitative
5362,Artemisia absinthium Ab.IgE.RAST class,Artemisia absinthium Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
5363,Babesia microti IgG,Babesia microti Ab.IgG:Titr:Pt:Ser:Qn
5364,(Foeniculum vulgare seed+Ocimum basilicum+Pimpinella anisum+Zingiber officinale) Ab.IgE,(Foeniculum vulgare seed+Ocimum basilicum+Pimpinella anisum+Zingiber officinale) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk
5365,Glucose,Glucose^30M post 0.05-0.15 U insulin/kg IV post 12H CFst:MCnc:Pt:Ser/Plas:Qn
5366,Blood group antigen Kp^a^,K little p super little a Ag:PrThr:Pt:RBC:Ord
5367,Propoxyphene,Propoxyphene:MCnc:Pt:Meconium:Qn
5368,Progress note,Subsequent evaluation note:Finding:Point in time:{Setting}:Document:{Provider}
5369,Glucose,Glucose^4H specimen:MCnc:Pt:Dial fld:Qn
5370,acid hemolysis,Acid hemolysis:PrThr:Pt:Bld:Ord
5371,Beta globulin/Protein.total,Beta globulin/Protein.total:MFr:Pt:CSF:Qn:Electrophoresis
5372,Streptococcus pneumoniae 7 Ab.IgG,Deprecated Streptococcus pneumoniae 7 IgG Ab [Units/volume] in Serum by Immunoassay
5373,Spermatozoa.viable/100 spermatozoa,Spermatozoa.viable/100 spermatozoa:NFr:Pt:Semen:Qn
5374,Study observation,Study observation:Finding:Point in time:Heart.ventricle.right.outflow tract^Fetus:Narrative:ULTRASOUND
5375,Primidone,Primidone:SCnc:Pt:Ser/Plas:Qn
5376,(Juniperus sabinoides+Quercus alba+Ulmus americana+Populus deltoides+Prosopis juliflora) Ab.IgE,(Juniperus sabinoides+Quercus alba+Ulmus americana+Populus deltoides+Prosopis juliflora) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk
5377,Chinchilla Ab.IgE.RAST class,Chinchilla Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
5378,20-alpha-Dihydroprogesterone,20-Hydroxyprogesterone:MCnc:Pt:Ser:Qn
5379,"4,4'-methylene-bis-(2-chloroaniline)","4,4'-Methylene bis(2-Chloroaniline):MCnc:Pt:Urine:Qn"
5380,Phyllostachys pubescens Ab.IgE,Phyllostachys pubescens Ab.IgE:ACnc:Pt:Ser:Qn
5381,HTLV-I Antibodies,HTLV I Ab:ACnc:Pt:Ser:Qn
5382,HTLV I+II p53 Ab,HTLV I+II p53 Ab:PrThr:Pt:Ser:Ord:IB
5383,Androsterone,Androsterone:SCnc:Pt:Ser/Plas:Qn
5384,Methamphetamine,Methamphetamine:MCnc:Pt:Meconium:Qn
5385,Glycerylphosphorylcholine,Glycerophosphocholine:SCnc:Pt:Semin plas:Qn
5386,Spermatid,Spermatids:NCnc:Pt:Semen:Qn:SAB
5387,Sperm-Zona Pellucida Penetration,Spermatozoa penetration:PrThr:Pt:Semen+Cvm:Ord:Kremer
5388,Blood flow.diastolic.early wave.max,Deprecated Tricuspid valve Peak E velocity US.doppler
5389,Thickness.systolic,Thickness.systolic:Len:Pt:Heart.ventricle.posterior wall.left^Fetus:Qn:US.measured.real time two dimension
5390,Nuclear Ab pattern,"Nuclear Antibody pattern:Impression/interpretation of study:Point in time:Body fluid, unsp:Nominal:IMMUNE FLUORESCENCE"
5391,Coliform bacteria,Coliform bacteria:PrThr:Pt:Water:Ord
5392,Creatinine,Creatinine:SCnc:Pt:Amnio fld:Qn
5393,Coagulation surface induced,Deprecated Activated partial thrombplastin time (aPTT) in Blood from control by Coagulation assay
5394,Equine infectious anemia virus antibody,Equine infectious anemia virus Ab:PrThr:Pt:Ser:Ord:Immune diffusion
5395,Hospital discharge medications,Hospital discharge medications:Finding:Point in time:^Patient:Narrative
5396,Bran wheat Ab.IgE,Bran wheat Ab.IgE:ACnc:Pt:Ser:Qn
5397,Entamoeba histolytica,Entamoeba histolytica:PrThr:Pt:Stool:Ord:Trichrome stain
5398,Antigen of Measles morbillivirus,Measles virus Ag:PrThr:Pt:Skin:Ord:IF
5399,Poa compressa Ab.IgE.RAST class,Poa compressa Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
5400,Agropyron repens Ab.IgE.RAST class,Agropyron repens Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
5401,Oxygen content level,Oxygen content:SCnc:Pt:Vena cava.superior:Qn
5402,Pollachius virens Ab.IgE,Pollachius virens Ab.IgE:ACnc:Pt:Ser:Qn
5403,Body Weight,Body weight:Mass:Pt:^Fetus:Qn:US+Estimated from AC&FL.Hadlock 1984
5404,Reverse ABO group,Reverse ABO group:Type:Pt:Bld:Nom
5405,Naphthol AS D Esterase,Alpha naphthylesterase:CCnc:Pt:Ser:Qn
5406,Diffusion capacity.carbon monoxide,Diffusion capacity.carbon monoxide:FldConduct:Pt:Respiratory system:Qn:Predicted
5407,Gas flow,Gas flow:VRat:Pt:Respiratory system.airway:Qn:Rebreathing
5408,Carotene,Carotene:MCnc:Pt:Bld:Qn
5409,Equine influenza virus A1 Ab,Equine influenza virus A1 Ab:Titr:Pt:Ser:Qn
5410,Theileria parva Ab,Theileria parva Ab:PrThr:Pt:Ser:Ord:IA
5411,Glyceraldehyde-3-phosphate dehydrogenase,Glyceraldehyde 3 phosphate dehydrogenase:CCnc:Pt:Ser:Qn
5412,Dextroamphetamine cutoff,Dextroamphetamine cutoff:MCnc:Pt:Urine:Qn:Screen
5413,Oxygen,Oxygen:PPres:8H^max:BldC:Qn
5414,Ova & parasites identified,Ova & parasites identified:Prid:Pt:Stool:Nom:Concentration.Baerman
5415,Paraquat,Paraquat:MCnt:Pt:Tiss:Qn
5416,leptin,Leptin:MCnc:Pt:Ser/Plas:Qn
5417,Influenza A virus antibody,Deprecated Influenza virus A Ab [Titer] in Serum
5418,Coxsackievirus B IgG,Coxsackievirus B Ab.IgG:ACnc:Pt:Ser:Qn:Neut
5419,Cephapirin,Cephapirin:Susc:Pt:Isolate:OrdQn:Agar diffusion
5420,Testosterone,Testosterone^30M post XXX challenge:MCnc:Pt:Ser/Plas:Qn
5421,Diamorphine cutoff,Diamorphine cutoff:MCnc:Pt:Urine:Qn:Confirm
5422,Oxygen/Inspired gas setting,Oxygen/Inspired gas setting:VFr:Pt:Ventilator:Qn
5423,Oxygen,Oxygen^on room air and eating:PPres:Stdy^min:BldC:Qn:Transcutaneous O2 monitor
5424,Cells.CD7/100 cells,Cells.CD7/100 cells:NFr:Pt:XXX:Qn
5425,Monocyte+Macrophage/100 leukocytes,Deprecated Monocytes+Macrophages/100 leukocytes in Body fluid by Manual count
5426,Chlamydia species antibody (substance),Chlamydia sp Ab:Titr:Pt:CSF:Qn:Comp fix
5427,Dehydroepiandrosterone Sulfate,Dehydroepiandrosterone sulfate^8th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
5428,"Dengue virus, type 1 antibody",Dengue virus 1 Ab:Titr:Pt:Ser:Qn
5429,Nordazepam,Deprecated Nordiazepam [Presence] in Serum or Plasma
5430,N-desmethylmethsuximide,Deprecated Desmethylmethsuximide:Mass Concentration:Point in time:Serum:Quantitative
5431,Cells.CD3+IL2R1+/100 cells,Cells.CD3+IL2R1+/100 cells:NFr:Pt:Bld:Qn
5432,Cells.CD3+DR+/100 cells,Cells.CD3+DR+/100 cells:NFr:Pt:Bld:Qn
5433,Cells.CD30/100 cells,Cells.CD30/100 cells:NFr:Pt:Bld:Qn
5434,Calcium,Calcium^^corrected for total protein:SCnc:Pt:Ser/Plas:Qn
5435,Glycochenodeoxycholic Acid,Chenodeoxycholylglycine:MCnc:Pt:Ser:Qn
5436,Avena sativa Ab.IgG.RAST class,Avena sativa Ab.IgG.RAST class:PrThr:Pt:Ser:Ord
5437,Mycoplasma antibody,Mycoplasma sp Ab:PrThr:Pt:Ser:Ord
5438,Leptospira sp Ag,Leptospira sp Ag:PrThr:Pt:Tiss:Ord:IF
5439,Multisection,Multisection:Find:Pt:Pelvis>Anus:Doc:US
5440,Trypanosoma brucei DNA,Trypanosoma brucei DNA:PrThr:Pt:Bld:Ord:Probe.amp.tar
5441,Cephradine,Cephradine:Titr:Pt:Isolate+Ser:Qn:SBT
5442,Tryptophan,Tryptophan:PrThr:Pt:Urine:Ord
5443,Levo-methamphetamine,Levomethamphetamine:PrThr:Pt:Urine:Ord:Screen
5444,Macro-Creatine Kinase,Creatine kinase.macromolecular:CCnc:Pt:Ser/Plas:Qn
5445,Placental Lactogen,Choriomammotropin:MCnc:Pt:Ser:Qn
5446,phosphate ion,Phosphate:MCnc:24H:Urine:Qn
5447,Cells.cytoplasmic CD79/100 cells,Cells.cytoplasmic CD79/100 cells:NFr:Pt:Bld:Qn
5448,Dipeptidyl-Peptidase IV,Adenosine deaminase binding protein:MCnc:Pt:Urine:Qn
5449,Mephobarbital,Mephobarbital:MCnc:Pt:Urine:Qn:Confirm
5450,Metamyelocytes/100 leukocytes,Metamyelocytes/100 leukocytes:NFr:Pt:Body fld:Qn
5451,Tidal volume.spontaneous+mechanical,Tidal volume.spontaneous+mechanical^on ventilator^corrected for compressible gas volume:Vol:Pt:Respiratory system:Qn
5452,Volume expired during 1.0 s of forced expiration,Volume at 1.0 s post forced expiration:Volume:Point in time:Respiratory system:Quantitative:Predicted
5453,Anaplasma marginale antibody,Anaplasma marginale Ab:PrThr:Pt:Ser:Ord:Aggl.card
5454,Biogenic Amines,Amines.biogenic:MCnt:Pt:Feed:Qn
5455,Solanum tuberosum Ab.IgE,Deprecated Potato IgE Ab [Units/volume] in Serum
5456,Propranolol,Propranolol:MCnc:Pt:Gast fld:Qn
5457,Gamma-glutamyl transferase,Gamma glutamyl transferase:CCnc:Pt:Ser/Plas:Qn
5458,Glycine,Glycine:PrThr:Pt:Urine:Ord
5459,Methandrostenolone,Metandienone:MCnc:Pt:Ser/Plas:Qn
5460,butalbital,Butalbital:PrThr:Pt:Urine:Ord:Confirm
5461,Maximal Voluntary Ventilation,Voluntary ventilation.max:Volume Rate:Point in time:Respiratory system:Quantitative:Predicted
5462,Maximal Voluntary Ventilation,Voluntary ventilation.max:Volume Rate:Point in time:Respiratory system:Quantitative
5463,Cardiac output/Body surface area.4 chamber,Cardiac output/Body surface area.4 chamber:ArVRat:Pt:Heart.ventricle.left:Qn:US.mod.single-plane.calculated
5464,Circumference 2,Circumference 2:Circ:Pt:Region of interest.XXX:Qn:US
5465,Brucella melitensis antibody,Brucella melitensis Ab:PrThr:Pt:Ser:Ord:Comp fix
5466,Alkaline Phosphatase,Alkaline phosphatase:CCnc:Pt:Urine:Qn
5467,Aluminum,Aluminum:MCnc:Pt:Body fld:Qn
5468,Bacteria identified,Bacteria identified^^^5:Prid:Pt:Bone:Nom:Aerobic culture
5469,Chaetomium globosum Ab.IgG,Chaetomium globosum Ab.IgG:ACnc:Pt:Ser:Qn
5470,Rickettsia rickettsii IgM,Rickettsia rickettsii Ab.IgM:ACnc:Pt:CSF:Qn
5471,Fungus colony count,Fungus colony count:NCnc:Pt:XXX:Qn:Culture
5472,Aminolevulinate,Delta aminolevulinate:MRat:24H:Urine:Qn
5473,Salmonella Pullorum Ab,Salmonella pullorum Ab:PrThr:Pt:Ser:Ord
5474,Mycoplasma mycoides subspecies mycoides small colony Ab,Mycoplasma mycoides subspecies mycoides small colony Ab:PrThr:Pt:Ser:Ord:Aggl
5475,Anticonvulsants,Anticonvulsants:Prid:Pt:Urine:Nom
5476,Bacteria identified,Bacteria identified:Prid:Pt:Wound.shlw:Nom:Aerobic culture
5477,Gradient 2.mean,Gradient 2.mean:Pres:Pt:Circulatory system.XXX:Qn:US+Calculated
5478,Dicloxacillin,Dicloxacillin:Susc:Pt:Isolate:Qn:MLC
5479,Followup&recurrent&death battery,Deprecated Followup&recurrent&death battery
5480,Caprine arthritis encephalitis virus antibody,Caprine arthritis encephalitis virus Ab:PrThr:Pt:Milk:Ord
5481,Myxoma virus Ab,Myxoma virus Ab:Titr:Pt:Ser:Qn:IF
5482,Airway resistance,Resistance.airway:FldResist:Stdy^mean:Respiratory system.airway:Qn:Plethysmograph.body box
5483,Keratin-19,Cytokeratin 19:ACnc:Pt:Ser/Plas:Qn
5484,mucinous carcinoma-associated antigen,Mucin-like carcinoma associated Ag:ACnc:Pt:Plr fld:Qn
5485,p-Hydroxyamphetamine,Para hydroxyamphetamine:PrThr:Pt:Urine:Ord:Screen
5486,Stroke volume/Body surface area,Stroke volume/Body surface area:ArVol:Pt:Heart.ventricle.left:Qn:US.2D.LVOT area.calculated
5487,CCR5 gene mutations tested for,CCR5 gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen
5488,Trichinella spiralis antibody,Trichinella spiralis Ab:Titr:Pt:Ser:Qn
5489,apramycin,Apramycin:Susc:Pt:Isolate:OrdQn
5490,Secobarbital cutoff,Secobarbital cutoff:MCnc:Pt:Urine:Qn:Screen
5491,Filling period.diastole,Filling period.diastole:Time:Pt:Heart.atrium.right:Qn:US.measured
5492,Borrelia burgdorferi IgG,Borrelia burgdorferi Ab.IgG:ACnc:Pt:Body fld:Qn:IA
5493,Hydrogen/Expired gas,Hydrogen/Expired gas^3.5H post dose glucose:VFr:Pt:Exhl gas:Qn
5494,Phenytoin,Phenytoin:MCnc:Pt:Urine:Qn
5495,Phosphatidylethanolamine Ab.IgM,Phosphatidylethanolamine Ab.IgM:PrThr:Pt:Ser:Ord
5496,Deoxyhemoglobin/Hemoglobin.total,Deoxyhemoglobin/Hemoglobin.total:MFr:Pt:BldC:Qn
5497,Cusp separation.max,Cusp separation.max:Len:Pt:Aortic valve:Qn:US
5498,Amphetamines cutoff,Amphetamines cutoff:MCnc:Pt:Urine:Qn:Confirm
5499,"Estrone, unconjugated",Estrone.unconjugated:MCnc:Pt:Amnio fld:Qn
5500,Duck hepatitis virus 3 Antigen,Duck hepatitis virus 3 Ag:PrThr:Pt:XXX:Ord:IF
5501,Eastern equine encephalitis virus Ag,Eastern equine encephalitis virus Ag:PrThr:Pt:Brain:Ord:Comp fix
5502,Porcine reproductive and respiratory syndrome virus antibody,Porcine reproductive and respiratory syndrome virus Ab:PrThr:Pt:Ser:Ord:Comp fix
5503,Feline herpesvirus 1 DNA,Feline herpesvirus 1 DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar
5504,PR interval feature,PR interval:Time:Pt:Lead V5:Qn:EKG
5505,QT interval feature (observable entity),QT interval:Time:Pt:Lead II:Qn:EKG
5506,benzodiazepines positive,Benzodiazepines positive:Prid:Pt:Urine:Nom:Confirm
5507,Opiates screen method,Opiates screen method:Prid:Pt:Urine:Nom:*
5508,Cuminum cyminum Ab.IgE.RAST class,Cuminum cyminum Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
5509,Gauchers disease type 1 gene mutations tested for,Gauchers disease type 1 gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen
5510,Brucella canis IgG,Brucella canis Ab.IgG:Titr:Pt:Ser:Qn
5511,Methionine/Creatinine,Methionine/Creatinine:SRto:Pt:Urine:Qn
5512,Rift valley fever virus Ab,Rift valley fever virus Ab:Titr:Pt:Ser:Qn
5513,Feline leukemia virus Ab,Feline leukemia virus Ab:Titr:Pt:Ser:Qn:Neut
5514,Carnosine,Carnosine:PrThr:Pt:Urine:Ord
5515,Chlorpyrifos,Chlorpyrifos:MCnc:Pt:Urine:Qn
5516,Streptococcus pneumoniae antibody,Streptococcus pneumoniae Ab:ACnc:Pt:Ser:Qn
5517,Procainamide,Procainamide:MCnc:Pt:Urine:Qn
5518,ST amplitude.J point+80 ms,ST amplitude.J point+80 ms:Elpot:Pt:Lead V1:Qn:EKG
5519,Thiazides confirm method,Thiazides confirm method:Prid:Pt:Urine:Nom:*
5520,Tidal volume.expired/Pressure.plateau,Tidal volume.expired/Pressure.plateau^post 1.5-2.0 s inspiratory hold on ventilator:Compli:Pt:Respiratory system:Qn
5521,Mycobacterium avium complex rRNA,Mycobacterium avium complex rRNA:PrThr:Pt:XXX:Ord:Probe.amp.tar
5522,Estriol,Estriol.unconjugated^^adjusted:MoM:Pt:Ser/Plas:Qn
5523,Chlamydia trachomatis IgM,Chlamydia trachomatis Ab.IgM:ACnc:Pt:CSF:Qn
5524,GD1b IgG ganglioside antibody,Ganglioside GD1b Ab.IgG:Titr:Pt:CSF:Qn:IA
5525,Aspergillus fumigatus Ab.IgG.RAST class,Aspergillus fumigatus Ab.IgG.RAST class:PrThr:Pt:Ser:Ord
5526,Rheumatoid arthritis nuclear antibody,Rheumatoid arthritis nuclear Ab:PrThr:Pt:Ser:Ord
5527,Amylase/Creatinine renal clearance,Amylase/Creatinine renal clearance:Ratio:24H:Urine+Ser/Plas:Qn
5528,Segmental wall motion,Segmental wall motion:Find:Pt:Heart.ventricle.left.basal septum:Ord:US
5529,Minor axis.papillary level.systole,Minor axis.papillary level.systole:Area:Pt:Heart.ventricle.left:Qn:US.2D
5530,Breaths.spontaneous,Breaths.spontaneous^on ventilator:NRat:Pt:Respiratory system:Qn
5531,Functional Residual Capacity,Capacity.functional residual:Vol:Pt:Respiratory system:Qn:Helium single breath
5532,Follicle Stimulating Hormone,Follitropin^45M post dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn
5533,SERPINA1 gene targeted mutation analysis,SERPINA1 GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NOM:MOLGEN
5534,Coxsackievirus A21 Ab,Coxsackievirus A21 Ab:Titr:Pt:Ser:Qn
5535,Bicarbonates,Bicarbonate:SCnc:Pt:XXX:Qn
5536,Spotted fever group rickettsia antibody,Rickettsia spotted fever group Ab:PrThr:Pt:Ser:Ord:IF
5537,Cerebroside-Sulfatase,Deprecated Cerebroside sulfatase [Enzymatic activity/mass] in Tissue
5538,Chlamydia species antigen,Chlamydia sp Ag:PrThr:Pt:Urine:Ord
5539,End-systolic volume,End-systolic volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by biplane ellipse method
5540,Anserine,Anserine:MCnc:Pt:Ser/Plas:Qn
5541,aprobarbital,Aprobarbital:PrThr:Pt:Urine:Ord:Screen
5542,aprobarbital,Aprobarbital:PrThr:Pt:Urine:Ord:Confirm
5543,Carbon Dioxide,Carbon dioxide:PPres:8H^max:BldC:Qn:Transcutaneous CO2 monitor
5544,Vitis vinifera Ab.IgG.RAST class,Vitis vinifera Ab.IgG.RAST class:PrThr:Pt:Ser:Ord
5545,TP53 gene targeted mutation analysis,TP53 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
5546,Foot and mouth disease virus serotype,Foot and mouth disease virus serotype:Prid:Pt:Tiss:Nom:IA
5547,Stimulant,Stimulants:Prid:Pt:Ser/Plas:Nom
5548,pyridoxine,Pyridoxine:PrThr:Pt:Bld:Ord
5549,Prealbumin,Prealbumin:MCnc:Pt:Ser/Plas:Qn:Electrophoresis
5550,Meprobamate,Meprobamate:MCnc:Pt:Gast fld:Qn
5551,View,Views^W contrast IS:Find:Pt:Lower extremity.bilateral>Knee:Doc:RF
5552,Dermatophagoides pteronyssinus Ab.IgG4,Dermatophagoides pteronyssinus Ab.IgG4:ACnc:Pt:Ser:Qn
5553,Osmolality,Osmolality:Osmol:Pt:Urine:Qn
5554,alpha-hydroxyalprazolam,Alpha hydroxyalprazolam:MCnt:Pt:Stool:Qn
5555,Interleukin 2 Receptor,Interleukin 2 receptor:MCnc:Pt:Ser/Plas:Qn
5556,Horse meat Ab.IgE.RAST class,Horse meat Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
5557,HLA-B27 Antigen,HLA-B27:PrThr:Pt:Bld/Tiss:Ord:Probe.amp.tar
5558,Thyroxine uptake,Deprecated Thyroxine (T4) uptake [Mass/volume] in Serum or Plasma
5559,Views 4,Views 4:Find:Pt:Lower extremity>Knee:Doc:XR
5560,Multisection,Multisection:Find:Pt:Pelvis:Doc:US
5561,Niacinamide,Nicotinamide:SCnc:Pt:Ser/Plas:Qn
5562,View,Views^W contrast IS:Find:Pt:Upper extremity.left>Shoulder:Doc:RF
5563,meat fibers,Meat fibers:Naric:Pt:Stool:Qn:Microscopy.light
5564,Glucose,Glucose^3.6H post dose glucose:SCnc:Pt:Ser/Plas:Qn
5565,Bluetongue virus 2 Ab,Bluetongue virus 2 Ab:ACnc:Pt:Ser:Qn
5566,Burkholderia pseudomallei IgG,Burkholderia pseudomallei Ab.IgG:ACnc:Pt:XXX:Qn
5567,Sodium,Sodium:Sub:XXX:Urine:Qn
5568,Pascopyrum smithii Ab.IgE,Pascopyrum smithii Ab.IgE:ACnc:Pt:Ser:Qn
5569,(Citharexylum caudatum+Juniperus monosperma+Juniperus scopulorum) Ab.IgE,(Citharexylum caudatum+Juniperus monosperma+Juniperus scopulorum) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk
5570,Progesterone,Progesterone^2nd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn
5571,Glucose,Glucose^3H post dose glucose:PrThr:Pt:Urine:Ord:Test strip
5572,Cells.CD11b+CD56+/100 cells,Cells.CD11b+CD56+/100 cells:NFr:Pt:XXX:Qn
5573,Porphyrins,Porphyrins:PrThr:Pt:Urine:Ord
5574,Producer code,Producer code:Type:Pt:Contact lens.prescription.right:Nom
5575,zinc protoporphyrin,Protoporphyrin.zinc:PrThr:Pt:RBC:Ord
5576,Age,Age:Time:Pt:^Patient:Qn:Calculated
5577,Mercury,Mercury:MCnc:XXX:Urine:Qn
5578,View,Views^W contrast IA:Find:Pt:Abdomen>Adrenal artery.bilateral:Doc:RF.angio
5579,Chlamydia trachomatis D+K Ab.IgM,Chlamydia trachomatis D+K Ab.IgM:ACnc:Pt:Ser:Qn
5580,Coccidioides immitis antibody,Coccidioides immitis Ab:PrThr:Pt:Body fld:Ord
5581,Orosomucoid,Alpha-1-Acid glycoprotein:MCnc:Pt:Ser/Plas:Qn
5582,Lincomycin,Lincomycin:Susc:Pt:Isolate:Qn:MLC
5583,Cytomegalovirus DNA,Cytomegalovirus DNA:PrThr:Pt:CSF:Ord:Probe.amp.tar
5584,Glycosaminoglycans,Glycosaminoglycans:MCnc:Pt:Urine:Qn
5585,IgG.canine,IgG.canine:MCnc:Pt:Ser:Qn:Immune diffusion
5586,Multisection,Multisection^WO & W contrast IV:Find:Pt:Abdomen:Doc:MR
5587,Lactoglobulin Ab.IgE.RAST class,Lactoglobulin Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
5588,Rotavirus IgG,Rotavirus Ab.IgG:PrThr:Pt:Ser:Ord
5589,View,Deprecated Carpal bones - bilateral X-ray
5590,Legionella polyvalent A Ab,Legionella polyvalent A Ab:PrThr:Pt:Ser:Ord
5591,TRANSKETOLASE,Transketolase:CCnc:Pt:Ser:Qn
5592,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes:NFr:Pt:Bld:Qn:Flow cytometry
5593,Blood Plasma Volume,Plasma volume:Vol:Pt:^Patient:Qn:Radnuc
5594,Equine influenza virus A1 Antigen,Equine influenza virus A1 Ag:ACnc:Pt:XXX:Qn
5595,Multisection,Multisection:Find:Pt:^Breast specimen:Doc:US
5596,Leucocyte esterase,Leukocyte esterase:CCnc:Pt:WBC:Qn
5597,Differential panel,Differential panel:-:Pt:Periton fld:-
5598,Heavy metals panel,Heavy metals panel:-:Pt:Urine:-
5599,Symptoms & diseases,History of symptoms & diseases:Finding:Point in time:^Patient:Narrative:Observed
5600,Erythroblasts,Erythrocytes.nucleated:NCnc:Pt:Bld:Qn
5601,Mesothelial cells/100 leukocytes,Mesothelial cells/100 leukocytes:NFr:Pt:Pericard fld:Qn
5602,Type - attribute,Type:ID:Pt:Vaccine:Nom
5603,Body Weight,Body weight:Mass:Pt:^Patient:Qn:Measured
5604,Fucosidase,Alpha fucosidase:CCnt:Pt:Fibroblasts:Qn
5605,Follicle Stimulating Hormone,Follitropin^7th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn:2nd IRP
5606,Glucose,Glucose^45M post XXX challenge:SCnc:Pt:Ser/Plas:Qn
5607,Methemoglobin/Hemoglobin.total,Methemoglobin/Hemoglobin.total:MFr:Pt:BldV:Qn
5608,Pressure device type,Pressure device type:Type:Point in time:*:Nominal:Perimetry
5609,Viral susceptibility panel,Viral susceptibility panel:-:Point in time:Isolate:Quantitative or Ordinal
5610,CYP21A2 gene targeted mutation analysis,CYP21A2 GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NOM:MOLGEN
5611,Abnormal monocytes,Monocytes.abnormal:NCnc:Pt:Bld:Qn
5612,myeloblast,Myeloblasts:NCnc:Pt:Bld:Qn
5613,View,Views^W contrast IV:Find:Pt:Chest+Abdomen>Vena cava.superior &or Vena cava.inferior:Doc:RF.angio
5614,View,Deprecated Views:Finding:Point in time:Wrist:Narrative:XR
5615,hydrastine,Hydrastine:PrThr:Pt:Ser/Plas:Ord
5616,Physical findings,Physical findings:Find:Pt:Anterior chamber.left:Nar
5617,Mareks disease virus Ag,Mareks disease virus Ag:PrThr:Pt:Feather:Ord
5618,Guidance for radiosurgery,Guidance for radiosurgery:Find:Pt:XXX:Doc:CT
5619,Isoleucine,Isoleucine:MCnc:Pt:Urine:Qn
5620,Parvovirus B19 IgG,Parvovirus B19 Ab.IgG:Titr:Pt:Ser:Qn:IF
5621,Morphine.free,Morphine.free:MCnc:Pt:Vitr fld:Qn
5622,Growth Hormone,Somatotropin^23rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
5623,bromodiphenhydramine,Bromodiphenhydramine:MCnc:Pt:Ser/Plas:Qn
5624,carbinoxamine,Carbinoxamine:MCnc:Pt:Ser/Plas:Qn
5625,Neutrophil cytoplasmic Ab.classic,Neutrophil cytoplasmic Ab.classic:PrThr:Pt:Ser:Ord
5626,View,Views^W contrast PO:Find:Pt:Chest>Esophagus:Doc:RF
5627,Multisection,Multisection:Find:Pt:Upper extremity.right>Forearm:Doc:MR
5628,Cannabinoids,Cannabinoids:ACnc:Pt:Urine:Qn
5629,cocaethylene,Cocaethylene:MCnc:Pt:Ser/Plas:Qn
5630,Cells.CD33+HLA-DR+/100 cells,Cells.CD33+HLA-DR+/100 cells:NFr:Pt:Bld:Qn
5631,Yersinia sp identified,Yersinia sp identified:Prid:Pt:Stool:Nom:Organism specific culture
5632,Echovirus+Coxsackievirus Ab.IgA,Echovirus+Coxsackievirus Ab.IgA:PrThr:Pt:Ser:Ord
5633,Acetylcholinesterase,Acetylcholinesterase:PrThr:Pt:Amnio fld:Ord
5634,Triiodothyronine.true,Triiodothyronine.true:MCnc:Pt:Ser/Plas:Qn
5635,Rabies virus antibody,Rabies virus Ab:PrThr:Pt:Ser:Ord
5636,Cannabinoids,Cannabinoids:PrThr:Pt:Meconium:Ord:Screen
5637,PM-SCL extractable nuclear antibody,PM-SCL extractable nuclear Ab:PrThr:Pt:Ser:Ord
5638,Powassan virus IgG,Powassan virus Ab.IgG:ACnc:Pt:XXX:Qn
5639,Coagulation factor V inhibitor,Coagulation factor V inhibitor:ACnc:Pt:PPP:Qn:Coag
5640,View,Views:Finding:Point in time:Foot:Narrative:XR
5641,Cell positive for CD23 antigen,Cells.CD23:NCnc:Pt:Bld:Qn
5642,Amikacin 12.0 ug/mL,Amikacin 12.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria
5643,Lathyrus sativus Ab.IgE,Deprecated Blue vetch IgE Ab [Units/volume] in Serum
5644,Chlorphentermine,Chlorphentermine:MCnc:Pt:Vitr fld:Qn
5645,phosphoethanolamine,Phosphoethanolamine:MCnc:Pt:Urine:Qn
5646,2-Oxoadipate/Creatinine,2-Oxoadipate/Creatinine:Ratio:Pt:Urine:Qn
5647,Multisection,Multisection:Find:Pt:Abdomen>Liver:Doc:US
5648,Lymphocytes.kappa,Lymphocytes.kappa:NCnc:Pt:Bld:Qn
5649,Colony count,Colony count:NCnc:Pt:Dial fld:Qn
5650,Orientia tsutsugamushi IgG,Orientia tsutsugamushi Ab.IgG:ACnc:Pt:Ser:Qn
5651,Multisection,Multisection:Find:Pt:Lower extremity>Hip:Doc:US
5652,Kanamycin 30.0 ug/mL,Kanamycin 30.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria
5653,Ammonia,Ammonia:SCnc:24H:Urine:Qn
5654,Methylmalonate,Methylmalonate:MCnc:Pt:Ser/Plas:Qn
5655,Guidance for placement of large bore central venous catheter,Guidance for placement of large bore central venous catheter:Find:Pt:XXX>Vein.left:Doc:{Imaging modality}
5656,Phosphofructokinase.F subunit/Phosphofructokinase.total,Phosphofructokinase.F subunit/Phosphofructokinase.total:CFr:Pt:Platelets:Qn
5657,Note (document),Note:Find:Pt:{Setting}:Doc:Social worker
5658,Zinc,Zinc:MCnt:Pt:Nail:Qn
5659,Mycoplasma pneumoniae DNA,Mycoplasma pneumoniae DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar
5660,Collection Time,Collection time:TmStp:Pt:Bld:Qn
5661,Heterophils/100 leukocytes,Heterophils/100 leukocytes:NFr:Pt:Bld:Qn
5662,Multisection,Multisection^WO contrast:Find:Pt:Lower extremity:Doc:CT
5663,heart rate,Heart rate^10M post birth:Fcn:Pt:^Patient:Ord:Apgar
5664,Specimen volume,Specimen volume:Vol:72H:Stool:Qn
5665,Ethambutol,Ethambutol:Susc:Pt:Isolate:OrdQn:Agar diffusion
5666,Cefixime,Cefixime:MCnc:Pt:XXX:Qn
5667,Guidance for percutaneous biopsy.core needle,Guidance for percutaneous biopsy.core needle:Find:Pt:Breast.left:Doc:MG
5668,Borrelia burgdorferi 41kD Ab,Deprecated Borrelia burgdorferi 41kD Ab [Presence] in Serum by Immunoblot (IB)
5669,Fibrinogen fragments,Fibrinogen fragments:MCnc:Pt:PPP:Qn:LA
5670,Axis,Axis:Angle:Pt:Eye.left:Qn:Autorefractor.man
5671,Refraction comment,Refraction comment:Imp:Pt:Eye:Nar:Autorefractor.auto
5672,Narcotics,Narcotics:Presence or Identity:Point in time:Bil fld:Nominal
5673,View,Views^W contrast IS:Find:Pt:Lower extremity>Knee:Doc:RF
5674,Views AP,View AP^W standing:Find:Pt:Lower extremity>Knee:Doc:XR
5675,View,Deprecated Liver and Spleen NM W Tc-99m calcium colloid IV
5676,Streptococcus pneumoniae 19 Ab.IgG,Deprecated Streptococcus pneumoniae 19 IgG Ab [Units/volume] in Serum --1st specimen
5677,Measles virus IgG,Measles virus Ab.IgG^1st specimen/2nd specimen:Ratio:Pt:Ser:Qn
5678,Isoleucine,Isoleucine:SCnc:24H:Urine:Qn
5679,Magnesium,Magnesium:SCnc:Pt:CSF:Qn
5680,Angioplasty,Deprecated Brachiocephalic artery - bilateral Fluoroscopic angiogram Angioplasty W contrast IA
5681,Myelin Basic Proteins,Myelin basic protein:MCnc:Pt:CSF:Qn
5682,Axis degree N 1,Axis degree N 1:Angle:Pt:Eye.right:Qn:Phoropter
5683,Thyrotropin-Releasing Hormone,Thyrotropin releasing hormone:MCnc:Pt:Plas:Qn
5684,Valine,Valine:MCnc:Pt:Ser/Plas:Qn
5685,Vibrio cholerae antibody,Vibrio cholerae Ab:ACnc:Pt:Ser:Qn
5686,factor VII clotting antigen,Coagulation factor VII Ag:ACnc:Pt:PPP:Qn:IA
5687,Obstetric 1996 panel,Obstetric 1996 panel:-:Pt:Ser+Bld:-
5688,Multisection,Multisection:Find:Pt:Head+Neck>Nasopharynx & Neck:Doc:CT
5689,View,Views^W barium contrast PO:Find:Pt:Abdomen>Gastrointestinal tract.upper+Small bowel:Doc:RF
5690,Lysine/Amino acids.total,Lysine/Amino acids.total:SFr:Pt:Ser/Plas:Qn
5691,Mannitol/Creatinine,Mannitol/Creatinine:SRto:Pt:Urine:Qn
5692,Lipoprotein-X,Lipoprotein.X:PrThr:Pt:Ser/Plas:Ord
5693,Nidus,Nidus:Mass:Pt:Calculus:Qn
5694,Prekallikrein,Prekallikrein:MCnc:Pt:PPP:Qn
5695,Glutamate/Amino acids.total,Glutamate/Amino acids.total:SFr:Pt:Bld.dot:Qn
5696,Glutamate/Amino acids.total,Glutamate/Amino acids.total:SFr:Pt:XXX:Qn
5697,Phenylalanine/Amino acids.total,Phenylalanine/Amino acids.total:SFr:Pt:XXX:Qn
5698,Pipecolate/Creatinine,Pipecolate/Creatinine:SRto:Pt:Urine:Qn
5699,HLA-B61(40),HLA-B61(40):PrThr:Pt:Bld/Tiss^Donor:Ord
5700,Stanozolol,Stanozolol:MCnc:Pt:Urine:Qn
5701,Nicotine,Nicotine:PrThr:Pt:Gast fld:Ord
5702,Alprenolol,Alprenolol:Mass:Pt:Dose:Qn
5703,Manganese,Manganese:SCnc:Pt:Urine:Qn
5704,Adenovirus antibody (substance),Adenovirus Ab:PrThr:Pt:Ser:Ord
5705,Tocainide,Tocainide:Mass:Pt:Dose:Qn
5706,Glucose,Glucose^2.5H post 50 g lactose PO:SCnc:Pt:Ser/Plas:Qn
5707,Monomeric prolactin,Deprecated Prolactin monomeric [Mass/volume] in Serum or Plasma
5708,Thyrotropin,Thyrotropin^pre dose triple bolus:ACnc:Pt:Ser/Plas:Qn
5709,Thioguanine,6-Thioguanine:PrThr:Pt:RBC:Ord
5710,alpha-hydroxyglutarate,2-Hydroxyglutarate:PrThr:24H:Urine:Ord
5711,Lymphocyte proliferation. 5 ug concanavalin A stimulation,Lymphocyte proliferation. 5 ug concanavalin A stimulation:NRat:Pt:Bld:Qn
5712,HLA-B35 Antigen,Deprecated HLA-B35 [Presence] in Blood
5713,Liver kidney microsomal 1 Ab.IgG,Liver kidney microsomal 1 Ab.IgG:ACnc:Pt:Ser:Qn:IA
5714,Guidance for biopsy.needle,Deprecated CT Guidance for needle biopsy of Abdomen
5715,View,Views^W flexion + W extension:Find:Pt:XXX>Spine:Doc:XR
5716,Ouabain,Ouabain:Mass:Pt:Dose:Qn
5717,Multisection perfusion qualitative,Multisection perfusion qualitative^at rest+W radionuclide IV:Find:Pt:Chest>Heart:Doc:NM.SPECT
5718,von Willebrand factor,von Willebrand factor.ristocetin cofactor:ACnc:Pt:PPP:Qn
5719,clostebol,Clostebol:Mass:Pt:Dose:Qn
5720,Haloperidol,Haloperidol:Mass:Pt:Dose:Qn
5721,Cells.CD4+CD7+/100 cells,Cells.CD4+CD7+/100 cells:Number Fraction:Point in time:Whole blood:Quantitative
5722,Oxazepam,Oxazepam:Mass:Pt:Dose:Qn
5723,Sickle Hemoglobin,Deprecated Hemoglobin S/Hemoglobin.total in Blood
5724,Views GE 3,Views GE 3:Find:Pt:Upper extremity.right>Hand:Doc:XR
5725,flunisolide,Flunisolide:MCnc:Pt:Ser/Plas:Qn
5726,Immunoglobulin light chains.kappa.free/Immunoglobulin light chains.lambda.free,Immunoglobulin light chains.kappa.free/Immunoglobulin light chains.lambda.free:MRto:Pt:Urine:Qn
5727,Bordetella pertussis IgM,Bordetella pertussis Ab.IgM:ACnc:Pt:Ser:Qn:IA
5728,Avian reovirus Ab,Avian reovirus Ab:PrThr:Pt:Ser:Ord:IF
5729,Clenbuterol,Clenbuterol:MCnc:Pt:Urine:Qn
5730,Thioridazine,Thioridazine:MCnc:Pt:Ser/Plas:Qn
5731,Cells.CD3+CD16+/100 cells,Cells.CD3-CD16+/100 cells:Number Fraction:Point in time:Marrow (bone):Quantitative
5732,Yeasts,Yeast:Naric:Pt:Body fld:Qn:Microscopy.light.HPF
5733,tigecycline,Tigecycline:Susc:Pt:Isolate:OrdQn:MIC
5734,Methylphenidate,Methylphenidate:Mass:Pt:Dose:Qn
5735,4-hydroxybenzoate,4-Hydroxybenzoate:PrThr:24H:Urine:Ord
5736,Human papillomavirus DNA,Human papilloma virus DNA:PrThr:Pt:XXX:Ord:Probe.amp.sig
5737,Pseudoephedrine,Pseudoephedrine:MCnc:Pt:Urine:Qn
5738,Calcium,Calcium^4H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
5739,Vancomycin,Vancomycin^random:MCnc:Pt:Ser/Plas:Qn
5740,Multisection,Multisection^WO contrast:Find:Pt:Abdomen>Superior mesenteric vessels:Doc:MR.angio
5741,ECOG performance status grade,Deprecated ECOG performance status grade Observed
5742,Ibuprofen,Ibuprofen:Mass:Pt:Dose:Qn
5743,Spermatozoa IgM binding location,Spermatozoa IgM binding location:Prid:Pt:Semen:Nom
5744,Views GE 3,Views GE 3:Find:Pt:Upper extremity>Wrist:Doc:XR
5745,Legionella pneumophila 11 IgM,Legionella pneumophila 11 Ab.IgM:Titr:Pt:Ser:Qn
5746,Multisection,Multisection^W In-111 Satumomab IV:Find:Pt:Pelvis>Prostate:Doc:NM.SPECT
5747,Views 1 or 2,Views 1 or 2:Find:Pt:Lower extremity>Knee:Doc:XR
5748,Immunoglobulin G antigen,IgG Ag:PrThr:Pt:Skin:Ord:IF
5749,Monoclonal IgG,IgG.monoclonal:PrThr:Pt:CSF:Ord:Immunofixation
5750,Adenosine monophosphate.cyclic/Creatinine,Adenosine monophosphate.cyclic/Creatinine^4H post XXX challenge:Ratio:Pt:Urine:Qn
5751,Ofloxacin 2.0 ug/mL,Ofloxacin 2.0 ug/mL:Susceptibility:Point in time:Isolate:Quantitative or Ordinal:Slow-growing Mycobacteria
5752,Bacteria,Bacteria:PrThr:Pt:Cvx:Ord:Wet preparation
5753,Bacteria,Bacteria:PrThr:Pt:Vag:Ord:Wet preparation
5754,Propranolol,Propranolol:Mass:Pt:Dose:Qn
5755,Urease,Urease^4H post incubation:PrThr:Pt:Tiss:Ord
5756,Secobarbital,Secobarbital:Mass:Pt:Dose:Qn
5757,Influenza A virus H5 RNA,Influenza virus A H5 RNA:ACnc:Pt:XXX:Qn:Probe.amp.tar
5758,Glucose,Glucose^18H post XXX challenge:SCnc:Pt:Ser/Plas:Qn
5759,Glucose,Glucose^3M pre XXX challenge:SCnc:Pt:Ser/Plas:Qn
5760,Zinc,Zinc:PrThr:Pt:Urine:Ord
5761,Vendor serial number,Vendor serial number:ID:Pt:Oxygen saturation device:Nom
5762,Clomipramine,Clomipramine:Mass:Point in time:Dose med or substance:Quantitative
5763,Insulin,Insulin^pre 100 g glucose PO:MCnc:Pt:Ser/Plas:Qn
5764,Histoplasma capsulatum antigen,Histoplasma capsulatum Ag:PrThr:Pt:Urine:Ord:IA
5765,Bartonella henselae & Bartonella quintana Ab.IgG & IgM panel,Bartonella henselae & Bartonella quintana Ab.IgG & IgM panel:-:Pt:Ser:-
5766,Bilirubin,Bilirubin:PrThr:Pt:Body fld:Ord
5767,Phenytoin,Phenytoin:PrThr:Pt:XXX:Ord
5768,Arsenic.inorganic/Creatinine,Arsenic.inorganic/Creatinine:MRto:24H:Urine:Qn
5769,Chlamydia trachomatis rRNA,Deprecated Chlamydia trachomatis rRNA [Presence] in Cervix by DNA probe
5770,Chlamydia species antigen,Deprecated Chlamydia sp Ag [Presence] in Penis
5771,Ergocalciferol,Calciferol:SCnc:Pt:Ser/Plas:Qn
5772,ADENOSINE DEAMINASE,Adenosine deaminase:EntCat:Pt:WBC:Qn
5773,Vendor software version,Vendor software version:ID:Pt:Pedometer device:Nom
5774,tipranavir,Tipranavir:Susc:Pt:Isolate:OrdQn
5775,Salmonella enterica subspecies enterica serovar Paratyphi C O antibody,Salmonella paratyphi C O Ab:Titr:Pt:Ser:Qn
5776,Citrulline/Creatinine,Citrulline/Creatinine:MRto:24H:Urine:Qn
5777,Vesicular stomatitis Indiana virus Ag,Vesicular stomatitis Indiana virus Ag:PrThr:Pt:XXX:Ord:Comp fix
5778,Hemoglobin Hope,Hemoglobin Hope:PrThr:Pt:Bld:Ord:Electrophoresis pH 6.3
5779,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count
5780,"Surgery of other regional site(s), distant site(s), or distant lymph node(s) at this facility 98-02","Surgery of other regional site(s), distant site(s), or distant lymph node(s) at this facility 98-02:Prid:Pt:Cancer.XXX:Nom"
5781,View,View:Find:90M:XXX:Doc:RF
5782,Views GE 3,Views GE 3:Find:Pt:Upper extremity.left>Thumb:Doc:XR
5783,Carbonyl hemoglobin/Hemoglobin.total,Deprecated Carboxyhemoglobin/Hemoglobin.total in Blood
5784,"3,4-methylenedioxyethamphetamine",Methylenedioxyethylamphetamine:MCnc:Pt:Urine:Qn:Confirm
5785,Phenylalanine hydroxylase Ab,Phenylalanine hydroxylase Ab:ACnc:Pt:Ser:Qn
5786,Norepinephrine,Norepinephrine^5th specimen post XXX challenge:SCnc:Pt:Urine:Qn
5787,Campylobacter sp Ab.IgA,Campylobacter sp Ab.IgA:PrThr:Pt:Ser:Ord
5788,thyrotropin alfa,Thyrotropin.alpha subunit:MCnc:Pt:Ser/Plas:Qn
5789,Special use section,Special use section:-:Point in time:^Patient:Set:NAACCR v.11
5790,Toxoplasma gondii antibody,Deprecated Toxoplasma gondii Ab [Presence] in Serum by Latex agglutination
5791,Arsenic,Arsenic:MCnc:Pt:Dial fld:Qn
5792,Human immunodeficiency virus 1 RNA,HIV 1 RNA:LnCnc:Pt:Ser/Plas:Qn:Probe.amp detection limit = 1.9 log copies/mL
5793,Comorbidities and complications 7,Comorbidities and complications 7:Presence or Identity:Point in time:^Patient:Nominal
5794,Comorbidities and complications 10,Comorbidities and complications 10:Presence or Identity:Point in time:^Patient:Nominal
5795,Views GE 5,Views GE 5:Find:Pt:Head>Skull:Doc:XR
5796,Selenium/Creatinine,Selenium/Creatinine:SRto:24H:Urine:Qn
5797,Treponema pallidum IgM,Treponema pallidum Ab.IgM:PrThr:Pt:Ser:Ord:IA
5798,Cells.CD23+CD38+,Cells.CD23+CD38+:NCnc:Pt:Bld:Qn
5799,Multisection limited,Multisection limited:Find:Pt:Chest:Doc:CT
5800,Multisection,Multisection^WO contrast:Find:Pt:Upper extremity>Wrist:Doc:MR
5801,Oxymetholone,Oxymetholone:MRat:24H:Urine:Qn
5802,Multisection,Multisection:Find:Pt:Abdomen+Pelvis>Iliac vessels:Doc:US.doppler
5803,Views first pass,Views first pass^at rest+W radionuclide IV:Find:Pt:Chest>Heart:Doc:NM
5804,Amino Acids,Amino acids:Presence or Identity:Point in time:Cerebral spinal fluid:Nominal
5805,Cholesterol,Cholesterol [Mass or Molecules/volume] in Serum or Plasma
5806,Norclomipramine,Norclomipramine:MCnc:Pt:Ser/Plas:Qn:Screen
5807,Cryptosporidium species antigen,Cryptosporidium sp Ag:PrThr:Pt:Stool:Ord:IF
5808,Views 2 phase,Views 2 phase^W radionuclide IV:Find:Pt:XXX>Bone:Doc:NM
5809,Hepatitis C virus Ab.IgG band pattern,Hepatitis C virus Ab.IgG band pattern:Imp:Pt:Ser:Nom:IB
5810,Platelets.large,Platelets.large:PrThr:Pt:Bld:Ord:Automated count
5811,Spermatozoa.immotile,Spermatozoa.immotile:NCnc:Pt:Semen:Qn
5812,Multisection,Multisection^WO contrast:Find:Pt:Pelvis>Sacrum:Doc:CT
5813,Multisection,Multisection^WO contrast:Find:Pt:Abdomen+Pelvis:Doc:CT
5814,HLA-B locus,human histocompatibility complex derived antigens-B locus:Type:Point in time:Whole blood:Nominal
5815,Spermatozoa.tail.motile with IgA/100 spermatozoa,Spermatozoa.tail.motile with IgA/100 spermatozoa:NFr:Pt:Semen:Qn:Immunobead
5816,Multisection for transplanted kidney,Multisection for transplanted kidney:Find:Pt:Pelvis:Doc:US
5817,Multisection,Multisection^at rest+W radionuclide IV:Find:Pt:Chest>Heart:Doc:NM.SPECT
5818,Clostridium botulinum,Clostridium botulinum:PrThr:Pt:Isolate:Ord:Organism specific culture
5819,salicylamide,Salicylamide^peak:MCnc:Pt:Ser/Plas:Qn
5820,butabarbital,Butabarbital:PrThr:Pt:Urine:Ord
5821,Multisection,Deprecated Calcaneus - left CT W contrast IV
5822,View axillary,View axillary:Find:Pt:Upper extremity.bilateral>Shoulder:Doc:XR
5823,View Brewerton,View Brewerton:Find:Pt:Upper extremity.bilateral>Hand:Doc:XR
5824,Beryllium,Beryllium:MCnc:Pt:Air:Qn
5825,Minute volume setting,Minute volume setting:VRat:Pt:Ventilator:Qn
5826,Francisella tularensis IgA,Francisella tularensis Ab.IgA:Titr:Pt:Ser:Qn
5827,Androsterone,Androsterone:SCnc:24H:Urine:Qn
5828,Cadmium,Cadmium:SCnc:24H:Urine:Qn
5829,Urate,Urate [Mass or Molecules/volume] in 24 hour Urine
5830,Chlamydia sp DNA,Chlamydia sp DNA:PrThr:Pt:Anal:Ord:Probe.amp.tar
5831,View Stryker Notch,View Stryker Notch:Find:Pt:Upper extremity.bilateral>Shoulder:Doc:XR
5832,Views 4,Views 4:Find:Pt:Head>Optic foramen:Doc:XR
5833,Views 2,Views 2:Find:Pt:Pelvis:Doc:XR
5834,Multisection,Multisection:Find:Pt:Pelvis>Penis vessels:Doc:US
5835,Wound irrigation &or cleaning fluid,Wound irrigation &or cleaning fluid:Type:Pt:Flu.nonbiological:Nom
5836,Hexacarboxylporphyrin,Hexacarboxylporphyrin:MRat:24H:Stool:Qn
5837,Cells counted.total,Cells counted.total:Num:Pt:Pericard fld:Qn
5838,Afipia felis IgM,Afipia felis Ab.IgM:PrThr:Pt:Ser:Ord
5839,Anti-ovarian antibody,Ovary Ab:Titr:Pt:Ser:Qn
5840,Surgical margin tumor involvement.mucosal,Surgical margin tumor involvement.mucosal:Find:Pt:Specimen:Nom:CAP cancer protocols
5841,dipipanone,Dipipanone:MCnc:Pt:Urine:Qn
5842,Views 2,Views 2:Find:Pt:Upper extremity.right>Acromioclavicular joint:Doc:XR
5843,Borrelia burgdorferi C6 Ab,Borrelia burgdorferi C6 Ab:ACnc:Pt:CSF:Qn:IA
5844,Herpes virus 6 IgM,Herpes virus 6 Ab.IgM:Titr:Pt:Ser:Qn
5845,Digoxin.free,Digoxin.free:MCnc:Pt:Ser/Plas:Qn
5846,Flupenthixol,Flupenthixol:MCnc:Pt:Ser/Plas:Qn
5847,Iodine/Creatinine,Iodine/Creatinine:SRto:Pt:Urine:Qn
5848,Chromosome Breakage,Chromosome breakage:ACnc:Pt:Bld:Qn:Diepoxybutane
5849,Disopyramide,Disopyramide:MCnc:Pt:Ser/Plas:Qn
5850,Cefixime,Cefixime:Susc:Pt:Isolate:OrdQn:Gradient strip
5851,Pain primary location,Pain primary location:Anat:Pt:*:Nom:Reported
5852,Coagulation factor X+Acarboxy Ag actual/Normal,Coagulation factor X+Acarboxy Ag actual/Normal:RelMCnc:Pt:PPP:Qn:IA
5853,Spermatozoa Ab.IgA,Spermatozoa Ab.IgA:PrThr:Pt:Semen:Ord
5854,Insulin,Insulin^2nd specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn
5855,Pregnanediol,Pregnanediol:SCnc:24H:Urine:Qn
5856,Note (document),Note:Find:Pt:{Setting}:Doc:Nephrology
5857,enrofloxacin,Enrofloxacin:Susc:Pt:Isolate:OrdQn:MIC
5858,gemifloxacin,Gemifloxacin:Susc:Pt:Isolate:OrdQn:Agar diffusion
5859,grepafloxacin,Grepafloxacin:Susc:Pt:Isolate:OrdQn:Agar diffusion
5860,Multisection,Multisection^W contrast IV:Find:Pt:Chest>Chest vessels:Doc:CT.angio
5861,Levorphanol,Levorphanol:MRat:24H:Urine:Qn
5862,C-Peptide,C peptide^15M post XXX challenge:MCnc:Pt:Ser/Plas:Qn
5863,metacresol,M-cresol:MCnc:Pt:Air:Qn
5864,Multisection for infarct,Multisection for infarct^W Tc-99m PYP IV:Find:Pt:Chest>Heart:Doc:NM.SPECT
5865,Glutamine,Glutamine:SCnc:Pt:Vitr fld:Qn
5866,5-methyltetrahydrofolate,5-Methyltetrahydrofolate:PrThr:Pt:CSF:Ord
5867,Histamine,Histamine:SCnc:Pt:Urine:Qn
5868,Salmonella enterica subspecies enterica serovar Typhi O antibody,Salmonella typhi O Ab:Titr:Pt:Ser:Qn:Aggl
5869,Saccharopolyspora rectivirgula IgG,Saccharopolyspora rectivirgula Ab.IgG:PrThr:Pt:Ser:Ord:Immune diffusion
5870,Mitochondria M4 Ab,Mitochondria M4 Ab:PrThr:Pt:Ser:Ord
5871,Pristinamycin,Pristinamycin:Susc:Pt:Isolate:OrdQn:MIC
5872,Loxapine,Loxapine:PrThr:Pt:Urine:Ord
5873,View,Views^W contrast IA:Find:Pt:Chest>Subclavian artery.bilateral:Doc:RF.angio
5874,Views lateral,View lateral:Find:Pt:Lower extremity.right>Knee:Doc:XR
5875,View XCCL,View XCCL:Find:Pt:Breast.right:Doc:MG
5876,Phenylpropanolamine,Phenylpropanolamine:MRat:24H:Urine:Qn
5877,Views for abscess,Views for abscess^W Ga-67 IV:Find:Pt:XXX:Doc:NM
5878,Phoma betae Ab.IgG.RAST class,Phoma betae Ab.IgG.RAST class:PrThr:Pt:Ser:Ord
5879,Admission evaluation note,Admission evaluation note:Find:Pt:{Setting}:Doc:Surgery
5880,Note (document),Note:Find:Pt:{Setting}:Doc:Emergency medicine
5881,4-phenylenediamine,"1,4-Benzenediamine:MCnc:Pt:Air:Qn"
5882,microscopic observation,Microscopic observation:Prid:Pt:XXX:Nom:Chloracetate esterase stain
5883,Prolactin,Prolactin^1H post 200 ug TRH IV:SCnc:Pt:Ser/Plas:Qn
5884,Urobilinogen,Urobilinogen:SCnc:Pt:Urine:Qn
5885,Herpes simplex virus identified,Herpes simplex virus identified:Prid:Pt:Penis:Nom:Organism specific culture
5886,Blasts/100 leukocytes,Blasts/100 leukocytes:NFr:Pt:Synv fld:Qn
5887,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted:ArVRat:Pt:Ser/Plas:Qn:Creatinine-based formula (MDRD)
5888,Giardia lamblia antigen,Giardia lamblia Ag:PrThr:Pt:Bil fld:Ord
5889,Multisection,Multisection:Find:Pt:Lower extremity.left>Hip:Doc:MR
5890,Views 3,Views 3:Find:Pt:Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccyx:Doc:XR
5891,Ova & parasites identified,Deprecated Microscopic observation [Identifier] in Stool by Ova & Parasite Preparation
5892,Human polyomavirus 1 DNA,BK virus DNA:PrThr:Pt:Ser/Plas:Ord:Probe.amp.tar
5893,Chlamydia sp Ab.IgG,Chlamydia sp Ab.IgG:ACnc:Pt:Ser:Qn:IA
5894,SPINK1 gene targeted mutation analysis,SPINK1 GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NAR:MOLGEN
5895,Multisection,Multisection^WO & W contrast IV:Find:Pt:Abdomen>Spine.lumbar:Doc:CT
5896,Crystal Structure,Crystals:Prid:Pt:Pericard fld:Nom:Microscopy.light
5897,Multisection limited,Multisection limited:Find:Pt:Extremity>Extremity vessels:Doc:US.doppler
5898,pipradrol,Pipradrol:MRat:24H:Urine:Qn
5899,Normoblasts/100 leukocytes,Normoblasts/100 leukocytes:NFr:Pt:Bld:Qn
5900,View,Views^W contrast IA:Find:Pt:Head+Neck>Carotid artery:Doc:RF.angio
5901,C-Peptide,C peptide^30M post XXX challenge:SCnc:Pt:Ser/Plas:Qn
5902,C-Peptide,C peptide^2.5H post XXX challenge:SCnc:Pt:Ser/Plas:Qn
5903,Sodium,Sodium:SCnc:Pt:BldV:Qn
5904,Sella-nasion plane to nasion-A point line,Sella-nasion plane to nasion-A point line:Angle:Pt:Skull:Qn:CT.measured
5905,Impacted tooth,Tooth impaction:Finding:Point in time:{Tooth}:Nominal
5906,Cimetidine,Cimetidine:PrThr:Pt:Urine:Ord
5907,Monocytes,Monocytes:NCnc:Pt:Body fld:Qn
5908,Multisection,Multisection^WO & W contrast IV:Find:Pt:Lower extremity.right>Knee vessels:Doc:MR.angio
5909,Collagen induced platelet aggregation,Platelet aggregation.collagen induced^high dose:RelACnc:Pt:PRP:Qn
5910,Information for patients section,Information for patients section:-:-:^FDA package insert:Nar
5911,Multisection,Multisection:Find:Pt:Pelvis>Scrotum+Testicle:Doc:MR
5912,Views 4,Views 4:Find:Pt:Head>Mastoid:Doc:XR
5913,Multisection,Multisection:Find:Pt:Chest>Lung parenchyma:Doc:CT
5914,Cells.CD14/100 cells,Cells.CD14/100 cells:NFr:Pt:Tiss:Qn
5915,Ristocetin induced platelet aggregation,Platelet aggregation.ristocetin induced^900 ug/mL:RelACnc:Pt:PRP:Qn
5916,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN","Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN:PrThr:Pt:Cancer specimen:Ord:Immune stain"
5917,Stroke volume/Body surface area,Stroke volume/Body surface area:ArVol:Pt:Heart.ventricle.right:Qn:CT spiral
5918,Cholinesterases,Deprecated Cholinesterase [Enzymatic activity/volume] in Serum or Plasma
5919,isoxanthopterin,Isoxanthopterin:SCnc:Pt:Ser/Plas:Qn
5920,Visual Acuity,Visual acuity^best corrected:LogLenRto:Pt:Eye.left:Qn:ETDRS eye chart
5921,Plan of care note,Plan of care note:Find:Pt:{Setting}:Doc:Orthopaedic surgery
5922,Leptospira interrogans serovar Szwajizak Ab,Leptospira interrogans serovar Szwajizak Ab:Titr:Pt:Ser:Qn:Aggl
5923,Allo-tetrahydrocorticosterone/Creatinine,Allo-tetrahydrocorticosterone/Creatinine:SRto:Pt:Urine:Qn
5924,Views Broden,Deprecated Hindfoot - bilateral and Midfoot - bilateral X-ray Broden
5925,Plan of care note,Plan of care note:Find:Pt:{Setting}:Doc:Obstetrics and Gynecology
5926,Diagnostic study note,Diagnostic study note:Find:Pt:{Setting}:Doc:Pulmonary disease
5927,(Arachis hypogaea+Bertholletia excelsa+Cocos nucifera+Corylus avellana+Prunus dulcis) Ab.IgE.RAST class,(Arachis hypogaea+Bertholletia excelsa+Cocos nucifera+Corylus avellana+Prunus dulcis) Ab.IgE.RAST class:PrThr:Pt:Ser:Ord:Multidisk
5928,Diameter (qualifier value),Diameter:Len:Pt:Aorta.root:Qn:US.2D
5929,HIV 1 RNA+proviral DNA,HIV 1 RNA+proviral DNA:PrThr:Pt:Bld:Ord:Probe.amp.tar
5930,Pressure half time.diastole,Pressure half time.diastole:Time:Pt:Aortic valve:Qn:US.doppler.CW
5931,Diameter.end systole,Diameter.end systole:Len:Pt:Aorta.root:Qn:US.2D
5932,Spotted fever group rickettsia antibody,Rickettsia spotted fever group Ab:ACnc:Pt:Ser:Qn
5933,Cells.CD16/100 cells,Cells.CD16/100 cells:NFr:Pt:Bld:Qn
5934,quinethazone,Quinethazone:MCnc:Pt:Urine:Qn
5935,Taenia solium larva 18kD Ab,Taenia solium larva 18kD Ab:PrThr:Pt:Ser:Ord:IB
5936,Transportation summary,Transportation summary:Find:Pt:{Setting}:Doc:{Role}
5937,Calcitonin,Calcitonin^1M post XXX challenge:SCnc:Pt:Ser/Plas:Qn
5938,BCL6 Gene Rearrangement,BCL6 gene rearrangements:Imp:Pt:Bld/Tiss:Nar:FISH
5939,Benzodiazepines,Benzodiazepines:PrThr:Pt:Ser/Plas:Ord:Screen>200 ng/mL
5940,Length.end diastole,Length.end diastole:Len:Pt:Heart.ventricle.left:Qn:US.2D.A4C
5941,Proteins,Protein:MCnc:Pt:Respiratory.lower:Qn
5942,Measurement site,MEASUREMENT SITE:ANATOMY:POINT IN TIME:PERIPHERAL ARTERY:NOMINAL
5943,Intravascular systolic,Intravascular systolic:Pres:Pt:Hepatic artery:Qn
5944,Fluid intake.synovial,Fluid intake.synovial:VRat:1H:Synovial space:Qn
5945,Du antigen,D little u Ag:PrThr:Pt:RBC:Ord
5946,Porphyrins,Porphyrins:MRat:24H:Stool:Qn
5947,d antibody,D Ab:PrThr:Pt:Ser/Plas^Donor:Ord
5948,Coxsackievirus A10 Ab,Coxsackievirus A10 Ab:Titr:Pt:CSF:Qn:Comp fix
5949,Cells.MYC gene rearrangements/Cells counted,Cells.MYC gene rearrangements/Cells counted:NFr:Pt:Bld/Tiss:Qn:FISH
5950,Cells.MLL gene rearrangements/Cells counted,Cells.MLL gene rearrangements/Cells counted:NFr:Pt:Bld/Tiss:Qn:FISH
5951,Hydroxylurasidone,Hydroxylurasidone:MCnc:Pt:Urine:Qn:Confirm
5952,dronabinol,Tetrahydrocannabinol:MCnt:Pt:Hair:Qn
5953,Amitriptyline & Nortriptyline panel,Amitriptyline & nortriptyline panel:-:Pt:Gast fld:-
5954,16-Alpha hydroxydehydroepiandrosterone/Creatinine,16-Alpha hydroxydehydroepiandrosterone/Creatinine:SRto:Pt:Urine:Qn
5955,LOINC class types,Class:Type:Pt:Oral tube:Nom
5956,Organochlorine pesticide,Organochlorine pesticides:Type:Pt:Ser/Plas:Nom
5957,dia antibody,D little i super little a Ab:PrThr:Pt:Ser/Plas^Donor:Ord
5958,TARDBP gene targeted mutation analysis,TARDBP gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
5959,Thickness.end diastole,Thickness.end diastole:Len:Pt:Heart.ventricle.right.anterior wall:Qn:US.M-mode
5960,Multisection for pregnancy+first trimester,Multisection for pregnancy+first trimester:Find:Pt:Pelvis+^Fetus:Doc:US
5961,(Ambrosia elatior+Chenopodium album+Cynodon dactylon+Lolium perenne+Plantago lanceolata+Paspalum notatum) Ab.IgE,(Ambrosia elatior+Chenopodium album+Cynodon dactylon+Lolium perenne+Plantago lanceolata+Paspalum notatum) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk
5962,Vendor model number,Vendor model number:Prid:Pt:Cardiac pacemaker prosthetic lead:Nom:EKG
5963,intraventricular conduction,Intraventricular conduction:Impression/interpretation of study:Point in time:Heart:Narrative:EKG
5964,P wave duration.lead AVF,P wave duration.lead AVF:Time:Pt:Heart:Qn:EKG
5965,Energy content,Energy content:EngCnt:24H:Stool.dried:Qn
5966,Flowsheet,Flowsheet:Find:Pt:{Setting}:Doc:Clinical genetics
5967,Progress note,Progress note:Find:Pt:{Setting}:Doc:Dermatology
5968,Initial evaluation note,Initial evaluation note:Find:Pt:{Setting}:Doc:Multi-specialty program
5969,Cranial nerve assessment panel,Cranial nerve assessment panel:-:Pt:Nerves.cranial:-
5970,Intravascular mean,Intravascular mean:Pres:Pt:Iliac artery.left:Qn
5971,Blood group antigen Bg^a^,DBG Ag:PrThr:Pt:RBC^BPU:Ord
5972,QRS terminal amplitude.lead III,QRS terminal amplitude.lead III:Elpot:Pt:Heart:Qn:EKG
5973,CALR gene exon 9 targeted mutation analysis,CALR gene exon 9 targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
5974,depression scale,Depression scale:Find:Pt:^Patient:Ord:UPDRS
5975,Aldosterone & renin concentration panel,Aldosterone & renin concentration panel:-:Pt:Plas:Qn
5976,Views GE 2,Views GE 2:Find:Pt:Lower extremity>Hip:Doc:XR
5977,Japanese encephalitis virus RNA,Japanese encephalitis virus RNA:PrThr:Pt:Ser:Ord:Probe.amp.tar
5978,Platelet associated Ab.IgM,Platelet associated Ab.IgM:ACnc:Pt:Bld:Qn
5979,Acenocoumarol,Acenocoumarol:MCnt:Pt:Hair:Qn
5980,Output.colostomy,Output.colostomy:MRat:1H:Lower GI tract:Qn
5981,R wave amplitude.lead V4,R wave amplitude.lead V4:Elpot:Pt:Heart:Qn:EKG
5982,Hepatitis B virus little e Ag & Ab panel,Hepatitis B virus little e Ag & Ab panel:-:Pt:Ser:-
5983,Niobium,Niobium:SCnc:Pt:Urine:Qn
5984,Modified Hoen and Yahr stage,Modified Hoen and Yahr stage:Find:Pt:^Patient:Ord:UPDRS
5985,Budgerigar serum proteins+feathers+droppings Ab.IgG,Budgerigar serum proteins+feathers+droppings Ab.IgG:MCnc:Pt:Ser:Qn
5986,Neurofilament heavy chain Ab,Neurofilament heavy chain Ab:MCnc:Pt:CSF:Qn
5987,CYP2C8 gene targeted mutation analysis,CYP2C8 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
5988,homocarnosine,Homocarnosine:SCnc:Pt:Ser/Plas:Qn
5989,R- & S-beta aminoisobutyrate & D- & L-serine panel,R- & S-beta aminoisobutyrate & D- & L-serine panel:-:Pt:Urine:-
5990,Pterins pattern,Pterins pattern:Imp:Pt:Urine:Nar
5991,Q wave depth,Q wave depth:Electrical Potential (Voltage):Point in time:Heart:Quantitative:EKG
5992,Total fluid output,Fluid output.total:VRat:24H:^Patient:Qn
5993,7-Hydroxyquetiapine,7-Hydroxyquetiapine:MCnc:Pt:Urine:Qn:Confirm
5994,"3,4-Dihydroxyhydrocinnamate/Creatinine","3,4-Dihydroxyhydrocinnamate/Creatinine:SRto:Pt:Urine:Qn"
5995,N(alpha)-acetyllysine,N-alpha acetyllysine:SCnc:Pt:Ser/Plas:Qn
5996,Cryoglobulin.IgM,Cryoglobulin.IgM:PrThr:Pt:Ser:Ord
5997,Escherichia coli K1 DNA,Escherichia coli K1 DNA:PrThr:Pt:CSF:Ord:Non-probe.amp.tar
5998,Cytomegalovirus DNA,Cytomegalovirus DNA:PrThr:Pt:CSF:Ord:Non-probe.amp.tar
5999,Hypersensitivity,History of allergies:Finding:Point in time:^Patient:Nominal:Reported
6000,Breath,Breaths:NRat:10H^max:Respiratory system:Qn
6001,Checklist,Checklist:Find:Pt:{Setting}:Doc:Cardiovascular disease+Pulmonary disease
6002,Oxypurinol,Oxipurinol:SCnc:Pt:CSF:Qn
6003,Eicosadienoate,Eicosadienoate:SCnc:Pt:Ser/Plas:Qn
6004,cis-13-Eicosenoate,cis-13-Eicosenoate:SCnc:Pt:Ser/Plas:Qn
6005,"Social, psychological & behavioral observations - 2015 Edition Health IT Certification Criteria set","Social, psychological & behavioral observations - 2015 Edition Health IT Certification Criteria set:-:Pt:{Setting}:-"
6006,Physical findings,Physical findings:Finding:Point in time:Ear:Nominal:Observed
6007,Blood product unit expiration,Blood product unit expiration:TmStp:Pt:^BPU:Qn
6008,Ristocetin induced platelet aggregation,Platelet aggregation.ristocetin induced^500 ug/mL:RelACnc:Pt:PRP:Qn
6009,Trimeprazine,Trimeprazine:MCnt:Pt:Hair:Qn
6010,Surgical operation note postoperative Dx,Operative note postoperative Dx:Impression/interpretation of study:Point in time:^Patient:Nominal
6011,Surgical operation note procedure,Surgical operation note procedure:Presence or Identity:Point in time:^Patient:Nominal
6012,Hydrocortisone,Cortisol^3M post XXX challenge:SCnc:Pt:Ser/Plas:Qn
6013,Flowsheet,Flowsheet:Find:Pt:{Setting}:Doc:Cardiovascular disease+Pulmonary disease
6014,Summary of encounters note,Summary of encounters note:Find:Pt:{Setting}:Doc:Ophthalmology
6015,Isoleucine intake,Isoleucine intake:MRat:24H:^Patient:Qn:Measured
6016,HIV 1 proviral DNA genotype,HIV 1 proviral DNA genotype:Imp:Pt:Bld MC:Nar:Genotyping
6017,Body Weight,Body weight:Mass:Pt:^Patient:Qn:Estimated
6018,Body Weight,Body weight^at birth:Mass:Pt:^Patient:Qn:Measured
6019,Opiates,Opiates:PrThr:Pt:Unk sub:Ord
6020,Stroke Volume,Stroke volume:Vol:Pt:Heart.ventricle.left:Qn:Indicator dilution
6021,Stroke Volume,Stroke volume:Vol:Pt:Heart.ventricle.right:Qn:US.doppler
6022,cefodizime,Cefodizime:Titr:Pt:Isolate+Ser:Qn:SBT
6023,Patient was hospitalized because of this condition,Patient was hospitalized because of this condition:Find:Pt:^Patient:Ord
6024,Patient demographics panel,Patient demographics panel:-:Pt:^Patient:-
6025,CYP4F2 gene product metabolic activity interpretation,CYP4F2 gene product metabolic activity interpretation:Imp:Pt:Bld/Tiss:Ord:CPIC
6026,Escherichia coli enteroaggregative pAA plasmid aggR+aatA genes,Escherichia coli enteroaggregative pAA plasmid aggR+aatA genes:PrThr:Pt:Stool:Ord:Non-probe.amp.tar
6027,Vitamin B12 intake,Vitamin B12 intake:MRat:24H:^Patient:Qn:Estimated
6028,Cells.CD8/100 cells,Cells.CD8/100 cells:Number Fraction:Point in time:Whole blood:Quantitative
6029,Discharge teaching note,Discharge teaching note:Find:Pt:Hospital:Doc:Cardiovascular disease
6030,History and physical note,History and physical note:Find:Pt:{Setting}:Doc:Critical Care Medicine
6031,Influenza A virus Bangkok Ab,Influenza virus A Bangkok Ab:ACnc:Pt:Ser:Qn
6032,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA:PrThr:Pt:Vag:Ord:Probe.amp.tar
6033,Marked operative site,Marked operative site:Finding:Point in time:^Patient:Ordinal
6034,Microsatellite instability markers assessed,Microsatellite instability markers assessed:Num:Pt:Cancer specimen:Qn
6035,Bartonella henselae IgM,Bartonella henselae Ab.IgM:Titr:Pt:Body fld:Qn
6036,Hydrogen/Expired gas,Hydrogen/Expired gas^4H post XXX challenge:VFr:Pt:Exhl gas:Qn
6037,Francisella tularensis antibody,Francisella tularensis Ab:Titr:Pt:Ser:Qn:LA
6038,Dodecanoylcarnitine (C12),Dodecanoylcarnitine (C12):SCnc:Pt:Urine:Qn
6039,Lycopersicon lycopersicum Ab.IgG4,Lycopersicon lycopersicum Ab.IgG4:MCnc:Pt:Ser:Qn
6040,Mytilus edulis Ab.IgG4,Mytilus edulis Ab.IgG4:MCnc:Pt:Ser:Qn
6041,Salmonella enterica subspecies enterica serovar Paratyphi C antibody,Salmonella paratyphi C Ab:Titr:Pt:Ser:Qn
6042,OTC - Keep out of reach of children section,OTC - Keep out of reach of children section:-:-:^FDA product label:Nar
6043,Populus balsamifera Ab.IgE,Populus balsamifera Ab.IgE:ACnc:Pt:Ser:Qn
6044,Herpes simplex virus 1 DNA,Herpes simplex virus 1 DNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar
6045,Cells.CD11b/100 cells,Cells.CD11b/100 cells:NFr:Pt:CSF:Qn
6046,Reticulin antibody,Reticulin Ab:Titr:Pt:Ser:Qn:IF
6047,HBA2 gene.c.429A>T,HBA2 gene.c.429A>T:PrThr:Pt:Bld:Ord:Molgen
6048,Hemoglobin Bart's,Hemoglobin Barts:PrThr:Pt:Bld:Ord:HPLC
6049,Ambrosia trifida Ab.IgG4,Ambrosia trifida Ab.IgG4:MCnc:Pt:Ser:Qn
6050,Dactylis glomerata leukotriene release,Dactylis glomerata leukotriene release:MCnc:Pt:WBC:Qn
6051,Dihydrocodeine.free+Hydrocodol.free,Dihydrocodeine.free+Hydrocodol.free:MCnc:Pt:Ser/Plas:Qn
6052,Cells.CD23/100 cells,Cells.CD23/100 cells:NFr:Pt:Tiss:Qn
6053,Cells.CD3+CD57+/100 cells,Cells.CD3+CD57+/100 cells:Number Fraction:Point in time:Marrow (bone):Quantitative
6054,Cells.CD3+CD57+/100 cells,Cells.CD3+CD57+/100 cells:NFr:Pt:Bld:Qn
6055,Borrelia burgdorferi 49736 IgG,Borrelia burgdorferi 49736 Ab.IgG:ACnc:Pt:Ser:Qn:IA
6056,Helicobacter pylori antibody,Helicobacter pylori Ab:ACnc:Pt:Ser:Qn:IA
6057,"Salmonella Paratyphi A, H antibody",Salmonella paratyphi A H Ab:PrThr:Pt:Ser:Ord:LA
6058,Arginine/Phenylalanine,Arginine/Phenylalanine:SRto:Pt:Bld.dot:Qn
6059,Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4),Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4):SRto:Pt:Bld.dot:Qn
6060,Fetus,Fetuses:Number:Point in time:^Patient:Quantitative
6061,Physical examination by body areas,Physical examination by body areas:-:Pt:^Patient:Set
6062,Ristocetin induced platelet aggregation,Platelet aggregation.ristocetin induced^500 mg/L:PrThr:Pt:PRP:Ord
6063,Bean white Ab.IgG4,Bean white Ab.IgG4:MCnc:Pt:Ser:Qn
6064,Pork Ab.IgG4,Pork Ab.IgG4:MCnc:Pt:Ser:Qn
6065,Chronic leukemia markers,Chronic leukemia markers:Impression/interpretation of study:Point in time:To be specified in another part of the message:Nominal
6066,Cortodoxone,11-Deoxycortisol^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
6067,Cells.CD4+CD7-/100 cells,Cells.CD4+CD7-/100 cells:NFr:Pt:Bone mar:Qn
6068,Cells.CD4+CD7-/100 cells,Cells.CD4+CD7-/100 cells:NFr:Pt:Body fld:Qn
6069,Chlamydia trachomatis rRNA,Chlamydia trachomatis rRNA:PrThr:Pt:Vag:Ord:Probe.amp.tar
6070,Dicarboxystearoylcarnitine (C18-DC),Dicarboxystearoylcarnitine (C18-DC):SCnc:Pt:Amnio fld:Qn
6071,fibroblast growth factor 23,Fibroblast growth factor 23 ^pre XXX challenge:ACnc:Pt:Plas:Qn:IA
6072,Choriogonadotropin.beta subunit,Choriogonadotropin.beta subunit:MCnc:Pt:Ser/Plas:Qn
6073,Ethanol+Methanol+Isopropyl alcohol+Acetone,Ethanol+Methanol+Isopropyl alcohol+Acetone:SCnc:Pt:Ser/Plas:Qn
6074,HLA-Dw6 antigen,HLA-Dw6:PrThr:Pt:Bld/Tiss:Ord
6075,Hepatitis B virus DNA,Hepatitis B virus DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar
6076,Listeria monocytogenes rRNA,Listeria monocytogenes rRNA:PrThr:Pt:XXX:Ord:Probe
6077,Chlamydophila pneumoniae Ab,Chlamydophila pneumoniae Ab:ACnc:Pt:Ser:Qn
6078,Cells.CD57/100 cells,Cells.CD57/100 cells:NFr:Pt:Body fld:Qn
6079,Bacteria identified,Bacteria identified:Prid:Pt:Sptt:Nom:Culture
6080,Glucose,Glucose^30M pre dose betaxolol:SCnc:Pt:Ser/Plas:Qn
6081,Crystal Structure,Crystals:PrThr:Pt:Urine sed:Ord:Microscopy.light
6082,Coagulation tissue factor induced.PIVKA insensitive actual/Normal,Coagulation tissue factor induced.PIVKA insensitive actual/Normal:RelTime:Pt:BldC:Qn:Coag
6083,Asparagine/Amino acids.total,Asparagine/Amino acids.total:SFr:Pt:Ser/Plas:Qn
6084,HLA-B67 antigen,HLA-B67:PrThr:Pt:Bld/Tiss:Ord
6085,Orientia tsutsugamushi Karp IgG,Orientia tsutsugamushi Karp Ab.IgG:Titr:Pt:Ser:Qn:IF
6086,HLA-DQ5(1),HLA-DQ5(1):PrThr:Pt:Bld/Tiss^Donor:Ord
6087,Boron/Creatinine,Boron/Creatinine:SRto:Pt:Urine:Qn
6088,Gastrin,Gastrin^pre or post XXX challenge:MCnc:Pt:Ser/Plas:Qn
6089,heart rate,Heart rate:NRat:Enctr^max:Arterial system:Qn
6090,Short blood count panel,Short blood count panel:-:Pt:Bld:Qn
6091,Antithrombin III,Deprecated Antithrombin in Platelet poor plasma
6092,Oxygen content level,Oxygen content:SCnc:Pt:BldCo:Qn
6093,Orientia tsutsugamushi,Orientia tsutsugamushi:PrThr:Pt:XXX:Ord:Organism specific culture
6094,syndecan 1 protein,CD138 Ag:PrThr:Pt:Tiss:Ord:Immune stain
6095,Paraquat,Paraquat:SCnc:Pt:Ser/Plas:Qn
6096,Herpes virus 8 IgG,Herpes virus 8 Ab.IgG:ACnc:Pt:Ser:Qn:IA
6097,Rheumatoid Factor,Rheumatoid factor:ACnc:Pt:Plr fld:Qn
6098,Peptidyl-Dipeptidase A,Angiotensin converting enzyme:CCnc:Pt:Periton fld:Qn
6099,Gamma globulin.abnormal band/Protein.total,Gamma globulin.abnormal band/Protein.total:MFr:Pt:Ser/Plas:Qn:Electrophoresis
6100,HEDIS 2009 Tests used in early prenatal care - ABO & Rh (PPC-C),HEDIS 2009 Tests used in early prenatal care - ABO & Rh (PPC-C):-:Point in time:^Patient:-
6101,Endocrine newborn screening panel (SI units),Endocrine newborn screening panel (SI units):-:Point in time:Blood filter paper:-
6102,CD44 Antigens,Deprecated CD44 cells/100 cells in Blood
6103,17-alpha-Hydroxyprogesterone,17-Hydroxyprogesterone^1H post dose corticotropin:SCnc:Pt:Ser/Plas:Qn
6104,CD97 Antigen,Deprecated CD97 cells/100 cells in Blood
6105,Cortodoxone,11-Deoxycortisol^4D post XXX challenge:MCnc:Pt:Ser/Plas:Qn
6106,GF border code,GF border code:Find:Pt:Eye.left:Nom:Perimetry
6107,Multisection,Multisection^WO contrast:Find:Pt:Head>Brain.temporal:Doc:MR
6108,Coxiella burnetii phase 1 IgG,Coxiella burnetii phase 1 Ab.IgG:Titr:Pt:Body fld:Qn:IF
6109,Coxiella burnetii phase 2 IgA,Coxiella burnetii phase 2 Ab.IgA:Titr:Pt:Body fld:Qn:IF
6110,Orientia tsutsugamushi Gilliam IgM,Orientia tsutsugamushi Gilliam Ab.IgM:Titr:Pt:Body fld:Qn:IF
6111,Strontium,Strontium:SRat:24H:Urine:Qn
6112,Clostridium tetani antibody,Clostridium tetani Ab:PrThr:Pt:Ser:Ord
6113,Hemoglobin pattern,Hemoglobin pattern:Find:Pt:Bld.dot:Nom:Isoelectric focusing
6114,Platelet aggregation.adenosine diphosphate induced ATP secretion,Platelet aggregation.adenosine diphosphate induced ATP secretion^5 umol/L:PrThr:Pt:Bld:Ord
6115,Views runoff,View runoff^WO & W contrast IA:Find:Pt:Lower extremity>Femoral artery:Doc:RF.angio
6116,CV2 Ab,CV2 Ab:Titr:Pt:Ser/Plas:Qn:IF
6117,Cefoperazone- and sulbactam-containing product,Cefoperazone+Sulbactam:Susc:Pt:Isolate:OrdQn
6118,Human leukocyte antigen Cw10(w3),HLA-Cw10(w3):PrThr:Pt:Bld/Tiss^Donor:Ord
6119,Dodecenedioate/Creatinine,Dodecenedioate/Creatinine:SRto:Pt:Urine:Qn
6120,Package label.Side panel,Package label.Side panel:-:-:^FDA product label:Nar
6121,Glutamate decarboxylase 65 antibody,Glutamate decarboxylase 65 Ab:SCnc:Pt:CSF:Qn
6122,Intercellular adhesion molecule 1,Deprecated CD54 cells/100 cells in Blood
6123,Furosemide,Furosemide:SCnc:Pt:Ser/Plas:Qn
6124,Indomethacin,Indomethacin:SCnc:Pt:Ser/Plas:Qn
6125,Oxyphenbutazone,Oxyphenbutazone:SCnc:Pt:Ser/Plas:Qn
6126,Hand dominance - use an eraser,Hand dominance - use an eraser:Find:Pt:^Patient:Nom:EHI
6127,HLA-Cw1 antigen,HLA-Cw1:PrThr:Pt:Bld/Tiss^Donor:Ord
6128,Platelet glycoprotein Ib-Ix Ab,Platelet glycoprotein Ib-Ix Ab:PrThr:Pt:Ser:Ord:IA
6129,Glucose,Glucose^3 AM specimen:MCnc:Pt:Ser/Plas:Qn
6130,Hydrocortisone,Cortisol^6 PM specimen:MCnc:Pt:Ser/Plas:Qn
6131,neutrophil,Neutrophils:PrThr:Pt:Nose:Ord:Wright stain
6132,Respiratory syncytial virus Ab.IgG & IgM panel,Respiratory syncytial virus Ab.IgG & IgM panel:ACnc:Pt:Ser:Qn
6133,Hydrogen/Expired gas,Hydrogen/Expired gas^30M post XXX challenge:VFr:Pt:Exhl gas:Qn
6134,C-Peptide,C peptide^6th specimen:SCnc:Pt:Ser/Plas:Qn
6135,Nocardia sp identified,Nocardia sp identified:Prid:Pt:Isolate:Nom
6136,HFE gene.c.187G>C,HFE gene.c.187G>C:PrThr:Pt:Bld/Tiss:Ord:Molgen
6137,Influenzavirus A antigen,Influenza virus A Ag:Prid:Pt:Isolate:Nom
6138,Creatinine,Creatinine:SRat:12H:Urine:Qn
6139,Herpes simplex virus 1 IgG,Herpes simplex virus 1 Ab.IgG:ACnc:Pt:Ser:Qn:IA
6140,Immunoglobulin G antibody to Rickettsia typhi,Rickettsia typhi Ab.IgG:Titr:Pt:Ser:Qn:IF
6141,Insulin bovine Ab.IgG4,Insulin bovine Ab.IgG4:MCnc:Pt:Ser:Qn
6142,TGM1 gene targeted mutation analysis,TGM1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen
6143,Intact parathyrin,Parathyrin.intact^6th specimen:MCnc:Pt:Ser/Plas:Qn
6144,Glucose,Glucose:SCnc:Pt:BldC:Qn
6145,sperm cell,Spermatozoa^post vasectomy:NCnc:Pt:Semen:Qn
6146,Herpes simplex virus 2 Ab,Herpes simplex virus 2 Ab:ACnc:Pt:Ser:Qn:IA
6147,Yeast.hyphae,Yeast.hyphae:Naric:Pt:Urine:Qn:Computer assisted
6148,Transitional Epithelial Cells,Transitional cells:NCnc:Pt:Urine:Qn:Computer assisted
6149,Trisomy 21,Trisomy 21:Hx:Pt:^Patient:Ord
6150,Palmitoylcarnitine (C16),Palmitoylcarnitine (C16):SCnc:Pt:CSF:Qn
6151,Hamster epithelium Ab.IgG4,Hamster epithelium Ab.IgG4:MCnc:Pt:Ser:Qn
6152,Thymidine,Thymidine:SCnc:Pt:Ser/Plas:Qn
6153,Orientia tsutsugamushi identified,Orientia tsutsugamushi identified:Prid:Pt:XXX:Nom:Sequencing
6154,Cortodoxone,11-Deoxycortisol^30M post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn
6155,Glucose tolerance 3H panel,Glucose tolerance 3H panel:-:-:Ser/Plas:Qn
6156,Blasts.cytoplasmic CD3,Blasts.cytoplasmic CD3:ACnc:Pt:Bone mar:Qn
6157,Reticulocytes.high light scatter/Reticulocytes.total,Reticulocytes.high light scatter/Reticulocytes.total:NFr:Pt:Bld:Qn
6158,Humulus lupus Ab.IgG4,Humulus lupus Ab.IgG4:MCnc:Pt:Ser:Qn
6159,Sorghum halepense Ab.IgG4,Sorghum halepense Ab.IgG4:MCnc:Pt:Ser:Qn
6160,Lycopersicon lycopersicum leukotriene release,Lycopersicon lycopersicum leukotriene release:MCnc:Pt:WBC:Qn
6161,Fibrinogen,Fibrinogen:MCnc:Pt:PPP:Qn:Coag.derived
6162,IgG.intrathecally synthesized,IgG.intrathecally synthesized:MCnc:Pt:Ser+CSF:Qn
6163,Orientia tsutsugamushi Gilliam IgM,Orientia tsutsugamushi Gilliam Ab.IgM:Titr:Pt:Ser:Qn
6164,Hydrocortisone,Cortisol^10th specimen post XXX challenge:MCnc:Pt:Saliva:Qn
6165,Hydrocortisone,Cortisol^11th specimen post XXX challenge:SCnc:Pt:Saliva:Qn
6166,Frankfort horizontal plane to mandibular plane using constructed Gonion,Frankfort horizontal plane to mandibular plane using constructed Gonion:Angle:Pt:Skull:Qn:XR.measured
6167,"How often did you drink regular colas and root beer (with caffeine, not diet)","How often did you drink regular colas and root beer (with caffeine, not diet):Find:Pt:^Patient:Ord:PhenX"
6168,Solidago virgaurea Ab.IgG,Solidago virgaurea Ab.IgG:MCnc:Pt:Ser:Qn
6169,micafungin,Micafungin:Susc:Pt:Isolate:OrdQn
6170,Have you ever had medical treatment to dissolve or remove gallstones,Have you ever had medical treatment to dissolve or remove gallstones:Find:Pt:^Patient:Ord:PhenX
6171,Study year,Study year:Time:Pt:Study:Qn:PhenX
6172,11-ketoetiocholanolone,11-Ketoetiocholanolone^pre dose dexamethasone:MCnc:24H:Urine:Qn
6173,Titanium,Titanium:MCnc:Pt:Urine:Qn
6174,Hydrocortisone,Cortisol^pre 1 ug/kg CRH IV:MCnc:Pt:Saliva:Qn
6175,Leucocyte esterase,Leukocyte esterase:PrThr:Pt:CSF:Ord:Test strip
6176,Plasminogen Activator Inhibitor 1,Plasminogen activator inhibitor 1:MCnc:Pt:PPP:Qn:Chromo
6177,Plasminogen Activator Inhibitor 2,Plasminogen activator inhibitor 2:ACnc:Pt:PPP:Qn:Chromo
6178,Brassica oleracea var capitata Ab.IgG,Brassica oleracea var capitata Ab.IgG:MCnc:Pt:Ser:Qn
6179,How many Y did you take vitamin B 6,How many Y did you take vitamin B 6:Time:Pt:^Patient:Qn:PhenX
6180,I cannot go out of the house to do the shopping,I cannot go out of the house to do the shopping:Find:Pt:^Patient:Ord:PhenX
6181,"Do you have a bone or joint problem, for example, back, knee or hip, that could be made worse by a change in your physical activity","Do you have a bone or joint problem, for example, back, knee or hip, that could be made worse by a change in your physical activity:Find:Pt:^Patient:Ord:rPARQ"
6182,microscopic observation,Microscopic observation:Prid:Pt:XXX:Nom:Giemsa stain
6183,Time adult activity starts,Time adult activity starts:Time:Pt:^Patient:Qn:PhenX
6184,Can exact number of adenomas be determined,Can exact number of adenomas be determined:Find:Pt:^Patient:Ord:PhenX
6185,TNM pathologic staging - nodal involvement - N,Deprecated TNM pathologic staging - nodal involvement - N [PhenX]
6186,17-alpha-Hydroxyprogesterone,17-Hydroxyprogesterone^9th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
6187,Creatinine,Creatinine:SCnc:Pt:Bld:Qn
6188,Pre ejection time,Pre ejection time:Time:Pt:Heart.ventricle.left:Qn:NI-ICG
6189,"Problem when you stopped, cut down or went without marijuana for 2D or longer","Problem when you stopped, cut down or went without marijuana for 2D or longer:Find:Pt:^Patient:Nom:SSAGA II"
6190,Does your child complain of an upset stomach at night,Does your child complain of an upset stomach at night:Find:Pt:^Patient:Ord:PhenX
6191,Leptospira sp identified,Leptospira sp identified:Prid:Pt:CSF:Nom:Organism specific culture
6192,Do you worry that you might be trapped without any way to escape,Do you worry that you might be trapped without any way to escape:Find:Pt:^Patient:Ord:CIDI-SF
6193,"Length of your highs as a rule, on the average","Length of your highs as a rule, on the average:Time:Pt:^Patient:Qn:HCL-32"
6194,"How much difficulty do you have managing your money, such as keeping track of your expenses or paying bills","How much difficulty do you have managing your money, such as keeping track of your expenses or paying bills:Find:Pt:^Patient:Ord:PhenX"
6195,How much difficulty do you have getting in or out of bed,How much difficulty do you have getting in or out of bed:Find:Pt:^Patient:Ord:PhenX
6196,My child usually speaks - frequency,My child usually speaks - frequency:Find:Pt:^Patient:Ord:PhenX
6197,Transcobalamin I+Transcobalamin III,Transcobalamin I+Transcobalamin III:SCnc:Pt:Ser:Qn
6198,Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)/Acetylcarnitine (C2),Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)/Acetylcarnitine (C2):SRto:Pt:Bld.dot:Qn
6199,Cryptosporidium species antigen,Cryptosporidium sp Ag:PrThr:Pt:Stool:Ord:IA
6200,"Has a health professional ever said that your child has attention-deficit disorder, ADD, or attention-deficit-hyperactivity disorder, ADHD","Has a health professional ever said that your child has attention-deficit disorder, ADD, or attention-deficit-hyperactivity disorder, ADHD:Find:Pt:^Patient:Ord:PhenX"
6201,Date your child has taken this medication,Date your child has taken this medication:Date:Pt:^Patient:Qn:PhenX
6202,Rubella virus identified,Rubella virus identified:Prid:Pt:Ser:Nom:Organism specific culture
6203,Stay was longer than 30 consecutive Ds 2Ys ago,Stay was longer than 30 consecutive Ds 2Ys ago:Find:Pt:^Patient:Ord:PhenX
6204,Cortolone,Alpha cortolone^2D post high dose dexamethasone:MRat:24H:Urine:Qn
6205,Androsterone,Androsterone^pre high dose dexamethasone:MCnc:24H:Urine:Qn
6206,Well child visit note,Well child visit note:Finding:Point in time:{Setting}:Document:{Provider}
6207,Dextromethorphan,Dextromethorphan:SCnc:Pt:Gast fld:Qn
6208,Myelin antibody,Myelin Ab:PrThr:Pt:CSF:Ord:IF
6209,I am very careful,I am very careful:Find:Pt:^Patient:Ord:UPPS-R-C
6210,"I like to know what to expect, before doing something new","I like to know what to expect, before doing something new:Find:Pt:^Patient:Ord:UPPS-R-C"
6211,Growth Hormone,Somatotropin^8H post XXX challenge:ACnc:Pt:Ser/Plas:Qn
6212,Follicle Stimulating Hormone,Follitropin^10M pre dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn
6213,Toxocara canis antibody,Toxocara canis Ab:ACnc:Pt:Body fld:Qn
6214,Vacuolated lymphocyte,Lymphocytes.vacuolated:PrThr:Pt:Bld:Ord:Microscopy.light
6215,PhenX measure - oral health - number of natural teeth,PhenX measure - oral health - number of natural teeth:-:Point in time:^Patient:-:PhenX
6216,Was emphysema confirmed by a doctor,Was emphysema confirmed by a doctor:Find:Pt:^Patient:Ord:PhenX
6217,For how many H per D were you exposed to smoke from other peoples cigarettes or tobacco products during this time at this location,For how many H per D were you exposed to smoke from other peoples cigarettes or tobacco products during this time at this location:NRat:Pt:^Patient:Qn:PhenX
6218,Have you ever had vaginal intercourse,Have you ever had vaginal intercourse:Find:Pt:^Patient:Ord:PhenX
6219,Reviewer initials,Reviewer initials:ID:Pt:XXX:Nom
6220,Volume expired during 6.0 s of forced expiration,Volume^at 6.0 s post forced expiration/predicted:Volume:Point in time:Respiratory system:Quantitative:PhenX
6221,cefepime,Deprecated Cefepime [Susceptibility] by Disk diffusion (KB)
6222,Spermatozoa.double forms/100 spermatozoa,Spermatozoa.double forms/100 spermatozoa:NFr:Pt:Semen:Qn
6223,Ever had angioplasty for claudication or peripheral arterial disease,Ever had angioplasty for claudication or peripheral arterial disease:Finding:Point in time:^Patient:Quantitative
6224,Leucocyte esterase,Leukocyte esterase:PrThr:Pt:Urine:Ord:Test strip.automated
6225,Sambucus nigra Ab.IgE,Sambucus nigra Antibody.immunoglobulin E:Arbitrary Concentration:Point in time:Serum:Quantitative
6226,Lysosomal storage disorders suspected,Lysosomal storage disorders suspected:Prid:Pt:Bld.dot:Nom
6227,How many Y in total did you take premarin - exclude those periods when you temporarily stopped,How many Y in total did you take premarin - exclude those periods when you temporarily stopped:Time:Pt:^Patient:Qn:California Teachers Study
6228,Did you have symptoms of gallstones,Did you have symptoms of gallstones:Find:Pt:^Patient:Ord:PhenX
6229,Do you currently take this pain-relieving medication at least once a week,Do you currently take this pain-relieving medication at least once a week:Find:Pt:^Patient:Ord:California Teachers Study
6230,When did your child first start wearing an eye patch,When did your child first start wearing an eye patch:TmStp:Pt:^Patient:Qn:PhenX
6231,Image name,Image name:ID:Pt:Knee:Nom:PhenX
6232,Urea,Urea:MCnc:24H:Dial fld prt:Qn
6233,Chest discomfort when quiet or resting,Chest discomfort when quiet or resting:Finding:Point in time:^Patient:Ordinal
6234,Intact parathyrin,Parathyrin.intact^post XXX challenge:MCnc:Pt:Ser/Plas:Qn
6235,Oxygen saturation test result,Oxygen saturation^pre treatment:MFr:Pt:BldA:Qn:Pulse oximetry
6236,Platelet factor 4 Ag,Platelet factor 4 Ag:MCnc:Pt:PPP:Qn:IA
6237,Campylobacter lari rRNA,Campylobacter lari rRNA:PrThr:Pt:XXX:Ord:Probe
6238,Mumps virus antigen,Mumps virus Ag:PrThr:Pt:Ser:Ord:IF
6239,Equivalent visual acuity from table based on number of letters read correctly,Equivalent visual acuity from table based on number of letters read correctly:Find:Pt:^Patient:Nom:PhenX
6240,Do you feel weak all over most of the time,Do you feel weak all over most of the time:Find:Pt:^Patient:Ord:PhenX
6241,"Metals, Heavy",Heavy metals:PrThr:Pt:Urine:Ord:Reinsch
6242,Referral note,Referral note:Find:Pt:{Setting}:Doc:Rheumatology
6243,Thyroid stimulating immunoglobulins,Thyrotropin receptor Ab:ACnc:Pt:Ser:Qn:IA
6244,hydroxybupropion,Hydroxybupropion:MCnc:Pt:Body fld:Qn
6245,Thyroperoxidase Antibody,Thyroperoxidase Ab:ACnc:Pt:Body fld:Qn:IA
6246,Chronic urticaria index,Chronic urticaria index:ACnc:Pt:Ser:Qn
6247,About how long has it been since you last visited a dentist,About how long has it been since you last visited a dentist:Time:Pt:^Patient:Qn:PhenX
6248,I have nightmares about my parents,I have nightmares about my parents:Find:Pt:^Patient:Ord:SCARED-R
6249,How well do you write in english,How well do you write in english:Find:Pt:^Patient:Ord:NLAAS
6250,Phencyclidine/Creatinine,Phencyclidine/Creatinine:MRto:Pt:Urine:Qn
6251,Tricyclic antidepressants/Creatinine,Tricyclic antidepressants/Creatinine:MRto:Pt:Urine:Qn
6252,Nitrous oxide gas delivered.case,Nitrous oxide gas delivered.case:Vol:Procedure dur:Gas delivery system:Qn
6253,Face all,Face all:Len:Pt:Skull:Qn:XR.measured
6254,Pinus strobus Ab.IgE,Pinus strobus Antibody.immunoglobulin E:Arbitrary Concentration:Point in time:Serum:Quantitative
6255,Inhalation challenge test report,Inhalation challenge test report^W methacholine inhaled:Find:Pt:^Patient:Doc
6256,Do you sometimes feel a fullness or blockage in your ears,Do you sometimes feel a fullness or blockage in your ears:Find:Pt:^Patient:Ord:PhenX
6257,Tobramycin Ab.IgE,Tobramycin Ab.IgE:ACnc:Pt:Ser:Qn
6258,GD1a IgG ganglioside antibody,Ganglioside GD1a Ab.IgG:ACnc:Pt:CSF:Qn:IA
6259,topiramate,Topiramate:MCnc:Pt:Bld:Qn
6260,Stopped or paused before 6M,Stopped or paused before 6M:Finding:Point in time:^Patient:Ordinal
6261,Problems or unusual findings,Problems or unusual findings:Find:Pt:Eye.left:Nom
6262,Tropomyosin Ab.IgE,Tropomyosin Ab.IgE:ACnc:Pt:Ser:Qn
6263,Fractional excretion of urea,Fractional excretion of urea:Ratio:XXX:Urine+Ser/Plas:Qn
6264,CD3+CD8+ cell,Cells.CD3+CD8+:NCnc:Pt:CSF:Qn
6265,"On the average of the entire time you smoked, how many cigarettes did you smoke per D","On the average of the entire time you smoked, how many cigarettes did you smoke per D:NRat:Pt:^Patient:Qn:PhenX"
6266,Amoeba identified,Amoeba identified:Prid:Pt:XXX:Nom:Organism specific culture
6267,Suicidality notes,Suicidality notes:Txt:Pt:^Patient:Nom:DI-PAD CGP V 1.4
6268,Elevated mood,Elevated mood:Find:Pt:^Patient:Ord:DI-PAD CGP V 1.4
6269,Hallucinations in any modality,Hallucinations in any modality:Find:Pt:^Patient:Ord:DI-PAD CGP V 1.4
6270,didesethylflurazepam,N-desalkylflurazepam:MCnc:Pt:Bld:Qn
6271,didesethylflurazepam,N-desalkylflurazepam:MCnt:Pt:Meconium:Qn:Confirm
6272,Body Temperature,Body temperature:Temp:Pt:Arterial system:Qn
6273,PhenX measure - calcium intake,PhenX measure - calcium intake:-:Point in time:^Patient:-:PhenX
6274,PhenX measure - childhood maltreatment,PhenX measure - childhood maltreatment:-:Point in time:^Patient:-:PhenX
6275,Petroselinum crispum Ab.IgG,Petroselinum crispum Ab.IgG:MCnc:Pt:Ser:Qn
6276,Albumins,Albumin:MRat:18H:Urine:Qn:Detection limit <= 20 mg/L
6277,"I see myself as someone who is ingenious, a deep thinker","I see myself as someone who is ingenious, a deep thinker:Find:Pt:^Patient:Ord:BFI"
6278,Age diabetes-related problem occurred,Age diabetes-related problem occurred:Time:Pt:^Patient:Qn:PhenX
6279,Magnesium,Magnesium:MRat:12H:Urine:Qn
6280,17-methylandrost-2-en-17-ol,Desoxymethyltestosterone:PrThr:Pt:Urine:Ord
6281,Closure to opening,Closure to opening:Time:Pt:Heart.valve.XXX:Qn:US
6282,desflurane,Desflurane:VFr/PPres:Pt:Gas delivery system:Qn
6283,desflurane,Desflurane^during expiration:VFr/PPres:Pt:Airway adaptor:Qn
6284,"Compared to others your age who currently smoke, what do you think are your chances of being diagnosed with lung cancer during your lifetime","Compared to others your age who currently smoke, what do you think are your chances of being diagnosed with lung cancer during your lifetime:Find:Pt:^Patient:Ord:PLCO"
6285,Personal health monitoring report,Personal health monitoring report:Find:Pt:{Setting}:Doc:Automated
6286,"Since the event, have you found yourself unable to see a future for yourself","Since the event, have you found yourself unable to see a future for yourself:Find:Pt:^Patient:Ord:PhenX"
6287,I've often missed things I promised to attend,I've often missed things I promised to attend:Find:Pt:^Patient:Ord:PhenX
6288,"How many times in the last Y have you been paid, or received other favors for having sex with someone","How many times in the last Y have you been paid, or received other favors for having sex with someone:NRat:1Y:^Patient:Qn:Denver Youth Survey"
6289,You don't get paid enough for what you do,You don't get paid enough for what you do:Find:Pt:^Patient:Ord:PhenX
6290,Phenylbutazone Ab.IgE,Phenylbutazone Ab.IgE:ACnc:Pt:Ser:Qn
6291,Cells.myeloperoxidase,Cells.myeloperoxidase:PrThr:Pt:Body fld:Ord
6292,Galactitol,Galactitol:PrThr:Pt:Urine:Ord
6293,Corticotropin,Corticotropin^3H post dose glucagon:SCnc:Pt:Plas:Qn
6294,Corticotropin,Corticotropin^8 AM specimen:SCnc:Pt:Plas:Qn
6295,Corticotropin,Corticotropin^pre dose dexamethasone:MCnc:Pt:Plas:Qn
6296,Nordazepam,Nordiazepam:MCnc:Pt:Bld:Qn
6297,Record ID section,Record ID section:-:Point in time:^Patient:Set:NAACCR v.12
6298,Acremonium sp Ab.IgG,Acremonium sp Ab.IgG:MCnc:Pt:Ser:Qn
6299,Centromere antibody,Centromere Ab:Titr:Pt:Body fld:Qn:IF
6300,Chlamydia trachomatis rRNA,Deprecated Chlamydia trachomatis rRNA [Presence] in Unspecified specimen by DNA probe
6301,H little e Ab,H little e Ab:PrThr:Pt:Ser/Plas:Ord
6302,Ku antibody,K little u Ab:PrThr:Pt:Ser/Plas:Ord
6303,Older adult activity,Older adult activity:Find:Pt:^Patient:Nom:PhenX
6304,Leukocytes other,Leukocytes other:NCnc:Pt:Bld^Fetus:Qn:Manual count
6305,Has anyone ever threatened to hurt you when they were standing right in front of you,Has anyone ever threatened to hurt you when they were standing right in front of you:Find:Pt:^Patient:Ord:LTVH
6306,"t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript/control transcript","t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript/control transcript:NRto:Pt:Bone mar:Qn:Molgen"
6307,Ibuprofen induced neutrophil Ab.IgG,Ibuprofen induced neutrophil Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
6308,Trisomy 18 prior risk,Trisomy 18 prior risk:Likelihood:Point in time:^Fetus:Narrative:Based on maternal age
6309,Parainfluenza virus 4 RNA,Parainfluenza virus 4 RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar
6310,History and physical note,History and physical note:Find:Pt:{Setting}:Doc:Pediatric nephrology
6311,Macular retinal edema,Macular edema:Find:Pt:Eye.right:Ord:Ophthalmoscopy
6312,"1,3-dimethylamylamine","1,3-Dimethylamylamine:MCnc:Pt:Urine:Qn:Confirm"
6313,MAM-2201 pentanoate,MAM-2201 pentanoate:PrThr:Pt:Bld:Ord
6314,Maprotiline,Maprotiline^trough:MCnc:Pt:Ser/Plas:Qn
6315,gabapentin,Gabapentin^trough:MCnc:Pt:Ser/Plas:Qn
6316,Haloperidol,Haloperidol^trough:MCnc:Pt:Ser/Plas:Qn
6317,Insulin,Insulin^1.75H post XXX challenge:ACnc:Pt:Ser/Plas:Qn
6318,Gas flow at 25-75% of forced expiration,Gas flow at 25-75% of forced expiration^pre bronchodilation:VRat:Pt:Respiratory system:Qn
6319,Electrocardiogram,ECG:Type:Pt:^Patient:Nom:NEMSIS
6320,Tunneling,Tunneling:Find:Pt:Wound:Ord
6321,Temazepam,Temazepam:MCnc:Pt:Saliva:Qn:Confirm
6322,desomorphine,Desomorphine:MCnc:Pt:Urine:Qn:Confirm
6323,Prunus domestica Ab.IgG,Prunus domestica Ab.IgG:ACnc:Pt:Ser:Qn
6324,HLA-A+B+C Ab.IgG,HLA-A+B+C Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IA
6325,NPM1 gene.c.956dupTCTG transcript/control transcript,NPM1 gene.c.956dupTCTG transcript/control transcript:NRto:Pt:Bone mar:Qn:Molgen
6326,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+66 DNA,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+66 DNA:PrThr:Pt:Tiss:Ord:Probe
6327,Other cells/100 leukocytes,Other cells/100 leukocytes:NFr:Pt:Bld^Fetus:Qn
6328,Poplar sp Ab.IgE,Deprecated Poplar sp Antibody.immunoglobulin E:Arbitrary Concentration:Point in time:Serum:Quantitative
6329,Positive end expiratory pressure (finding),Pressure.positive end expiratory^on ventilator:Pres:Pt:Respiratory system:Qn
6330,ARGININOSUCCINATE SYNTHASE,Argininosuccinate synthase:CCnt:Pt:Amnio fld cells:Qn
6331,Engraulis encrasicolus Ab.IgE,Engraulis encrasicolus Ab.IgE:ACnc:Pt:Ser:Qn
6332,Neutrophils/leukocytes,Neutrophils/leukocytes:NFr.DF:Pt:Bld:Qn:Manual count
6333,"t(11;14)(q13;q32)(CCND1,IGH) fusion transcript","t(11;14)(q13;q32)(CCND1,IGH) fusion transcript:PrThr:Pt:Bone mar:Ord:Molgen"
6334,"16-Beta,18-dihydroxydehydroepiandrosterone","16-Beta,18-dihydroxydehydroepiandrosterone:SRat:24H:Urine:Qn"
6335,Pork Ab.IgG,Pork Ab.IgG:ACnc:Pt:Ser:Qn
6336,"Centers for medicare - medicaid, CMS, service level","Centers for medicare - medicaid, CMS, service level:Find:Pt:^Patient:Ord:NEMSIS"
6337,Interleukin-3,Interleukin 3:MCnc:Pt:Ser/Plas:Qn
6338,Rabies virus IgM,Rabies virus Ab.IgM:Titr:Pt:CSF:Qn:IF
6339,Alert,Alert:Type:Point in time:^Patient:Nominal
6340,Glutaryl-CoA dehydrogenase,Glutaryl CoA dehydrogenase:CCnt:Pt:Fibroblasts:Qn
6341,Homogentisate/Creatinine,Homogentisate/Creatinine:SRto:24H:Urine:Qn
6342,Crystal Structure,Crystals:Prid:Pt:Body fld:Nom:Microscopy.light
6343,Obstructive apnea index,Obstructive apnea index:NRat:24H:^Patient:Qn
6344,Erythrocytes,Erythrocytes:PrThr:Pt:XXX:Ord:Wet preparation
6345,1-methylhistidine,1-Methylhistidine:SCnc:Pt:Ser/Plas^Fetus:Qn
6346,Lacrimal,Lacrimal:Finding:Point in time:^Patient:Narrative
6347,6-O-monoacetylmorphine,6-Monoacetylmorphine:MCnc:Pt:Saliva:Qn:Confirm
6348,Problems with your heart or circulation,Problems with your heart or circulation:Hx:Pt:^Patient:Nom:PhenX
6349,3-hydroxysebacate,3-Hydroxysebacate:SCnc:Pt:Ser/Plas:Qn
6350,Oxygen saturation test result,Oxygen saturation:MFr:Pt:BldMV:Qn:Calculated from oxygen partial pressure
6351,Chemotherapy or other medication for this condition,Chemotherapy or other medication for this condition:Hx:Pt:^Patient:Nom:PhenX
6352,Stroke scale overall interpretation,Stroke scale overall interpretation:Imp:Pt:^Patient:Nom:NEMSIS
6353,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 E6+E7 mRNA,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 E6+E7 mRNA:PrThr:Pt:Cvx:Ord:Probe.amp.tar
6354,Phencyclidine,Phencyclidine:PrThr:Pt:Saliva:Ord:Confirm
6355,Have you ever been unfairly denied a promotion,Have you ever been unfairly denied a promotion:Find:Pt:^Patient:Ord:PhenX
6356,Lymphocytes.abnormal/100 leukocytes,Lymphocytes.abnormal/100 leukocytes:NFr:Pt:Vitr fld:Qn:Manual count
6357,macrophage,Macrophages:NCnc:Pt:Pericard fld:Qn:Manual count
6358,Oxygen saturation test result,Oxygen saturation:MFr.DF:Pt:BldA:Qn:Calculated from oxygen partial pressure
6359,Oval fat bodies (globules),Oval fat bodies (globules):Naric:Pt:Stool:Qn:Microscopy.light.LPF
6360,Nucleated cell,Nucleated cells:NCnc:Pt:Body fld:Qn:Manual count
6361,EMS exposures or injuries of EMS personnel,EMS exposures or injuries of EMS personnel:-:Pt:Provider:Nar:NEMSIS
6362,EMS billing,EMS billing:-:Pt:^Patient:Nar:NEMSIS
6363,Phenylbutazone,Phenylbutazone:SCnc:Pt:Gast fld:Qn
6364,Multisection,Multisection^WO contrast:Find:Pt:Upper extremity.bilateral>Shoulder:Doc:CT
6365,Cholesterol.periton fld/Cholesterol.serum,Cholesterol.periton fld/Cholesterol.serum:RelRto:Pt:Periton fld+Ser/Plas:Qn
6366,Multisection,Multisection:Find:Pt:Chest>Axilla.left:Doc:US
6367,Sertraline induced neutrophil Ab.IgM,Sertraline induced neutrophil Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
6368,Sertraline induced neutrophil Ab.IgG,Sertraline induced neutrophil Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
6369,Methotrexate induced platelet Ab.IgM,Methotrexate induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
6370,finafloxacin,Finafloxacin:Susc:Pt:Isolate:OrdQn:Agar diffusion
6371,fropenem,Faropenem:Susc:Pt:Isolate:OrdQn:Agar diffusion
6372,fondaparinux,Fondaparinux:MCnc:Pt:Ser/Plas:Qn:LC/MS/MS
6373,Promethazine,Promethazine:MCnc:Pt:Bld:Qn:Confirm
6374,"t(11;19)(q23;p13.1)(MLL,ELL) fusion transcript","t(11;19)(q23;p13.1)(MLL,ELL) fusion transcript:Arb:Pt:Bld/Tiss:Ord:Molgen"
6375,Birch White Ab.IgE,Deprecated Birch White Ab.IgE
6376,methylone,Methylone:PrThr:Pt:Urine:Ord:Screen
6377,Summary registry report,Summary registry report:Find:Pt:{Setting}:Doc:HIV
6378,tapentadol,Tapentadol:MCnc:Pt:Ser/Plas/Bld:Qn
6379,Rubus idaeus basophil bound Ab,Rubus idaeus basophil bound Ab:ACnc:Pt:Bld:Qn:LHR
6380,At which age did you start smoking,At which age did you start smoking:Time:Pt:^Patient:Qn:PhenX
6381,"HEDIS 2012, 2013 Codes to identify anticonvulsant serum concentration monitoring tests (MPM-E)","HEDIS 2012, 2013 Codes to identify anticonvulsant serum concentration monitoring tests (MPM-E):-:Point in time:^Patient:-"
6382,La Crosse virus ribonucleic acid,La Crosse virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar
6383,2-hydroxysebacate,2-Hydroxysebacate:SCnc:Pt:Ser/Plas:Qn
6384,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes:NFr:Pt:Body fld:Qn:Automated count
6385,Alpha 1 globulin/Protein.total,Alpha 1 globulin/Protein.total:MFr.DF:24H:Urine:Qn:Electrophoresis
6386,INS gene full mutation analysis,INS gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing
6387,IEEE Rosetta gas delivery panel,IEEE Rosetta gas delivery panel:-:Pt:Gas delivery system:-
6388,Mumps virus antigen,Mumps virus Ag:PrThr:Pt:Isolate:Ord:IF
6389,Post-operative evaluation and management note,Postoperative evaluation and management note:Find:Pt:Hospital:Doc:{Role}
6390,Multisection,Multisection^WO contrast:Find:Pt:Upper extremity.bilateral:Doc:MR
6391,Azithromycin,Azithromycin:Susc:Pt:Isolate:OrdQn:Gradient strip
6392,Gentamicin induced neutrophil Ab.IgM,Gentamicin induced neutrophil Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
6393,Note (document),Note:Find:Pt:{Setting}:Doc:Mental health.case manager
6394,Air delivered.total,Air delivered.total:Vol:RptPeriod:Gas delivery system:Qn
6395,Diagnostic study note,Diagnostic study note:Find:Pt:{Setting}:Doc:Allergy+Immunology
6396,2-hydroxyadipate,2-Hydroxyadipate:SCnc:Pt:Ser/Plas:Qn
6397,"Metanephrine, Normetanephrine, 3-Methoxytyramine & Creatinine panel","Metanephrine, Normetanephrine, 3-Methoxytyramine & Creatinine panel:-:Pt:Urine:-"
6398,Human immunodeficiency virus 1 proviral DNA,HIV 1 proviral DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar
6399,Note (document),Note:Find:Pt:Outpatient:Doc:Pharmacology
6400,ST amplitude.lead V5,ST amplitude.lead V5:Elpot:Pt:Heart:Qn:EKG
6401,Anesthetic agent.XXX,Anesthetic agent.XXX:VFr/PPres:Pt:Airway adaptor:Qn
6402,Photographic image,Photographic image:Find:Pt:{Setting}:Doc:{Author Type}
6403,Epicoccum purpurascens Ab.IgE,Deprecated Epicoccum purpurascens IgE Ab [Units/volume] in Serum
6404,Eptifibatide induced platelet Ab.IgM,Eptifibatide induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry
6405,"2,4,4'-trichlorobiphenyl","2,4,4'-Trichlorobiphenyl:MCnc:Pt:Ser/Plas:Qn:Confirm"
6406,Progress note,Progress note:Find:Pt:Telehealth:Doc:{Role}
6407,Allium cepa basophil bound Ab,Allium cepa basophil bound Ab:ACnc:Pt:Bld:Qn:LHR
6408,Transferrin saturation measurement,Deprecated Iron/Iron binding capacity.total [Mass ratio] in Serum or Plasma
6409,cyclobenzaprine,Cyclobenzaprine:MCnc:Pt:Ser/Plas:Qn
6410,Discharge summary note,Discharge summary note:Find:Pt:{Setting}:Doc:Pain medicine
6411,Appearance,Appearance:Aper:Pt:Periton fld:Nom
6412,Cotton western Ab.IgE.RAST class,Cotton western Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
6413,Vendor model number,Vendor model number:Prid:Pt:Intravascular tube:Nom
6414,Vendor model number,Vendor model number:Prid:Pt:Nasogastric tube:Nom
6415,Amyloid.microscopic observation,Amyloid.microscopic observation:Prid:Pt:Tiss:Nom:Bennhold stain.Putchler modified
6416,Aminolevulinate,Delta aminolevulinate:MCnc:Pt:Urine:Qn
6417,little i -2 Ab,Deprecated little i-2 Antibody:Arbitrary Concentration:Point in time:Serum:Ordinal:AGGLUTINATION RBC
6418,2-Oxoisovalerate/Creatinine,2-Oxoisovalerate/Creatinine:MRto:Pt:Urine:Qn
6419,alpha-Fetoproteins,Alpha-1-Fetoprotein:SCnc:Pt:Amnio fld:Qn
6420,(Arachis hypogaea+Bertholletia excelsa+Cocos nucifera+Corylus avellana+Prunus dulcis) Ab.IgE,(Arachis hypogaea+Bertholletia excelsa+Cocos nucifera+Corylus avellana+Prunus dulcis) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk
6421,Echinococcus sp Ab.IgE.RAST class,Echinococcus sp Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
6422,Vendor serial number,Vendor serial number:ID:Pt:Nasogastric tube:Nom
6423,Fungus.microscopic observation,Fungus.microscopic observation:Prid:Pt:Tiss:Nom:Methenamine silver stain.Grocott
6424,Asparagine/Creatinine,Asparagine/Creatinine:MRto:Pt:Urine:Qn
6425,Glutaconate/Creatinine,Glutaconate/Creatinine:MRto:Pt:Urine:Qn
6426,Smooth muscle antibody,Smooth muscle Ab:PrThr:Pt:Ser:Ord
6427,Copper,Copper:SCnc:Pt:Ser/Plas:Qn
6428,Desipramine,Desipramine:SCnc:Pt:Urine:Qn
6429,Bacteria identified,Bacteria identified:Prid:Pt:Urethra:Nom:Culture
6430,Gestational Age,Gestational age:Time:Pt:^Fetus:Qn:US+Estimated from AC.Campbell 1975
6431,Gestational Age,Gestational age:Time:Pt:^Fetus:Qn:US+Estimated from CRL.Nelson 1981
6432,Salmonella typhi O D Ab,S typhi O D Ab Ser Ql
6433,butalbital,Butalbital:MCnc:Pt:Urine:Qn:Confirm
6434,Secobarbital,Secobarbital:MCnc:Pt:Urine:Qn:Confirm
6435,Setomelanomma rostrata Ab.IgE.RAST class,Setomelanomma rostrata Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
6436,Carya illinoinensis nut Ab.IgE.RAST class,Carya illinoinensis nut Antibody.immunoglobulin E.RAST class:Arbitrary Concentration:Point in time:Serum:Ordinal
6437,Insulin bovine Ab.IgE.RAST class,Insulin bovine Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
6438,Echinochloa crus-galli Ab.IgE.RAST class,Echinochloa crus-galli Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
6439,ED disposition consult &or referral,ED disposition consult &or referral:Type:Pt:^Patient:Nom
6440,Gestational Age,Gestational age:Time:Point in time:^Fetus:Quantitative:ULTRASOUND.estimated from GSD.Rempen.91
6441,P Blood group antibodies,Deprecated P NOS Ab [Presence] in Serum or Plasma from Blood product unit
6442,Palinurus spp Ab.IgE.RAST class,Palinurus spp Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
6443,BR-2 Ag,BR-2 Ag:PrThr:Pt:Tiss:Ord:Immune stain
6444,basement membrane antibody,Basement membrane Ab:Titr:Pt:Ser:Qn
6445,Leukocytes other,Leukocytes other:NCnc:Pt:CSF:Qn:Manual count
6446,S' wave amplitude.lead I,S' wave amplitude.lead I:Elpot:Pt:Heart:Qn:EKG
6447,Long axis.mean,Long axis.mean:Len:Pt:Radius.diaphysis^Fetus:Qn:Estimated from gestational age.Merz 1987
6448,Perimeter topographical modifier,Perimeter:Len:Pt:Abdomen^Fetus:Qn:US.measured.ellipse overlay
6449,Hydroxytriazolam,Hydroxytriazolam:PrThr:Pt:Stool:Ord
6450,Cystine,Cystine:MCnc:Pt:CSF:Qn
6451,Thyrotropin,Thyrotropin^1.5H post dose TRH IV:MCnc:Pt:Ser/Plas:Qn
6452,Magnesium,Magnesium:PrThr:Pt:Calculus:Ord
6453,Raphanus sativus Ab.IgE.RAST class,Raphanus sativus Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
6454,S' wave duration.lead AVF,S' wave duration.lead AVF:Time:Pt:Heart:Qn:EKG
6455,Vendor model number,Vendor model number:Prid:Pt:Upper GI tube:Nom
6456,Chromogranin A antigen,Chromogranin A Ag:PrThr:Pt:Tiss:Ord:Immune stain
6457,Follitropin.alpha subunit Ag,Follitropin.alpha subunit Ag:PrThr:Pt:Tiss:Ord:Immune stain
6458,Ephestia kuehniella Ab.IgE,Ephestia kuehniella Ab.IgE:ACnc:Pt:Ser:Qn
6459,Physical findings,Physical findings:Finding:Point in time:Foot:Narrative:Observed
6460,microscopic observation,Microscopic observation:Prid:Pt:CSF:Nom:Gram stain
6461,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes:NFr:Pt:Synv fld:Qn:Manual count
6462,Tyrophagus putrescentiae Ab.IgE.RAST class,Tyrophagus putrescentiae Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
6463,Astragalus spp Ab.IgE.RAST class,Astragalus spp Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
6464,Physical findings,Physical findings:Finding:Point in time:Hip:Nominal:Observed
6465,Calcium/Osmolality,Calcium/Osmolality:MRto:Pt:Ser/Plas:Qn
6466,Thallium/Creatinine,Thallium/Creatinine:MRto:Pt:Urine:Qn
6467,Mycobacterium tuberculosis DNA,Mycobacterium tuberculosis DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar
6468,Glucose,Glucose^1.5H post 0.5 g/kg glucose IV:MCnc:Pt:Ser/Plas:Qn
6469,(Avena sativa+Fagopyrum esculentum+Sesamum indicum+Triticum aestivum+Zea mays) Ab.IgE,(Avena sativa+Fagopyrum esculentum+Sesamum indicum+Triticum aestivum+Zea mays) Antibody.immunoglobulin E:Arbitrary Concentration:Point in time:Serum:Ordinal:Multidisk
6470,ACROSIN,Acrosin:EntCat:Pt:Spermatozoa:Qn
6471,microscopic observation,Microscopic observation:Prid:Pt:Bone mar:Nom:Wright Giemsa stain
6472,albumin/protein.total,Albumin/Protein.total:MFr:Pt:CSF:Qn:Electrophoresis
6473,Uroporphyrin 1 isomer,Uroporphyrin 1 isomer:SCnc:Pt:Ser/Plas:Qn
6474,Uroporphyrin 3 isomer,Uroporphyrin 3 isomer:SCnc:Pt:Ser/Plas:Qn
6475,Abnormal blood cells.CD13/Abnormal blood cells.total,Abnormal blood cells.CD13/Abnormal blood cells.total:NFr:Pt:Bld:Qn
6476,Abnormal blood cells.CD14/Abnormal blood cells.total,Abnormal blood cells.CD14/Abnormal blood cells.total:NFr:Pt:Bld:Qn
6477,Infectious bronchitis virus Ark-99 Ab,Infectious bronchitis virus Ark-99 Ab:Titr:Pt:Ser:Qn:HAI
6478,Temazepam,Deprecated Temazepam [Mass/volume] in Serum or Plasma
6479,Melatonin,Melatonin:MCnc:Pt:Ser/Plas:Qn
6480,Melatonin,Melatonin:VRat:24H:Urine:Qn
6481,metharbital,Metharbital:PrThr:Pt:Stool:Ord
6482,Cell positive for CD34 antigen,Cells.CD34:NCnc:Pt:Bld:Qn
6483,Procainamide+N-acetylprocainamide,Procainamide+N-acetylprocainamide:SCnc:Pt:Ser/Plas:Qn
6484,ST wave displacement.end.lead AVF,ST wave displacement.end.lead AVF:Elpot:Pt:Heart:Qn:EKG
6485,Cells other than spermatozoa,Cells other than spermatozoa:NCnc:Pt:Semen:Qn
6486,Thiazolidine-2-Thione-4-Carboxylic acid,Thiazolidine-2-Thione-4-Carboxylic acid:MCnc:Pt:Urine:Qn
6487,Xylose,Xylose^5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
6488,microscopic observation,Microscopic observation:Prid:Pt:Bld:Nom:Crystal violet stain
6489,Ciprofloxacin,Ciprofloxacin^trough:MCnc:Pt:Ser/Plas:Qn
6490,Hydrocortisone,Cortisol^1H post 250 ug corticotropin IM:MCnc:Pt:Ser/Plas:Qn
6491,Carbon Dioxide,Carbon dioxide:SCnc:Pt:Stool:Qn
6492,Chlamydia trachomatis,Chlamydia trachomatis:PrThr:Pt:Urine sed:Ord:Organism specific culture
6493,Creatine kinase.BB/Creatine kinase.total,Creatine kinase.BB/Creatine kinase.total:CFr:Pt:Ser/Plas:Qn:Electrophoresis
6494,Parrot serum proteins Ab.IgE.RAST class,Parrot serum proteins Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
6495,Vespa crabro Ab.IgE,Vespa crabro Ab.IgE:ACnc:Pt:Ser:Qn
6496,Parainfluenza virus 1 IgG,Parainfluenza virus 1 Ab.IgG:PrThr:Pt:Ser:Ord
6497,Activities,Activity:Finding:Point in time:Trunk^Fetus:Nominal:ULTRASOUND
6498,Systolic flow/Diastolic flow,Systolic flow/Diastolic flow:VelRto:Pt:Ovarian artery.left:Qn:US.doppler
6499,C-Peptide,C peptide^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
6500,Phosphatidylethanolamine Ab.IgG,Phosphatidylethanolamine Ab.IgG:ACnc:Pt:Ser:Qn
6501,Glucose,Glucose^1H post 50 g glucose PO:MCnc:Pt:Urine:Qn
6502,Glucagon,Glucagon:SCnc:Pt:Ser/Plas:Qn
6503,Service comment 28,Service comment 28:Impression/interpretation of study:Point in time:To be specified in another part of the message:Nominal
6504,Service comment 37,Service comment 37:Impression/interpretation of study:Point in time:To be specified in another part of the message:Nominal
6505,Equine herpesvirus 1 Ab,Equine herpesvirus 1 Ab:Titr:Pt:Ser:Qn:Neut
6506,Equine influenza virus A1 Ab,Equine influenza virus A1 Ab:Titr:Pt:Ser:Qn:HAI
6507,Present illness,History of present illness:Finding:Point in time:^Patient:Narrative:Reported
6508,Spermatozoa.motile with IgG/100 spermatozoa,Spermatozoa.motile with IgG/100 spermatozoa:NFr:Pt:Semen:Qn:Mixed antiglobulin reaction
6509,Megakaryocytes/100 cells,Megakaryocytes/100 cells:NFr:Pt:Bone mar:Qn:Manual count
6510,Blood flow.mean,Blood flow.mean:Vel:Pt:Umbilical artery.at placenta^Fetus:Qn:US.doppler
6511,Antigen in LW blood group system,LW Ag:PrThr:Pt:RBC:Ord
6512,Creatinine renal clearance/1.73 sq M,CREATININE RENAL CLEARANCE/1.73 SQ M:VOLUME RATE:24 HOURS:URINE AND SERUM/PLASMA:QUANTITATIVE
6513,Asialoganglioside GM1 Ab.IgG,Deprecated Asialoganglioside GM1 Ab.IgG
6514,Temazepam,Temazepam:PrThr:Pt:Ser/Plas:Ord
6515,Pneumocystis jiroveci antigen,Pneumocystis jiroveci Ag:PrThr:Pt:Thrt:Ord:IF
6516,Chromium,Chromium:SCnc:Pt:Bld:Qn
6517,Ethanol,Ethanol:SCnc:Pt:Bld:Qn
6518,Symptoms & diseases,History of symptoms & diseases:Finding:Point in time:Musculoskeletal system:Narrative:Reported
6519,Phosphate/Creatinine,Phosphate/Creatinine:MRto:Pt:Urine:Qn
6520,Beta lactoglobulin Ab.IgG,Beta lactoglobulin Ab.IgG:ACnc:Pt:Ser:Qn
6521,Blood flow.systolic.max,Blood flow.systolic.max:Vel:Pt:Heart.ventricle.left.outflow tract^Fetus:Qn:US.doppler
6522,Glucose,Glucose^12H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
6523,Blatella germanica Ab.IgE.RAST class,Blatella germanica Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
6524,Vendor model number,Vendor model number:Prid:Pt:Cardiac measurement device:Nom
6525,Renin,Deprecated Renin [Enzymatic activity/volume] in Plasma
6526,Immune complex,Immune complex:MCnc:Pt:Ser/Plas:Qn:PEG assay
6527,cholesteryl sulfate,Cholesterol sulfate:MCnc:Pt:Ser:Qn
6528,Complement C3b.inactive,Complement C3b.inactive:MCnc:Pt:Plas:Qn
6529,Streptococcus pneumoniae Danish serotype 23F Ab,Streptococcus pneumoniae 23f Ab^2nd specimen:ACnc:Pt:Ser:Qn
6530,Streptococcus pneumoniae Danish serotype 3 Ab,Deprecated Streptococcus pneumoniae 3 Ab [Units/volume] in Serum --2nd specimen
6531,Complement C1 esterase inhibitor free Ab.IgM,Complement C1 esterase inhibitor free Ab.IgM:MCnc:Pt:Ser/Plas:Qn
6532,Carbon Dioxide,Carbon dioxide^post chest physiotherapy:PPres:Pt:BldC:Qn
6533,Volume expired during 1.0 s of forced expiration/Forced vital capacity,Volume at 1.0 s post forced expiration/Vital capacity.forced:Volume Ratio:Point in time:Respiratory system:Quantitative:Predicted
6534,Path report.relevant Hx,Path report.relevant Hx:Find:Pt:Specimen:Nar
6535,Path report.staging evidence,Path report.staging evidence:Find:Pt:Specimen:Nar
6536,Theileria parva Ab,Theileria parva Ab:Titr:Pt:Ser:Qn:IF
6537,Borrelia burgdorferi Ab index,Borrelia burgdorferi Ab index:PrThr:Pt:Ser+CSF:Ord
6538,Glutathione,Glutathione:MCnc:Pt:RBC:Qn
6539,beta-Galactosidase,Beta galactosidase:CCnt:Pt:Tiss:Qn
6540,Oxyhemoglobin/Hemoglobin.total,Deprecated Fractional oxyhemoglobin in 8 hour minimum by Pulse oximetry
6541,Maximum,Max^during inspiration on ventilator:Pres:Pt:Trachea.airway:Qn
6542,Calcium,Calcium:SCnc:Pt:Dial fld:Qn
6543,Oxygen saturation test result,Oxygen saturation:MFr:Pt:Bld:Qn
6544,Plant identified,PLANT IDENTIFIED:TYPE:POINT IN TIME:PLANT:NOMINAL
6545,Avian infectious laryngotracheitis virus Ag,Avian infectious laryngotracheitis virus Ag:PrThr:Pt:Trac:Ord:IA
6546,Transmissible gastroenteritis virus Ag,Transmissible gastroenteritis virus Ag:PrThr:Pt:Tsmi:Ord:IF
6547,Coproporphyrins,Deprecated Coproporphyrin [Mass/time] in 24 hour Stool
6548,Comparison.study,Comparison.study:Impression/interpretation of study:Point in time:Heart:Narrative:EKG
6549,Arginine,Arginine:MRat:24H:Urine:Qn
6550,Nalidixate,Nalidixate:Susc:Pt:Isolate:OrdQn
6551,Ethylmorphine,Ethylmorphine:PrThr:Pt:Urine:Ord:Confirm
6552,Sarcocystis neurona antibody,Sarcocystis neurona Ab:PrThr:Pt:Body fld:Ord:IB
6553,Shigella sp identified,Shigella sp identified:Prid:Pt:Feed:Nom:Organism specific culture
6554,Leptospira interrogans serovar Pomona antibody,Leptospira interrogans serovar Pomona Ab:PrThr:Pt:Ser:Ord:Aggl
6555,Leptospira species antibody,Leptospira sp Ab:PrThr:Pt:Ser:Ord:IA
6556,Osmotic Fragility test,Osmotic fragility^0.75% sodium chloride 24H 37 deg C incubation:NFr:Pt:RBC:Qn
6557,Trichinella spiralis antibody,Trichinella spiralis Ab:PrThr:Pt:Ser:Ord:LA
6558,Coproporphyrins,Coproporphyrin:MCnc:Pt:Bld:Qn
6559,Clarithromycin,Clarithromycin:Susc:Pt:Isolate:OrdQn
6560,Peak inspiratory flow rate,Peak inspiratory flow^at 1.5 liter per second on ventilator:Pres:Pt:Respiratory system.airway opening:Qn
6561,Peak inspiratory flow rate,Peak inspiratory flow^at 2.0 liter per second on ventilator:Pres:Pt:Respiratory system.airway opening:Qn
6562,Border disease virus Ab,Border disease virus Ab:Titr:Pt:Ser:Qn:Neut
6563,Border disease virus Ag,Border disease virus Ag:PrThr:Pt:Bld:Ord:IA
6564,Spontaneous tidal volume,Tidal volume.spontaneous^on ventilator:Vol:Pt:Respiratory system:Qn
6565,Albumins,Albumin^2H post peritoneal dialysis:MCnc:Pt:Ser/Plas:Qn
6566,Pisum sativum Ab.IgG.RAST class,Pisum sativum Ab.IgG.RAST class:PrThr:Pt:Ser:Ord
6567,Prunus persica Ab.IgG.RAST class,Prunus persica Ab.IgG.RAST class:PrThr:Pt:Ser:Ord
6568,Pepper cayenne Ab.IgG.RAST class,Pepper cayenne Ab.IgG.RAST class:PrThr:Pt:Ser:Ord
6569,Bovine diarrhea virus Antigen,Bovine diarrhea virus Ag:PrThr:Pt:Bld:Ord:IA
6570,Lutropin/Follitropin,Follitropin/Lutropin:SRto:Pt:Ser/Plas:Qn
6571,Alpha 2 globulin/Protein.total,Alpha 2 globulin/Protein.total:MFr:Pt:Body fld:Qn:Electrophoresis
6572,Aspergillus terreus Ab.IgE.RAST class,Aspergillus terreus Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
6573,Version used,Version used:ID:Pt:TNM classification:Nom
6574,Date 1st cancer Rx (any).SEERS,Date 1st cancer Rx (any).SEERS:Time Stamp -- Date and Time:Point in time:Cancer.To be specified in another part of the message:Quantitative
6575,3-methylhistidine,3-Methylhistidine:PrThr:Pt:Ser/Plas:Ord
6576,"5,10-Methylenetetrahydrofolate Reductase (FADH2)","5,10-Methylenetetrahydrofolate reductase:CCnc:Pt:Ser:Qn"
6577,Chlortetracycline,Chlortetracycline:Susc:Pt:Isolate:OrdQn:Agar diffusion
6578,Albumin bound estradiol,Estradiol.albumin bound:MCnc:Pt:Ser/Plas:Qn
6579,Circumference.XXX/Circumference 2.XXX,Circumference.XXX/Circumference 2.XXX:CircFr:Pt:Region of interest.XXX:Qn:US
6580,Dx &or stage,Dx &or stage:ID:Pt:Procedure:Nom
6581,Gastrin releasing peptide,Gastrin releasing polypeptide:MCnc:Pt:CSF:Qn
6582,Viral hemorrhagic disease virus Ab,Viral hemorrhagic disease virus Ab:Titr:Pt:Ser:Qn
6583,Adenosine Triphosphate,Adenosine triphosphate:MCnc:Pt:Bld:Qn
6584,Neutrophil Ab.IgM,Neutrophil Ab.IgM:ACnc:Pt:Ser:Qn
6585,Cardiac Output,Cardiac output:VRat:Pt:Heart.ventricle.XXX:Qn:US.2D+Calculated by modified Simpson method
6586,End-diastolic volume,End-diastolic volume:Vol:Pt:Heart.ventricle.left:Qn:US.cubed.calculated
6587,Site&laterality&sequence number override flag,Site&laterality&sequence number override flag:Arb:Pt:Cancer case.XXX:Ord
6588,Surgery&diagnosis confirm override flag,Surgery&diagnosis confirm override flag:Arb:Pt:Cancer case.XXX:Ord
6589,CRC checksum,CRC checksum:Number:Point in time:Cancer case.To be specified in another part of the message:Quantitative
6590,Streptococcus pneumoniae Danish serotype 14 IgG,Deprecated Streptococcus pneumoniae 14 IgG Ab [Units/volume] in Serum
6591,Fructose,Fructose:MCnc:Pt:Semen:Qn
6592,Mycoplasma putrefaciens Ab,Mycoplasma putrefaciens Ab:PrThr:Pt:Ser:Ord:IA
6593,Maximal Voluntary Ventilation,Voluntary ventilation.max^pre bronchodilator/Voluntary ventilation.max predicted:RelVRat:Pt:Respiratory system:Qn
6594,Cells.CD56/100 cells,CD56 Cells fr XXX
6595,Text diagnosis battery,Deprecated Text diagnosis battery
6596,Strongyloides species antibody,Deprecated Strongyloides sp Ab [Units/volume] in Serum
6597,Campylobacter fetus antigen,Campylobacter fetus Ag:PrThr:Pt:Tiss:Ord:IF
6598,Glucose,Glucose^1st specimen post XXX challenge:PrThr:Pt:Urine:Ord
6599,Haemophilus influenzae IgG,Haemophilus influenzae Ab.IgG:ACnc:Pt:Ser:Qn
6600,A-C duration,A-C duration:Time:Pt:Mitral valve.leaflet.anterior:Qn:US.M-mode
6601,Acetylcarnitine (C2),Acetylcarnitine (C2):MCnc:Pt:Ser/Plas:Qn
6602,Diameter.systole,Diameter.systole:Len:Pt:Heart.ventricle.right:Qn:US
6603,Stroke Volume,Stroke volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by biplane ellipse method
6604,Eastern equine encephalitis virus Antibody,Eastern equine encephalitis virus Ab:PrThr:Pt:Ser:Ord:HAI
6605,Wheat dust Ab.IgE,Wheat dust Ab.IgE:ACnc:Pt:Ser:Qn
6606,Blastomyces dermatitidis antibody,Blastomyces dermatitidis Ab:ACnc:Pt:Ser:Qn
6607,Cinoxacin,Cinoxacin:Susc:Pt:Isolate:OrdQn:Agar diffusion
6608,Cis-4-decenoylcarnitine (Cis 4 C10:1),Cis-4-decenoylcarnitine (Cis 4 C10:1):MCnc:Pt:Ser/Plas:Qn
6609,Metoclopramide,Metoclopramide:MCnc:Pt:Urine:Qn
6610,Prostate-Specific Antigen,Prostate specific Ag:SCnc:Pt:Ser/Plas:Qn
6611,Prostate-Specific Antigen,Prostate specific Ag:MCnc:Pt:Semen:Qn
6612,Psilocybin cutoff,Psilocybin cutoff:MCnc:Pt:Urine:Qn:Screen
6613,Magnesium,Magnesium:SCnc:24H:Stool:Qn
6614,Pasteurella multocida serotype,Pasteurella multocida serotype:Prid:Pt:XXX:Nom:IF
6615,Canine distemper virus Ab.IgM,Canine distemper virus Ab.IgM:Titr:Pt:Ser:Qn:IF
6616,Herpes simplex virus 2 DNA,Herpes simplex virus 2 DNA:PrThr:Pt:Ser/Plas:Ord:Probe.amp.tar
6617,Herpes simplex virus 2 DNA,Herpes simplex virus 2 DNA:PrThr:Pt:CSF:Ord:Probe.amp.tar
6618,Alanine Transaminase,Alanine aminotransferase:CCnc:Pt:Ser/Plas:Qn:With P-5'-P
6619,Phenazopyridine,Phenazopyridine:MCnc:Pt:Ser/Plas:Qn
6620,Reference beat,Reference beat:Type:Point in time:Reference beat:Nominal:EKG
6621,Icteric Specimen,Sample icteric:PrThr:Pt:Ser/Plas:Ord
6622,Cobalt,Cobalt:MCnc:24H:Urine:Qn
6623,CFTR gene mutations tested for,CFTR gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen
6624,fumarate,Fumarate:MCnc:Pt:Urine:Qn
6625,Duck hepatitis virus 2 Ab,Duck hepatitis virus 2 Ab:PrThr:Pt:Ser:Ord:Neut
6626,Eastern equine encephalitis virus Antibody,Eastern equine encephalitis virus Ab:PrThr:Pt:Ser:Ord:Neut
6627,Ionized calcium,Calcium.ionized^4th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn
6628,Rotavirus antigen,Rotavirus Ag:PrThr:Pt:Stool:Ord
6629,Plasminogen activator inhibitor-2 antigen,Plasminogen activator inhibitor 2 Ag:ACnc:Pt:PPP:Qn:IA
6630,ST amplitude.J point+20 ms,ST amplitude.J point+20 ms:Elpot:Pt:Lead V6:Qn:EKG
6631,Benzodiazepines cutoff,Benzodiazepines cutoff:MCnc:Pt:Urine:Qn:Confirm
6632,Sheep whey Ab.IgE,Sheep whey Ab.IgE:ACnc:Pt:Ser:Qn
6633,Alloisoleucine,Alloisoleucine:SCnc:Pt:CSF:Qn
6634,Coproporphyrins,Coproporphyrin:SCnc:Pt:Ser/Plas:Qn
6635,Cannabinoids,Cannabinoids:MCnc:Pt:Ser/Plas:Qn:Confirm
6636,Pseudomonas aeruginosa antibody,Pseudomonas aeruginosa Ab:ACnc:Pt:Ser:Qn
6637,Carnitine,Carnitine:PrThr:Pt:Ser/Plas:Ord
6638,Leptospira species,Leptospira sp:PrThr:Pt:Tiss:Ord:Organism specific culture
6639,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subspecies paratuberculosis:PrThr:Pt:Tiss:Ord:Organism specific culture
6640,Estriol,Estriol.unconjugated^^unadjusted:MoM:Pt:Ser/Plas:Qn
6641,Glutamine/Creatinine,Glutamine/Creatinine:SRto:Pt:Urine:Qn
6642,Equine arteritis virus antibody,Equine arteritis virus Ab:Titr:Pt:Ser:Qn:Comp fix
6643,Equine herpesvirus 1+4 Ab,Equine herpesvirus 1+4 Ab:Titr:Pt:Ser:Qn:Neut
6644,Equine herpesvirus 1+4 Ab,Equine herpesvirus 1+4 Ab:Titr:Pt:Ser:Qn:Comp fix
6645,GD1b IgM ganglioside antibody,Ganglioside GD1b Ab.IgM:Titr:Pt:CSF:Qn:IA
6646,Cystathionine,Cystathionine:PrThr:Pt:Urine:Ord
6647,Catecholamines,Catecholamines^5th specimen post XXX challenge:MCnc:Pt:Plas:Qn
6648,Insulin,Insulin^20M post XXX challenge:MCnc:Pt:Ser/Plas:Qn
6649,Measles antibody,Measles virus Ab:ACnc:Pt:CSF:Qn
6650,Alpha hydroxyalprazolam cutoff,Alpha hydroxyalprazolam cutoff:MCnc:Pt:Urine:Qn:Confirm
6651,Chorionic Gonadotropin,Choriogonadotropin:MoM:Pt:Ser/Plas:Qn
6652,Coxsackievirus B1 Ab,Coxsackievirus B1 Ab:Titr:Pt:CSF:Qn
6653,Coxsackievirus B3 Ab,Coxsackievirus B3 Ab:Titr:Pt:Ser:Qn
6654,Salmonella Pullorum Ab,Salmonella pullorum Ab:Titr:Pt:Ser:Qn:Aggl
6655,Isocyanate Ab.IgM,Isocyanate Ab.IgM:ACnc:Pt:Ser:Qn
6656,St. Louis encephalitis virus antibody,Saint Louis encephalitis virus Ab:ACnc:Pt:CSF:Qn
6657,Study observation,Study observation:Finding:Point in time:Heart.valves:Narrative:ULTRASOUND
6658,Apolipoprotein A-I,Apolipoprotein A-I:MCnc:Pt:Ser/Plas:Qn
6659,Amphetamine cutoff,Amphetamine cutoff:MCnc:Pt:Urine:Qn:Confirm
6660,aprobarbital,Aprobarbital:MCnc:Pt:Urine:Qn:Confirm
6661,Anatid herpesvirus 1 antibody,Duck enteritis virus Ab:PrThr:Pt:Ser:Ord
6662,African horse sickness virus Ab,African horse sickness virus Ab:Titr:Pt:Ser:Qn
6663,Coccidioides immitis IgG,Coccidioides immitis Ab.IgG:ACnc:Pt:CSF:Qn
6664,Dinoprost,Prostaglandin F2 alpha:MCnc:Pt:Urine:Qn
6665,Streptococcus pneumoniae Danish serotype 1 Ab,Deprecated Streptococcus pneumoniae 1 Ab [Units/volume] in Serum --2nd specimen
6666,Streptococcus pneumoniae Danish serotype 12F Ab,Deprecated Streptococcus pneumoniae 12 Ab [Ratio] in Serum --2nd specimen/1st specimen
6667,Chocolate Ab.IgE.RAST class,Chocolate Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
6668,2-methylcitrate,2-Methylcitrate:SCnc:Pt:Ser/Plas:Qn
6669,Serine,Serine:MCnc:Pt:Ser/Plas:Qn
6670,West Nile virus antibody,West Nile virus Ab:Titr:Pt:XXX:Qn
6671,Flunitrazepam,Flunitrazepam:SCnc:Pt:Ser/Plas:Qn
6672,Dopamine,Dopamine^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
6673,Blood flow.systole.max/Blood flow.diastole.max,Blood flow.systole.max/Blood flow.diastole.max:VelRto:Pt:Pulmonary vein.left upper:Qn:US.doppler
6674,neutrophil,Polymorphonuclear cells:PrThr:Pt:Synv fld:Ord:Wright stain
6675,Leukocytes other,Leukocytes other:NCnc:Pt:CSF:Qn
6676,Prism base distance,Prism base distance:InvLen:Pt:Glasses prescription.lens.left:Qn
6677,Cylinder N 2,Cylinder N 2:InvLen:Pt:Glasses prescription.lens.left:Qn
6678,Views max abduction,Views max abduction:Find:Pt:Pelvis & Lower extremity.bilateral>Hip:Doc:XR
6679,View,Views:Find:Pt:Upper extremity>Finger.fourth:Doc:XR
6680,F2 gene targeted mutation analysis,F2 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
6681,(Ambrosia elatior+Artemisia vulgaris+Chenopodium album+Plantago lanceolata+Salsola kali) Ab.IgE.RAST class,(Ambrosia elatior+Artemisia vulgaris+Chenopodium album+Plantago lanceolata+Salsola kali) Ab.IgE.RAST class:PrThr:Pt:Ser:Ord:Multidisk
6682,neutrophil,Neutrophils:NCnc:Pt:Plr fld:Qn
6683,Blood Platelets,Platelets:NCnc:Pt:Plas:Qn
6684,Herpes virus 6 deoxyribonucleic acid,Herpes virus 6 DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar
6685,Cysticercus antibody,Deprecated Taenia solium larva Ab [Units/volume] in Cerebral spinal fluid
6686,CD16+CD56+ cell,Cells.CD16+CD56+:NCnc:Pt:XXX:Qn
6687,Ammonia,Ammonia:MCnc:24H:Urine:Qn
6688,Methadone,Methadone:MCnc:Pt:Milk:Qn
6689,Lactation established (finding),Milk production:MRat:24H:^Patient:Qn
6690,View,Views^W contrast IA:Find:Pt:Abdomen>Aorta.abdominal:Doc:RF.angio
6691,Borrelia burgdorferi Ab.IgG band pattern,Borrelia burgdorferi Ab.IgG band pattern:Imp:Pt:CSF:Nom:IB
6692,Cannabinoids,Cannabinoids:MCnt:Pt:Stool:Qn
6693,Streptococcus pneumoniae 9 Ab,Deprecated Streptococcus pneumoniae 9 Ab [Mass/volume] in Serum
6694,Beryllium/Creatinine,Beryllium/Creatinine:MRto:24H:Urine:Qn
6695,Cytomegalovirus IgM Antibody,Cytomegalovirus Ab.IgM:PrThr:Pt:Ser/Plas:Ord
6696,C-Peptide,C peptide^13th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn
6697,Cladosporium cladosporioides Ab.IgG,Cladosporium cladosporioides Ab.IgG:ACnc:Pt:Ser:Qn
6698,Leucine,Leucine:MCnc:Pt:Ser/Plas:Qn
6699,5-hydroxylysine,Hydroxylysine:SCnc:Pt:Ser/Plas:Qn
6700,phosphoethanolamine,Phosphoethanolamine:SCnc:Pt:Ser/Plas:Qn
6701,Bile Acids,Bile acid^2H post meal:SCnc:Pt:Ser:Qn
6702,14-3-3 Ag,14-3-3 Ag:ACnc:Pt:CSF:Qn:IA
6703,Vanadium,Vanadium:MCnc:24H:Urine:Qn
6704,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes:NFr:Pt:Plr fld:Qn
6705,Human immunodeficiency virus 1 RNA,HIV 1 RNA:Imp:Pt:Ser:Nom
6706,View,Views:Find:Pt:Upper extremity.bilateral>Radius+Ulna:Doc:XR
6707,View,Views:Find:Pt:Upper extremity.bilateral>Thumb:Doc:XR
6708,Jamestown canyon virus Ab,Jamestown canyon virus Ab:PrThr:Pt:Ser:Ord
6709,Comment,Comment:Imp:Pt:LM glasses.lens.left:Nom
6710,2-Ethyl-3-Hydroxypropionate/Creatinine,2-Ethyl-3-Hydroxypropionate/Creatinine:SRto:Pt:Urine:Qn
6711,Cesium/Creatinine,Cesium/Creatinine:MRto:24H:Urine:Qn
6712,Interferon.beta 1 Ab,Interferon.beta 1 Ab:ACnc:Pt:Ser/Plas:Qn
6713,Perimeter format,Perimeter format:Prid:Pt:Visual sensory:Nom:Perimetry.Kowa
6714,Monocytes.abnormal/100 leukocytes,Monocytes.abnormal/100 leukocytes:NFr:Pt:Bld:Qn
6715,LACROSSE VIRUS ANTIBODY,La Crosse virus Ab:PrThr:Pt:XXX:Ord
6716,Influenzavirus A antigen,Influenza virus A Ag:PrThr:Pt:XXX:Ord
6717,Multisection,Multisection:Find:Pt:Upper extremity>Wrist:Doc:US
6718,Multisection,Multisection:Find:Pt:Chest>Brachial plexus.left:Doc:MR
6719,Physical findings,Physical findings:Find:Pt:Iris.left:Nar
6720,(Budgerigar feather+Canary feather+Parrot feather+Finch feather) Ab.IgE,(Budgerigar feather+Canary feather+Parrot feather+Finch feather) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk
6721,Date of other vaccinations given within 4W prior to the date of vaccine causing adverse event,Date of other vaccinations given within 4 weeks prior to the date of vaccine causing adverse event:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative
6722,GM1 IgM ganglioside antibody,Ganglioside GM1 Ab.IgM:ACnc:Pt:Ser:Qn
6723,Neisseria gonorrhoeae DNA,Neisseria gonorrhoeae DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar
6724,View,Views^during surgery:Find:Pt:XXX:Doc:RF
6725,Magnesium,Magnesium:SCnt:Pt:Stool:Qn
6726,Cocaine,Cocaine:MCnc:Pt:Vitr fld:Qn
6727,Platelet associated antibody,Deprecated Platelet associated Ab [Presence] in Blood
6728,Insulin,Insulin^2H post XXX challenge:ACnc:Pt:Ser/Plas:Qn
6729,Lecithin,Lecithin:MCnc:Pt:Plas:Qn
6730,Delavirdine,Delavirdine:ACnc:Pt:Ser/Plas:Qn
6731,Growth Hormone,Somatotropin^4H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
6732,Luteinizing Hormone,Lutropin:ACnc:24H:Urine:Qn
6733,Voltage-gated calcium-channel antibody,Voltage-gated calcium channel Ab:PrThr:Pt:Ser:Ord
6734,Tetrahydrocortisone/Creatinine,Tetrahydrocortisone/Creatinine:MRto:Pt:Urine:Qn
6735,Tetrahydroaldosterone/Creatinine,Tetrahydroaldosterone/Creatinine:MRto:Pt:Urine:Qn
6736,Mycoplasma pneumoniae IgA,Mycoplasma pneumoniae Ab.IgA:PrThr:Pt:Ser:Ord
6737,Sample weight,Specimen weight:Mass:Pt:XXX:Qn
6738,Immunoglobulin IgG4,IgG subclass 4:MCnc:Pt:Ser:Qn
6739,Follicle Stimulating Hormone,Follitropin^3rd specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn
6740,Mycoplasma pneumoniae antibody,Mycoplasma pneumoniae Ab:Titr:Pt:CSF:Qn:Comp fix
6741,Rickettsia australis antibody,Rickettsia australis Ab:PrThr:Pt:Ser:Ord
6742,Burkholderia pseudomallei IgG,Burkholderia pseudomallei Ab.IgG:Titr:Pt:XXX:Qn:IF
6743,Legionella pneumophila 1 IgM,Legionella pneumophila 1 Ab.IgM:Titr:Pt:CSF:Qn:IF
6744,Multisection,Multisection:Find:Pt:Upper extremity>Forearm:Doc:MR
6745,Staphylococcus aureus enterotoxin C Ab.IgE.RAST class,Staphylococcus aureus enterotoxin C Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
6746,Mephentermine,Mephentermine:MCnc:Pt:Urine:Qn
6747,Methadone,Methadone:MCnt:Pt:Stool:Qn
6748,Taurine/Creatinine,Taurine/Creatinine:Ratio:Pt:Urine:Qn
6749,Canine parvovirus Ab,Canine parvovirus Ab:PrThr:Pt:Stool:Ord:HAI
6750,Haptoglobins,Haptoglobin:MCnc:Pt:Body fld:Qn
6751,Multisection,Multisection^WO & W contrast IV:Find:Pt:Neck>Neck vessels:Doc:CT.angio
6752,Rhodococcus equi Ab,Rhodococcus equi Ab:PrThr:Pt:Ser:Ord
6753,Lactate,Lactate:SCnc:Pt:CSF:Qn
6754,3-Methylhistidine/Creatinine,3-Methylhistidine/Creatinine:SRto:24H:Urine:Qn
6755,Multisection limited,Multisection limited:Find:Pt:Breast.right:Doc:US
6756,Guidance for reposition of central venous catheter,Guidance for reposition of central venous catheter^W contrast IV:Find:Pt:XXX>Vein.bilateral:Doc:RF.angio
6757,Calcium,Calcium:PrThr:Pt:Urine:Ord
6758,Rubella virus antigen,Rubella virus Ag:PrThr:Pt:Eye:Ord
6759,Polio virus 3 Ab,Polio virus 3 Ab^2nd specimen:Titr:Pt:Ser:Qn
6760,LACROSSE VIRUS ANTIBODY,La Crosse virus Ab^1st specimen:Titr:Pt:Ser:Qn
6761,Beta alanine/Creatinine,Beta alanine/Creatinine:SRto:24H:Urine:Qn
6762,Coproporphyrins,Coproporphyrin:SCnc:24H:Urine:Qn
6763,Creatinine,Creatinine:SCnc:24H:Urine:Qn
6764,Testosterone/Creatinine,Testosterone/Creatinine:MRto:24H:Urine:Qn
6765,Lipid bound sialate,Sialate.lipid bound:MCnc:Pt:Ser/Plas:Qn
6766,2-hydroxyisobutyrate,2-Hydroxyisobutyrate:PrThr:Pt:Urine:Ord
6767,Cylinder (shape),Cylinder:InvLen:Pt:Eye.left:Qn:Autorefractor.auto
6768,View,Views:Find:Pt:Chest:Doc:RF
6769,Views 3,Views 3:Find:Pt:Upper extremity.right>Hand:Doc:XR
6770,Visual Acuity,Deprecated Visual acuity Left eye Autorefractor.sciascopy
6771,Aspergillus fumigatus 2 Ab,Aspergillus fumigatus 2 Ab:PrThr:Pt:Ser:Ord
6772,Multisection,Multisection^W contrast IT:Find:Pt:Neck>Spine.cervical:Doc:CT
6773,Bacteria,Bacteria:PrThr:Pt:Plr fld:Ord:Microscopy.light
6774,Multisection limited,Multisection limited:Find:Pt:Abdomen+Pelvis>Iliac graft:Doc:US.doppler
6775,Acylcarnitine/Carnitine.free (C0),Acylcarnitine/Carnitine.free (C0):Ratio:Pt:Urine:Qn
6776,Babesia species antibody,Babesia sp Ab:PrThr:Pt:Ser:Ord
6777,Cyclic AMP,Deprecated Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --6th specimen post XXX challenge
6778,FGF23 gene targeted mutation analysis,FGF23 GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NOM:MOLGEN
6779,View,Views:Finding:Point in time:Sella turcica:Narrative:XR
6780,Views for tumor,Views for tumor^W radionuclide IV:Find:Pt:Whole body:Doc:NM
6781,Bromides,Bromide:SCnc:Pt:Urine:Qn
6782,Echovirus 30 Ab,Echovirus 30 Ab:PrThr:Pt:Body fld:Ord
6783,Creatinine,Creatinine^2H specimen:SCnc:Pt:Dial fld:Qn
6784,Borrelia burgdorferi 23kD IgG,Deprecated Borrelia burgdorferi 23kD IgG Ab [Presence] in Serum by Immunoassay
6785,Salmonella typhi O D Ab,Deprecated Salmonella typhi O D Antibody:Arbitrary Concentration:Point in time:Serum:Ordinal
6786,Bacteria identified,Bacteria identified^^^7:Prid:Pt:XXX:Nom:Culture
6787,Bacteria identified,Bacteria identified^^^6:Prid:Pt:XXX:Nom:Anaerobic culture
6788,Epithelial Cells,Epithelial cells:Naric:Pt:Urine sed:Qn:Microscopy.light.LPF
6789,Arachis hypogaea leukotriene release,Arachis hypogaea leukotriene release:MCnc:Pt:WBC:Qn
6790,Epstein Barr virus capsid IgM,Epstein Barr virus capsid Ab.IgM:PrThr:Pt:Ser:Ord:IF
6791,Coxsackievirus A Ab,Coxsackievirus A Ab:Titr:Pt:CSF:Qn
6792,Ethosuximide,Ethosuximide^trough:MCnc:Pt:Ser/Plas:Qn
6793,Giardia lamblia IgM,Giardia lamblia Ab.IgM:PrThr:Pt:Ser:Ord
6794,Josamycin,Josamycine:Susc:Pt:Isolate:OrdQn:Gradient strip
6795,Borrelia burgdorferi DNA,Borrelia burgdorferi DNA:PrThr:Pt:^Tick:Ord:Probe.amp.tar
6796,Hemoglobin A/Hemoglobin.total,Hemoglobin A/Hemoglobin.total:MFr:Pt:Bld:Qn:HPLC
6797,Parrot droppings Ab.IgG,Parrot droppings Ab.IgG:PrThr:Pt:Ser:Ord
6798,GLUTATHIONE PEROXIDASE,Glutathione peroxidase:CCnt:Pt:RBC:Qn
6799,Maprotiline,Maprotiline:SCnc:Pt:Gast fld:Qn
6800,Proinsulin,Proinsulin^baseline:SCnc:Pt:Ser/Plas:Qn
6801,HLA-A*23 antigen,HLA-A23(9):PrThr:Pt:Bld/Tiss^Donor:Ord
6802,Medium &or short chain acyl-CoA dehydrogenase deficiency,Medium &or short chain acyl-CoA dehydrogenase deficiency:Imp:Pt:Bld.dot:Nom
6803,Interleukin-12,Interleukin 12:MCnc:Pt:Body fld:Qn:IA
6804,Views quantitative,Views quantitative^W radionuclide IV:Find:Pt:Chest>Lung:Doc:NM
6805,Practolol,Practolol:Mass:Pt:Dose:Qn
6806,Fatty acids pattern,Fatty acids:Impression/interpretation of study:Point in time:Serum/Plasma:Nominal
6807,Herpes simplex virus 2 Antigen,Herpes simplex virus 2 Ag:PrThr:Pt:Anal:Ord
6808,Leucine crystals (substance),Leucine crystals:Naric:Pt:Urine sed:Qn:Microscopy.light.LPF
6809,Yeasts,Yeast:PrThr:Pt:Stool:Ord
6810,Multisection,Multisection:Find:Pt:Head>Orbit:Doc:CT
6811,Guidance for biopsy.needle,Deprecated CT Guidance for needle biopsy of Pancreas
6812,Phosphatidylcholine Ab.IgG.B2GP1 independent,Phosphatidylcholine Ab.IgG.B2GP1 independent:MoM:Pt:Ser:Qn
6813,Phosphatidylserine Ab.IgM.B2GP1 dependent,Phosphatidylserine Ab.IgM.B2GP1 dependent:MoM:Pt:Ser:Qn
6814,Herpes simplex virus antigen,Herpes simplex virus Ag:PrThr:Pt:Vag:Ord
6815,Theophylline,Theophylline:MCnc:Pt:Bld:Qn
6816,11-Oxo-Androsterone/Creatinine,11-Oxo-Androsterone/Creatinine:MRto:24H:Urine:Qn
6817,VWF gene.p.Arg816Trp,VWF gene.p.Arg816Trp:PrThr:Pt:Bld/Tiss:Ord:Molgen
6818,Mitogen-Activated protein kinase 14 Antigen,Mitogen-Activated protein kinase 14 Ag:PrThr:Pt:Tiss:Ord:Immune stain
6819,Hemoglobin A2/Hemoglobin.total,Hemoglobin A2/Hemoglobin.total:MFr:Pt:Bld:Qn:Electrophoresis pH 6.3
6820,Coagulation thrombin induced,Coagulation thrombin induced^after addition of heparinase:Time:Pt:PPP:Qn:Coag
6821,Tube number,Tube number:ID:Pt:Ser/Plas/Bld:Nom
6822,Protriptyline,Protriptyline:PrThr:Pt:Ser/Plas:Ord
6823,Enoxacin,Enoxacin:Mass:Pt:Dose:Qn
6824,HLA Ab positive cells,HLA Ab positive cells:Num:Pt:Ser:Qn
6825,Erythrocytes,Erythrocytes:NCnc:Pt:Dial fld prt:Qn:Manual count
6826,Gross blood,Gross blood:PrThr:Pt:Stool:Ord
6827,View,Views:Find:Pt:Lower extremity>Foot.sesamoid bones:Doc:XR
6828,Legionella pneumophila 9 IgG,Legionella pneumophila 9 Ab.IgG:Titr:Pt:Ser:Qn
6829,Legionella pneumophila 9 IgM,Legionella pneumophila 9 Ab.IgM:Titr:Pt:Ser:Qn
6830,Norovirus RNA,Norovirus RNA:PrThr:Pt:XXX:Ord:Probe
6831,Views AP,View AP:Find:Pt:Neck:Doc:XR
6832,Treponema pallidum antibody,Treponema pallidum Ab:ACnc:Pt:Body fld:Qn
6833,Extension.passive range of motion,Extension.passive range of motion:Angle:Pt:Elbow:Qn
6834,Yeast.hyphae,Yeast.hyphae:PrThr:Pt:Urine:Ord:Computer assisted
6835,Chlamydophila pneumoniae IgM,Chlamydophila pneumoniae Ab.IgM:PrThr:Pt:Ser:Ord:IF
6836,Views for shunt patency,Views for shunt patency^W Tc-99m MAA inj:Find:Pt:Abdomen+Pelvis:Doc:NM
6837,Choriogonadotropin.intact,Choriogonadotropin.intact:ACnc:Pt:Amnio fld:Qn
6838,Multisection for graft,Multisection for graft:Find:Pt:Upper extremity.bilateral>Upper extremity vessel:Doc:US.doppler
6839,Chlamydia trachomatis DNA,Chlamydia trachomatis DNA:PrThr:Pt:Anal:Ord:Probe.amp.tar
6840,Chlamydia trachomatis antigen,Chlamydia trachomatis Ag:PrThr:Pt:Genital:Ord
6841,Multisection,Multisection^W contrast IV:Find:Pt:Breast.unilateral:Doc:MR
6842,Multisection,Multisection^W contrast IV:Find:Pt:Lower extremity>Lower extremity vessels:Doc:MR.angio
6843,Confirmatory consultation note,Confirmatory consultation note:Find:Pt:{Setting}:Doc:{Role}
6844,Legionella pneumophila 14 IgG,Legionella pneumophila 14 Ab.IgG:Titr:Pt:Ser:Qn:IF
6845,Glucose,Glucose^4M post XXX challenge:SCnc:Pt:Ser/Plas:Qn
6846,Vespula spp Ab.IgG,Vespula spp Ab.IgG:MCnc:Pt:Ser:Qn
6847,West Nile virus antibody,West Nile virus Ab:PrThr:Pt:Ser:Ord
6848,Vendor device name,Vendor device name:ID:Pt:Height device:Nom
6849,"15 Beta, 17 Alpha-Dihydroxypregnanolone/Creatinine","15 Beta, 17 Alpha-Dihydroxypregnanolone/Creatinine:MRto:Pt:Urine:Qn"
6850,Chlamydia sp identified,Chlamydia sp identified:Prid:Pt:Body fld:Nom:Organism specific culture
6851,hemoglobin G Philadelphia,Hemoglobin G-Philadelphia:PrThr:Pt:Bld:Ord:Electrophoresis pH 8.9
6852,Salicylates,Salicylates:PrThr:Pt:Urine:Ord
6853,Snowshoe hare virus Ab,Snowshoe hare virus Ab:Titr:Pt:Ser:Qn
6854,Immunoglobulin A antibody to Influenza A virus,Influenza virus A Ab.IgA:PrThr:Pt:Ser:Ord
6855,Benztropine,Benztropine:PrThr:Pt:Ser/Plas:Ord
6856,Vesicular stomatitis Indiana virus Ag,Vesicular stomatitis Indiana virus Ag:PrThr:Pt:XXX:Ord:IA
6857,Ascorbate,Ascorbate^post dose:SCnc:Pt:Ser/Plas:Qn
6858,Epinephrine,Epinephrine^2H post 300 ug cloNIDine PO:SCnc:Pt:Plas:Qn
6859,Parasite identified,Parasite identified:Prid:Pt:Bld:Nom:Thick film
6860,Polio virus 3 Ab,Polio virus 3 Ab:Titr:Pt:Body fld:Qn
6861,Views GE 3,Finger fifth - right Narrative X-ray GE 3 views
6862,Streptomycin,Streptomycin:Susc:Pt:Isolate:Qn:MLC
6863,Coagulation tissue factor induced.INR,Coagulation tissue factor induced.INR:RelTime:Pt:BldC:Qn:Coag
6864,Erythrocytes,Erythrocytes:Naric:Pt:Urine sed:Qn:Automated count
6865,Citrate (si)-Synthase,Citrate synthase:CCnt:Pt:Fibroblasts:Qn
6866,Bartonella henselae Ab.IgG & IgM panel,Bartonella henselae Ab.IgG & IgM panel:-:Pt:Ser:Qn
6867,Collaborative staging site-specific factor 5,Collaborative staging site-specific factor 5:Prid:Pt:Cancer.XXX:Nom
6868,Complement activity.cell surface induced,Complement activity.cell surface induced:ACnc:Pt:Ser/Plas:Qn
6869,Complement Factor Bb,Complement factor Bb:MCnc:Pt:Ser/Plas:Qn
6870,Chlamydia trachomatis L2 DNA,Chlamydia trachomatis L2 DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar
6871,bentiromide,Deprecated Bentiromide SerPl-mCnc
6872,Triazolam,Triazolam:MCnc:Pt:Ser/Plas:Qn
6873,Views GE 3,Deprecated Finger.5th-R XR GE 3V
6874,Bordetella pertussis antigen,Bordetella pertussis Ag:PrThr:Pt:Nph:Ord
6875,Pancreatic islet cell complement fixing Ab,Pancreatic islet cell complement fixing Ab:Titr:Pt:Ser:Qn:IF
6876,Aspergillus fumigatus B Ab,Aspergillus fumigatus B Ab:PrThr:Pt:Ser:Ord
6877,Note (document),Note:Find:Pt:Hospital:Doc:{Role}
6878,crotetamide,Crotetamide:MCnc:Pt:Urine:Qn
6879,Dichlorphenamide,Dichlorphenamide:MRat:24H:Urine:Qn
6880,tetrahydrofuran,Tetrahydrofuran:MCnc:Pt:Urine:Qn
6881,Multisection,Multisection:Find:Pt:Lower extremity.left:Doc:US
6882,Pseudocholinesterase phenotype,Pseudocholinesterase phenotype:Prid:Pt:Ser/Plas:Nom
6883,Neuronal nuclear type 1 antibody,Neuronal nuclear type 1 Ab:PrThr:Pt:Ser:Ord
6884,Cells.CD10+CD25+,Cells.CD10+CD25+:NCnc:Pt:Bld:Qn
6885,Docosapentaenate w3,Docosapentaenate w3:SCnc:Pt:Ser/Plas:Qn
6886,View lateral spot,View lateral spot:Find:Pt:Abdomen+Pelvis>Spine.lumbosacral junction:Doc:XR
6887,Penicillin V,Penicillin V:Titr:Pt:Isolate+Ser:Qn:SBT
6888,Homocysteine cysteine disulfide,Homocysteine cysteine disulfide:SCnc:Pt:Ser/Plas:Qn
6889,Gestational Age,Gestational age:Time:Pt:^Fetus:Qn:US+Estimated from HC.Lessoway 1998
6890,Protein pattern,Protein pattern:Impression/interpretation of study:Point in time:Serum/Plasma:Nominal
6891,Protons,Hydrogen ion:SCnc:Pt:BldA:Qn
6892,Multisection,Multisection^W contrast IV:Find:Pt:Head+Neck>Larynx:Doc:CT
6893,Proteins,Protein:MCnc:XXX:Urine:Qn
6894,Multisection,Multisection^WO contrast:Find:Pt:Abdomen>Adrenal gland:Doc:MR
6895,Spermatozoa Ab.IgG,Spermatozoa Ab.IgG:PrThr:Pt:Ser:Ord
6896,ACADM gene.c.985A>G,ACADM gene.c.985A>G:PrThr:Pt:Bld/Tiss:Ord:Molgen
6897,17-Ketosteroids/Creatinine,17-Ketosteroids/Creatinine:SRto:Pt:Urine:Qn
6898,phosphate ion,Phosphate [Mass or Molecules/volume] in Dialysis fluid
6899,"N,N-Dimethyltryptamine",Dimethyltryptamine:MCnc:Pt:Ser/Plas:Qn
6900,Multisection,Multisection^W contrast IV:Find:Pt:Upper extremity.left>Elbow:Doc:MR
6901,View Jones,View Jones:Find:Pt:Upper extremity.left>Elbow:Doc:XR
6902,View,Views^W contrast IV:Find:Pt:Lower extremity>Lower extremity vessels:Doc:RF.angio
6903,Glucose,Glucose^9H post XXX challenge:SCnc:Pt:Ser/Plas:Qn
6904,West Nile virus antibody,West Nile virus Ab:ACnc:Pt:Ser:Qn
6905,17-Ketosteroids/Creatinine,17-Ketosteroids/Creatinine:MRto:Pt:Urine:Qn
6906,Agglutinated spermatozoa,Spermatozoa.agglutinated:PrThr:Pt:Semen:Ord
6907,Mycoplasma species,Mycoplasma sp:PrThr:Pt:XXX:Ord:Hoechst stain
6908,Chlamydia sp rRNA,Chlamydia sp rRNA:PrThr:Pt:Nose:Ord:Probe
6909,Multisection,Multisection^W contrast IV:Find:Pt:Upper extremity.left>Forearm:Doc:CT
6910,Multisection,Multisection^W contrast IV:Find:Pt:Chest>Heart:Doc:MR
6911,Views lateral,View lateral:Find:Pt:Upper extremity>Finger.fifth:Doc:XR
6912,Guidance limited for localization of tumor,Guidance limited for localization of tumor^W radionuclide IV:Find:Pt:XXX:Doc:NM
6913,"Sulfates, Inorganic",Sulfate:MRat:24H:Urine:Qn
6914,Cystine crystals,Cystine crystals:PrThr:Pt:Urine:Ord:Computer assisted
6915,MEN1 gene targeted mutation analysis,MEN1 GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NAR:MOLGEN
6916,dipipanone,Dipipanone:PrThr:Pt:Urine:Ord
6917,Etilefrine,Etilefrine:PrThr:Pt:Urine:Ord
6918,View,Views:Find:Pt:Upper extremity.bilateral>Hand:Doc:XR
6919,Albumins,Albumin^pre XXX challenge:MCnc:Pt:Ser/Plas:Qn
6920,Glucose,Glucose^16H post XXX challenge:SCnc:Pt:Ser/Plas:Qn
6921,Heptacarboxylporphyrin/Creatinine,Heptacarboxylporphyrin/Creatinine:SRto:24H:Urine:Qn
6922,Karyotype (cell structure),Karyotype:Presence or Identity:Point in time:CVS:Nominal
6923,Cotinine,Cotinine:SCnc:Pt:Urine:Qn
6924,Cephalexin,Cephalexin:Susc:Pt:Isolate:OrdQn:Gradient strip
6925,Pain severity.consolability,Pain severity.consolability:Find:Pt:^Patient:Ord:Observed.FLACC
6926,"1,2,4-trichlorobenzene","1,2,4-Trichlorobenzene:MCnc:Pt:Air:Qn"
6927,Trichloroethylene,Trichloroethylene:MCnc:Pt:Air:Qn
6928,Neisseria gonorrhoeae DNA,Neisseria gonorrhoeae DNA:PrThr:Pt:Vag:Ord:Probe.amp.tar
6929,Sodium,Sodium:SCnc:Pt:BldA:Qn
6930,Aminocaproate,Aminocaproate^trough:MCnc:Pt:Ser/Plas:Qn
6931,Carbenicillin,Carbenicillin:MCnc:Pt:Ser/Plas:Qn
6932,Consultation note,Consultation note:Find:Pt:{Setting}:Doc:Occupational medicine
6933,Amylases,Amylase^3rd specimen post dose sincalide:CCnc:Pt:Body fld:Qn
6934,Multisection,Multisection^W contrast IV:Find:Pt:Lower extremity.right>Lower leg:Doc:CT
6935,Multisection,Multisection^WO & W contrast IV:Find:Pt:Abdomen>Aorta.abdominal:Doc:MR.angio
6936,Brucella canis IgG,Brucella canis Ab.IgG:PrThr:Pt:Ser:Ord
6937,Acetate,Acetate:MCnc:Pt:Air:Qn
6938,Views for shunt detection,Views for shunt detection^W Tc-99m MAA IV:Find:Pt:Chest>Heart:Doc:NM
6939,Histidine,Histidine:SCnc:Pt:Body fld:Qn
6940,11-Ketoandrosterone/Creatinine,11-Ketoandrosterone/Creatinine:SRto:Pt:Urine:Qn
6941,Salmonella enterica subspecies enterica serovar Typhi H antibody,Salmonella typhi H Ab:Titr:Pt:Ser:Qn:Aggl
6942,Coproporphyrin/Hemoglobin,Coproporphyrin/Hemoglobin:MRto:Pt:RBC:Qn
6943,Doxylamine,Doxylamine:PrThr:Pt:Ser/Plas:Ord
6944,Multisection,Multisection^WO & W contrast IV:Find:Pt:Lower extremity:Doc:CT
6945,Views 3,Views 3:Find:Pt:Upper extremity.bilateral>Elbow:Doc:XR
6946,Views 3,Views 3:Find:Pt:Upper extremity>Finger:Doc:XR
6947,Multisection,Multisection^WO contrast:Find:Pt:XXX>Soft tissue:Doc:MR
6948,Morphine.free,Morphine.free:PrThr:Pt:Urine:Ord
6949,BCL2 Ag,BCL2 Ag:PrThr:Pt:Tiss:Ord:Immune stain
6950,Clindamycin,Clindamycin:MCnc:Pt:Ser/Plas:Qn
6951,Ampicillin / Sulbactam,Ampicillin+Sulbactam:Titr:Pt:Isolate+Ser:Qn:SBT
6952,Rickettsia sp Ab.IgG,Rickettsia sp Ab.IgG:ACnc:Pt:Ser:Qn
6953,Views magnification,Views magnification:Find:Pt:Breast.bilateral:Doc:MG
6954,View,Views^W standing:Find:Pt:Abdomen>Spine.lumbar:Doc:XR
6955,vinyl bromide,Vinyl bromide:MCnc:Pt:Air:Qn
6956,"Toluene 2,4-Diisocyanate","2,4-Toluene diisocyanate:MCnc:Pt:Air:Qn"
6957,Prion protein.abnormal,Prion protein.abnormal:PrThr:Pt:Tiss:Ord:IB
6958,View West Point,View West Point:Find:Pt:Upper extremity.right>Shoulder:Doc:XR
6959,View,Views:Find:Pt:Pelvis & Lower extremity.right>Hip:Doc:XR
6960,Unidentified cell,Unidentified cells:NCnc:Pt:Pericard fld:Qn
6961,Multisection,Multisection^WO & W contrast IV:Find:Pt:Head>Temporomandibular joint:Doc:MR
6962,Views 5,Views 5:Find:Pt:Upper extremity.right>Wrist:Doc:XR
6963,View,Views^W contrast intra lymphatic:Find:Pt:Extremity.right>Extremity lymphatic vessels:Doc:RF.angio
6964,Amoxapine,Amoxapine:PrThr:Pt:Ser/Plas:Ord
6965,Immunoglobulin light chains.lambda.free,Immunoglobulin light chains.lambda.free:MCnc:Pt:Ser/Plas:Qn
6966,SHOX gene targeted mutation analysis,SHOX GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NAR:MOLGEN
6967,EGR2 gene targeted mutation analysis,EGR2 gene mutation analysis:Prid:Pt:Bld/Tiss:Nar:Molgen
6968,neutrophil,Polymorphonuclear cells:NCnc:Pt:Plr fld:Qn
6969,clorprenaline,Clorprenaline:MCnc:Pt:Urine:Qn
6970,Multisection,Multisection^WO & W contrast IV:Find:Pt:Abdomen>Portal vein:Doc:MR.angio
6971,Multisection,Multisection^WO contrast:Find:Pt:Head>Temporomandibular joint:Doc:MR
6972,View,Views:Find:Pt:Abdomen>Spine.lumbar & Pelvis>Sacrum:Doc:XR
6973,Multisection,Multisection^W contrast IV:Find:Pt:Upper extremity.left>Shoulder:Doc:MR
6974,Multisection,Multisection^WO contrast:Find:Pt:Upper extremity.left:Doc:MR
6975,Views 2 oblique,Views 2 oblique:Find:Pt:Upper extremity.left>Elbow:Doc:XR
6976,Tooth space discrepancy,Tooth space discrepancy:Len:Pt:{Dental arch}:Qn:Estimated
6977,Inspiratory breath,Inspiratory breath^on ventilator:Time:Pt:^Patient:Qn
6978,Tooth development evaluation,Tooth development evaluation:Find:Pt:{Subject tooth}+{Reference tooth}:Nom
6979,"Hemogram, Platelets, Differential & Reticulocyte panel","Deprecated Hemogram, Platelets, Differential & Reticulocyte panel in Blood"
6980,HEXA gene.c.1277insTATC,HEXA gene.c.1277insTATC:PrThr:Pt:Bld/Tiss:Ord:Molgen
6981,Multisection,Multisection:Find:Pt:Upper extremity.left>Hand:Doc:CT
6982,Multisection,Multisection:Find:Pt:Upper extremity>Wrist+Hand:Doc:MR
6983,Multisection,Multisection^WO & W contrast IV:Find:Pt:Head>Head vessels:Doc:MR.angio
6984,View,Views^W I-131 MIBG IV:Find:Pt:XXX:Doc:NM
6985,Physical findings,Physical findings:Find:Pt:Nostril:Nom:Observed
6986,Physical findings,Physical findings:Find:Pt:Pupil:Nom:Observed
6987,West Nile virus antibody,West Nile virus Ab:PrThr:Pt:XXX:Ord
6988,Edentulous ridge relationship,Edentulous ridge relationship:Find:Pt:Maxilla.left+Mandible.left:Nom
6989,Cephalothin,Cephalothin:MCnc:Pt:Ser/Plas:Qn
6990,Body temperature panel,Body temperature panel:-:Point in time:^Patient:-
6991,Views 2,Views 2:Find:Pt:Abdomen>Spine.lumbar:Doc:XR
6992,MLL gene mutations tested for,MLL gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen
6993,PTCH gene targeted mutation analysis,PTCH GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NOM:MOLGEN
6994,Amiodarone,Amiodarone^peak:MCnc:Pt:Ser/Plas:Qn
6995,Retention - dental,Retention:Imp:Pt:{Dental arch}.denture.complete:Ord:Reported
6996,Support - dental,Support:Imp:Pt:{Dental arch}.denture.partial:Ord:Observed
6997,Brompheniramine,Brompheniramine:PrThr:Pt:Ser/Plas:Ord
6998,Anti-thyrotropin antibody,Thyrotropin Ab:PrThr:Pt:Ser:Ord
6999,Saccharum officinarum Ab.IgG,Saccharum officinarum Ab.IgG:MCnc:Pt:Ser:Qn
7000,Netilmicin,Netilmicin:Susc:Pt:Isolate:OrdQn:Agar diffusion
7001,Multisection,Multisection:Find:Pt:Head>Brain:Doc:MR.spectroscopy
7002,SDHC gene targeted mutation analysis,SDHC GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NAR:MOLGEN
7003,VA C&P exam.brain &or spinal cord note,VA C&P exam.brain &or spinal cord note:Find:Pt:{Setting}:Doc:{Role}
7004,Bilirubin.non-glucuronidated,Bilirubin.non-glucuronidated:SCnc:Pt:Body fld:Qn
7005,Cells.CD3+CD25+,Cells.CD3+CD25+:NCnc:Pt:XXX:Qn
7006,Plan of care note,Plan of care note:Find:Pt:{Setting}:Doc:Clinical genetics
7007,Phadiatop Infant Ab.IgE.RAST class,Phadiatop Infant Ab.IgE.RAST class:PrThr:Pt:Ser:Ord
7008,Phencyclidine,Phencyclidine:PrThr:Pt:Unk sub:Ord
7009,Surgical operation note date,Surgical operation note date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative
7010,Stroke volume/Body surface area,Stroke volume/Body surface area:ArVol:Pt:Heart.ventricle.right:Qn:Angiography.single plane
7011,Plasmodium malariae IgG,Plasmodium malariae Ab.IgG:ACnc:Pt:Ser:Qn
7012,Salmonella sp Ab.IgG,Salmonella sp Ab.IgG:ACnc:Pt:Ser:Qn
7013,chlorobenzene,Chlorobenzene:MCnc:Pt:Ser/Plas:Qn
7014,Nordazepam,Nordiazepam:SCnc:Pt:XXX:Qn
7015,Pupil shape,Pupil shape:Shape:Pt:Pupil.left:Nom:Slit lamp biomicroscopy
7016,tetrahydrocorticosterone,Tetrahydrocorticosterone:MRat:24H:Urine:Qn
7017,View Harris,Deprecated Hindfoot - bilateral and Midfoot - bilateral X-ray Harris
7018,Thunnus albacares basophil bound Ab,Thunnus albacares basophil bound Ab:ACnc:Pt:Bld:Qn:LHR
7019,Methylenedioxypyrovalerone cutoff,Methylenedioxypyrovalerone cutoff:MCnc:Pt:Urine:Qn:Confirm
7020,Sulfate.total/Creatinine,Sulfate.total/Creatinine:SRto:Pt:Urine:Qn
7021,Fluid intake.enteral tube.nutritional formula composition,Fluid intake.enteral tube.nutritional formula composition:Find:Pt:^Patient:Nom
7022,activity level,Activity level:Acceleration:Point in time:^Patient:Quantitative
7023,Tissue velocity.A wave.max,Tissue velocity.A wave.max:Vel:Pt:Mitral valve.annulus.medial:Qn:US.tissue doppler
7024,Sulfides,Sulfide:MCnc:Pt:Bld:Qn
7025,AM-2201 4-hydroxypentyl cutoff,AM-2201 4-hydroxypentyl cutoff:MCnc:Pt:Urine:Qn:Confirm
7026,Discharge summary note,Discharge summary note:Find:Pt:{Setting}:Doc:Geriatric medicine
7027,Intravascular diastolic,Intravascular diastolic:Pres:Pt:Celiac trunk artery:Qn
7028,Silicone Ab.IgE,Silicone Ab.IgE:ACnc:Pt:Ser:Qn
7029,Smelt Ab.IgE,Smelt Ab.IgE:ACnc:Pt:Ser:Qn
7030,Enhanced note,Enhanced note:Find:Pt:{Setting}:Doc:{Author Type}
7031,Blood group antibody screen.cells I+II+III,Blood group antibody screen.cells I+II+III:PrThr:Pt:Ser/Plas:Ord:Prewarmed
7032,End-systolic volume/Body surface area,End-systolic volume/Body surface area:ArVol:Pt:Heart.atrium.left:Qn:US.2D+Calculated by area-length method
7033,Astrovirus,Astrovirus:PrThr:Pt:Stool:Ord:Microscopy.electron
7034,N-caproylglycine,Hexanoylglycine:SCnc:Pt:Ser/Plas:Qn
7035,Guidance for biopsy.core needle,Deprecated US Guidance for core needle biopsy of Breast - right
7036,Consultation note,Consultation note:Find:Pt:{Setting}:Doc:Clinical pathology
7037,protein intake,Protein intake:Mass:Pt:^Patient:Qn:Estimated
7038,microscopic observation,Deprecated Microscopic observation [Identifier] in Stool by Ova and Parasite Preparation
7039,Legionella pneumophila serogroup 1 antibody,Legionella pneumophila 1 Ab:Titr:Pt:Ser:Qn:IF
7040,Reporting,Report:Finding:Point in time:{Setting}:Document:{Role}
7041,Progress note,Progress note:Find:Pt:{Setting}:Doc:Pharmacology
7042,Intravascular systolic,Intravascular systolic:Pres:24H^mean:Arterial system:Qn
7043,Intravascular mean,Intravascular mean:Pres:Pt:Dorsal pedal artery:Qn
7044,Body temperature special circumstances,Body temperature special circumstances^*:Type:Point in time:^Patient:Nominal
